UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM 20-F
(Mark
One)
o
|
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) or
(g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
OR
|
|
|
x
|
ANNUAL REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended
December 31, 2009
|
|
|
OR
|
|
|
o
|
TRANSITION REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
OR
|
|
|
o
|
SHELL COMPANY REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Commission
file number: 000-31815
HYDROGENICS CORPORATION -
CORPORATION HYDROGÉNIQUE
|
(Exact name of Registrant as specified in its charter)
|
|
Canada
|
(Jurisdiction of incorporation or organization)
|
|
5985 McLaughlin Road
Mississauga, Ontario
Canada L5R 1B8
(905) 361-3660
|
(Address of principal executive office)
|
|
Lawrence Davis, Chief Financial Officer
5985 McLaughlin Road
Mississauga, Ontario
Canada L5R 1B8
(905) 361-3660 Fax (905) 361-3626
|
(Name, Telephone, Email and/or Facsimile number and Address of
Company Contact Person)
|
Securities
registered or to be registered pursuant to Section 12(b) of the Act.
Title of each
class
|
|
Name of each
exchange on which registered
|
Common Shares
|
|
The Nasdaq Global Market
|
Securities
registered or to be registered pursuant to Section 12(g) of the Act.
None
Securities
for which there is a reporting obligation pursuant to Section 15(d) of
the Act.
Warrants
Indicate
the number of outstanding shares of each of the issuers classes of capital or
common stock as of the close of the period covered by the annual report.
At December 31, 2009, 3,701,987
common shares were issued and outstanding
(as adjusted to reflect the share
consolidation implemented on March 12, 2010)
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405
of the Securities Act.
o
Yes
x
No
If
this report is an annual or transition report, indicate by check mark if the
registrant is not required to file reports pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934.
o
Yes
x
No
Indicate
by check mark whether the registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.
x
Yes
o
No
Indicate
by check mark whether the registrant has submitted electronically and posted on
its corporate Web site, if any, every Interactive Data File required to be
submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this
chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files).
x
Yes
o
No
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, or a non-accelerated filer. See definition of accelerated
filer and large accelerated filer in Rule 12b-2 of the Exchange Act.
Large accelerated filer
o
|
|
Accelerated filer
o
|
|
Non-accelerated filer
x
|
Indicate
by check mark which basis of accounting the registrant has used to prepare the
financial statements included in this filing:
U.S. GAAP
o
|
|
International Financial Reporting Standards as issued
by the International Accounting Standards Board
o
|
|
Other
x
|
If
Other has been checked in response to the previous question, indicate by
check mark which financial statement item the registrant has elected to follow.
o
Item 17
x
Item 18
If
this is an annual report, indicate by check mark whether the registrant is a
shell company (as defined in Rule 12b-2 of the Exchange Act).
o
Yes
x
No
TABLE OF CONTENTS
INTRODUCTION AND USE OF CERTAIN
TERMS
|
1
|
|
|
FORWARD LOOKING STATEMENTS
|
1
|
|
|
PART I
|
3
|
ITEM 1.
|
IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS
|
3
|
ITEM 2.
|
OFFER STATISTICS AND EXPECTED TIMETABLE
|
3
|
ITEM 3.
|
KEY INFORMATION
|
3
|
ITEM 4.
|
INFORMATION ON THE COMPANY
|
18
|
ITEM 4A.
|
UNRESOLVED STAFF COMMENTS
|
28
|
ITEM 5.
|
OPERATING AND FINANCIAL REVIEW AND PROSPECTS
|
29
|
ITEM 6.
|
DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES
|
48
|
ITEM 7.
|
MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS
|
63
|
ITEM 8.
|
FINANCIAL INFORMATION
|
65
|
ITEM 9.
|
THE OFFER AND LISTING
|
66
|
ITEM 10.
|
ADDITIONAL INFORMATION
|
68
|
ITEM 11.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
75
|
ITEM 12.
|
DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES
|
75
|
|
|
|
PART II
|
|
76
|
ITEM 13.
|
DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES
|
76
|
ITEM 14.
|
MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS
AND USE OF PROCEEDS
|
76
|
ITEM 15.
|
CONTROLS AND PROCEDURES
|
78
|
ITEM 16A.
|
AUDIT COMMITTEE FINANCIAL EXPERT
|
79
|
ITEM 16B.
|
CODE OF ETHICS
|
80
|
ITEM 16C.
|
PRINCIPAL ACCOUNTANT FEES AND SERVICES
|
80
|
ITEM 16D.
|
EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES
|
81
|
ITEM 16E.
|
PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED
PURCHASERS
|
81
|
ITEM 16F.
|
CHANGE IN REGISTRANTS CERTIFYING ACCOUNTANT
|
81
|
ITEM 16G.
|
CORPORATE GOVERNANCE
|
81
|
|
|
|
PART III
|
|
82
|
ITEM 17.
|
FINANCIAL STATEMENTS
|
82
|
ITEM 18.
|
FINANCIAL STATEMENTS
|
82
|
ITEM 19.
|
EXHIBITS
|
84
|
i
INTRODUCTION
AND USE OF CERTAIN TERMS
In this Form 20-F,
references to the United States or to U.S. are to the United States of
America. You will find the words we, our, us and similar words or phrases
in this Form 20-F. We use those words to comply with the requirement of
the U.S. Securities and Exchange Commission to use plain English in public
documents like this Form 20-F. Each executive identified in this Form 20-F
reports directly to other executives of the Company by whom the executive is
employed, or to the Companys Board of Directors.
In this Form 20-F,
unless the context otherwise requires, the terms Hydrogenics, Company, we,
us and our refer to Hydrogenics Corporation, the Registrant, and its
consolidated subsidiaries and, where the context requires, includes our predecessor
(Old Hydrogenics) and its consolidated subsidiaries prior to October 27,
2009. References to common shares or Shares
herein refer to common shares of Hydrogenics.
Unless otherwise
indicated, all references in this document to our securities have, where
necessary, been adjusted to reflect the share consolidation effected on March 12,
2010, which resulted in one post-consolidation common share for every
twenty-five pre-consolidation common shares.
FORWARD
LOOKING STATEMENTS
This Form 20-F
contains forward-looking information, within the meaning of applicable
Canadian securities laws and forward-looking statements within the meaning of
the United States Private Securities Litigation Reform Act of 1995
(collectively referred to herein as forward-looking statements). Forward-
looking statements can be identified by the use of words, such as plans, expects,
or is expected, budget, scheduled, estimates, forecasts, intends, anticipates,
or believes or variations of such words and phrases or state that certain
actions, events or results may, could, would, might or will be taken,
occur or be achieved. These forward-looking statements relate to, among other
things, our future results, levels of activity, performance, goals or
achievements or other future events. These forward-looking statements are based
on current expectations and various assumptions and analyses made by us in
light of our experience and our perceptions of historical trends, current
conditions and expected future developments and other factors that we believe
are appropriate in the circumstances. These forward-looking statements involve
known and unknown risks, uncertainties and other factors that may cause actual
results or events to differ materially from those anticipated in our
forward-looking statements.
These risks,
uncertainties and factors include, but are not limited to: our inability to
increase our revenues or raise additional funding to continue operations,
execute our business plan, or to grow our business; inability to address a
sustained or broad economic recession, and its impact on our business, results
of operations and consolidated financial condition; our limited operating
history; inability to implement our business strategy; inability to obtain
shareholder approval to allow an adjustment to the exercise price of our series
B warrants; unfavorable outcome of our litigation with Alpha Capital Anstalt;
fluctuations in our quarterly results; failure to maintain our customer base that
generates the majority of our revenues; currency fluctuations; failure to
maintain sufficient insurance coverage; changes in value of our goodwill;
failure of a significant market to develop for our products; failure of
hydrogen being readily available on a cost-effective basis; changes in
government policies and regulations; failure of uniform codes and standards for
hydrogen-fuelled vehicles and related infrastructure to develop; failure to
compete with other developers and manufacturers of products in our industry;
failure to compete with developers and manufacturers of traditional and
alternative technologies; failure to develop partnerships with original
equipment manufacturers, governments, systems integrators and other third
parties; inability to obtain sufficient materials and components for our
products from suppliers; failure to manage expansion of our operations; failure
to manage foreign sales and operations; failure to recruit, train and retain
key management personnel; inability to integrate acquisitions; failure to
develop adequate manufacturing processes and capabilities; failure to complete
the development of commercially viable products; failure to produce
cost-competitive products; failure or delay in field testing of our products;
failure to produce products free of defects or errors; inability to adapt to
technological advances or new codes and standards; failure to protect our
intellectual property; our involvement in intellectual property litigation;
exposure to product liability claims; failure to meet rules regarding
passive foreign investment companies; actions of our significant and principal
shareholders; dilution as a result of significant issuances of our common
shares and preferred shares; inability of U.S. investors to enforce U.S. civil
liability judgments against us; volatility of our common share price; and
dilution as a result of the exercise of options. These risk factors and others are discussed
in more detail herein, including under Item 3. Key Information Risk Factors,
Item 4. Information on the Company, Item 5. Operating and Financial Review
and Prospects, and Item 14. Material Modifications to the Rights of Security
Holders and Use of Proceeds.
These factors may cause
the Companys actual performance and financial results in future periods to
differ materially from any estimates or projections of future performance or
results expressed or implied by such forward-looking statements.
Forward-looking statements do not take into account the effect that transactions
or non-recurring or other special items announced or occurring after the
statements are made have on the Companys business. For example, they do not
include the effect of business dispositions, acquisitions, other business
1
transactions,
asset write-downs or other charges announced or occurring after forward-looking
statements are made. The financial impact of such transactions and
non-recurring and other special items can be complex and necessarily depends on
the facts particular to each of them.
We believe that the
expectations represented by our forward-looking statements are reasonable, yet
there can be no assurance that such expectations will prove to be correct. The
purpose of the forward-looking statements is to provide the reader with a
description of managements expectations regarding the Companys fiscal 2010
financial performance and may not be appropriate for other purposes.
Furthermore, unless otherwise stated, the forward-looking statements contained
herein are made as of the date of this Form 20-F, and we do not undertake
any obligation to update publicly or to revise any of the included
forward-looking statements, whether as a result of new information, future
events or otherwise unless required by applicable legislation or regulation.
The forward-looking statements contained in this report are expressly qualified
by this cautionary statement.
2
PART I
ITEM 1.
IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS
Not applicable.
ITEM 2.
OFFER STATISTICS AND EXPECTED TIMETABLE
Not applicable.
ITEM 3.
KEY INFORMATION
SELECTED
FINANCIAL DATA
All financial data
presented in this Form 20-F with respect to the years ended December 31,
2009, 2008 and 2007 are qualified in their entirety by reference to the
relevant information in the consolidated financial statements and their notes.
3
HYDROGENICS
CORPORATION
BALANCE
SHEETS DATA
(in thousands of U.S. dollars, except for share
amounts)
|
|
2009
|
|
2008
|
|
2007
|
|
2006
|
|
2005
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
Current Assets
|
|
|
|
|
|
|
|
|
|
|
|
Cash
and cash equivalents
|
|
$
|
9,159
|
|
$
|
21,601
|
|
$
|
15,460
|
|
$
|
5,937
|
|
$
|
5,394
|
|
Restricted
cash
|
|
1,603
|
|
1,130
|
|
|
|
|
|
|
|
Short-term
investments
|
|
|
|
|
|
15,032
|
|
54,350
|
|
80,396
|
|
Accounts
receivable
|
|
3,685
|
|
3,974
|
|
12,713
|
|
9,740
|
|
7,733
|
|
Grants
receivable
|
|
490
|
|
505
|
|
850
|
|
1,901
|
|
1,909
|
|
Inventories
|
|
11,746
|
|
10,101
|
|
12,659
|
|
12,718
|
|
8,685
|
|
Prepaid
expenses
|
|
1,270
|
|
1,161
|
|
1,077
|
|
1,539
|
|
2,353
|
|
|
|
27,953
|
|
38,472
|
|
57,791
|
|
86,185
|
|
106,470
|
|
Restricted cash
|
|
240
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment
|
|
3,169
|
|
4,082
|
|
4,847
|
|
5,435
|
|
5,682
|
|
Intangible assets
|
|
|
|
|
|
249
|
|
500
|
|
33,972
|
|
Goodwill
|
|
5,446
|
|
5,025
|
|
5,025
|
|
5,025
|
|
68,505
|
|
Other non-current assets
|
|
|
|
|
|
28
|
|
28
|
|
28
|
|
|
|
$
|
36,
808
|
|
$
|
47,579
|
|
$
|
67,940
|
|
$
|
97,173
|
|
$
|
214,657
|
|
LIABILITIES
|
|
|
|
|
|
|
|
|
|
|
|
Current Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
Accounts
payable and accrued liabilities
|
|
$
|
14,782
|
|
$
|
17,298
|
|
$
|
18,166
|
|
$
|
21,380
|
|
$
|
14,918
|
|
Unearned
revenue
|
|
4,546
|
|
4,785
|
|
9,042
|
|
8,809
|
|
3,772
|
|
|
|
19,328
|
|
22,083
|
|
27,208
|
|
30,189
|
|
18,690
|
|
Long-term debt
|
|
|
|
|
|
11
|
|
94
|
|
325
|
|
Deferred research and development grants
|
|
|
|
13
|
|
337
|
|
133
|
|
135
|
|
|
|
19,328
|
|
22,096
|
|
27,556
|
|
30,416
|
|
19,150
|
|
Shareholders Equity
|
|
|
|
|
|
|
|
|
|
|
|
Common
Shares
|
|
307,038
|
|
307,000
|
|
306,872
|
|
307,376
|
|
306,957
|
|
Warrants
|
|
|
|
|
|
|
|
|
|
|
|
Contributed
surplus
|
|
16,713
|
|
16,300
|
|
15,606
|
|
13,718
|
|
11,847
|
|
Deficit
|
|
(300,795
|
)
|
(291,420
|
)
|
(277,101
|
)
|
(249,033
|
)
|
(118,274
|
)
|
Accumulated
other comprehensive loss
|
|
(5,476
|
)
|
(6,397
|
)
|
(4,993
|
)
|
(5,304
|
)
|
(5,023
|
)
|
Total
deficit and accumulated other comprehensive loss
|
|
(306,271
|
)
|
(297,817
|
)
|
(282,094
|
)
|
(254,337
|
)
|
(123,297
|
)
|
|
|
17,480
|
|
25,483
|
|
40,384
|
|
66,757
|
|
195,507
|
|
|
|
$
|
36,808
|
|
$
|
47,579
|
|
$
|
67,940
|
|
$
|
97,173
|
|
$
|
214,657
|
|
Weighted
average number of shares
|
|
3,697,740
|
|
3,683,226
|
|
3,671,916
|
|
3,672,642
|
|
3,649,076
|
|
Note
:
*
Weighted average number of shares is presented
post-consolidation.
4
HYDROGENICS
CORPORATION
STATEMENTS OF INCOME DATA
(in thousands of U.S. dollars, except for share and
per share
amounts)
|
|
2009
|
|
2008
|
|
2007
|
|
2006
|
|
2005
|
|
Revenues
|
|
$
|
18,841
|
|
$
|
39,340
|
|
$
|
37,990
|
|
$
|
30,059
|
|
$
|
37,191
|
|
Cost of revenues
|
|
15,113
|
|
31,446
|
|
33,601
|
|
29,360
|
|
33,881
|
|
|
|
3,728
|
|
7,894
|
|
4,389
|
|
699
|
|
3,310
|
|
Operating expenses
|
|
|
|
|
|
|
|
|
|
|
|
Selling,
general and administrative
|
|
16,995
|
|
15,022
|
|
24,006
|
|
27,891
|
|
24,616
|
|
Research
and product development
|
|
5,219
|
|
7,296
|
|
9,690
|
|
9,379
|
|
7,745
|
|
Wind-up
of test equipment business
|
|
|
|
|
|
2,016
|
|
|
|
|
|
Impairment
of property, plant and equipment
|
|
317
|
|
|
|
|
|
|
|
|
|
Amortization
of property, plant and equipment
|
|
984
|
|
855
|
|
903
|
|
1,285
|
|
1,365
|
|
Amortization
of intangible assets
|
|
|
|
249
|
|
251
|
|
7,139
|
|
8,429
|
|
Integration
costs
|
|
|
|
|
|
|
|
|
|
1,123
|
|
Impairment
of intangible assets and goodwill
|
|
|
|
|
|
|
|
90,834
|
|
|
|
|
|
23,515
|
|
23,422
|
|
36,866
|
|
136,528
|
|
43,278
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
/ Loss from continuing operations
|
|
(19,787
|
)
|
(15,528
|
)
|
(32,477
|
)
|
(135,829
|
)
|
(39,968
|
)
|
Other income
(expenses)
|
|
|
|
|
|
|
|
|
|
|
|
Sale
of assets
|
|
|
|
44
|
|
|
|
477
|
|
|
|
Loss
on disposal of property, plant and equipment
|
|
(14
|
)
|
|
|
(308
|
)
|
|
|
|
|
Provincial
capital tax
|
|
(154
|
)
|
170
|
|
(127
|
)
|
(42
|
)
|
(91
|
)
|
Interest,
net
|
|
169
|
|
923
|
|
2,249
|
|
3,551
|
|
2,936
|
|
Foreign
currency gains (losses)
|
|
40
|
|
188
|
|
2,617
|
|
904
|
|
(251
|
)
|
|
|
41
|
|
1,325
|
|
4,431
|
|
4,890
|
|
2,594
|
|
Loss before income taxes
|
|
(19,746
|
)
|
(14,203
|
)
|
(28,046
|
)
|
(130,939
|
)
|
(37,374
|
)
|
Current income tax expense
(recovery)
|
|
(10,371
|
)
|
116
|
|
22
|
|
(180
|
)
|
|
|
Net loss for the year
|
|
(9,375
|
)
|
$
|
(14,319
|
)
|
$
|
(28,068
|
)
|
$
|
(130,759
|
)
|
(37,374
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share
/ Net loss from continuing operations per share
|
|
|
|
|
|
|
|
|
|
|
|
Basic
and diluted
|
|
$
|
(2.54
|
)
|
$
|
(3.89
|
)
|
$
|
(7.64
|
)
|
$
|
(35.60
|
)
|
$
|
(10.24
|
)
|
Shares
used in calculating basic and diluted net loss per share
|
|
3,697,740
|
|
3,683,226
|
|
3,671,916
|
|
3,672,642
|
|
3,649,076
|
|
We have never declared or
paid any cash dividends on our common shares.
The current income tax
expense (recovery) includes $10,464 of proceeds received from the APIF
Transaction (which is defined below under Item 4. Information on the Company). This amount will not reoccur in future years.
The financial information
in this Form 20-F has been prepared in accordance with Canadian generally
accepted accounting practices (GAAP). Certain financial information
under U.S. GAAP are as follows:
5
(in thousands of U.S. dollars, except for share and
per share amounts)
|
|
2009
|
|
2008
|
|
2007
|
|
2006
|
|
2005
|
|
Revenues
|
|
$
|
18,841
|
|
$
|
39,340
|
|
$
|
37,990
|
|
$
|
30,059
|
|
$
|
37,191
|
|
Loss
from operations before taxes
|
|
$
|
(19,636
|
)
|
$
|
(15,440
|
)
|
$
|
(32,477
|
)
|
$
|
(120,058
|
)
|
$
|
(55,739
|
)
|
Loss
from continuing operations before taxes
|
|
$
|
(19,636
|
)
|
$
|
(15,440
|
)
|
$
|
(32,477
|
)
|
$
|
(120,058
|
)
|
$
|
(55,739
|
)
|
Net
loss for the year
|
|
$
|
(9,224
|
)
|
$
|
(14,231
|
)
|
$
|
(28,068
|
)
|
$
|
(114,988
|
)
|
$
|
(53,145
|
)
|
Total
assets
|
|
$
|
36,387
|
|
$
|
47,579
|
|
$
|
67,940
|
|
$
|
97,173
|
|
$
|
198,881
|
|
Net
assets
|
|
$
|
17,719
|
|
$
|
25,571
|
|
$
|
40,384
|
|
$
|
66,757
|
|
$
|
179,736
|
|
Shareholders
Equity
|
|
$
|
17,719
|
|
$
|
25,571
|
|
$
|
40,384
|
|
$
|
66,757
|
|
$
|
179,736
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
and fully diluted comprehensive net loss per share
|
|
$
|
(2.49
|
)
|
$
|
(3.86
|
)
|
$
|
(7.64
|
)
|
$
|
(31.30
|
)
|
$
|
(14.56
|
)
|
Weighted
average number of shares used in calculating loss per share
|
|
3,697,740
|
|
3,683,226
|
|
3,671,916
|
|
3,672,642
|
|
3,649,076
|
|
For a discussion of the
material differences between Canadian GAAP and U.S. GAAP as they relate to our
financial statements and a reconciliation of certain additional financial
information, see Note 20 Differences
Between Canadian and United States Accounting Principles to our consolidated
financial statements, which can be found beginning on page F-35 of this
form, and is incorporated by reference herein.
CAPITALIZATION
AND INDEBTEDNESS
Not applicable.
REASONS
FOR THE OFFER AND USE OF PROCEEDS
Not applicable.
RISK
FACTORS
Risk Factors Related to Our Financial
Condition
If we are unsuccessful in increasing our revenues and
raising additional funding, we may possibly cease to continue as we currently
do.
The report of our
independent auditors in respect of the 2009 fiscal year contains an explanatory
paragraph regarding our ability to continue as a going concern. In addition, while our consolidated financial
statements for the year ended December 31, 2009 have been prepared on a
going concern basis, which contemplates the realization of assets and
liquidation of liabilities during the normal course of operations, our ability
to continue as a going concern is dependent on the successful execution of the
Companys business plan. This plan
includes an increase in revenue and additional funding to be provided by
potential investors as well as non-traditional sources of financing. We have
disclosed in our financial statements for the year ended December 31, 2009
that there are material
uncertainties
that cast substantial doubt upon our ability to continue as a going concern.
We have sustained losses
and negative cash flows from operations since our inception. We expect that
this will continue throughout 2010 and 2011. If we do not raise enough
additional capital during 2010, we do not expect our operations to generate
sufficient cash flow to fund our obligations as they come due.
Additional funding may be
in the form of debt or equity or a hybrid instrument depending on the needs of
the investor. Given the prevailing global economic and credit market
conditions, we may not be able to raise additional cash resources through these
traditional sources of financing. Although we are also pursuing non-traditional
sources of financing, the global credit market crisis has also adversely
affected the ability of potential parties to pursue such transactions.
Accordingly, as a result of the foregoing, we continue to review traditional
sources of financing, such as private and public debt or equity financing
alternatives, as well as other alternatives to enhance shareholder value,
6
including, but not
limited to, non-traditional sources of financing, such as alliances with
strategic partners, the sale of assets or licensing of our technology, a
combination of operating and related initiatives or a substantial
reorganization of our business.
We had filed a final
short form base shelf prospectus with certain Canadian securities regulatory
authorities on January 4, 2010 and a corresponding registration statement
on Form F-3, which was declared effective by the U.S. Securities and
Exchange Commission on December 31, 2009, to enhance our ability to access
the capital markets. Pursuant to the Form F-3,
we may offer up to $16 million of debt, equity or other securities over a
25-month period from December 31, 2009, provided that we cannot issue
securities with a value exceeding one-third of our public float (i.e., the
aggregate market value of our outstanding common shares held by non-affiliates)
in any 12-month period. On January 14,
2010, we issued common shares and warrants having a value of $11.5 million,
which is significantly greater than one-third of our current public float, to
two institutional investors in a registered direct offering pursuant to the Form F-3. As a result, we may not issue any additional
securities pursuant to the Form F-3 until January 14, 2011 based on
our current public float unless there was a significant increase in the market
price of our common shares. In addition,
even if the market price of our common shares were to increase significantly,
we could not in any event issue more than $4.5 million of additional securities
pursuant to our existing shelf prospectus.
In addition, there are
other limits on our ability to issue securities to raise additional funding.
The Nasdaq generally requires an issuer to obtain shareholder approval prior to
the issuance of common shares or securities convertible into or exercisable for
common shares, other than in a public offering, equal to 20% or more of the
common shares outstanding prior to such issuance in one or an integrated series
of offerings if such securities are issued at a price below market value. In light of our registered direct offering in
January 2010, we may be required to obtain shareholder approval for
certain issuances of our securities.
Furthermore, the
securities purchase agreement that we entered into with the two institutional
investors in connection with the registered direct offering contains certain
restrictions that may affect our ability to obtain financing. See the risk factor We require shareholder
approval to allow an adjustment to the exercise price of our series B warrants,
the failure of which could materially adversely affect our flexibility in
obtaining necessary financing and our financial condition for information
regarding such restrictions. In
addition, under the securities purchase agreement, we agreed that until April 15,
2010, neither the Company nor any of its subsidiaries shall directly or
indirectly issue, offer, sell, grant any option to purchase, or otherwise
dispose of (or announce any such action with respect to) any of their
respective equity or equity equivalent securities, including, without
limitation, any debt, preferred stock, rights, options, warrants or other
instrument that is convertible into or exchangeable for capital stock and other
securities of the Company.
There can be no
assurances that we will achieve profitability or positive cash flows or be able
to obtain additional funding or that, if obtained, they will be sufficient, or
whether any other initiatives will be successful, such that we may continue as
a going concern. There are material uncertainties related to certain adverse
conditions and events that cast significant doubt on our ability to remain a
going concern.
Our inability to generate sufficient cash flows, raise
additional capital and actively manage our liquidity may impair our ability to
execute our business plan, and result in our reducing or eliminating product
development and commercialization efforts, reducing our sales and marketing
efforts, and having to forego attractive business opportunities.
At December 31,
2009, we had approximately $11.0 million of cash and cash equivalents and
restricted cash (December 31, 2008 - $22.7 million). Restricted cash of
$1.8 million is held as partial security for standby letters of credit and
letters of finance. There are uncertainties related to the timing and use of
our cash resources and working capital requirements. These uncertainties
include, among other things, the timing and volume of commercial sales and
associated gross margins of our existing products and the development of
markets for, and customer acceptance, of new products. Due to these and other
factors, many of which are outside of our control, we may not be able to
accurately predict our necessary cash expenditures or obtain financing in a
timely manner to cover any shortfalls.
If we are unable to
generate sufficient cash flows or obtain adequate additional financing, which
given the current global economy and credit markets is challenging, we may be
unable to respond to the actions of our competitors or we may be prevented from
executing our business plan, or conducting all or a portion of our planned
operations. In particular, the development and commercialization of our
products could be delayed or discontinued if we are unable to fund our research
and product development activities or the development of our manufacturing
capabilities. In addition, we may be forced to reduce our sales and marketing
efforts or forego attractive business opportunities.
A sustained and broad economic recession could
continue to have a negative impact on our business, results of operations and
consolidated financial condition, or our ability to accurately forecast our
results, and it may cause a number of the risks that we currently face to
increase in likelihood, magnitude and duration.
Macro-level changes in
the global economy began to affect our business in the fourth quarter of 2008.
Operationally, we experienced a delay in closing orders. Financially, we
experienced more challenging conditions as a result of weaker capital markets
worldwide and anticipate these changes may adversely alter our ability to raise
capital on favourable terms and could change the terms of our credit facility.
7
The condition of the
current global economy and credit markets affects our outlook in three distinct
ways. First, our products depend, to some degree, on general world economic
conditions and activity. If the current condition of the economy results in a sustained
broad economic recession, demand for our products is likely to decline. Second,
the current economic and credit climate could adversely affect our ability to
conduct normal day-to-day selling activities which depend on the granting of
short-term credit to a wide variety of purchasers and particularly the
corresponding need of those purchasers. Third, those purchasers have a
corresponding need to finance purchases by accessing their own lines of credit.
If the current condition of the economy is not resolved in a manner that will
provide access to credit to potential purchasers of our products, our business
will likely suffer as a result.
With a sustained or
expanding economic downturn, we expect we will continue to experience
significant difficulties on a number of fronts, depending on the duration and
severity of the downturn. As a result, we may face new risks as yet
unidentified, and a number of risks which we ordinarily face and which are
further described herein may increase in likelihood, magnitude and duration.
These risks include but are not limited to deferrals or reductions of customer
orders, potential deterioration of our customers ability to finance purchases,
reduced revenue, further deterioration in our cash balances and liquidity due
to foreign exchange impacts, and an inability to access capital markets. The
financial crisis and economic downturn will also reduce our ability to
accurately forecast our performance, results or cash position.
We
have a limited operating history, and because our mix of revenues in the recent
past does not reflect our current business strategy, it may be difficult to
assess our business and future prospects.
We commenced operation of
our fuel cell
test business in 1996 and since that time we have been engaged principally in
the manufacture and sale of fuel cell test and diagnostic equipment, the
provision of related engineering and testing services, and research and product
development relating to fuel cell systems and subsystems. For the year ended December 31,
2009, we derived $12.3 million, or 65%, of revenues from our sales of hydrogen
generation products and services, and $6.5 million, or 35%, of our revenues
from sales of power products and services. For the year ended December 31,
2008, we derived $31.2 million, or 79%, of revenues from our sales of hydrogen
generation products and services, $5.6 million, or 15%, of our revenues from
sales of power products and services, and $2.5 million, or 6%, of our revenues
from sales of fuel cell test equipment and services. For the year ended December 31,
2007, we derived $19.6 million, or 52%, of revenues from our sales of hydrogen
generation products and services, $6.1 million, or 16%, of our revenues from
sales of power products and services, and $12.3 million, or 32%, of our
revenues from sales of fuel cell test equipment and services. On November 7,
2007, we announced our decision to commence an orderly wind-up of our fuel cell
test products design, development and manufacturing business, which is
anticipated to be completed in early 2010.
Our current business strategy is to develop, manufacture and sell fuel
cell power products in larger quantities. In addition, following our
acquisition of Stuart Energy Systems Corporation (Stuart Energy) in January 2005,
a significant part of our business now relates to hydrogen
generation products. Because we have made limited sales of fuel cell power
products to date and have added a new revenue stream with our hydrogen
generation business, our historical operating data may be of limited value in
evaluating our future prospects.
Because
we expect to continue to incur net losses, we may not be able to implement our
business strategy, and the price of our common shares may decline.
We have not generated
positive net income since our inception. Our current business strategy is to
develop a portfolio of hydrogen and fuel cell products with market leadership
positions for each product. In so doing, we will continue to incur significant
expenditures for general administrative activities, including sales and
marketing and research and development. As a result of these costs, we will
need to generate and sustain significantly higher revenues and positive gross
margins to achieve and sustain profitability. We incurred net losses for the
year ended December 31, 2009 of $9.4 million, a net loss of
$14.3 million for the year ended December 31, 2008, and a net loss of $28.1 million for the year
ended December 31, 2007. Our accumulated deficit as at December 31,
2009 was $301.0 million, at December 31, 2008 was $291.4 million, and as
at December 31, 2007 was $277.1 million.
We expect to incur
significant operating expenses over the next several years. As a result, we
expect to incur further losses in 2010 and 2011, and we may never achieve
profitability. Accordingly, we may not be able to implement our business
strategy, and the price of our common shares may decline.
We
require shareholder approval to allow an adjustment to the exercise price of
our series B warrants, the failure of which could materially adversely affect
our flexibility in obtaining necessary financing and our financial condition.
On January 14, 2010,
we issued common shares, series A warrants and series B warrants to two
institutional investors in a registered direct offering (the Offering). The terms of the Offering were set out in a
securities purchase agreement (the Purchase Agreement) dated as of January 11,
2010 between us and the two institutional investors. The Purchase Agreement requires us to seek shareholder
approval (i) to allow an adjustment to the exercise price of the series B
warrants below the $12.00 floor price (the Floor Price) in certain
circumstances and (ii) acknowledging that, as a result of such
resolutions, the aggregate number of our common shares deemed to be have been
issued in connection with the Offering exceeds a certain shareholder approval
threshold pursuant to the rules of the Nasdaq Global Market (the Warrant
Resolution). We plan on seeking
shareholder approval at the May 12, 2010 annual and special meeting of
shareholders. Until the Warrant
8
Resolution is approved,
the terms of the series B warrants dictate that no adjustment to the exercise
price of the series B warrants shall cause the exercise price to be less than
the Floor Price (as adjusted for any dividend, share split, share combination,
reclassification or similar transaction).
If we do not obtain
shareholder approval, the Purchase Agreement requires us to hold an additional
shareholder meeting in each semi-annual period thereafter until shareholder
approval is obtained or until shareholder approval is no longer required under
the rules and regulations of the Nasdaq Global Market or is no longer
required to eliminate restrictions on adjustments to the exercise price below
the Floor Price set forth in the series B warrants.
In addition, until
shareholder approval is obtained, with certain exceptions, we may not, directly
or indirectly, issue or sell, or in accordance with the terms of the warrants,
be deemed to have issued or sold, any common shares for consideration per
common share less than the Floor Price at any time while any of the warrants
are outstanding without the prior written consent of each investor, which
consent may be granted or withheld in each investors sole discretion. Until shareholder approval is obtained, we
are not able to issue, or be deemed to have issued, certain other securities
(including options or shares of common stock to directors, officers or
employees of Hydrogenics pursuant to an employee benefit plan, certain
convertible securities or unregistered common shares to a person who enters
into a strategic alliance with us) for less than the fair market value of the
common shares at the time such securities are issued or are deemed to be
issued. Our Board of Directors and management of the Company believe that the
failure to obtain shareholder approval for the Warrant Resolution may
materially adversely affect the Companys flexibility in obtaining any
necessary financing and our financial condition.
We
are currently involved in litigation with Alpha Capital Anstalt, the outcome of
which could adversely affect our financial condition.
Alpha Capital Anstalt (Alpha)
filed suit against Hydrogenics and two of our officers on February 23,
2010 in the Supreme Court of the State of New York (County of New York)
regarding our share consolidation, which was completed on March 12, 2010.
We issued common shares
and warrants to Alpha and another institutional investor in the Offering
(described above). Under the terms of
the Offering, Alpha and the other institutional investor each paid $2,500,000
for 250,000 common shares, 119,678 series A warrants and 130,323 series B
warrants of the Company.
In its complaint, Alpha
alleges that our share consolidation triggers a put right pursuant to the terms
of the warrants and gives rise to breach of contract, negligent
misrepresentation and fraud claims.
Alpha is seeking damages of at least $2,000,000 plus interest, costs and
fees with respect to the alleged put right and damages of at least $1,375,000
plus interest, costs and fees with respect to the alleged breach of contract,
negligent misrepresentation and fraud claims.
We have also received correspondence from the other institutional
investor making similar allegations.
While we believe the
claims are without merit and we are taking such action as is advised to protect
our interests, the outcome of litigation is inherently uncertain, and an unfavorable
outcome to the above litigation matter could have an adverse effect on our
financial condition and threaten our viability. In addition, we expect that our
legal fees and expenses will be substantial so long as this matter remains
outstanding.
Our quarterly
operating results are likely to fluctuate significantly and may fail to meet
the expectations of securities analysts and investors, and may cause the price
of our common shares to decline.
Our quarterly revenues
and operating results have varied significantly in the past and are likely to
vary in the future. These quarterly fluctuations in our operating performance
result from the length of time between our first contact with a customer and
the recognition of revenue from sales to that customer. Our products are highly
engineered and many are still in development stages; therefore, the length of
time between approaching a customer and delivering our products to that
customer can span many quarterly periods. In many cases a customers decision
to buy our products and services may require the customer to change its
established business practices and to conduct its business in new ways. As a
result, we must educate customers on the use and benefits of our products and
services. This can require us to commit significant time and resources without
necessarily generating any revenues. Many potential customers may wish to enter
into test arrangements with us in order to use our products and services on a
trial basis. The success of these trials may determine whether or not the
potential customer purchases our products or services on a commercial basis.
Potential customers may also need to obtain approval at a number of management
levels and one or more regulatory approvals. This may delay a decision to purchase
our products.
The length and
variability of the sales cycles for our products make it difficult to forecast
accurately the timing and amount of specific sales and corresponding revenue
recognition. The delay or failure to complete one or more large sales
transactions could significantly reduce our revenues for a particular quarter.
We may expend substantial funds and management effort during our sales cycle
with no assurance that we will successfully sell our products. As a result, our
quarterly operating results are likely to fluctuate significantly and we may
fail to meet the expectations of securities analysts and investors, and the
price of our common shares may decline.
9
We
currently depend on a relatively limited number of customers for a majority of
our revenues and a decrease in revenue from these customers could materially
adversely affect our business, consolidated financial condition and results of
operations.
To date, a relatively
limited number of customers have accounted for a majority of our revenues and
we expect they will continue to do so for the foreseeable future. Our four
largest customers accounted for 27% of revenues for the year ended December 31, 2009,
35% of our revenues for the year ended December 31, 2008, and 26% of our
revenues for the year ended December 31, 2007. The identities of some of
our largest customers have changed from year to year. Our arrangements with
these customers are generally non-exclusive, have no volume commitments and are
often on a purchase-order basis. We cannot be certain that customers who have
accounted for significant revenue in past periods will continue to purchase our
products and generate revenues. Accordingly, our revenue and results of operations
may vary from period to period. We are also subject to credit risk associated
with the concentration of our accounts receivable from these significant
customers. If one or more of these significant customers were to cease doing
business with us, significantly reduce or delay purchases from us, or fail to
pay on a timely basis, our business, consolidated financial condition and
results of operations could be materially adversely affected.
Our
operating results may be subject to currency fluctuation.
Our monetary assets and
liabilities denominated in currencies other than the U.S. dollar will give rise
to a foreign currency gain or loss reflected in earnings. To the extent that
the Canadian dollar or the euro strengthens against the U.S. dollar, we may incur
net foreign exchange losses on our net consolidated monetary asset balance
which is denominated in those currencies. Such losses would be included in our
financial results and, consequently, may have an adverse effect on our share
price.
As we currently have
operations based in Canada and Europe, a significant portion of our expenses
are in Canadian dollars and euros. However, a significant part of our revenues
are currently generated in U.S. dollars and euros, and we expect that this will
continue for the foreseeable future. In addition, we may be required to finance
our European operations by exchanging Canadian dollars or U.S. dollars into
euros. The exchange rates between the Canadian dollar, the U.S. dollar and the
euro are subject to daily fluctuations in the currency markets and these
fluctuations in market exchange rates are expected to continue in the future.
Such fluctuations affect both our consolidated revenues as well as our
consolidated costs. If the value of the U.S. dollar weakens against the
Canadian dollar or the euro, the profit margin on our products may be reduced.
Also, changes in foreign exchange rates may affect the relative costs of
operations and prices at which we and our foreign competitors sell products in
the same market. We currently have limited currency hedging through financial
instruments. We carry a portion of our short-term investments in Canadian
dollars and euros.
Our
insurance may not be sufficient.
We carry insurance that
we consider adequate considering the nature of the risks and costs of coverage.
We may not, however, be able to obtain insurance against certain risks or for
certain products or other resources located from time to time in certain areas
of the world. We are not fully insured against all possible risks, nor are all
such risks insurable. Thus, although we maintain insurance coverage, such
coverage may not be adequate.
Certain
external factors may affect the value of goodwill, which may require us to
recognize an impairment charge.
Goodwill arising from our
acquisition of Stuart Energy in 2005 comprise approximately 14.8% of our total
assets as at December 31, 2009, 10.6% of our total assets as at December 31,
2008 and 8% of our total assets as at December 31, 2007. Economic, market,
legal, regulatory, competitive, customer, contractual and other factors may
affect the value of goodwill. If any of these factors impair the value of these
assets, accounting rules require us to reduce their carrying value and
recognize an impairment charge. This would reduce our reported assets and
earnings in the year the impairment charge is recognized.
Risk Factors Related to
Our Business and Industry
Significant
markets for fuel cell and other hydrogen energy products may never develop or
may develop more slowly than we anticipate, which would significantly harm our
revenues and may cause us to be unable to recover the losses we have incurred
and expect to incur in the development of our products.
Significant markets may
never develop for fuel cell and other hydrogen energy products or they may
develop more slowly than we anticipate. Any such delay or failure would
significantly harm our revenues and we may be unable to recover the losses we
have incurred and expect to continue to incur in the development of our products.
If this were to occur, we may never achieve profitability and our business
could fail. Fuel cell and other hydrogen energy products represent an emerging
market, and whether or not end-users will want to use them may be affected by
many factors, some of which are beyond our control, including:
10
·
the
emergence of more competitive technologies and products, including other
environmentally clean technologies and products that could render our products
obsolete;
·
the
future cost of hydrogen and other fuels used by our fuel cell systems;
·
the
future cost of the membrane electrode assembly used in our fuel cell systems;
·
the
future cost of platinum group metals, a key catalyst used in our fuel cell and
hydrogen generation systems;
·
the
regulatory requirements of agencies, including the development of uniform codes
and standards for fuel cell products, hydrogen refueling infrastructure and
other hydrogen energy products;
·
government
support by way of legislation, tax incentives, policies or otherwise, of fuel
cell technology, hydrogen storage technology and hydrogen refueling technology;
·
the
manufacturing and supply costs for fuel cell components and systems;
·
the
perceptions of consumers regarding the safety of our products;
·
the
willingness of consumers to try new technologies;
·
the
continued development and improvement of existing power technologies; and
·
the
future cost of fuels used in existing technologies.
Hydrogen
may not be readily available on a cost-effective basis, in which case our fuel
cell products may be unable to compete with existing power sources, and our
revenues and results of operations would be materially adversely affected.
If our fuel cell product
customers are not able to obtain hydrogen on a cost-effective basis, we may be
unable to compete with existing power sources, and our revenues and results of
operations would be materially adversely affected. Our fuel cell products
require oxygen and hydrogen to operate. While ambient air can typically supply
the necessary oxygen, our fuel cells rely on hydrogen derived from water or
from fuels such as natural gas, propane, methanol and other petroleum products.
We manufacture and develop hydrogen generation systems called electrolyzers
that use electricity to separate water into its constituent parts of hydrogen
and oxygen. In addition, third parties are developing systems to extract, or
reform, hydrogen from fossil fuels. Significant growth in the use of
hydrogen-powered devices, particularly in the mobile market, may require the
development of an infrastructure to deliver the hydrogen. There is no guarantee
that such an infrastructure will be developed on a timely basis or at all. Even
if hydrogen is available for our products, if its price is such that
electricity or power produced by our systems would cost more than electricity
provided through other means, we may be unable to compete successfully.
Changes
in government policies and regulations could hurt the market for our products.
The fuel cell and
hydrogen industry is in its development phase and is not currently subject to
industry-specific government regulations in Canada, the European Union and the
United States as well as other jurisdictions, relating to matters such as
design, storage, transportation and installation of fuel cell systems and
hydrogen infrastructure products. However, given that the production of
electrical energy has typically been an area of significant government
regulation, we expect that we will encounter industry-specific government
regulations in the future in the jurisdictions and markets in which we operate.
For example, regulatory approvals or permits may be required for the design,
installation and operation of stationary fuel cell systems under federal, state
and provincial regulations governing electric utilities and mobile fuel cell
systems under federal, state and provincial emissions regulations affecting
automobile manufacturers. To the extent that there are delays in gaining such
regulatory approval, our development and growth may be constrained.
Furthermore, the inability of our potential customers to obtain a permit, or
the inconvenience often associated with the permit process, could harm demand
for fuel cell and other hydrogen products and, therefore, harm our business.
Our business will suffer
if environmental policies change and no longer encourage the development and
growth of clean power technologies. The interest by automobile manufacturers in
fuel cell technology has been driven in part by environmental laws and
regulations. There is no guarantee that these laws and regulations will not
change and any such changes could result in automobile manufacturers abandoning
their interest in fuel cell powered vehicles. In addition, if current laws and
regulations are not kept in force or if further environmental laws and
regulations are not adopted, demand for vehicular fuel cells may be limited.
The market for stationary
and portable energy-related products is influenced by federal, state and
provincial governmental regulations and policies concerning the electric
utility industry. Changes in regulatory standards or public policy could deter
further investment in the research and development of alternative energy
sources, including fuel cells and fuel cell products, and could result in a
significant reduction in the potential market demand for our products. We
cannot predict how changing government regulation and policies regarding the
electric utility industry will affect the market for stationary and portable
fuel cell systems.
11
Although the development
of alternative energy sources, and in particular fuel cells, has been
identified as a significant priority by many governments, we cannot be assured
that governments will not change their priorities or that any such change would
not materially affect our revenues and our business. If governments change
their laws and regulations such that the development of alternative energy sources
is no longer required or encouraged, the demand for alternative energy sources
such as our fuel cell products may be significantly reduced or delayed and our
sales would decline.
The
development of uniform codes and standards for hydrogen powered vehicles and
related hydrogen refueling infrastructure may not develop in a timely fashion,
if at all.
Uniform codes and
standards do not currently exist for fuel cell systems, fuel cell components,
hydrogen internal combustion engines or for the use of hydrogen as a vehicle
fuel. Establishment of appropriate codes and standards is a critical element to
allow fuel cell system developers, fuel cell component developers, hydrogen
internal combustion engine developers, hydrogen infrastructure companies and
hydrogen storage and handling companies to develop products that will be
accepted in the marketplace.
The development of
hydrogen standards is being undertaken by numerous organizations. Given the
number of organizations pursuing hydrogen codes and standards, it is not clear
whether universally accepted codes and standards will result in a timely
fashion, if at all.
We
currently face and will continue to face significant competition from other
developers and manufacturers of fuel cell power products and hydrogen
generation systems. If we are unable to compete successfully, we could
experience a loss of market share, reduced gross margins for our existing
products and a failure to achieve acceptance of our proposed products.
In our markets for
hydrogen generation systems, we compete with a number of companies that develop
and manufacture hydrogen generation products based on on-site water
electrolysis and/or reforming technologies. We also compete with suppliers of
hydrogen gas that deliver hydrogen to the customers site in tube trailers or
cylinders or by pipeline. In many cases, these suppliers have established
delivery infrastructure and customer relationships.
In the commercial
production of fuel cell power products, we compete with a number of companies
that currently have fuel cell and fuel cell system development programs. We
expect that several of these competitors will be able to deliver competing
products to certain markets before we do. While our strategy is the development
of fuel cell and hydrogen generation technologies for sale to end users,
systems integrators, governments and market channel partners, many of our
competitors are developing products specifically for use in particular markets.
These competitors may be more successful in penetrating their specific markets
than we are. In addition, an increase in the popularity of fuel cell power in
particular market channels may cause certain of our customers to develop and
produce some or all of the fuel cell technologies that we are developing.
Competition in the
markets for fuel cell power modules and hydrogen generation equipment is
significant and will likely persist and intensify over time. We compete
directly and indirectly with a number of companies that provide products and
services that are competitive with all, some or part of our products and
related services. Many of our existing and potential competitors have greater
brand name recognition and their products may enjoy greater initial market
acceptance among our potential customers. In addition, many of these
competitors have significantly greater financial, technical, sales, marketing,
distribution, service and other resources than we have and may also be better
able to adapt quickly to customers changing demands and to changes in technology.
If we are unable to
continuously improve our products and if we cannot generate effective responses
to our competitors brand power, product innovations, pricing strategies,
marketing campaigns, partnerships, distribution channels, service networks and
other initiatives, our ability to gain market share or market acceptance for
our products could be limited, our revenues and our profit margins may suffer,
and we may never become profitable.
We
face competition for fuel cell power products from developers and manufacturers
of traditional technologies and other alternative technologies.
Each of our target
markets is currently served by existing manufacturers with existing customers
and suppliers. These manufacturers use proven and widely accepted traditional
technologies such as internal combustion engines and turbines, as well as coal,
oil, gas and nuclear powered generators. Additionally, there are competitors
working on developing technologies that use other types of fuel cells and other
alternative power technologies, advanced batteries and hybrid battery/internal
combustion engines, which may compete for our target customers. Given that
proton exchange membrane (PEM) fuel cells have the potential to replace these
existing power sources, competition in our target markets will also come from
these traditional power technologies, from improvements to traditional power
technologies and from new alternative power technologies, including other types
of fuel cells.
If we are unable to
continuously improve our products and if we cannot generate effective responses
to incumbent and/or alternative energy competitors brand power, product
innovations, pricing strategies, marketing campaigns, partnerships,
distribution channels, service
12
networks and other
initiatives, our ability to gain market share or market acceptance for our
products could be limited, our revenues and our profit margins may suffer, and
we may never become profitable.
Our
strategy for the sale of fuel cell power products depends upon developing
partnerships with original equipment manufacturers (OEMs), governments,
systems integrators, suppliers and other market channel partners who will
incorporate our products into theirs.
Other than in a few
specific markets, our strategy is to develop and manufacture products and
systems for sale to OEMs, governments, systems integrators, suppliers and other
market channel partners that have mature sales and distribution networks for
their products. Our success may be heavily dependent upon our ability to
establish and maintain relationships with these partners who will integrate our
fuel cell products into their products and on our ability to find partners who
are willing to assume some of the research and development costs and risks
associated with our technologies and products. Our performance may, as a
result, depend on the success of other companies, and there are no assurances
of their success. We can offer no guarantee that OEMs, governments, systems
integrators, suppliers and other market channel partners will manufacture
appropriate products or, if they do manufacture such products, that they will
choose to use our products as components. The end products into which our fuel
cell technology will be incorporated will be complex appliances comprising many
components and any problems encountered by such third parties in designing,
manufacturing or marketing their products, whether or not related to the
incorporation of our fuel cell products, could delay sales of our products and
adversely affect our financial results. Our ability to sell our products to the
OEM markets depends to a significant extent upon our partners worldwide sales
and distribution networks and service capabilities. In addition, some of our
agreements with customers and partners require us to provide shared
intellectual property rights in certain situations, and there can be no
assurance that any future relationships that we enter into will not require us
to share some of our intellectual property. Any change in the fuel cell,
hydrogen or alternative fuel strategies of one of our partners could have a
material adverse effect on our business and our future prospects.
In addition, in some
cases, our relationships are governed by a non-binding memorandum of
understanding or a letter of intent. We cannot assure you that we will be able
to successfully negotiate and execute definitive agreements with any of these
partners, and failure to do so may effectively terminate the relevant relationship.
We also have relationships with third party distributors who also indirectly
compete with us. For example, we have targeted industrial gas suppliers as
distributors of our hydrogen generators. Because industrial gas suppliers
currently sell hydrogen in delivered form, adoption by their customers of our
hydrogen generation products could cause them to experience declining demand
for delivered hydrogen. For this reason, industrial gas suppliers may be
reluctant to purchase our hydrogen generators. In addition, our third party
distributors may require us to provide volume price discounts and other
allowances, or customize our products, either of which could reduce the
potential profitability of these relationships.
We
are dependent upon third party suppliers for key materials and components for
our products. If these suppliers become unable or unwilling to provide us with
sufficient materials and components on a timely and cost-effective basis, we
may be unable to manufacture our products cost-effectively or at all, and our
revenues and gross margins would suffer.
We rely upon third party
suppliers to provide key materials and components for our fuel cell power
products, hydrogen generation products and fuel cell test equipment. A suppliers
failure to provide materials or components in a timely manner, or to provide
materials and components that meet our quality, quantity or cost requirements,
or our inability to obtain substitute sources for these materials and
components in a timely manner or on terms acceptable to us, may harm our
ability to manufacture our products cost-effectively or at all, and our
revenues and gross margins might suffer. To the extent that we are unable to
develop and patent our own technology and manufacturing processes, and to the
extent that the processes that our suppliers use to manufacture materials and
components are proprietary, we may be unable to obtain comparable materials or
components from alternative suppliers, and that could adversely affect our
ability to produce commercially viable products.
We
may not be able to manage successfully the anticipated expansion of our
operations.
The uneven pace of our
anticipated expansion in facilities, staff and operations may place serious
demands on our managerial, technical, financial and other resources. We may be
required to make significant investments in our engineering and logistics
systems and our financial and management information systems, as well as
retaining, motivating and effectively managing our employees. Our management
skills and systems currently in place may not enable us to implement our
strategy or to attract and retain skilled management, engineering and
production personnel. Our failure to manage our growth effectively or to
implement our strategy in a timely manner may significantly harm our ability to
achieve profitability.
If
we do not properly manage foreign sales and operations, our business could
suffer.
We expect that a
substantial portion of our future revenues will continue to be derived from foreign
sales. Our international activities may be subject to inherent risks, including
regulatory limitations restricting or prohibiting the provision of our products
and services, unexpected changes in regulatory requirements, tariffs, customs,
duties and other trade barriers, difficulties in staffing and managing foreign
13
operations, longer
payment cycles, problems in collecting accounts receivable, fluctuations in
currency exchange rates, foreign exchange controls that restrict or prohibit
repatriation of funds, technology export and import restrictions or
prohibitions, delays from customs brokers or government agencies, seasonal
reductions in business activity and potentially adverse tax consequences resulting
from operating in multiple jurisdictions. As a result, if we do not properly
manage foreign sales and operations, our business could suffer.
We
will need to recruit, train and retain key management and other qualified
personnel to successfully expand our business.
Our future success will
depend in large part upon our ability to recruit and retain experienced
research and development, engineering, manufacturing, operating, sales and
marketing, customer service and management personnel. We compete in young
markets and there are a limited number of people with the appropriate
combination of skills needed to provide the services that our customers
require. In the past, we have experienced difficulty in recruiting qualified
personnel and we expect to experience continued difficulties in personnel
recruiting. If we do not attract such personnel, we may not be able to expand
our business. In addition, new employees generally require substantial
training, which requires significant resources and management attention. Our
success also depends upon retaining our key management, research, product
development, engineering, marketing and manufacturing personnel. Even if we
invest significant resources to recruit, train and retain qualified personnel,
we may not be successful in our efforts.
We
may acquire technologies or companies in the future, and these acquisitions
could disrupt our business and dilute our shareholders interests.
We may acquire additional
technologies or other companies in the future and we cannot provide assurances
that we will be able to successfully integrate their operations or that the
cost savings we anticipate will be fully realized. Entering into an acquisition
or investment entails many risks, any of which could materially harm our business,
including:
·
diversion
of managements attention from other business concerns;
·
failure
to effectively assimilate our acquired technology, employees or other assets
into our business;
·
the
loss of key employees from either our current business or the acquired
business; and
·
assumption
of significant liabilities of the acquired company.
If we complete additional
acquisitions, we may dilute the ownership of current shareholders. In addition,
achieving the expected returns and cost savings from our past and future
acquisitions will depend in part upon our ability to integrate the products and
services, technologies, research and development programs, operations, sales
and marketing functions, finance, accounting and administrative functions, and
other personnel of these businesses into our business in an efficient and
effective manner. We cannot ensure that we will be able to do so or that the
acquired businesses will perform at anticipated levels. If we are unable to
successfully integrate acquired businesses, our anticipated revenues may be
lower and our operational costs may be higher.
We
have no experience manufacturing our products on a large scale basis, and if we
do not develop adequate manufacturing processes and capabilities to do so in a
timely manner, we will be unable to achieve our growth and profitability
objectives.
We have manufactured most
of our products for prototypes and initial sales, and we have limited
experience manufacturing products on a larger scale. In order to produce
certain of our products at affordable prices we will have to manufacture a
large volume of such products. We do not know when or whether we will be able
to develop efficient, low-cost manufacturing capabilities and processes that
will enable us to meet the quality, price, engineering, design and production
standards or production volumes required to successfully mass market such
products. Even if we are successful in developing our manufacturing
capabilities and processes, we do not know whether we will do so in time to
meet our product commercialization schedule or to satisfy the requirements of
our customers and the market. Our failure to develop these manufacturing
processes and capabilities in a timely manner could prevent us from achieving
our growth and profitability objectives.
Risk Factors Related to
Our Products and Technology
We
may never complete the development of commercially viable fuel cell power
products and/or commercially viable hydrogen generation systems for new
hydrogen energy applications, and if we fail to do so, we will not be able to
meet our business and growth objectives.
We have made commercial
sales of hydrogen generation, fuel cell test and diagnostic equipment, fuel
cell power modules, integrated fuel cell systems and hydrogen refueling
stations for a relatively short period of time. Because both our business and
industry are still in the developmental stage, we do not know when or whether
we will successfully complete research and development of commercially viable
fuel cell power products and commercially viable hydrogen generation equipment
for new hydrogen energy applications. If we do not complete the development of
such commercially viable products, we will be unable to meet our business and
growth objectives. We expect to face unforeseen challenges, expenses and
difficulties as a developing company seeking to design, develop and manufacture
new products in each of
14
our targeted markets. Our
future success also depends upon our ability to effectively market fuel cell
products and hydrogen generation products once developed.
We
must lower the cost of our fuel cell and hydrogen generation products and
demonstrate their reliability, or consumers will be unlikely to purchase our
products and we will therefore not generate sufficient revenues to achieve and
sustain profitability.
Fuel cells currently cost
more than many established competing technologies, such as internal combustion
engines and batteries. The prices of fuel cell and hydrogen generation products
are dependent largely upon material and manufacturing costs. We cannot
guarantee that we will be able to lower these costs to a level where we will be
able to produce a competitive product or that any product we produce using
lower cost materials and manufacturing processes will not suffer from lower
performance, reliability and longevity. If we are unable to produce fuel cell
and hydrogen generation products that are competitive with other technologies
in terms of price, performance, reliability and longevity, consumers will be
unlikely to buy our fuel cell and hydrogen generation products. Accordingly, we
would not be able to generate sufficient revenues with positive gross margins
to achieve and sustain profitability.
Any
failures or delays in field tests of our products could negatively affect our
customer relationships and increase our manufacturing costs.
We regularly field test
our products and we plan to conduct additional field tests in the future. Any
failures or delays in our field tests could harm our competitive position and
impair our ability to sell our products. Our field tests may encounter problems
and delays for a number of reasons, including the failure of our technology,
the failure of the technology of others, the failure to combine these
technologies properly, operator error and the failure to maintain and
service the test prototypes properly. Many of these potential problems and
delays are beyond our control. In addition, field test programs, by their
nature, may involve delays relating to product roll-out and modifications to
product design, as well as third party involvement. Any problem or perceived
problem with our field tests, whether it originates from our technology, our
design, or third parties, could hurt our reputation and the reputation of our
products and limit our sales. Such field test failures may negatively affect
our relationships with customers, require us to extend field testing longer
than anticipated before undertaking commercial sales and require us to develop
further our technology to account for such failures prior to the field tests,
thereby increasing our manufacturing costs.
The
components of our
products
may
contain defects or errors that could negatively
affect our customer relationships and increase our development, service and
warranty costs.
Our products are complex
and must meet the stringent technical requirements of our customers. The software and
other components used in our fuel cell and hydrogen generation products may
contain undetected defects or errors, especially when first introduced, which
could result in the failure of our products to perform, damage to our
reputation, delayed or lost revenue, product returns, diverted development
resources and increased development, service and warranty costs.
Rapid
technological advances or
the ado
ption of new codes and standards could
impair our ability to deliver our products in a timely manner and, as a result,
our revenues would suffer.
Our success depends in
large part on our ability to keep our products current and compatible with
evolving technologies, codes and standards. Unexpected changes in technology
or in codes and standards could disrupt the development of our products and
prevent us from meeting deadlines for the delivery of products. If we are
unable to keep pace with technological advancements and adapt our products to
new codes and standards in a timely manner, our products may become
uncompetitive or obsolete and our revenues would suffer.
We
depend upon intellectual property and our failure to protect that intellectual
property could adversely affect our future growth and success.
Failure to protect our
intellectual property rights may reduce our ability to prevent others from
using our technology. We rely on a combination of patent, trade secret,
trademark and copyright laws to protect our intellectual property. Some of our
intellectual property is currently not covered by any patent or patent
application. Patent protection is subject to complex factual and legal criteria
that may give rise to uncertainty as to the validity, scope and enforceability
of a particular patent. Accordingly, we cannot be assured that:
·
any
of the United States, Canadian or other patents owned by us or third party
patents licensed to us will not be invalidated, circumvented, challenged,
rendered unenforceable, or licensed to others; or
·
any
of our pending or future patent applications will be issued with the breadth of
protection that we seek, if at all.
In addition, effective
patent, trademark, copyright and trade secret protection may be unavailable,
limited, not applied for or unenforceable in foreign countries.
15
Furthermore, although we
typically retain sole ownership of the intellectual property we develop, in
certain circumstances, such as with Dow Corning and General Motors, we provide
for shared intellectual property rights. For instance, where intellectual
property is developed pursuant to our use of technology licensed from General
Motors, we have committed to provide certain exclusive or non-exclusive
licences in favour of General Motors, and in some cases the intellectual
property is jointly owned. As a result of these licences, we may be limited or
precluded, as the case may be, in the exploitation of such intellectual
property rights.
We have also entered into
agreements with other customers and partners that involve shared intellectual
property rights. Any developments made under these agreements will be available
for future commercial use by all parties to the agreement.
We also seek to protect
our proprietary intellectual property through contracts including, when
possible, confidentiality agreements and inventors rights agreements with our
customers and employees. We cannot be sure that the parties that enter into
such agreements with us will not breach them, that we will have adequate
remedies for any breach or that such persons or institutions will not assert
rights to intellectual property arising out of these relationships. If
necessary or desirable, we may seek licences under the patents or other
intellectual property rights of others. However, we cannot be sure that we will
obtain such licences or that the terms of any offered licences will be acceptable
to us. Our failure to obtain a license from a third party for intellectual
property we use in the future could cause us to incur substantial liabilities
and to suspend the manufacture and shipment of products or our use of processes
that exploit such intellectual property.
Our
involvement in intellectual property litigation could negatively affect our
business.
Our future success and
competitive position depend in part upon our ability to obtain or maintain the
proprietary intellectual property used in our principal products. In order to
establish and maintain such a competitive position we may need to prosecute
claims against others who we believe are infringing our rights and defend
claims brought by others who believe that we are infringing their rights. Our
involvement in intellectual property litigation could result in significant
expense to us, adversely affect the sale of any products involved or the use or
licensing of related intellectual property and divert the efforts of our
technical and management personnel from their principal responsibilities,
regardless of whether such litigation is resolved in our favour. If we are
found to be infringing on the intellectual property rights of others, we may,
among other things, be required to:
·
pay
substantial damages;
·
cease
the development, manufacture, use, sale or importation of products that
infringe upon such intellectual property rights;
·
discontinue
processes incorporating the infringing technology;
·
expend
significant resources to develop or acquire non-infringing intellectual
property; or
·
obtain
licences to the relevant intellectual property.
We cannot offer any
assurance that we will prevail in any such intellectual property litigation or,
if we were not to prevail in such litigation, that licences to the intellectual
property that we are found to be infringing upon would be available on
commercially reasonable terms, if at all. The cost of intellectual property
litigation as well as the damages, licensing fees or royalties that we might be
required to pay could have a material adverse effect on our business and
financial results.
Our
products use flammable fuels that are inherently dangerous substances and could
subject us to product liabilities.
Our financial results
could be materially impacted by accidents involving either our products or those
of other fuel cell manufacturers, either because we face claims for damages or
because of the potential negative impact on demand for fuel cell products. Our
products use hydrogen, which is typically generated from gaseous and liquid
fuels such as propane, natural gas or methanol in a process known as reforming.
While our fuel cell products do not use these fuels in a combustion process,
natural gas, propane and other hydrocarbons are flammable fuels that could leak
and then combust if ignited by another source. In addition, certain of our OEM
partners and customers may experience significant product liability claims. As
a supplier of products and systems to these OEMs, we face an inherent business
risk of exposure to product liability claims in the event that our products, or
the equipment into which our products are incorporated, malfunction and result
in personal injury or death. We may be named in product liability claims even if
there is no evidence that our systems or components caused the accidents.
Product liability claims could result in significant losses from expenses
incurred in defending claims or the award of damages. Since our products have
not yet gained widespread market acceptance, any accidents involving our
systems, those of other fuel cell products or those used to
produce hydrogen could materially impede acceptance of our products. In
addition, although our management believes that our liability coverage is
currently adequate to cover these risks, we may be held responsible for damages
beyond the scope of our insurance coverage.
16
Risk
Factors Related to Ownership of Our Common Shares
If at any time we qualify as a passive foreign
investment company under United States tax laws, our shareholders may be
subject to adverse tax consequences.
We would be classified as
a passive foreign investment company (PFIC), for United States federal income
tax purposes, in any taxable year in which, after applying relevant
look-through rules with respect to the income and assets of our
subsidiaries, either at least 75% of our gross income is passive income, or
on average at least 50% of the gross value of our assets is attributable to
assets that produce passive income or are held for the production of passive
income.
Based on the structure of
the Company, and the composition of our income and assets, the Company does not
believe that it was a PFIC for the taxable year ended December 31, 2009 or
its prior taxable year. However, there can be no assurance that the Internal
Revenue Service will not successfully challenge our position or that we will
not become a PFIC in a future taxable year, as PFIC status is re-tested each
year and depends on our assets and income in such year. If we are classified as
a PFIC at any time that a U.S. Holder (as defined below) holds our common
shares, such holder may be subject to an increased United States federal income
tax liability and a special interest charge in respect of gain realized from
the sale or other disposition of our common shares and upon the receipt of
certain excess distributions (as defined in the United States Internal
Revenue Code of 1986, as amended).
U.S. Holders should
consult their own tax advisors concerning the United States federal income tax
consequences of holding our common shares if we were a PFIC in any taxable year
and its potential application to their particular situation.
A limited number of shareholders collectively own a
significant portion of our common shares and may act, or prevent corporate
actions, to the detriment of other shareholders.
A limited number of
shareholders, including our founders and General Motors, currently own a
significant portion of our outstanding common shares. General Motors currently
owns approximately 10.8% of our outstanding common shares. In addition, each of Alpha and Iroquois
Master Fund Ltd. currently owns approximately 5.9% of our outstanding common
shares, as well as 119,678 series A warrants (representing the right to acquire
the equivalent number of common shares) and 130,323 series B warrants of the
Company (representing the right to acquire the equivalent number of common
shares). Accordingly, these shareholders
may exercise significant influence over all matters requiring shareholder
approval, including the election of a majority of our directors and the
determination of significant corporate actions. This concentration could also
have the effect of delaying or preventing a change in control that could
otherwise be beneficial to our shareholders.
In addition to General
Motors current ownership of our common shares, pursuant to our strategic
alliance with General Motors, for so long as General Motors holds at least 10%
of our outstanding shares, if any of our founders, Pierre Rivard, Joseph
Cargnelli or Boyd Taylor, wish to transfer (i) all or substantially all of
their shares to any person, or (ii) any of their shares to a person
actively competing with General Motors in the automotive or fuel cell industry,
he must first offer the shares to General Motors. Moreover, if we issue
additional equity securities or securities convertible into equity securities
for cash consideration, we have granted General Motors the right to participate
in such offering on a pro rata basis based on the fully diluted number of
common shares that it holds, subject to certain limited exceptions. We have also
agreed that one director nominated by General Motors shall be included in the
slate of directors that is presented to shareholders for approval at our
general meeting. As a principal shareholder and party to the strategic alliance
and representative on our Board, General Motors has the ability to influence
our corporate actions and in a manner that may be adverse to your interests.
Future sales of common shares by our principal
shareholders could cause our share price to fall and reduce the value of a
shareholders investment.
If our principal
shareholders, including our founders, sell substantial amounts of their common
shares in the public market, the market price of our common shares could fall
and the value of a shareholders investment could be reduced. The perception
among investors that these sales may occur could have a similar effect. Share
price declines may be exaggerated if the low trading volume that our common
shares have experienced to date continues. These factors could also make it more
difficult for us to raise additional funds through future offerings of our
common shares or other securities.
Our articles of incorporation authorize us to issue an
unlimited number of common and preferred shares, and significant issuances of
common or preferred shares could dilute the share ownership of our
shareholders, deter or delay a takeover of us that our shareholders may
consider beneficial or depress the trading price of our common shares.
Our articles of
incorporation permit us to issue an unlimited number of common and preferred
shares. If we were to issue a significant number of common shares, it would
reduce the relative voting power of previously outstanding shares. Such future
issuances could be at prices less than our shareholders paid for their common
shares. If we were to issue a significant number of common or preferred shares,
these
17
issuances could
also deter or delay an attempted acquisition of us that a shareholder may
consider beneficial, particularly in the event that we issue preferred shares
with special voting or dividend rights. While Nasdaq and TSX rules may
require us to obtain shareholder approval for significant issuances, we would
not be subject to these requirements if we ceased, voluntarily or otherwise, to
be listed on Nasdaq and the TSX. Significant issuances of our common or
preferred shares, or the perception that such issuances may occur, could cause
the trading price of our common shares to drop.
U.S. investors may not be able to enforce U.S. civil
liability judgments against us or our directors and officers.
We are organized under
the laws of Canada. A majority of our directors and officers are residents of
Canada and all or a substantial portion of their assets and substantially all
of our assets are located outside of the United States. As a result, it may be
difficult for U.S. holders of our common shares to effect service of process on
these persons within the United States or to realize in the United States upon
judgments rendered against them. In addition, a shareholder should not assume
that the courts of Canada (i) would enforce judgments of U.S. courts
obtained in actions against us or such persons predicated upon the civil
liability provisions of U.S. federal securities laws or other laws of the
United States, or (ii) would enforce, in original actions, claims against
us or such persons predicated upon the U.S. federal securities laws.
Our share price is volatile and we may continue to
experience significant share price and volume fluctuations.
Since our common shares
were initially offered to the public in November 2000, the stock markets,
particularly in the technology and alternative energy sectors, and our share
price have experienced significant price and volume fluctuations. Our common
shares may continue to experience volatility for reasons unrelated to our own
operating performance, including:
·
performance of other companies in the
fuel cell or alternative energy business;
·
news announcements, securities analysts
reports and recommendations and other developments with respect to our industry
or our competitors; or
·
changes in general economic conditions.
As at March 25, 2010, there were 239,162, on a
post-consolidation basis, options to purchase our common shares, 239,356 series
A warrants and 260,646 series B warrants. If these securities are exercised,
our shareholders will incur substantial dilution.
A significant element in
our plan to attract and retain qualified personnel is the issuance to such
persons of options to purchase our common shares. As at March 25, 2010, we
have issued and outstanding 239,162 options to purchase our common shares at an
average price of Cdn. $ 65.00 per common share.
Accordingly, to the extent that we are required to issue significant
numbers of options to our employees, and such options are exercised, our
shareholders could experience significant dilution. As of March 25, 2010,
we also have 239,356 series A warrants and 260,646 series B warrant issued and
outstanding, whereby each warrant entitles the holder to purchase a common
share. To the extent such series A
warrants and series B warrants are exercised, our shareholders could experience
significant dilution.
ITEM
4. INFORMATION ON THE COMPANY
HISTORY AND DEVELOPMENT OF HYDROGENICS CORPORATION
We were incorporated on June 10,
2009 under the Canada Business Corporations Act, under the name 7188501 Canada
Inc. We changed our name to Hydrogenics CorporationCorporation Hydrogenique
on October 27, 2009 in connection with the transaction involving Algonquin
Power Income Fund (APIF), as described further below under APIF Transaction.
Old Hydrogenics was
founded in 1988 under the name Traduction Militech Translation Inc. It
subsequently changed its name to Societe Hydrogenique IncorporéeHydrogenics
Corporation Incorporated. From 1990 to August 1995, Societe Hydrogenique
IncorporéeHydrogenics Corporation Incorporated did not actively carry on
business. In August 1995, it commenced our fuel cell technology
development business, and in 2000, changed its name to Hydrogenics Corporation Corporation
Hydrogenique. Until October 27, 2009, we were a wholly-owned subsidiary of
Old Hydrogenics.
We are a globally
recognized developer and provider of hydrogen generation and fuel cell
products. We conduct our business through the following business units: (i) OnSite
Generation, which focuses on hydrogen generation products for renewable energy,
industrial and transportation customers; and (ii) Power Systems, which
focuses on fuel cell products for original equipment manufacturers, or OEMs,
systems integrators and end users for stationary applications, including backup
power, and motive applications, such as forklift truck. In November 2007,
we announced that we were exiting the fuel cell test products, design,
development and manufacturing business, that was
18
conducted through
our Test Systems business unit. The orderly wind-up of the Test Systems unit, which
focused on fuel cell test and diagnostic products and contract testing services
for third parties, is expected to be completed in 2010.
Our business units are
supported by a corporate services group providing finance, insurance, investor
relations, communications, treasury, human resources, strategic planning,
compliance, and other administrative services.
Our principal executive
offices are located at 5985 McLaughlin Road, Mississauga, Ontario, Canada L5R
1B8. Our telephone number is (905) 361-3600.
Our agent for service in the United States is CT Corporation System, 111
Eighth Avenue, New York, New York 10011,
(212) 894-8400.
Capital expenditures for
the year ended December 31, 2009 were $0.8 million, compared with $0.9
million and $1.3 million for the years ended December 31, 2008 and 2007,
respectively, and consisted primarily of capital expenditures for equipment and
computer equipment. We expect capital
expenditure plans for 2010 and subsequent years to result in further investment
in capital assets as we continue our manufacturing and development initiatives.
Our current budget for 2010 includes a capital budget of $0.2 million to
purchase and manufacture testing and other equipment, primarily for our
research and development programs but also in support of ongoing operational
needs. We expect that less than half of
our investments will be in Canada. Our capital requirements will be affected by
many factors, including the success of our current product offerings, the
ability to enhance our current products and our ability to develop and
introduce new products that keep pace with technological developments in the
marketplace.
As at December 31,
2009 we had cash and cash-equivalents and restricted cash of approximately
$11.0 million.
There are currently no
public takeover offers by third parties in respect of the Companys shares.
APIF
Transaction
On June 11, 2009,
we, Old Hydrogenics, the Board of Trustees of APIF and APIFs manager,
Algonquin Power Management Inc., agreed upon the terms of a series of
transactions (collectively, the APIF Transaction) and agreements, pursuant to
which Old Hydrogenics agreed to transfer its entire business and operations to
us, including all assets, liabilities, directors, management and employees, but
excluding its tax attributes. Concurrently, the APIF Transaction enabled
unitholders of APIF to continue to hold their interest in APIF as shareholders
of Old Hydrogenics, which was renamed Algonquin Power & Utilities
Corp. (APUC), a publicly traded Canadian corporation. APUC has the ability
to make efficient use of our accumulated tax attributes in the continued
execution of APIFs business plans. Under the APIF Transaction, our
shareholders had their common shares in the capital of Old Hydrogenics redeemed
for our common shares on a one-for-one basis. At the same time APIF unitholders
exchanged their units for APUC common shares.
As a result of completion
of the APIF Transaction on October 27, 2009, unitholders of APIF did not
retain any interest in the business of the Company nor did the Companys
shareholders retain any interest in the business of APIF. We have continued to
carry on the hydrogen generation and fuel cell business as a public entity with
all of the assets (including the intellectual property), except for certain tax
assets, of our predecessor prior to the APIF Transaction.
Pursuant to continuity of
interest accounting, the assets transferred and liabilities assumed were
recorded at their carrying values as reported by the Company immediately prior
to the completion of the APIF Transaction. As a result, the cash proceeds were
recorded as a recovery of income taxes.
The Company recorded a benefit of $10.4 million in the consolidated
financial statements. $10.0 million of
the benefit was received in cash during the year and the remaining amount was
included in Accounts Receivable. The
amount included in Accounts Receivable was collected subsequent to December 31,
2009. The Company incurred transaction
costs of $3.3 million relating to the APIF Transaction and these costs were
included within selling, general and administrative expenses for 2009. In
addition, as the future income tax benefits of Old Hydrogenics Canadian
non-capital losses, capital losses, scientific research and development
expenditures and investment tax credits generated through to the date of the
completion of the transaction are not available to the Company after the
completion of the transaction, the gross future income tax assets related to
these Canadian tax pools was reduced to $nil, with a corresponding reduction of
the related valuation allowance (see note 16 to our consolidated financial
statements beginning on page F-30).
Details of the APIF
Transaction are described more fully in Old Hydrogenics management proxy
circular dated June 25, 2009.
which was filed as Exhibit 99.1
to Old Hydrogenics Report of Foreign Private Issuer on Form 6-K with the
U.S. Securities and Exchange Commission on June 29, 2009.
See also notes 2
and 16 to our consolidated financial statements beginning on pages F-
12
and F-
30, respectively
.
BUSINESS OVERVIEW
Overview
Hydrogenics, together
with its subsidiaries, designs, develops and manufactures hydrogen generation
products based on water electrolysis technology and fuel cell products based on
proton exchange membrane, or PEM technology. Hydrogenics mission is to provide
19
safe, secure,
sustainable and emission free energy as a leading global provider of clean
energy solutions based on hydrogen. We
maintain operations in Belgium, Canada and Germany. We operate in various geographical markets
and organize ourselves in four reportable segments.
Our OnSite Generation
business segment is based in Oevel, Belgium and develops products for
industrial gas, hydrogen fueling and renewable energy storage markets. For the
year ended December 31, 2009, our OnSite Generation business reported
revenues of $12.3 million and at December 31, 2009 had 61 full time
employees.
Our Power Systems business
segment is based in Mississauga, Canada with a satellite facility in Gladbeck,
Germany. This segment develops products
for stationary and motive power applications. For the year ended December 31,
2009, our Power Systems business reported revenues of $6.5 million and at December 31,
2009 had 65 full time employees.
Our Test Systems business
segment is based in Burnaby, Canada and provided fuel cell testing services and
sold fuel cell test stations. In November 2007, we announced that we would
implement an orderly wind up of our Test Systems business in order to focus our
resources on our OnSite Generation and Power Systems businesses. We expect to
finalize the wind up in early 2010. For the year ended December 31, 2009
our Test Systems business did not report any revenue and at December 31,
2008 no longer had employees.
Our Corporate and Other
business segment provides corporate services and administrative support. At December 31,
2009, our Corporate and Other business had four full time employees.
Our business is
summarized below.
OnSite Generation
Our OnSite Generation
business segment is based on alkaline water electrolysis technology which
involves the decomposition of water (H
2
O)
into oxygen (O
2
) and hydrogen gas (H
2
) by passing an electric current through a liquid
electrolyte. The resultant hydrogen gas is then captured and used for
industrial gas applications, hydrogen fueling applications, and used to store
renewable energy in the form of hydrogen gas. Our HySTAT
®
branded
electrolyzer products are based on 60 years of hydrogen experience, meet
international standards such as ASME, CE, Rostechnadzor and UL and are
certified ISO 9001 from design to delivery. We configure our HySTAT
®
products for
both indoor and outdoor applications and tailor our products to accommodate
various hydrogen gas requirements. We
have also developed and delivered products in a smaller scale range based on
PEM water electrolysis.
The worldwide market for
hydrogen, which includes the merchant gas market for hydrogen, is estimated at
$5 billion annually, and is served by industrial gas companies as well as
on-site hydrogen generation product manufacturers such as ourselves. We believe
that the annual market for on-site hydrogen generation equipment is
approximately $100 million to $200 million.
Our OnSite Generation
products are sold to leading merchant gas companies such as Air Liquide S.A.
and Linde AG and end users requiring high purity hydrogen produced on-site for
industrial applications. We also sell
products to progressive oil and gas companies, such as Shell Hydrogen,
requiring hydrogen fueling stations for transportation applications. Recently,
we have begun to sell our products to leading electric power utilities,
including BC Powertech, and Newfoundland and Labrador Hydro requiring renewable
energy storage.
The business objectives
for our OnSite Generation group are to: (i) further increase the gross
margins of existing product lines by improving our procurement and
manufacturing processes; (ii) further increase the reliability and
durability of our products to exceed the expectations of our applications; (iii) reduce
the cost of ownership of our products through design and technology
improvement; (iv) continue to pursue opportunities for customers to
convert renewable energy, such as wind and solar energy, into hydrogen; and (v) further
expand into ready markets such as Eastern Europe (including Russia), Asia and
the Middle East.
Our Onsite Generation
business competes with merchant gas companies such as Air Liquide S.A. and
Linde Gas AG which, in addition to being customers, operate large scale
hydrogen production plants and are providers of alternative on-site hydrogen
generation products using steam methane reforming, or SMR technology and
other electrolsis technology. We compete on performance, reliability and cost
and believe we are well positioned in situations where there is a need for high
purity hydrogen manufactured on-site.
Power Systems
Our Power Systems
business segment is based on PEM fuel cell technology which transforms chemical
energy liberated during the electrochemical reaction of hydrogen and oxygen to
electrical energy. Our HyPM
®
branded fuel cell products are based on our
extensive track record of on-bench testing and real-time deployments across a
wide range of stationary and motive power profiles. We configure our HyPM
®
products to
multiple electrical power outputs ranging from 4 to 65 kilowatts with ease of
integration, high reliability and operating efficiency, delivered in a highly
compact area.
20
Our target markets
include backup power for data centres and telecom installations plus motive
power applications, such as buses, trucks and utility vehicles. The military,
historically an early technology adopter, is a specialized market for our
innovative fuel cell based systems. The worldwide market for data centre backup
power is estimated to be in excess of $6 billion and the market for telecom
backup power is estimated to be $2 to $3 billion in the U.S. alone, based on a
complete displacement of existing battery systems.
Our Power Systems
products are sold to leading OEMs such as Commscope Inc. to provide backup
power applications for data centres and telecom sites. Additionally, they are
also sold for prototype field tests of our fuel cell products intended to be
direct replacements for traditional lead-acid battery packs on indoor
industrial forklift applications. We also sell our Power Systems products to
the military and other early adopters of emerging technologies.
The business objectives
for our Power Systems group are to: (i) offer a standard fuel cell
platform for many markets thereby enabling ease of manufacturing and reduced
development spending; (ii) achieve further market penetration in the
backup power and motive power markets by tailoring our HyPM
®
fuel cell
products to meet market specific requirements including price, performance and
features; (iii) invest in sales and market development activities in the
backup power and motive power markets; (iv) continue to target the
military and other early adopters of emerging technologies as a bridge to
future commercial markets; and (v) secure the requisite people and
processes to align our anticipated growth plans with our resources and
capabilities.
Our Power Systems
business competes with several well-established battery and combustion
generator companies in addition to several other fuel cell companies. We
compete on relative price/performance and design innovation. In the back-up
power market, we believe our HyPM
®
systems have an advantage over batteries and
internal combustion engines for customers seeking extended run requirements, by
offering a more reliable and economic performance. In motive power markets, we
believe our HyPM
®
products are well positioned against lead-acid
batteries by offering increased productivity and lower operational costs.
There are four types of
fuel cells other than PEM fuel cells that are generally considered to have
possible commercial applications: phosphoric acid fuel cells, molten carbonate
fuel cells, solid oxide fuel cells and alkaline fuel cells. Each of these fuel
cell technologies differ in their component materials, and operating
characteristics. While all fuel cell
types may have potential environmental and efficiency advantages over
traditional power sources, we believe that PEM fuel cells can be manufactured
less expensively and are more efficient and more practical in small-scale
stationary and motive power applications. Further, most automotive companies
have selected PEM technology for fuel-cell-powered automobiles. We expect this
will help establish a stronger industry around PEM technology and may result in
a lower cost as compared to the other fuel cell technologies.
Test Systems
Segmented Revenues
|
|
2009
(in millions)
|
|
2008
(in millions)
|
|
2007
(in millions)
|
|
OnSite
Generation
|
|
$
|
12.3
|
|
$
|
31.2
|
|
$
|
19.6
|
|
Power
Systems
|
|
6.5
|
|
5.6
|
|
6.1
|
|
Test
Systems(1)
|
|
|
|
2.5
|
|
12.3
|
|
Total
|
|
$
|
18.8
|
|
$
|
39.3
|
|
$
|
38.0
|
|
Note
:
(1)
Test Systems revenues include $nil million for engineering services in 2009,
$0.4 million for engineering services in 2008 and $3.5 million for engineering
services in 2007, primarily provided to General Motors.
For additional financial information by business segment,
see Note 19 Segmented Financial Information to our consolidated financial
statements, which can be found beginning on page F-
32
of this form, and is incorporated by reference herein.
21
Our revenues are
segmented by geographic location as follows:
|
|
2009
|
|
2008
|
|
2007
|
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
2,561
|
|
$
|
8,428
|
|
$
|
5,609
|
|
Canada
|
|
2,320
|
|
534
|
|
4,378
|
|
Germany
|
|
2,227
|
|
655
|
|
1,395
|
|
Turkey
|
|
1,857
|
|
77
|
|
|
|
France
|
|
1,678
|
|
1,144
|
|
2,633
|
|
India
|
|
1,361
|
|
85
|
|
774
|
|
Austria
|
|
1,147
|
|
|
|
3
|
|
Russia
|
|
793
|
|
12,927
|
|
5,629
|
|
Spain
|
|
791
|
|
1,815
|
|
138
|
|
Sweden
|
|
210
|
|
1,600
|
|
119
|
|
United Arab Emirates
|
|
187
|
|
20
|
|
1,255
|
|
United Kingdom
|
|
178
|
|
1,076
|
|
552
|
|
China
|
|
127
|
|
1,351
|
|
1,435
|
|
Romania
|
|
74
|
|
83
|
|
277
|
|
Belgium
|
|
43
|
|
2,020
|
|
|
|
Poland
|
|
34
|
|
639
|
|
|
|
Japan
|
|
24
|
|
492
|
|
2,256
|
|
Saudi Arabia
|
|
11
|
|
1,790
|
|
|
|
Brazil
|
|
1
|
|
712
|
|
2,017
|
|
Korea
|
|
|
|
1,271
|
|
1,070
|
|
Argentina
|
|
|
|
8
|
|
2,010
|
|
Slovenia
|
|
|
|
3
|
|
1,275
|
|
Rest of world
|
|
3,217
|
|
2,610
|
|
5,165
|
|
|
|
$
|
18,841
|
|
$
|
39,340
|
|
$
|
37,990
|
|
Our
Strategy
Our strategy is to
develop electrolyzer and fuel cell products for sale to OEMs, electric
utilities, merchant gas companies and end-users requiring highly reliable
products offered at competitive prices. We believe that our success will be
substantially predicated on the following factors:
Advancing Our Product Designs
Within our OnSite
Generation business segment, we are focused on reducing the cost of our HySTAT
®
electrolyzer
and improving its efficiency. Innovation in the design, elimination of non-
value adding components, improved sourcing and fundamental electrochemical
improvements have all contributed to continous cost reduction in 2009.
Recognizing the opportunity for larger scale energy storage installations we
are developing significant scale-up designs.
Within our Power Systems
business segment, we are focused on reducing the cost of a fuel cell system.A
remaining impediment to large scale adoption.
Significant milestones were reached in 2009. For market opportunities such as the home and
backup power market
22
requiring between
4 and 12 kilowatts of electrical power, we are developing a PEM based
electrolyzer. We are attempting to offset a portion of the associated
development expenses by entering into cost sharing agreements with OEMs and
government agencies.
Recently, we have seen
considerable interest in using hydrogen as a medium to store renewable energy,
particularly wind and solar power, due to the favourable characteristics of
hydrogen as an energy carrier. We are developing a renewable energy storage
product incorporating an alkaline electrolyzer, PEM fuel cell electrical
generator and associated systems integration software. We anticipate adding
other proprietary technologies to this product offering based on continued
market intelligence. In time, we anticipate developing a product offering that
will benefit from ancillary electrical power services such as grid balancing
and load profiling.
Increasing Market Penetration
As at December 31,
2009, we had seven full time staff employed in sales functions. Our senior
management team is also actively involved in sales initiatives including
maintaining close contact with our more significant customers.
Additionally, we have
developed relationships with third parties that we believe are well positioned
in our relevant markets to identify new market opportunities for our products.
In the industrial gas market, these third parties include leading merchant gas
companies such as Air Liquide and Linde Gas. In the backup power market, these
third parties include leading OEMs such as Commscope Inc.
We have recently begun to
sell our renewable energy storage products to progressive electric power
utilities throughout the world seeking a robust and cost effective solution for
renewable energy storage. We have begun to access this market through trade
events, meeting directly with electrical utilities, and marketing to
governmental agencies mandated to provide power to remote communities.
Responding to Market Conditions
Macro-level changes in
the global economy began to impact our business in the fourth quarter of 2008
and continued to impact our business throughout 2009. While many things were
happening beyond our control, we focused on the actions we can control. We enhanced and realigned our sales
force. We intensified our marketing
efforts in the renewable energy storage field.
We undertook numerous further cost reduction initiatives to enhance our
overall cost structure and product cost profile.
The greatest areas of
concern for us were delays in decision making and project progress with our
customers. This led to delays in closing
orders and delays in product shipments as a result of customers not being able
to pay for the balance of their orders.
We have taken a number of
initiatives to better position ourselves including: (i) revised our annual
and three-year financial plans to reflect a more conservative outlook in our
relevant markets; (ii) incurred a charge of $0.5 million to implement a downsizing
in January 2009 involving 25 full-time positions representing
approximately $1.3 million of annual payroll costs; (iii) incurred a
charge of $0.4 to implement a further downsizing in December 2009
involving 11 full-time positions representing approximately $0.9 million of
annual payroll costs; (iv) implemented reduced work week programs; and (v) continued
to curtail or defer operating expenditures to reduce our overhead levels.
Securing Additional Capital
As at December 31,
2009, we had $11.0 million of cash, cash equivalents and restricted cash and
had $17.5 million of shareholders equity.
We have been pursuing a
number of options to raise additional capital to fund our cash requirements. In
2009, we completed the APIF Transaction raising $10.4 million prior to
transaction costs and established a credit facility for up to 3.5 million euro
with a Belgian based financial institution. Additionally, in January 2010,
we raised $5.0 million, before transaction costs, in a registered direct
offering. We continue to experience
challenging conditions as a result of weak capital markets and a lower share
price and anticipate this might adversely impact our ability to raise capital
on favourable terms in the future.
We do not anticipate
achieving a consistent level of profitability, and hence, generating consistent
positive cash flow from operations for the next several quarters. In 2009, our
business units incurred a net loss of $9.4 million.
The failure to raise
sufficient funds necessary to finance future cash requirements could adversely
affect our ability to pursue our strategy and negatively affect our operations
in future periods. We are addressing this matter by maintaining contact with
analysts and institutional investors to better articulate our investment
merits, and, advancing discussions with possible strategic investors.
We filed a final short
form base shelf prospectus with certain
Canadian
securities regulatory authorities on January 4, 2010 and a corresponding
registration statement on Form F-3, which was declared effective by the
U.S.
Securities and Exchange Commission on December 31, 2009. This will enhance our ability to access the
capital markets. On January 14,
2010, we completed a registered direct offering of common shares and warrants
with two institutional investors, resulting in gross proceeds of $5 million,
before placement agents fees and other offering expenses, pursuant to our
registration statement on Form F-3.
As a result of this offering, we may not issue any
23
additional
securities pursuant to the Form F-3 until January 14, 2011 based on
our current public float unless there was a significant increase in the market
price of our common shares. In addition,
even if the market price of our common shares were to increase significantly,
we could not in any event issue more than $4.5 million of additional securities
pursuant to our existing shelf prospectus.
For information regarding the shelf prospectus and the direct offering,
including information regarding restrictions that may affect our ability to
obtain financing as a result of the registered direct offering, see Item
3. Key Information Risk Factors
Risk
Factors Related to Our Financial Condition
If we are unsuccessful in increasing our revenues
and raising additional funding, we may possibly cease to continue as we
currently do, and Item 14. Material
Modifications to the Rights of Security Holders and Use of Proceeds Material
Modifications to the Rights of Security Holders. See also Item 3. Key Information Risk
Factors
Risk Factors Related to Our Financial Condition
We are currently involved in litigation
with Alpha Capital Anstalt, the outcome of which could adversely affect our
financial condition for information regarding our litigation with one of the
institutional investors.
Retaining and Engaging Our Staff
As at December 31,
2009, we had 130 full-time staff, the majority of whom have been employed by
the Company for several years and possess strong technical backgrounds with
extensive industry experience. We strive to maintain a high level of employee
engagement by offering compensation at market rates, providing interesting and
challenging work, and, over time, the opportunity to create wealth by
participating in our stock ownership program.
Our
Products and Services
Our products include
HySTAT hydrogen generation equipment in our OnSite Generation business and
HyPM® fuel cell products in our Power Systems business. A summary of our product lines is noted
below.
HySTAT Hydrogen Stations
HySTAT Hydrogen Stations
offer a dependable on-site supply of hydrogen for a variety of hydrogen
applications, including vehicle fueling, distributed power, and a variety of
industrial processes. From a selection
of versatile modular components, we configure the optimum HySTAT Hydrogen
Station to precisely meet customer needs for hydrogen generation and storage.
We also provide spare parts and service for our entire installed base.
We currently offer our
HySTAT Hydrogen Station in multiple configurations depending on the amount of
hydrogen required. This product is suitable for producing continuous or batch
supplies of hydrogen typically for industrial processing applications and
generates between 15 - 60 normal cubic meters per hour (Nm3/hr) of hydrogen.
Multiple standard units can be installed for larger applications with the
capability of generating up to 500 Nm3/hr of hydrogen.
HyPM® Fuel Cell Products
Our HyPM® fuel cell products provide high
performance, high efficiency electrical power from clean hydrogen fuel. The HyPM® product is well suited to compete
with existing battery applications by offering longer runtimes and life, at a
significantly smaller size and weight.
The HyPM® product line also competes with certain diesel power
applications by offering clean, quiet operation and higher demand
reliability. Our products are built on a
common platform allowing us to achieve volume purchasing and manufacturing
efficiencies.
·
HyPM® Fuel Cell Power Modules
.
Our HyPM® power module runs on high purity hydrogen and produces DC
power in standard outputs of 8, 12, 16 and 65 kW. This product is suitable for a wide range of
stationary, mobile and portable power applications. The HyPM® XR model is targeted at backup
power applications and the HyPM® HD model is targeted at motive power
applications.
·
HyPXTM Fuel Cell Power Pack
.
Our HyPXTM Power Pack includes a standard HyPM® power module integrated
with hydrogen storage tanks and ultracapacitors that provide higher power in
short bursts. This product has the same
form, fit and function as large battery packs used in devices such as forklift
trucks and tow tractors.
·
Integrated Fuel Cell Systems
.
Our integrated fuel cell systems are built around our HyPM® power
modules and are targeted to portable and stationary applications including
portable and auxiliary power units for military applications and direct current
or DC backup power system for cellular tower sites.
·
Engineering Development Services
.
We also enter into engineering development contracts with certain
customers for new or custom products.
24
Recent Developments
Fuel Cells
On April 27, 2009 we
sold a third HyPM® HD fuel cell power module as part of the Federal
Transit Administrations National Fuel Cell Bus Program (NFCBP).
On May 5, 2009, we
announced that two additional Hydrogenics fuel cell powered hybrid MidiBuses
have been put into operation. As we previously announced in 2008, the buses
were purchased by Vestische Strassenbahnen GmbH, a regional urban transit
authority located in Herten, Germany. There are now ten Hydrogenics-powered
MidiBuses in operation in Europe based on a Tecnobus S.p.A electric bus
platform.
On August 4, 2009,
we announced that we had received an additional order from Proterra LLC for a
zero-emission bus to be deployed in Fort Lewis, Washington. This is part of a
project led by the Center for Transportation and the Environment (CTE), sponsored under the Defense
Logistics Agencys (DLA)
Hydrogen and Fuel Cell Research and Development Program, and the third Proterra
EcoRide transit bus that will utilize our fuel cell power modules. Separately,
we have begun building two HyPM® HD 16 units for a zero-emission
EVAmerica, LLC Ecobus transit bus project to be demonstrated in Birmingham,
Alabama. This initiative, supported by a grant from the U.S. Department of Transportations
Federal Transit Administration to the University of Alabama at Birmingham (UAB), is led by a UAB research team
and also coordinated by CTE. The EVAmerica bus will be operated by the
Birmingham-Jefferson County Transit Authority and service the UAB campus as
well as metropolitan Birmingham.
On September 3,
2009, we announced that we were awarded a contract to provide HyPM 16 fuel
modules for use in zero emission class 8 short haul trucks being developed by
Vision Industries Corp. (OTC.BB:VIIC) of California. Visions Tyrano truck is
thought to be the worlds first plug-in electric/hydrogen fuel cell powered
heavy duty class 8 vehicle.
On January 4, 2010,
we announced that we have entered into an agreement with Rosetti Marino S.p.A.,
to jointly design, develop and commercialize utility-scale hydrogen power
plants for peak shaving and energy management. The plants will incorporate our
electrolyzer and fuel cell systems for turnkey applications that produce
hydrogen for energy storage and electricity generation. Rosetti Marino will
provide expertise in large-scale gas compression, storage, and facility design.
Electrolyzers
On April 30, 2009,
we announced the installation of two HySTAT electrolyzers in Europe for
fueling station applications. In conjunction with Heliocentris Fuel Cells AG, a
German fuel cell systems integrator, we have installed a hydrogen-generating
electrolyzer at a bus fueling station in Barth, Germany. Also we installed,
with Schwelm of Germany, an electrolyzer in Dunkirk, France for a similar
hydrogen fueling application. In Barth, our electrolyzer will be the heart of a
solar-assisted gas generation system, providing a zero-emission fueling
solution for a bus also powered by one of our fuel cells. While producing
clean, renewable fuel, the gas generation system will simultaneously provide
oxygen to increase the efficiency of a municipal water treatment facility,
saving capital costs for an otherwise necessary extension of treatment
capacity. The Dunkirk fueling station is already operational, with buses
running on a blend of hydrogen and natural gas. Dunkirk is the first city in
France to have a public hydrogen station.
On August 31, 2009,
we announced that we had received orders from Groupe Cevital of Algeria and the
Obeikan Investment Group of Saudi Arabia for electrolyzers worth, in aggregate,
approximately $5 million. These Hydrogenics HySTAT units will be used to
produce high-quality hydrogen for vegetable oil processing and glass
production.
On September 23,
2009, we announced that we had received an order from one of Indias largest
steel manufacturers, Bhushan Power & Steel Limited, for a 2 megawatt
installation of HySTAT electrolyzers.
As noted above, on January 4,
2010, we announced that we have entered into an agreement with Rosetti Marino
S.p.A., to jointly design, develop and commercialize utility-scale hydrogen
power plants for peak shaving and energy management.
On January 8, 2010,
we announced the award of a development contract with the Canadian Space Agency
for the development of a next generation power system to be used for surface
mobility applications on the moon. The scope of the contract includes an
electrolyzer that produces both hydrogen and oxygen using solar power and a
fuel cell system to be used for mobility, auxiliary, and life support systems.
Pursuant to this contract we have partnered with MacDonald, Dettwiler and
Associates Ltd., Routes AstroEngineering and the University of Waterloo.
We recently
entered
into a global purchase and supply agreement with Linde AG, dated as of March 22,
2010, which supersedes our previous agreements with Linde AG and will govern
sales of electrolytic hydrogen generators and other industrial gas production
and purification equipment and related accessories and services to Linde AG.
25
Renewable Energy Projects
in Europe
On July 28, 2009 we
received orders for two fuel cell power module systems one in Greenland and
the other in France for renewable energy projects. At both locations, we will
deliver HyPM Rack stationary systems to be utilized for primary and backup
power. In Greenland, the power modules will be delivered to Nukissiorfiit, the
national energy company, in the capital of Nuuk as part of project H2KT. This
initiative will demonstrate the
potential of using hydrogen for
energy storage and management in Greenland, such that the country can better
utilize its natural hydro-generation resources. In France, the power modules
will be used for energy generation to supplement photovoltaic and wind power at
the new headquarters of the Abalone Group, a human resources consulting firm
located in the city of Nantes. The Abalone building is planned to be totally
independent of the national electricity grid.
Sales and Marketing
We have a direct sales
force of seven full-time sales professionals in Belgium, Canada, China,
Germany, India, Russia and the United States, along with a global network of
sales agents and distribution channels.
We believe that our ability to market and sell a diversified product
portfolio through global sales and distribution channels provides us with an
advantage over our competitors. Our
sales force is largely organized by region for each business unit.
Customers
The primary customers for
our OnSite Generation products are leading industrial gas companies, industrial
end users, oil and gas companies and utilities. The primary customers for our
Power Systems products are OEMs, systems integrators and end users.
In 2009, three customers
comprised 9%, 7% and 6% of our revenue (in 2008, three customers comprised 18%,
7% and 5% of our revenue). In 2009, 34%
of our revenues were derived from Europe, 26% from North America,
8
%
from Asia, and the remaining 32% were derived from other foreign jurisdictions
(in 2008, these numbers were 24%, 22%, 45% and 9%, respectively). Accordingly, we have mitigated risk to any
single market or adoption rate by diversifying our product portfolio across the
markets in which we operate.
We have entered into
agreements with several customers to pursue commercial opportunities which we
view as important to our success. Our
key customer agreements are summarized below.
·
Military OEM
.
In December 2005, we entered into a multi-year joint cooperation
agreement with a military OEM. For
reasons of confidentiality, we cannot disclose the name of this OEM. In conjunction with the signing of the
cooperation agreement, we were awarded an $8 million contract for multiple
units of fuel cell power systems based on our 500 series fuel cell stack
technology.
·
Leading Global Industrial Gas
Companies
. We have previously established preferred
supplier agreements with Air Liquide S.A., Air Products and Chemicals, Inc.,
and Linde A.G., three of the leading global industrial gas companies. Typically, these agreements provide that, for
industrial applications, we will be the preferred supplier of onsite,
electrolysis-based hydrogen generators to the applicable industrial gas
company. We believe that these
relationships represent valuable sales channels, while providing validation of
our technology from highly credible partners.
·
General Motors
.
In October 2001, we entered into an agreement with General Motors
to accelerate the development of fuel cell technology. This agreement includes shared intellectual
property rights and joint efforts in fuel cell product development, engineering,
prototyping, testing, branding and marketing strategies. In connection with
this agreement, we issued General Motors approximately 11.4 million of our
common shares on a pre-consolidation basis, or 456,000 common shares on a
post-consolidation basis, or approximately 21% of our then outstanding common
shares, and warrants to purchase approximately 2.5 million additional common
shares on a pre-consolidation basis, or approximately 100,000 additional common
shares on a post-consolidation basis.
These warrants were subsequently cancelled in December 2005 (see Item
7. Major Shareholders and Related Party Transactions Related Party
Transactions Transactions with General Motors).
Research and Product Development
Our research and product
development team consists of approximately 11 staff, the substantial majority
of whom are located in Mississauga, Ontario and are focused primarily on our
fuel cell activities. The remainder is located in Oevel, Belgium. Collectively, these individuals have many years
of experience in the design of electrolysis and fuel cell products. Our product
development team combines leaders with extensive experience in their fields
with younger graduates from leading universities.
Our objective is to
develop complete products rather than components and to ensure that these
products are constantly improved throughout the product life. Our research activities are unique to each of
our business units but typically focus on the cost, performance and durability
of our products. Our product development activities commence with a market
requirement document establishing the business case
26
for the proposed
product. This process involves staff from our business development, finance,
engineering and operations departments who balance the requirements of
performance, time to market, and product cost.
Prototypes are often validated by lead customers such as CommScope, Inc.
We seek cost-sharing
projects with various government agencies, mainly in North America, to
partially offset our research and product development expenses. We currently have contribution agreements
with the Province of Ontario, Ministry of Research and Innovation, and with the
Canada Foundation for Sustainable Development Technology, a corporation without
share capital incorporated under the Canada Corporations Act and continued
under the Sustainable Development Technology Act (Canada). In 2009, $1.4 million, or 21% of our research
and product development expenses were funded by various governments.
Our current research and
product development plans are summarized below:
·
OnSite Generation
. Our research activities are focused on
performance improvements of our electrolyzer cell stacks. Our product
development activities are focused on large scale electrolyzers to store
renewable or other zero-emission energy as hydrogen, thereby helping to address
the intermittency problem associated with most renewable energies, or to refuel
vehicles from locally-produced non-fossil sources. Our larger-scale and
lower-scale product developments aim to make Hydrogenics the one-stop shop
for all on-site hydrogen generation needs.
·
Power Systems
.
At the fuel cell stack, or component level, we are focused on testing,
adapting and integrating new materials, design concepts, manufacturing
techniques, and on cost reduction. At
the module or product level, we are focused on cost reduction and on meeting
market specific requirements for durability and performance. Additionally, our
product development focuses on size reduction, allowing the same power module
to be deployed in both mobile and stationary applications. Our product development
also focuses on small scale PEM electrolyzers, which we believe will have
greater demand due to their lower cost and size in the small capacity range of
<10 Nm3/h.
Intellectual Property
We protect our
intellectual property by means of a combination of patent protection,
copyrights, trademarks, trade secrets, licences, non-disclosure agreements and
contractual provisions. We generally enter into a non-disclosure and
confidentiality agreement with each of our employees, consultants and third
parties that have access to our proprietary technology. We currently hold 87 patents in a variety of
jurisdictions and have more than 88 patent applications pending. Additionally, we enter into commercial
licences and cross-licences to access third party intellectual property.
We typically retain sole
ownership of intellectual property developed by us. In certain situations, such
as with Dow Corning and General Motors, we provide for shared intellectual
property rights. In the case of General Motors, we have a non-exclusive,
royalty-free license to use certain of General Motors proprietary fuel cell
stack intellectual property in certain applications and markets. We have these rights in perpetuity, including
subsequent improvements to the licensed technology. In the case of Dow Corning,
we jointly own a U.S. patent application, together with all inventions falling
within the description of such patent application specific to sealing and
sealing materials for fuel cell and electrolyzer assemblies.
Given the relative early
stages of our industry, our intellectual property is and will continue to be
important in providing differentiated products to customers.
Manufacturing
The majority of our
manufacturing services, including parts procurement, kitting, assembly and
repair, are carried out in-house at our respective business unit manufacturing
facilities. We also perform certain manufacturing related functions in-house,
including manufacturing engineering, and the development of manufacturing test
procedures and fixtures.
We anticipate being able
to move various aspects of our manufacturing operations to third parties or
other lower cost jurisdictions as production volumes increase. By moving to third parties, we would benefit
from contract manufacturing economies of scale, access to high quality
production resources and reduced equipment capital costs and equipment
obsolescence risk. We have also
commenced sourcing components from third parties in Asia and expect to increase
the volume over time to reduce our material costs.
We are dependent upon
third party suppliers for certain key materials and components for our products
such as membrane electrode assemblies and ultra capacitors. We believe that we have sufficient sources
and price stability of our key materials and components.
We have certifications in
ISO 9001-2000 in both of our Oevel and Mississauga facilities, and ISO 14001
and OHSAS 18001 in our Oevel facility.
27
Government
Regulation
We are not subject to
regulatory commissions governing traditional electric utilities and other
regulated entities in any of the jurisdictions in which we operate. Our
products are however subject to oversight and regulation by governmental bodies
in regard to building codes, fire codes, public safety, electrical and gas
pipeline connections and hydrogen siting, among others.
ORGANIZATIONAL
STRUCTURE
As of March 25,
2010, we beneficially owned, directly or indirectly, 100% of the voting and
non-voting securities of the material subsidiaries listed below.
Subsidiaries
|
|
Jurisdiction
of Incorporation
|
|
|
|
Hydrogenics Europe NV
|
|
Belgium
|
|
|
|
Hydrogenics GmbH
|
|
Germany
|
PROPERTY,
PLANT AND EQUIPMENT
We have the following
facilities:
·
Mississauga, Ontario, Canada
.
Our 96,000 square foot facility in Mississauga, Ontario serves as our
corporate headquarters and Power Systems manufacturing facility and is leased
until August 31, 2010. Principal activities at this facility include the
manufacture and assembly of our fuel cell power and research and product
development for our fuel cell power products, fuel cell testing services and
our corporate activities. We expect to
vacate this facility upon its expiration on August 31, 2010 and enter into
a new lease in Mississauga for a smaller facility and lower annual cost
compared to our current Mississauga facility.
·
Oevel-Westerlo, Belgium
.
Our 32,000 square foot facility in Oevel-Westerlo, Belgium serves as our
manufacturing facility for our OnSite Generation business and is leased until August 30,
2014. Principal activities at this
facility include the manufacture and assembly of our hydrogen generation
equipment, water electrolysis research and product development as well as
administrative functions related to our OnSite Generation business.
·
Gladbeck, Germany
.
Our Power Systems group maintains a 6,458 square foot facility in
Gladbeck, Germany, which is leased until November 2010. This facility is used to provide fuel cell
integration services for European customers and serves as our European office
for fuel cell activities of our Power Systems business.
·
Shanghai, China
.
Our procurement group maintains a 100 square foot facility in Shanghai,
China. This facility is used for sourcing of products in China and other Asian
countries.
In 2005, we assumed lease
obligations previously established by Stuart Energy, including a vacant 53,240
square foot facility in Shawinigan, Quebec, with an annual lease cost of
approximately $0.3 million expiring in May 2011. This Shawinigan property was sublet in
2006. In connection with its acquisition
of Vandenborre Technologies NV in February 2003, Stuart Energy sought to
rationalize its operations in 2003. As a
result, Stuart Energy has previously taken a financial charge relating to the
Shawinigan, Quebec facility.
We also have small sales
offices in Asia, Europe, and North America.
We believe our facilities are presently adequate for our operations and
we will be able to maintain suitable space needed on commercially reasonable
terms.
ITEM
4A. UNRESOLVED STAFF COMMENTS
None.
28
ITEM
5. OPERATING AND FINANCIAL REVIEW AND
PROSPECTS
OPERATING
RESULTS
This section provides a
detailed discussion of our financial performance based on our consolidated
financial statements. All references to
per share amounts pertain to net loss per share. Certain of the prior years
figures have been reclassified to conform to the current years presentation.
Summary
Financial Analysis
(in thousand of U.S.
dollars, except per share amounts)
|
|
|
|
|
|
|
|
% Increase
(Decrease)
|
|
|
|
200
9
|
|
2008
|
|
2007
|
|
2009
|
|
2008
|
|
Consolidated Statements of Operations
|
|
|
|
|
|
|
|
|
|
|
|
OnSite
Generation
|
|
12,303
|
|
31,207
|
|
19,608
|
|
(61
|
)
%
|
59
|
%
|
Power
Systems
|
|
6,538
|
|
5,643
|
|
6,103
|
|
16
|
%
|
(8
|
)%
|
|
|
18,841
|
|
36,850
|
|
25,711
|
|
(49
|
)
%
|
43
|
%
|
Test
Systems
|
|
|
|
2,490
|
|
12,279
|
|
(100
|
)
%
|
(80
|
)%
|
Revenues
|
|
18,841
|
|
39,340
|
|
37,990
|
|
(52
|
)
%
|
4
|
%
|
Gross
Margin
|
|
3,728
|
|
7,894
|
|
4,389
|
|
(52
|
)
%
|
80
|
%
|
% of
Revenues
|
|
20
|
%
|
20
|
%
|
12
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling,
General and Administrative Expenses
|
|
16,995
|
|
15,022
|
|
24,006
|
|
13
|
%
|
(37
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
Research
and Product Development Expenses
|
|
5,219
|
|
7,296
|
|
9,690
|
|
(28
|
)
%
|
(25
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Loss
|
|
(9,375
|
)
|
(14,319
|
)
|
(28,068
|
)
|
(35
|
)
%
|
(49
|
)%
|
Net
Loss Per Share
|
|
$
|
(2.54
|
)
|
$
|
(3.89
|
)
|
$
|
(7.64
|
)
|
(35
|
)
%
|
(49
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
Cash
used in Operating Activities
|
|
(11,085
|
)
|
(6,758
|
)
|
(28,416
|
)
|
64
|
%
|
(76
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Measures
|
|
|
|
|
|
|
|
|
|
|
|
Cash
Operating Costs(1)
|
|
21,801
|
|
21,624
|
|
32,143
|
|
1
|
%
|
(33
|
)%
|
Earnings
Before Interest, Taxes, Depreciation and Amortization (EBITDA) (1)
|
|
(18,486
|
)
|
(14,424
|
)
|
(31,323
|
)
|
28
|
%
|
(54
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note
:
(1)
Cash Operating Costs and EBITDA are Non-GAAP measures. Please refer to Item
5. Operating and Financial Review and Prospects Operating Results
Reconciliation and Definition of Non-GAAP Measures.
Highlights for 2009 compared to 2008
·
Revenues were $18.8 million for the year
ended December 31, 2009. Excluding Test Systems, revenues decreased 49%
from the comparable period in 2008 resulting from variations in timing of
delivery of products combined with lower order intake, primarily in our OnSite
Generation business unit.
·
Cash operating costs, exclusive of $3.3
million of transaction related expenses associated with our transaction with
the trustees of Algonquin Power Income Fund, were $18.5 million, a 14% decrease
from $21.6 million in 2008. Cash
operating costs for the year ended December 31, 2009 include: (i) $1.0
million of costs related to business streamlining initiatives; (ii) $0.4
million of
29
costs associated
with deferred compensation arrangements indexed to our share price; and (iii) $0.6
million of costs attributable to our Test Systems business unit.
·
EBITDA loss increased $4.1 million or
28%, reflecting: (i) a $4.1 million decrease in gross margin as a result
of lower revenues; (ii) $3.3 million of transaction related expenses
associated with the APIF Transaction; offset by (iii) a $2.1 million decrease
in research and product development expenses; and (iv) $1.2 million of
other items.
·
Net loss decreased $4.9 million or 35%
($0.06 per share), reflecting an $18.5 million EBITDA loss, offset by a $10.4
million recovery of income taxes as a result of the APIF Transaction.
·
Cash used in operating activities
increased $4.3 million or 64%, reflecting; (i) a $4.8 million decrease in
our net loss; offset by (ii) an $8.3 million increase in non-cash working
capital requirements; and (iii) $0.8 million of capital expenditures.
Highlights for 2008 compared to 2007
·
Revenues increased $11.1 million or 43%,
exclusive of Test Systems revenues, as a result of revenue growth in our OnSite
Generation business unit.
·
Cash operating costs decreased $10.5
million or 33%, primarily resulting from our 2007 business streamlining
initiatives and the decision to wind up our test equipment business and the
absence of $4.1 million in severance and related expenses.
·
EBITDA loss decreased $16.9 million or
54%, reflecting: (i) a $3.5 million increase in gross margin corresponding
to an increase of eight percentage points; (ii) a $9.0 million decrease in
selling, general and administrative expenses; (iii) a $2.4 million
decrease in research and product development expenses; and (iv) the
absence of a $2.0 million provision recorded in 2007 in respect of the wind up
of our test equipment business.
·
Net loss decreased $13.8 million or 49%
($3.75 per share), reflecting a lower EBITDA loss, partially offset by
decreased interest income and foreign currency gains.
·
Cash used in operating activities
decreased $21.6 million, or 76% reflecting; (i) a $16.9 million decrease
in our EBITDA loss; (ii) an $8.9 million decrease in non-cash working
capital requirements; offset by (iii) a $3.8 million decrease in net
interest income and
foreign currency gains; and (iv) $0.3
million of other items.
Business
Segment Review
We report our results in
four business segments, OnSite Generation, Power Systems, Test Systems, and
Corporate and Other. These segments are differentiated by the products
developed. Our reporting structure reflects how we manage our business and how
we classify our operations for planning and measuring performance. See Item
4. Information on the Company Business
Overview for a description of our business segments.
OnSite Generation
Summary Financial
Analysis
|
|
|
|
|
|
|
|
% Increase
(Decrease)
|
|
(in thousand of U.S. dollars)
|
|
2009
|
|
2008
|
|
2007
|
|
2009
|
|
2008
|
|
Revenues
|
|
12,303
|
|
31,207
|
|
19,608
|
|
(61
|
)
%
|
59
|
%
|
Gross
Margin
|
|
2,608
|
|
6,919
|
|
610
|
|
(62
|
)
%
|
1034
|
%
|
% of
Revenues
|
|
21
|
%
|
22
|
%
|
3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling,
General and Administrative Expenses
|
|
2,877
|
|
3,552
|
|
4,182
|
|
(19
|
)
%
|
(15
|
)%
|
Research
and Product Development Expenses
|
|
1,489
|
|
1,261
|
|
1,865
|
|
18
|
%
|
(32
|
)%
|
Segment
Income/(Loss)
|
|
(1,758
|
)
|
2,106
|
|
(5,436
|
)
|
(183
|
)
%
|
(139
|
)%
|
Revenues
for 2009 were $12.3
million, a decrease of $18.9 million or 61%
. This decrease is due to: (i) variations in the
timing of project deliveries; (ii) a 6% increase in the value of the U.S.
dollar relative to the euro; and (iii) lower order intake. We believe the
lower order intake is the result of prevailing conditions in credit markets and
the current global economy. Revenues for
the year ended December 31, 2009 consisted of the sale of electrolyzer
products to customers in industrial gas and renewable energy markets. As at December 31,
2009, we had $16.4 million of confirmed orders (December 31, 2008 - $14.8
million), substantially all of which are anticipated to be delivered and
recognized as revenue in 2010.
30
Revenues for 2008 were
$31.2 million, an increase of $11.6 million or 59% compared to 2007, as a
result of increased product demand, operational improvements and product cost
reductions. Revenues in 2008 consisted of the sale of electrolyzer products to
customers in industrial gas, hydrogen fueling and renewable energy storage
markets.
Gross
Margin
for
2009 was $2.6 million (21% of revenues), compared to $6.9 million (22% of
revenues) in 2008. The decrease in gross
margin in 2009 over 2008 is primarily the result of lower revenue as well as a
6% increase in the value of the U.S. dollar relative to the euro. Gross margin
for 2008 was $6.9 million (22% of
revenues), compared to $0.6 million (3% of revenues) in 2007, reflecting
operational improvements and increased overhead absorption.
Selling, General and Administrative (SG&A) Expenses
for 2009 were $2.9 million, a decrease of $0.7 million or 19%.
SG&A expenses for 2008 were $3.6 million, a decrease of $0.6 million or 15%
compared to 2007. These decreases are primarily the result of
streamlining and cost reduction initiatives.
In 2009, these decreases reflect a 6% increase in the U.S. dollar relative to
the euro.
Research
and Product Development (R&D) Expenses
for 2009 were $1.5 million, an increase
of $0.2 million or 18%. The increase in 2009 is attributable to increased
material consumption for experimentation and prototyping trials to support our
renewable energy product development efforts. R&D expenses for 2008 were
$1.3 million, a decrease of $0.6 million or 32% compared to 2007,and reflect
the adoption of a standard product platform to service multiple market
applications.
Segment
Loss
for 2009
was $1.8 million, an increase of $3.8 million or 183% primarily reflecting
decreased gross margins resulting from lower revenues. Segment income for 2008 was $2.1 million
compared to a segment loss of $5.4 million in 2007, reflecting increased
product demand combined with operational improvements, cost efficiencies and
increased overhead absorption.
Power Systems
Summary Financial
Analysis
|
|
|
|
|
|
|
|
% Increase
(Decrease)
|
|
(in thousand of U.S. dollars)
|
|
2009
|
|
2008
|
|
2007
|
|
2009
|
|
2008
|
|
Revenues
|
|
6,538
|
|
5,643
|
|
6,103
|
|
16
|
%
|
(8
|
)%
|
Gross
Margin
|
|
853
|
|
214
|
|
846
|
|
299
|
%
|
(75
|
)%
|
% of
Revenues
|
|
13
|
%
|
4
|
%
|
14
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling,
General and Administrative Expenses
|
|
4,309
|
|
4,162
|
|
8,247
|
|
4
|
%
|
(50
|
)%
|
Research
and Product Development Expenses
|
|
3,516
|
|
5,808
|
|
6,882
|
|
(39
|
)
%
|
(16
|
)%
|
Segment
Loss
|
|
(6,972
|
)
|
(9,757
|
)
|
(14,283
|
)
|
(29
|
)
%
|
(32
|
)%
|
Revenues
for 2009 were $6.5 million, an increase of $0.9
million or 16% compared to 2008 and primarily reflect timing of project
deliveries and a higher proportion of revenues from custom and pre-commercial
markets. As at December 31, 2008, we had $3.3 million (December 31,
2008-$7.6 million) of confirmed orders for Power Systems products and services,
over half of which are anticipated to be delivered and recognized as revenue in
2010. Revenues for 2008 were $5.6 million, a decrease of $0.5 million or 8%
compared to 2007 and reflect a higher proportion of revenues from backup power
and motive power markets, as opposed to pre-commercial markets, consistent with
our business plan.
Gross
Margin
for
2009 was $0.9 million (13% of revenues) compared to $0.2 million (4% of
revenues) in 2008, reflecting a higher proportion of custom and pre-commercial
market revenues which generally have a higher gross margin. Gross margin for 2008 was $0.2 million (4% of
revenues) compared to $0.8 million (14% of revenues) in 2007 reflecting a
higher proportion of revenues from backup power and motive power markets which generally
have lower margin as we aim to replace incumbent technologies in these markets.
SG&A
Expenses
for 2009 were $4.3 million, an increase
of $0.2 million or 4%. This increase reflects $1.0 million of costs incurred associated
with business streamlining initiatives during the first and fourth quarters of
2009, partially offset by the resulting decreased costs from these business
streamlining initiatives and an increase in the value of the U.S. dollar
relative to the euro. SG&A expenses for 2008 were $4.2 million, a decrease of $4.1
million or 50%, compared to 2007, and reflect the results of streamlining
and cost reduction initiatives and the absence of $2.9 million in severance and
related expenses associated with initiatives commenced in 2007.
R&D
Expenses
for
2009 were $3.5 million, a decrease of $2.3 million or 39% compared to 2008, and
are attributable to streamlining and cost reduction initiatives. R&D
expenses for 2008 were $5.8 million, a decrease of $1.1 million or 16% compared
to 2007, and reflect a $0.3 million decrease in R&D expenditures
attributable to developing standard products for multiple market applications
combined with $0.8 million of increased third party funding as a result of the
partial deployment of Class 1 forklifts for long-term customer testing.
31
Segment
Loss
for 2009 was $7.0 million compared to $9.8 million
in 2008, reflecting increased gross margin and decreased R&D expenditures
resulting from our streamlining and cost reduction initiatives undertaken
during 2009, offset by a $0.2 million increase in SG&A expenses. Segment
loss for 2008 was $9.8 million compared to a segment loss of $14.3 million in
2007, reflecting $0.5 million of decreased gross margin, $4.1 million in
decreased SG&A expenses, and $2.0 million in decreased R&D expenditures
resulting from our streamlining and cost reduction initiatives undertaken
during 2007, and lower gross margin.
Test
Systems
Summary Financial Analysis
|
|
|
|
|
|
|
|
% Increase (Decrease)
|
|
(in thousand of U.S. dollars)
|
|
2009
|
|
2008
|
|
2007
|
|
200
9
|
|
2008
|
|
Revenues
|
|
|
|
2,490
|
|
12,279
|
|
(100
|
)
%
|
(80
|
)%
|
Gross Margin
|
|
267
|
|
762
|
|
2,936
|
|
(65
|
)
%
|
(74
|
)%
|
% of Revenues
|
|
n/a
|
%
|
31
|
%
|
24
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, General and Administrative Expenses
|
|
574
|
|
1,171
|
|
2,069
|
|
(51
|
)
%
|
(43
|
)%
|
Research and Product Development Expenses
|
|
|
|
60
|
|
318
|
|
(100
|
)
%
|
(81
|
)%
|
Wind-up of Test Equipment Business Expense
|
|
|
|
|
|
2,016
|
|
0
|
%
|
(100
|
)%
|
Segment Income/(Loss)
|
|
(307
|
)
|
(469
|
)
|
(1,465
|
)
|
(35
|
)
%
|
(68
|
)%
|
Revenues
for 2009 were nil, compared
to $2.5 million in 2008 and $12.3 million in 2007. These decreases are the
result of our decision in 2007 to wind up our test equipment business. Test Systems revenues for 2008 relate to the
delivery of orders received prior to our decision to wind up this business. As
at December 31, 2009, we had no orders for Test Systems products and
services remaining to be delivered.
Gross
Margin
for 2009 was $0.2 million compared to $0.8 million
(31% of revenues) in 2008 and $2.9 million (24% of revenues) in 2007,
reflecting the reversal of warranty accruals .
Gross margin in 2008 and 2007 reflected the gross margin realized on our
remaining orders.
SG&A
Expenses
for 2009 were $0.6 million, a decrease of $0.6
million from 2008 and $0.9 million for 2007. The reductions in both years
reflect our decision to downsize and subsequently wind-up our test equipment
business.
R&D
Expenses
for 2008 and 2009 were less than $0.1 million, a
decrease of $0.3 million from 2007. The reductions in both years reflect our
decision to downsize and subsequently wind-up our test equipment business.
Wind-up of Test
Equipment Business
Expenses
for
2008 and 2009 were nil, a decrease of $2.0 million or 100% compared to 2007 as
a result of incurring $2.0 million of costs in 2007 relating to the wind-up of
our test equipment business as announced on November 7, 2007. In 2008, we
incurred $0.6 million of costs attributable to the wind-up of our test
equipment business which were allocated to the various accounts as incurred. We
anticipate incurring less than $0.1 million of costs in 2010 to complete the wind-up
of our test equipment business. In November 2007, we indicated that we
anticipated incurring a cash cost and corresponding charge to earnings between
$3.5 million and $4.0 million to complete the wind-up of our test equipment
business. Consistent with 2008, we continue to expect to incur a total of $3.5
million to wind-up our test equipment business, ahead of our initial outlook.
Segment
Loss
for 2009 was $0.3 million compared to a segment loss
of $0.5 million in 2008 and a segment loss of$1.5 million in 2007.
Corporate
and Other
Summary Financial Analysis
|
|
|
|
|
|
|
|
% Increase (Decrease)
|
|
(in thousands of U.S. dollars)
|
|
2009
|
|
2008
|
|
2007
|
|
2009
|
|
2008
|
|
Selling, General and Administrative Expenses
|
|
9,235
|
|
5,444
|
|
7,957
|
|
69
|
%
|
(32
|
)%
|
Research and Development Expenses
|
|
214
|
|
167
|
|
625
|
|
28
|
%
|
(73
|
)%
|
Segment Loss
|
|
(338
|
)
|
(6,199
|
)
|
(6,884
|
)
|
(95
|
)
%
|
(10
|
)%
|
SG&A
Expenses
for 2009 were $9.2 million in 2009, an increase
of $3.8 million or 70%. This increase is the result of: (i) $3.3 million
transaction related expenses associated with the APIF Transaction; (ii) $1.0
million of costs related to business streamlining initiatives; and (ii)
32
$0.5 million of deferred
compensation costs indexed to our share price; partially offset by (iii) lower
costs as a result of business streamlining initiatives. SG&A expenses for
2008 were $5.4 million, a decrease of $2.5 million or 32% compared to 2007
reflecting: (i) the results of our streamlining and cost reduction initiatives
undertaken in the fourth quarter of 2007; and (ii) the absence of $1.0
million in severance and other related expenses associated with these
streamlining and cost reduction initiatives; partially offset by (iii) $0.3
million of costs incurred associated with various financing initiatives.
R&D
Expenses
for 2009 were $0.2 million, an increase of less
than $0.1 million compared to 2008, reflecting increased intellectual property
fees in 2009. R&D expenses for 2008
decreased $0.5 million or 73% compared to 2007, reflecting decreased
intellectual property fees.
Segment
Loss
for 2009 was $0.3 million, a decrease of $5.9
million or 95% primarily as a result of the APIF Transaction generating
proceeds of Cdn. $10.8 million, prior to transaction costs. Segment loss for
2008 was $6.2 million, a decrease of $0.7 million or 10% compared to 2007,
attributable to reduced operating costs as a result of streamlining initiatives
taken in 2007.
Financial Condition
A discussion of the significant changes in our consolidated
balance sheets.
As at December 31, (in thousands of U.S.
dollars)
|
|
|
|
|
|
Change
|
|
|
|
|
|
2009
|
|
2008
|
|
$
|
|
%
|
|
Commentary
|
|
Cash, cash equivalents
restricted cash and short-term investments
|
|
$
|
11,002
|
|
$
|
22,731
|
|
(11,729
|
)
|
(52
|
)%
|
·
Refer to Item 5. Operating and Financial Review and
Prospects Liquidity and Capital Resources.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
3,685
|
|
3,974
|
|
(289
|
)
|
(7
|
)%
|
·
Lower
revenues, offset by $0.4 million receivable from the APIF Transaction.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventory
|
|
11,746
|
|
10,101
|
|
1,645
|
|
16
|
%
|
·
$3.2 million increase in finished goods awaiting customer payment
and/or delivery offset by $1.7 million of decreased raw materials.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable and
accrued liabilities
|
|
14,782
|
|
17,298
|
|
(2,516
|
)
|
(15
|
)%
|
·
Improved product lead times and decreased raw material inventory
levels. Refer to note 9 to our consolidated financial statements for a
breakdown of this account.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unearned revenue
|
|
4,546
|
|
4,785
|
|
(239
|
)
|
(5
|
)%
|
·
Reduction in revenues offset by higher proportion of deposits.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33
As at December 31, (in thousands of U.S.
dollars)
|
|
|
|
|
|
Change
|
|
|
|
|
|
2008
|
|
2007
|
|
$
|
|
%
|
|
Commentary
|
|
Cash, cash equivalents
restricted cash and short-term investments
|
|
$
|
22,731
|
|
$
|
30,492
|
|
(7,761
|
)
|
(25
|
)
|
·
Please refer to Item 5. Operating and Financial Review and Prospects
Liquidity and Capital Resources.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
3,974
|
|
12,713
|
|
(8,739
|
)
|
(69
|
)
|
·
Improved management of accounts receivable and strong cash
collections prior to year-end.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventory
|
|
10,101
|
|
12,659
|
|
(2,558
|
)
|
(20
|
)
|
·
Decreased work-in-process as a result of improved product lead times.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable and
accrued liabilities
|
|
17,298
|
|
18,166
|
|
(868
|
)
|
(5
|
)
|
·
Improved product lead times and decreased inventory levels.
·
Refer to note 11 to our consolidated financial statements for the
year ended December 31, 2008, which was filed with the SEC on
August 12, 2009 as part of our amendment no. 1 to the Form 20-F for
the year ended December 31, 2008, for a breakdown of this account.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unearned revenue
|
|
4,785
|
|
9,042
|
|
(4,257
|
)
|
(47
|
)
|
·
Fewer deposits for orders received prior to the end 2008 compared to
2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34
Summary Of Quarterly
Results
A summary view of our quarterly financial performance.
The following
table highlights selected financial information for the eight consecutive
quarters ending December 31, 2009.*
(in thousands of U.S. dollars, except for share
and per share amounts)
|
|
2009
|
|
2008
|
|
|
|
Q4
|
|
Q3
|
|
Q2
|
|
Q1
|
|
Q4
|
|
Q3
|
|
Q2
|
|
Q1
|
|
Revenues
|
|
$
|
4,207
|
|
$
|
3,558
|
|
$
|
5,540
|
|
$
|
5,536
|
|
$
|
8,855
|
|
$
|
10,984
|
|
$
|
8,790
|
|
$
|
10,711
|
|
Gross Margin
|
|
665
|
|
575
|
|
857
|
|
1,631
|
|
2,568
|
|
1,488
|
|
1,973
|
|
1,865
|
|
% of Revenues
|
|
16
|
%
|
16
|
%
|
16
|
%
|
30
|
%
|
29
|
%
|
14
|
%
|
22
|
%
|
17
|
%
|
EBITDA**
|
|
(4,058
|
)
|
(5,159
|
)
|
(5,510
|
)
|
(3,759
|
)
|
(2,004
|
)
|
(3,446
|
)
|
(5,066
|
)
|
(3,908
|
)
|
Net Profit (Loss)
|
|
6,071
|
|
(5,439
|
)
|
(6,010
|
)
|
(3,997
|
)
|
(1,950
|
)
|
(3,728
|
)
|
(4,319
|
)
|
(4,322
|
)
|
Net Profit (Loss) Per
Share (Basic and diluted)
|
|
1.64
|
|
(1.47
|
)
|
(1.63
|
)
|
(1.08
|
)
|
(0.53
|
)
|
(1.01
|
)
|
(1.18
|
)
|
(1.18
|
)
|
Weighted Average Common
Shares Outstanding
|
|
3,699,795
|
|
3,696,607
|
|
3,696,284
|
|
3,696,226
|
|
3,696,267
|
|
3,695,149
|
|
3,670,627
|
|
3,670,628
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note
:
* Certain minor variances exist between the
annual consolidated financial statements and this summary.
**
Refer to Reconciliation and Definition of Non-GAAP Measures below for a
reconciliation of Non-GAAP measures.
In the first quarter of
2009, our net loss decreased by $0.3 million ($0.10 per common share) compared
to the first quarter of 2008 due to increased gross margin and cost control
measures, inclusive of $0.6 million of business streamlining expenses, offset
by a 48% decrease in revenue.
In the second quarter of
2009, our net loss increased by $1.7 million ($0.45 per common share) compared
to the second quarter of 2008 due to (i) a $3.3 million decrease in
revenues; (ii) $1.2 million of transaction related expenses associated
with the APIF Transaction; and (iii) a 6% decrease in gross margin.
In the third quarter of
2009, our net loss increased by $1.7 million ($0.46 per common share) compared
to the third quarter of 2008 due to: (i) a $7.4 million decrease in
revenue; and (ii) $1.8 million of transaction related expenses associated
with the APIF Transaction; partially offset by; (iii) a 2% increase in
gross margin.
In the fourth quarter of
2009, we recorded net profit of $6.1 million ($1.64 per common share) compared
to a net loss of $2.0 million ($0.53 per common share) in the fourth quarter of
2008 as noted below.
·
Revenues
decreased $4.6 million, or 52%, reflecting a decrease of $6.0 million in
revenues in our OnSite Generation business unit due to the timing of project
execution, which we believe is the result of prevailing conditions in credit
markets and the current global economy. This decrease was partially offset by
increased revenue in our Power Systems business unit of $1.4 million, or 163%.
·
Gross
margin was $0.7 million (16% of revenues) in the fourth quarter of 2009
compared to $2.6 million (29% in the fourth quarter of 2008), reflecting a
higher proportion of revenues from our Power Systems business unit and lower
overhead absorption as a result of lower revenues in our OnSite Generation
business unit.
·
SG&A expenses
for the fourth quarter of 2009 were
$4.0 million, an increase of $1.2 million or 41% compared to the comparable
period of 2008 reflecting $0.4 million of severance and business streamlining
related expenses
·
R&D
expenses
for the fourth quarter of
2009 were $0.7 million, a decrease of $1.0 million or 59% compared to the
fourth quarter of 2008 reflecting streamlining and cost reduction initiatives
coupled with the receipt of research and product development funding
totalling $0.8 million during the fourth
quarter of 2009.
35
·
Recovery
of current income taxes for the fourth quarter of 2009 was $10.4 million, reflecting a gain recorded in
connection with the transaction with the trustees of Algonquin Power Income
Fund.
The information in this
section was obtained from our quarterly unaudited consolidated financial
statements, which are denominated in U.S. dollars and have been prepared in
accordance with Canadian GAAP. This information is, in the opinion of
management, prepared using accounting policies consistent with the audited
consolidated financial statements and includes all adjustments necessary for
the fair presentation of the results of the interim periods. We expect our
operating results to vary significantly from quarter to quarter and they should
not be relied upon to predict future performance.
Reconciliation and
Definition of Non-GAAP Measures
A description, calculation, and reconciliation of
certain measures used by management.
Non-GAAP financial
measures including earnings before interest, taxes, depreciation and amortization
(EBITDA) and cash operating expenses are used by management to provide
additional insight into our performance and financial condition. We believe
these Non-GAAP measures are an important part of the financial reporting
process and are useful in communicating information that complements and
supplements the consolidated financial statements. Accordingly, we are
presenting EBITDA and cash operating expenses in this annual report on Form
20-F to enhance the usefulness of this form. In accordance with Canadian
Securities Administration Staff Notice 52-306, we have provided reconciliations
of our Non-GAAP financial measures to the most directly comparable Canadian
GAAP number, disclosure of the purposes of the Non-GAAP measure, and how the Non-GAAP
measure is used in managing the business.
Earnings
before interest, taxes, depreciation and amortization (EBITDA)
We report EBITDA because
it is a key measure used by management to evaluate performance of business
units and the Company. EBITDA is a measure commonly reported and widely used by
investors as an indicator of a companys operating performance and ability to
incur and service debt, and as a valuation metric. We believe EBITDA assists
investors in comparing a companys performance on a consistent basis without
regard to depreciation and amortization, which are non-cash in nature and can
vary significantly depending upon accounting methods or non-operating factors
such as historical cost.
EBITDA is not a
calculation based on Canadian GAAP or U.S. GAAP and should not be considered an
alternative to operating income or net income in measuring our performance, nor
should it be used as an exclusive measure of cash flow, because it does not
consider the impact of working capital growth, capital expenditures, debt
principal reductions and other sources and uses of cash, which are disclosed in
the consolidated statements of cash flows. Investors should carefully consider
the specific items included in our computation of EBITDA. While EBITDA has been
disclosed herein to permit a more complete comparative analysis of our
operating performance relative to other companies, investors should be
cautioned that EBITDA as reported by us may not be comparable in all instances
to EBITDA as reported by other companies.
The following is a
reconciliation of EBITDA with Net loss. EBITDA is regularly reported to the
chief operating decision maker and corresponds to the definition used in our
historical quarterly discussions.
EBITDA
(in thousands of us dollars)
|
|
2009
|
|
2008
|
|
2007
|
|
Net loss
|
|
$
|
(9,375
|
)
|
$
|
(14,319
|
)
|
$
|
(28,068
|
)
|
Amortization of property, plant and equipment
|
|
984
|
|
855
|
|
903
|
|
Amortization of intangible assets
|
|
|
|
249
|
|
251
|
|
Impairment of property, plant and equipment
|
|
317
|
|
|
|
|
|
Other income
|
|
41
|
|
1,325
|
|
4,431
|
|
Income tax expense (recovery)
|
|
(10,371
|
)
|
116
|
|
22
|
)
|
EBITDA
|
|
$
|
(18,486
|
)
|
$
|
(14,424
|
)
|
$
|
(31,323
|
)
|
Cash
Operating Expenses
We report cash operating expenses
because it is a key measure used by management to measure the fixed operating
costs required to operate the ongoing business units of the Company. We believe
cash operating expenses is a useful measure in assessing our fixed operating
costs.
36
Cash operating expenses
are not based on Canadian or U.S. GAAP and should not be considered an
alternative to loss from operations in measuring the Companys performance, nor
should it be used as an exclusive measure of our operating costs because it
does not consider certain stock based compensation expenses which are disclosed
in the consolidated statements of operations. Investors should carefully
consider the specific items included in our computation of cash operating expenses.
While cash operating expenses are disclosed herein to permit a more complete
comparative analysis of our cost structure relative to other companies,
investors should be cautioned that cash operating expenses as reported by us
may not be comparable in all instances to cash operating expenses as reported
by other companies.
The following is a reconciliation
of cash operating expenses with loss from operations. Cash operating expenses
are regularly reported to the chief operating decision maker and corresponds to
the definition used in our historical quarterly discussions.
Cash Operating Costs
(in thousands of U.S. dollars)
|
|
2009
|
|
2008
|
|
2007
|
|
Loss from operations
|
|
$
|
(19,787
|
)
|
$
|
(15,528
|
)
|
$
|
(32,477
|
)
|
Less: Gross margin
|
|
(3,728
|
)
|
(7,894
|
)
|
(4,389
|
)
|
Less: Wind-up of test equipment business
|
|
|
|
|
|
2,016
|
|
Less: Stock-based compensation
|
|
413
|
|
694
|
|
1,553
|
|
Less: Amortization of property, plant and
equipment
|
|
984
|
|
855
|
|
903
|
|
Less: Amortization of intangible assets
|
|
|
|
249
|
|
251
|
|
Less: Impairment of property, plant and equipment
|
|
317
|
|
|
|
|
|
Cash Operating Costs
|
|
$
|
21,801
|
|
$
|
21,624
|
|
$
|
32,143
|
|
Impact of Inflation
None.
Impact of Foreign
Currency Fluctuations
For information regarding
the impact of foreign currency fluctuations on our Company, see Item 5.
Operating and Financial Review and Prospects Liquidity and Capital Resources
Foreign Currency Risk and Note 4 Risk Management Arising from Financial
Instruments Foreign Currency Risk to our consolidated financial statements,
which can be found beginning on page F-
19
of this form, and is incorporated by reference herein. We currently have limited currency hedging
through financial instruments. We carry a portion of our short-term investments
in Canadian dollars and euros.
Governmental Policies
For information regarding
the potential impact of changes in governmental policies on the Company, see Item
3. Key Information Risk Factors Risk
Factors Related to Our Business and Industry.
37
LIQUIDITY AND CAPITAL RESOURCES
The following section
explains how we manage our cash and capital resources to carry out our strategy
and deliver results.
Cash Used in Operating
Activities
(in
thousands of U.S. dollars)
|
|
|
|
|
|
Change
|
|
|
|
2009
|
|
2008
|
|
$
|
|
%
|
|
EBITDA loss
|
|
(18,486
|
)
|
(14,424
|
)
|
(4,062
|
)
|
(28
|
)%
|
Other income
|
|
41
|
|
1,325
|
|
(1,284
|
)
|
(97
|
)%
|
Change in non-cash working capital
|
|
(3,632
|
)
|
4,817
|
|
(8,449
|
)
|
(175
|
)%
|
Other items
|
|
10,992
|
|
1,524
|
|
9,468
|
|
621
|
%
|
Cash used in operating activities
|
|
(11,085
|
)
|
(6,758
|
)
|
(4,327
|
)
|
(64
|
)%
|
Changes in cash used in
operating activities in 2009 compared to 2008 are discussed below.
·
EBITDA
loss increased $4.1 million or 28% as more particularly described in Item 5.
Operating and Financial Review and Prospectus Operating Results.
·
Other
income decreased $1.3 million or 97% as a result of $0.8 million of lower
interest income, net $0.3 million of increased provincial capital tax resulting
from certain elections filed in connection with the APIF Transaction, and $0.2
million of lower foreign currency gains.
The decrease in lower interest income, net, was the result of lower
interest rates and a lower asset base.
The decrease in foreign currency gains resulted from variations in the
U.S. dollar relative to the Canadian dollar and the euro during 2009.
·
Changes
in non-cash working capital increased $8.4 million as more particularly
described in Item 5. Operating and Financial Review and Prospectus Operating
Results Financial Condition.
·
Other
items increased $11.0 million or 621%, primarily as a result of the recovery of
income taxes of $10.4 million. This
resulted from the closing of the APIF Transaction, which generated proceeds of $10.4
million, prior to transaction costs.
At current operating
levels, we anticipate consuming between $10.0 million and $15.0 million in 2010
to fund our anticipated EBITDA losses, non-cash working capital requirements
and capital expenditures. In the event
that we are successful in securing orders in excess of our base-case revenue
outlook, our cash requirements would increase.
The report of our
independent auditors in respect of the 2009 fiscal year contains an explanatory
note regarding our ability to continue as a going concern. In addition, while
our consolidated financial statements have been prepared on a going concern
basis, which contemplates the realization of assets and liquidation of
liabilities during the normal course of operations, there are material
uncertainties related to certain conditions and events that cast significant
doubt upon the Companys ability to continue as a going concern.
These events and conditions that cast significant doubt include the
Companys recurring operating losses and negative cash flows from operations.
The Company expects these conditions to continue in the near term.
The Company needs to
increase its revenue to generate profits and related operating cash flows.
During 2009, the Company experienced a decline in revenue due to variations in
the timing of delivery combined with lower order intake due to the prevailing conditions
in the Companys markets and the current global economy. There are
various uncertainties affecting our revenues related to the current market
environment including the level of sales orders, the length of sales cycles,
the continuing development of products by the Company, the adoption of new
technologies by customers, price competition, and continuation of government
incentives for the Companys customers and the ability of customers to finance
purchases.
The Company also requires
additional funding in the form of debt or equity in addition to the funding
obtained during the year and subsequent to year-end. During the year, the
Company generated cash proceeds of $10.4 million from the transaction with the
trustees of Algonquin Power Income Fund. Subsequent to December 31,
2009, the Company completed an offering of common shares and warrants for gross
cash proceeds of $5 million before placement agents fees and other offering
expenses. While the Company is pursuing various sources of financing,
there are no definitive plans at this stage and there is no assurance these
initiatives will be successful or provide additional funds sufficient to
continue operations.
38
The material uncertainties
referred to above relate to the Companys ability to increase revenue and to
raise additional funding to support operations. Additionally, a
continuation of the broad economic recession or slow recovery could continue to
have a negative impact on the Companys business, results of operations and
consolidated financial condition, or Hydrogenics ability to forecast results
and cash flows, and it may cause a number of the risks the Company currently
faces (such as the ability to increase revenue and to raise capital) to
increase in likelihood, magnitude and duration. Macro-level changes in
the global economy began to affect the Companys business in the fourth quarter
of 2008 and have continued throughout 2009.
The Companys ability to
continue as a going concern and manage the material uncertainties is dependent
on the successful execution of its business plan, which involves: (i) securing
additional financing to fund its operations, (ii) continued investment in
research and development through advancing product designs for efficiency,
durability, cost reduction and entry into complementary markets to improve
overall gross margins; (iii) increasing market penetration and sales to
improve operating cash flow; and (iv) actively managing its working
capital to preserve cash resources. At present, the success of these
initiatives cannot be assured due to the material uncertainties described
above.
See also the risks
related to our financial condition contained in Item 3. Key Information Risk
Factors.
At present, the success
of these initiatives cannot be assured due to certain material uncertainties
and hence the appropriateness of the use of accounting principles applicable to
a going concern. We had filed a final short form base shelf prospectus with
certain
Canadian
securities regulatory authorities on January 4, 2010 and a corresponding
registration statement on Form F-3, which was declared effective by the
U.S.
Securities and Exchange Commission on December 31, 2009. On January 14, 2010, we completed a
registered direct offering of common shares and warrants with two institutional
investors, resulting in gross proceeds of $5 million, before placement agents
fees and other offering expenses, pursuant to our registration statement on Form F-3. As a result of this offering, we may not
issue any additional securities pursuant to the Form F-3 until January 14,
2011 based on our current public float unless there was a significant increase
in the market price of our common shares.
In addition, even if the market price of our common shares were to
increase significantly, we could not in any event issue more than $4.5 million
of additional securities pursuant to our existing shelf prospectus. For information regarding the shelf
prospectus and the direct offering, including information regarding
restrictions that may affect our ability to obtain financing as a result of the
registered direct offering, see Item 3.
Key Information Risk Factors
Risk Factors Related to Our Financial Condition If we are unsuccessful
in increasing our revenues and raising additional funding, we may possibly
cease to continue as we currently do, and Item 14. Material Modifications to the Rights of
Security Holders and Use of Proceeds Material Modifications to the Rights of
Security Holders. See also Item 3.
Key Information Risk Factors Risk
Factors Related to Our Financial Condition We are currently involved
in litigation with Alpha Capital Anstalt, the outcome of which could adversely
affect our financial condition for information regarding our litigation with
one of the institutional investors.
We anticipate we will
require additional funding during 2010.
We continue to review sources of financing, a combination of operating
and related initiatives, as well as other alternatives to enhance shareholder
value, including, but not
limited to, alliances with strategic partners, private and public debt or
equity financing alternatives, the sale or licensing of our technology or a
substantial reorganization of our business.
At present, we have not
entered into any definitive agreement or arrangement to implement any of these
alternatives and there can be no assurance that we will identify or be able to
negotiate or carry out any of them. Further information will be provided if we
intend to propose or pursue any or more of such alternatives.
Cash Provided by (Used
in) Investing Activities
(in
thousands of U.S. dollars)
|
|
|
|
|
|
Change
|
|
|
|
2009
|
|
2008
|
|
$
|
|
%
|
|
Cash provided by (used in) investing activities
|
|
$
|
(1,465
|
)
|
$
|
13,017
|
|
(14,482
|
)
|
(111
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
39
Cash used by investing
activities was $1.5 million in 2009, a decrease of $14.5 million or 111%
compared to 2008. The $1.5 million of cash used in investing activities reflects
a $0.7 million increase in restricted cash as well as $0.8 million of capital
expenditures.
Cash Provided by (Used
in) Financing Activities
(in
thousands of U.S. dollars)
|
|
|
|
|
|
Change
|
|
|
|
2009
|
|
2008
|
|
$
|
|
%
|
|
Cash provided by (used in) financing activities
|
|
$
|
108
|
|
$
|
(118
|
)
|
$
|
226
|
|
191
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash provided by
financing activities was $0.1 million in 2009, an increase of $0.2 million
compared to 2008, reflecting a $0.1 million decrease in deferred research and
product development grants and less than $0.1 million of funds received on the
exercise of stock options.
Credit Facilities
We utilize a credit
facility with Dexia Bank (Dexia), a Belgian based financial institution, to
better manage our short-term cash requirements and to support letters of
guarantee provided to customers. As at December 31, 2009, we had operating
lines of credit available up to 3.5 million euro or $5.0 million compared to
$11.5 million as at December 31, 2008. The change in the available lines
of credit from December 31, 2008 is the result of the termination of the
credit facility with a Canadian chartered bank and the establishment of a new
credit facility with Dexia. As at December 31, 2009 and 2008, we had no
indebtedness on our credit facilities.
Pursuant to the terms of
a new credit facility with Dexia, Hydrogenics Europe NV (the Borrower), a
wholly-owned Belgian based subsidiary, may borrow a maximum of 75% of the value
of awarded sales contracts approved by Dexia, to a maximum of 2.0 million euro,
along with a maximum of 1.5 million euro for general business purposes. The credit facility bears interest at a rate
of Euribor plus 1.45% per annum and is secured by a 1.0 million euro first charge secured against all the assets of the
Borrower. This credit facility, which may be increased by an additional 1.5
million euro in certain circumstances, contains a negative pledge precluding
the Borrower from providing security over its assets. Additionally, the
Borrower is required to maintain a solvency covenant, defined as equity plus
current account divided by total liabilities, of not less than 25%, and ensure
that its inter-company account with Hydrogenics does not fall below a certain
level. As at December 31, 2009, the solvency covenant was 35%. As at December 31,
2009, the inter-company account was in compliance with these covenants.
The amount of the
available line of credit is reduced by the amount of outstanding standby
letters of credit and letters of guarantee, if any, issued from time to time by
Dexia.
As at December 31,
2009, there is no availability under this line of credit as the Company has not
submitted any sales orders for approval.
Financial Instruments
The Companys financial
instruments and the nature of the risks, existing or potential, are as set out
in the following table:
|
|
Risk
|
|
|
|
|
|
|
|
Market Risks
|
|
|
|
Credit
|
|
Liquidity
|
|
Currency
|
|
Interest Rate
|
|
Cash and cash equivalents and restricted cash
(which are primarily held in euros and Canadian and U.S. dollars)
|
|
X
|
|
|
|
X
|
|
X
|
|
Short-term investments
|
|
X
|
|
|
|
X
|
|
X
|
|
Accounts receivable
|
|
X
|
|
|
|
X
|
|
|
|
Grants receivable
|
|
X
|
|
|
|
X
|
|
X
|
|
Accounts payable and accrued liabilities
|
|
|
|
X
|
|
X
|
|
|
|
40
Credit risk
Credit risk arises from
the potential that a counterparty will fail to perform its obligations. Credit
risk associated with cash and cash equivalents and short-term investments is
minimized by ensuring that financial assets are placed for short periods of
time, generally less than 90 days, with governments, well-capitalized financial
institutions and other creditworthy counterparties. An ongoing review is
performed by management to evaluate changes in the status of counterparties.
Credit risk associated
with accounts receivable is minimized by carrying out a detailed review and approval
by senior management of credit extensions to customers taking into account
customer history, any amounts that are past due and any available relevant
information on the customers liquidity and potential going concern
problems. In addition, progress payments
are generally required by customers as contracts are executed which generally
results in between 35% and 100% of a contract value being collected before
shipments are made. Where credit terms
are extended beyond shipment, terms are generally not granted beyond 60
days. We maintain provisions for
potential credit losses and any such losses to date have been insignificant.
Credit risk associated
with grants receivable is substantially minimized by ensuring that funding
agreements are accepted from government entities or well-capitalized
corporations.
Foreign currency risk
While our functional
currency is the U.S. dollar, we conduct a significant portion of our business
in foreign currencies including the Canadian dollar and euro. Monetary assets and liabilities denominated
in foreign currencies are affected by changes in the exchange rate between the
U.S. dollar and these foreign currencies.
Our objective in managing
foreign currency risk is to minimize our net exposures to foreign currency cash
flows by converting cash balances into foreign currencies to the extent
practical to match other foreign currency obligations. Our foreign exchange
risk management program includes the use of foreign exchange currency forward
contracts to fix the exchange rates on short-term Canadian dollar and euro
denominated transactions and commitments.
Interest rate risk
Interest rate risk arises
because of the fluctuation in market interest rates. We are subject to interest rate risk on our
cash and cash equivalents and short-term investments; however, we do not have
any long-term debt and hence are not subject to interest rate risk from
borrowings.
Liquidity
Liquidity risk arises
from our general funding needs and in the management of our assets, liabilities
and optimal capital structure. We manage liquidity risk to maintain sufficient
liquid financial resources to fund our balance sheet and to meet our
commitments and obligations in the most cost-effective manner possible.
We have sustained losses
and negative cash flows from operations since our inception. At December 31,
2009, we had approximately $11.0 million of cash and cash equivalents and
restricted cash. Subsequent to year end,
we raised $5 million, before transaction costs, in a registered direct offering
of common shares. There are significant uncertainties related to the timing and
use of our cash resources and working capital requirements. These uncertainties
include, among other things, the timing and volume of commercial sales and
associated gross margin of our existing products and the development of markets
for, and customer acceptance of new products.
Throughout 2010 and 2011,
we do not expect our operations to generate sufficient cash flow to fund our
obligations as they come due. As such, these obligations will be funded out of
existing cash resources to the extent possible.
In the first and fourth quarters of 2009, we took actions to streamline
our business, including additional headcount reductions as well as additional
cost saving measures in order to minimize the impact on our existing cash
resources.
As a result of the
expected use of our existing cash resources, we anticipate requiring additional
funding to meet our anticipated obligations. Such funding may be in the form of
debt or equity or a hybrid instrument depending on the needs of the investor.
In order to improve our chances of securing funding, we filed a base shelf
prospectus on January 4, 2010. We are also pursuing additional traditional
and non-traditional sources of financing. There is no assurance that we will be
successful in our financing efforts or that they will be sufficient.
As mentioned under Item
4. Information of the Company History and Development of Hydrogenics
Corporation, we completed the APIF Transaction, which provided us with working
capital. In addition, we filed a final
short form base shelf prospectus with certain
Canadian
securities regulatory authorities on January 4, 2010 and a corresponding
registration statement on Form F-3, which was declared effective by the
U.S.
Securities and Exchange Commission on December 31, 2009, to enhance our
ability to access the capital markets.
On January 14, 2010, we completed a registered direct offering of
common shares and warrants with two institutional investors, resulting in gross
41
proceeds of $5 million,
before placement agents fees and other offering expenses, pursuant to our
registration statement on Form F-3.
For information regarding the shelf prospectus and the direct offering,
see Item 3. Key Information Risk
Factors
Risk
Factors Related to Our Financial Condition If we are unsuccessful in
increasing our revenues and raising additional funding, we may possibly cease
to continue as we currently do, and Item 14.
Material Modifications to the Rights of Security Holders and Use of
Proceeds Material Modifications to the Rights of Security Holders. See also Item 3. Key Information Risk
Factors Risk Factors Related to
Our Financial Condition We are currently involved in litigation with
Alpha Capital Anstalt, the outcome of which could adversely affect our
financial condition for information regarding our litigation with one of the
institutional investors.
The condition of the
current global economy and credit markets affect our outlook in two primary
ways. First, our products depend, to some degree, on general world economic
conditions and activity. If the current condition of the economy results in a
sustained broad economic recession, demand for our products is likely to
decline. Secondly, the current economic and credit climate could adversely
affect our ability to conduct, normal, day-to-day selling activities which
depend on the granting of short-term credit to a wide variety of purchasers and
particularly the corresponding need of those purchasers to finance purchases by
accessing credit. Our business is
dependent on purchasers of our products having access to adequate levels of
credit. If the current condition of the
economy is not resolved in a manner that will provide access to credit to
potential purchasers of our products, our business will likely suffer as a
result. Given these uncertainties, we will continue to monitor our operating
strategy.
Commitments
The following table of
our material contractual obligations as at December 31, 2009 sets forth
the aggregate effect that these obligations are expected to have on our cash
flows for the period indicated:
(in thousands of U.S. dollars)
Payments due in
|
|
Operating Leases
|
|
2010
|
|
$
|
1,039
|
|
2011
|
|
587
|
|
2012
|
|
589
|
|
2013
|
|
501
|
|
2014 and thereafter
|
|
415
|
|
|
|
$
|
3,131
|
|
We cannot be certain that
we have or will be able to raise sufficient capital to repay our short and
long-term contractual obligations and maintain planned levels of operations.
We do not have any
material obligations under forward foreign exchange contracts, guarantee
contracts, retained or contingent interests in transferred assets, outstanding
derivative instruments or non-consolidated variable interests.
Our treasury policy is to
invest in high-yield monetary interests to maximize yield and safeguard capital
to fund our operating requirements.
42
RESEARCH AND DEVELOPMENT
For information regarding our research and development
policies, see Item 4. Information of the Company Business Overview
Research and Product Development. For information regarding research and
product development expenses for the fiscal years ended December 31, 2007,
December 31, 2008, and December 31, 2009, see Note 11 Research and
Product Development to our consolidated financial statements, which can be
found beginning on page F-27 of this form, and is incorporated by
reference herein.
Advancing
Our Product Designs
.
Within our OnSite Generation business segment,
we are focused on reducing the cost of our HySTAT
®
electrolyzer and improving its efficiency.
Innovation in the design, elimination of non- value adding components, improved
sourcing and fundamental electrochemical improvements have all contributed to
continuous cost reduction in 2009. We recognize the opportunity for larger
scale energy storage installations we are developing significant scale-up
designs.
Within our Power Systems
business segment, we are focused on reducing the cost of a fuel cell system, a
remaining impediment to large scale adoption.
Significant milestones were reached in 2009. For market opportunities such as the home and
backup power market requiring between 4 and 12 kilowatts of electrical power,
we are developing a PEM based electrolyzer. We are attempting to offset a
portion of the associated development expenses by entering into cost sharing
agreements with OEMs and government agencies.
Recently, we have seen
considerable interest in using hydrogen as a medium to store renewable energy,
particularly wind and solar power, due to the favourable characteristics of
hydrogen as an energy carrier. We are developing a renewable energy storage
product incorporating an alkaline electrolyzer, PEM fuel cell electrical
generator and associated systems integration software. We anticipate adding
other proprietary technologies to this product offering based on continued
market intelligence. In time, we anticipate developing a product offering that
will benefit from ancillary electrical power services such as grid balancing
and load profiling.
Research costs and costs
incurred in applying for patents and licenses are expensed as incurred. Product
development costs are expensed as incurred until the product or process is
clearly defined and the associated costs can be identified, technical
feasibility is reached, there is an intention to produce or market the product,
the future market is clearly defined and adequate resources exist or are
expected to be available to complete the project. To date, no product
development costs have been capitalized.
Funding for research and
product development includes government and non-government research and product
development support. Research and product development support is recognized as
the applicable costs are incurred unless it is for reimbursement of an asset,
in which case it is accounted for as a reduction in the cost of the applicable
asset.
TREND INFORMATION
Current Market
Environment
Recent market events and
the resulting tightening of credit continues to reduce available liquidity and
overall economic activity. While governments around the world have taken
unprecedented actions to limit the impact of these events, it is still too
early to assess the duration of this slowdown. As a global corporation, we are
subject to the risks arising from adverse changes in global economic
conditions. For example, as a result of the financial crisis in the credit
markets, the direction and relative strength of many economies have become
increasingly uncertain. If economic growth in leading or emerging economies is
slowed, our current or potential customers may continue to delay or reduce
purchases. This could result in reductions in sales of our products, longer
sales cycles, slower adoption of new technologies and increased price
competition, which could materially and adversely affect our business, results
of operations and consolidated financial condition.
Over the past few years,
the Company has taken significant steps to streamline its operations and
consolidated financial position to better face a difficult economic situation.
During the first and fourth quarters of 2009, in order to further streamline
operations, the Company reduced its headcount as well as implementing
additional cost saving measures in order to maximize the Companys cash
resources. We have no funded or secured debt obligations outstanding, and
maintain an order backlog of $19.7 million as at December 31, 2009 spread
across numerous geographical regions.
Recently, we have
witnessed governments in many jurisdictions show a willingness to increase
spending on alternative energy projects to stimulate the economy and we believe
we are well positioned to benefit from government initiatives in Canada, the
European Union and the U.S., which will positively impact our business.
However, as no business is immune to a slowdown in the economy, we have
experienced adverse effects of the recent economic downturn in 2009. The Company closely monitors its exposure to
the following potential risks, which could impact future profitability and cash
flows: (i) sustained lower levels of orders, higher cancellation rates or
significant delay of orders, any one of which would require production
adjustments; and (ii) lower available customer financing, which could
affect our customers ability to finance their purchases.
43
With a sustained or
expanding economic downturn, we expect we will continue to experience
significant difficulties on a number of fronts, depending on the duration and
severity of the downturn. As a result, we may face new risks as yet
unidentified, and a number of risks which we ordinarily face and which are
further described herein may increase in likelihood, magnitude and duration.
These risks include but are not limited to deferrals or reductions of customer
orders, potential deterioration of our customers ability to finance purchases,
reduced revenue, further deterioration in our cash balances and liquidity due
to foreign exchange impacts, and an inability to access capital markets. The
financial crisis and economic downturn will also reduce our ability to
accurately forecast our performance, results or cash position. At current operating levels, we anticipate
consuming between $10.0 and $15.0 million in 2010 to fund our anticipated
EBITDA losses, non-cash working capital requirements and capital expenditures. In the event that we are successful in
securing orders in excess of our base-case revenue outlook, our cash
requirements would increase. For further
discussion of our revenues and delivery outlook, see Delivery Outlook below.
Delivery Outlook
We operate in various
markets and in this Annual Report on Form 20-F, define the market in which
we have a product offering as a relevant market. Our delivery outlook is
segmented by market and is subject to a number of factors that are within our
control, such as product development and market engagement initiatives, as well
as a number of factors that are beyond our control, such as macro economic
conditions. As part of our annual business planning cycle, we make a number of
assumptions regarding delivery outlook in each of our relevant markets in order
to best allocate our resources, including value of orders received, timing of
orders received and timing of receipt of progress and final payments, among
others.
Set forth below is a
summary assessment of those factors we anticipate will most significantly
influence deliveries by relevant market as well as our anticipated level of
deliveries by relevant market. We
caution that readers should not place undue reliance on this assessment and
refer to our caution regarding forward-looking statements on page 1 of
this Form 20-F.
44
Relevant
Market
|
|
Economic
Activity in
200
9
|
|
External and Company Specific Considerations
|
|
Anticipated Economic
Activity
in 2010
|
Industrial Gas
|
|
25
units delivered
|
|
We expect GDP growth in emerging markets and developing economies
will remain above worldwide average real GDP growth levels over the next
three years but lower than recent years.
We expect the rebound from the economic slowdown in 2009 to be slow
and historical order levels to resume in the later part of 2010.
|
|
We anticipate that revenues and orders delivered will be higher than
in 2009.
|
|
|
|
|
|
|
|
Hydrogen Fueling Stations
|
|
1
unit delivered
|
|
Governments have recently announced initiatives to accelerate the use
of hydrogen fueling stations for the transportation sector in Benelux and
Germany.
Our continued market presence positions us to secure additional
business.
|
|
We anticipate that revenues and orders delivered will be higher than
in 2009.
|
|
|
|
|
|
|
|
Renewable Energy Storage
|
|
2
units delivered
|
|
Renewable energy storage is continuing to receive considerable
attention throughout the world.
We saw growth in this market in 2009 and it has the potential to
become our fastest growing market segment in 2010.
We are dedicating more resources to this market opportunity in 2010.
|
|
We anticipate revenues and orders delivered will be higher than in
2009.
|
|
|
|
|
|
|
|
Backup Power
|
|
18
units delivered
|
|
30% tax credit introduced in the U.S. for fuel cell backup power
products.
Progress with OEMs advancing.
Product development initiatives now well advanced.
Significant product cost reductions are being realized.
|
|
We anticipate revenues and orders delivered will be higher than in
2009.
|
|
|
|
|
|
|
|
Motive/Mobile Power
|
|
25
units delivered
|
|
30% tax credit introduced in the U.S. for motive power products.
Our system integration
capability is well respected by
OEMs. Good progress in
bus, truck, utility vehicle and boat markets.
Product development initiatives advanced in
2009.
|
|
We anticipate that revenues and orders delivered will be lower than
in 2009.
|
|
|
|
|
|
|
|
Other Power Products
|
|
16
units delivered
|
|
Our work on other niche mobility applications will continue with
similar revenue targets.
|
|
We anticipate revenues and orders delivered will be similar to 2009.
|
45
American Power
Conversion Corporation
On July 22, 2009, we
announced that we formally notified American Power Conversion Corporation (APC)
of the termination of the manufacturing and supply agreement (the Supply
Agreement) dated August 9, 2006 between Hydrogenics and APC. The Supply Agreement provided that APC would
purchase up to 500 HyPM XR 12 kW Fuel Cell Power Modules for integration into
APCs NCPI solutions, specifically its InfraStruXure architecture, over a three
year period, subject to the terms of the Supply Agreement. In the notice of
termination, we demanded a termination payment of approximately $2.1 million by
APC, as determined by a formula in the Supply Agreement based on the number of
products for which APC has issued orders and paid for under the Supply
Agreement. We are aggressively pursuing this matter.
On November 13,
2009, we filed a complaint against APC in the U.S. District Court for the District
of Massachusetts in connection with the Supply Agreement. On December 23,
2009, APC filed its answer to our complaint and counterclaims, denying
liability on our claim, and seeking unspecified damages based on APCs
assertion that, pursuant to an alleged oral agreement, APC believed that we
would not seek the termination payment under the Supply Agreement.
Industry Trends
A discussion of industry
trends, by its nature, necessarily contains certain forward-looking
statements. Forward-looking statements
require us to make assumptions and are subject to inherent risks and
uncertainties that could cause actual results or events to differ materially
from current expectations. Please refer
to the caution regarding forward-looking statements contained in the Forward
Looking Statements section on page 1 and Item 3. Key Information Risk Factors for a
discussion of such risks and uncertainties and the material factors and
assumptions related to the statements set forth in this section.
We anticipate our
business will continue to benefit from several broad trends including: (i) high
prices for oil and natural gas; (ii) increased government legislation and
programs worldwide promoting alternative energy sources such as synthetic
fuels, including hydrogen; (iii) increased awareness of the adverse impact
of fossil fuels on our climate and environment; and (iv) the need for
industrialized economies to access alternative sources of energy to reduce
fossil fuel dependency. We anticipate
these trends will continue and intensify in the future, allowing the benefits
of hydrogen to be further demonstrated in numerous applications. In particular, green hydrogen can be
generated universally from renewable power sources such as hydroelectric,
geothermal, solar and wind or from low-emission sources such as biomass and
nuclear. These industry trends are
discussed below.
High prices for oil and natural
gas.
In recent years, oil and natural gas prices have
increased and it is anticipated that the general trend of prices will continue
to rise over the long term due to increased demand from emerging market
economies such as China and India, localized supply constraints and political
instability in oil producing areas. As
the cost of these commodities increase relative to the price of electricity,
our electrolysis-based on-site hydrogen generation products stand to become
more cost competitive with other forms of hydrogen production and delivery,
thereby increasing on-site generation market share. Similarly, we expect that the higher
efficiency of fuel cells will make them increasingly appealing relative to
conventional internal combustion engines.
Increased government legislation
and programs worldwide promoting alternative energy sources including hydrogen.
In recent years,
numerous governments have introduced legislation to promote and develop the use
of hydrogen in energy applications as a partial response to the risks and
adverse effects associated with fossil fuels.
We anticipate this interest will accelerate over time. Recent government legislation has been
proposed or passed in many jurisdictions to support renewable energy
initiatives including passage of the American Recovery and Reinvestment Act of
2009 in the United States and the Green Energy and Green Economy Act, 2009 in
Ontario, Canada.
The European Union has
adopted an action plan to replace 20% of vehicles using diesel and gasoline
fuels in the road transportation sector with vehicles that use natural gas and
hydrogen by 2020. European efforts include
the European Commission (EC) establishing a platform to bring hydrogen and
fuel cells to market and a proposed Joint Technology Initiative for
public-private partnership. The ECs 6th
Framework Programme is currently providing $2.2 billion over five years for
hydrogen and fuel cell initiatives under the European Hydrogen and Fuel Cell
Technology Platform. As well, the EC has
announced spending of approximately 1 billion euros per year between 2007 and
2013 as part of a European Strategic Energy Technology Plan tied to a proposed
new energy policy for Europe. Hydrogen and fuel cells are included in that
plan.
Additionally, several
Asian countries are responding to environmental, energy, security and
socio-economic concerns by introducing legislation and initiatives to promote
hydrogen and fuel cell technologies.
Japan, Korea, India and China continue to invest significantly in the
development and commercialization of hydrogen and fuel cells.
Increased awareness of the
adverse impact of fossil fuels on our climate, environment and air
quality.
Governments
worldwide continue to enact legislation aimed at curtailing the impact of
fossil fuels on the environment. Most
notably, the Kyoto Accord, a United Nations sanctioned protocol, attempts to
address global warming problems by reducing greenhouse gas emissions. Jurisdictions are also
46
enacting legislation
aimed at curbing idling or emissions that affect urban air quality, or affect
indoor operation of utility vehicles. In October 2006, the Canadian
government announced the Clean Air Act designed to tackle pollution and
greenhouse gas emissions. This act
strictly enforces industry compliance to a set of national standards on both
air pollution and emissions of greenhouse gases.
The need for industrialized
economies to access alternative sources of energy to reduce their dependency on
fossil fuels.
Many
industrialized nations, including some of the fastest growing economies, import
most of the fossil fuels consumed in their respective economies. This creates a
dependency on external sources and exposes them to significant trade
imbalances.
For stationary power, in
the United States alone, approximately 400,000 megawatts of new electricity
generating capacity is forecast to be needed by 2020 to meet growing demand and
to replace retiring generating units.
The existing electricity transmission and distribution grid in the
United States is overburdened in many regions.
By locating power generation products close to where the power is used,
known as distributed generation, it is possible to bypass the overloaded
transmission and distribution grid.
Hydrogen and fuel cell technologies are well suited to a distributed generation
model thereby providing an emerging opportunity for hydrogen fuel cells and
hydrogen powered internal combustion engines to provide stationary generating
capacity.
China and India also have
growing concerns about energy supply and security which are leading those
countries to pursue initiatives promoting hydrogen and energy efficiency
programs. Further, as the introduction of automobiles continues to accelerate
in India and China, such dependency on fossil fuels may become increasingly
unsustainable, creating an opportunity for hydrogen and fuel cells.
Additional Trends
Information
For additional trends
information, see Item 3. Key Information Risk Factors and Item 4.
Information of the Company Business Overview Our Strategy in this Form 20-F.
OFF-BALANCE SHEET ARRANGEMENTS
Contingent Off-Balance
Sheet Arrangements
We do not have any
material obligations under forward foreign exchange contracts, guarantee
contracts, retained or contingent interests in transferred assets, outstanding
derivative instruments or non-consolidated variable interests.
As a result of the
Government of Canadas commitment to developing domestic alternative energy
technologies, we have entered into repayable contribution and other R&D
arrangements with various Canadian governmental ministries and public sector
enterprises. Under these arrangements, we have received $12.7 million of
funding toward agreed upon R&D project costs. Pursuant to the agreements,
the funding parties have a right to receive as repayment, between 0.3% and 4.0%
of gross revenues attributable to the commercial exploitation of the associated
technologies and in one case, 0.53% of our OnSite Generation business units
gross business revenues. To date, we have recognized $51.3 million in revenues
from these technologies and recorded a repayable amount of $0.3 million. At
this time, the amount of further product revenues to be recognized is
uncertain, and accordingly no further liabilities for repayment have been
accrued. These arrangements expire between September 30, 2006 and March 31,
2016, or when total amounts repaid reach the utilized amount of the advance,
depending on the terms of the individual contracts. The amount of funding
available to us under similar arrangements varies from year to year, and
although we believe that these agencies and enterprises will continue to
support the industry, there is no guarantee of the amount of future funding.
In 1998, Stuart Energy a
wholly-owned subsidiary of the Company until October 27, 2009, entered
into an agreement with Technologies Partnerships Canada (TPC), a program of
Ministry of Industry of the Canadian government to develop and demonstrate
Hydrogen Fleet Fuel Appliances. This agreement was amended in 2003 to expand
Stuart Energys scope of work and resulted in Stuart Energy receiving a total
of $5.6 million of funding from TPC. Pursuant to the amended TPC agreement,
Stuart Energy undertook to repay 150% of the funds advanced by TPC, or $14.2
million (the Repayable Loan Amount). The amended agreement requires Stuart
Energy to commence making royalty payments against the Repayable Loan Amount on
the earlier of Stuart Energy revenues reaching Cdn. $90 million or April 1,
2007. In accordance with the terms of the amended agreement, Stuart Energy (now
the Company) is required to commence payments to TPC at 0.53% of its annual
gross business revenues for a period of 12 years or until the Repayable Loan
Amount is fully repaid. To date, we have recognized $51.3 million in revenues
and recorded a repayable amount of $0.3 million.
We have entered into
indemnification agreements with our current and former directors and officers
to indemnify them, to the extent permitted by law, against any and all charges,
costs, expenses, and amounts paid in settlement and damages incurred as a
result of any lawsuit or any other judicial, administrative or investigative
proceeding in which they are involved as a result of their services. Any such
indemnification claims will be subject to any statutory or other legal
limitation periods. The nature of the indemnification agreements prevents us
from making a reasonable estimate of the maximum potential amount we could be
required to pay to counterparties. We have purchased directors and officers
liability insurance. No amount has been recorded in the consolidated financial
statements with respect to these indemnification agreements.
47
In the normal course of
operations, we may provide indemnification agreements, other than those listed
above, to counterparties that would require us to compensate them for costs
incurred as a result of changes in laws and regulations or as a result of litigation
claims or statutory sanctions that may be suffered by the counterparty as a
consequence of the transaction. The terms of these indemnification agreements
will vary. The nature of the indemnification agreements prevents us from making
a reasonable estimate of the maximum potential amount we could be required to
pay to counterparties. No amount has been recorded in the consolidated
financial statements with respect to these indemnification agreements.
TABULAR
DISCLOSURE OF CONTRACTUAL OBLIGATIONS
As of December 31, 2009
|
|
Payments due by period
|
|
Contractual Obligations
|
|
Total
|
|
less than 1 year
|
|
1-3 years
|
|
3-5 years
|
|
more than
5
years
|
|
Long-Term
Debt Obligations
|
|
|
|
|
|
|
|
|
|
|
|
Capital
(Finance) Lease Obligations
|
|
|
|
|
|
|
|
|
|
|
|
Operating
Lease Obligations
|
|
3,131
|
|
1,039
|
|
1,677
|
|
415
|
|
|
|
Purchase
Obligations
|
|
|
|
|
|
|
|
|
|
|
|
Other
Long-Term Liabilities Reflected on the Companys Balance Sheet under the GAAP
of the primary financial statements
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
3,131
|
|
1,039
|
|
1,677
|
|
415
|
|
|
|
ITEM 6. DIRECTORS,
SENIOR MANAGEMENT AND EMPLOYEES
DIRECTORS
AND SENIOR MANAGEMENT
Directors
The following table sets
forth information with respect to our directors as of March 25, 2010:
Name and Province or State
and Country of Residence
|
|
Title
|
|
Director or
Executive Officer Since
|
Douglas Alexander
(1)
Ontario, Canada
|
|
Chairman of our Board of Directors
|
|
2006
|
|
|
|
|
|
Michael Cardiff
(1)(2)
Ontario, Canada
|
|
Director
|
|
2007
|
|
|
|
|
|
Joseph Cargnelli
Ontario, Canada
|
|
Chief Technology Officer and Director
|
|
1996
|
|
|
|
|
|
Henry J. Gnacke
Michigan, U.S.A.
|
|
Director
|
|
2008
|
|
|
|
|
|
Norman M. Seagram
(1)(3)
Ontario, Canada
|
|
Director
|
|
2000
|
|
|
|
|
|
Daryl Wilson
Ontario, Canada
|
|
President and Chief Executive Officer and Director
|
|
2006
|
48
Notes
:
(1)
|
|
Member of the Audit
Committee and the Human Resources and Corporate Governance Committee.
|
(2)
|
|
Chairman of the Human
Resources and Corporate Governance Committee.
|
(3)
|
|
Chairman of the Audit
Committee.
|
Each director will hold
office until the next annual and special meeting of shareholders, or until his
successor is duly elected or appointed.
Douglas
S. Alexander,
Chairman of our Board of
Directors
.
Mr. Alexander joined our Board of
Directors in May 2006 and has served as Chairman of our Board of Directors
since May 2009. Mr. Alexander
is a Director and member of the Audit Committee of Critical Outcome
Technologies Inc., and has served as the Chief Financial Officer of various
Canadian public companies for 15 years. Mr. Alexander was formerly lead
director and chair of the Audit Committee of Saxon Financial Inc. Mr. Alexander
served as a director of Stuart Energy from 2003 to January 2005. From 1999
to 2004, Mr. Alexander was Executive Vice President and Chief Financial
Officer of Trojan Technologies Inc., an international environmental high
technology company. Mr. Alexander is a Chartered Director, having
graduated from the Directors College, a joint venture between McMaster
University and the Conference Board of Canada. Mr. Alexander resides in Ontario, Canada.
Michael
Cardiff,
Director
. Mr. Cardiff joined our Board of Directors in November 2007.
Currently, Mr. Cardiff is the Chief Executive Officer of Accelerents, a
consulting firm focused on strategy development. Prior to holding that
position, Mr. Cardiff held numerous senior positions in a number of
technology companies including large multinationals such as EDS and IBM as well
as startup companies such as Fincentric, Convergent Technologies, Tandem, and
Stratus Computer. Mr. Cardiff is currently a director of Descartes Systems
Group and Burntsand Inc. Mr. Cardiff has also served as a director of
Husky Injection Molding Systems, Solcorp, Visible Genetics, Spectra Security
Software Visible Decisions and the Toronto Film Festival, Roy Thomson Hall. Mr. Cardiff
has received many awards including A Canadian Export Life Time Achievement
Award. In 1998, Mr. Cardiff was named one of Canadas Top 40 Under 40,
recognizing him as one of the nations most successful young leaders. Mr. Cardiff
is a member of, and holds the ICD.d designation from, the Institute of
Corporate Directors. Mr. Cardiff resides in Ontario, Canada.
Joseph
Cargnelli,
Chief Technology Officer and
Director
.
Mr. Cargnelli is one of our founders and served as a director from January 1996
to January 2005, when he resigned in connection with the closing of the
Stuart Energy acquisition. Mr. Cargnelli was re-elected at the meeting of
shareholders on May 17, 2005. Mr. Cargnelli served as our Treasurer
from January 1996 until July 2000.
Mr. Cargnelli was appointed as our Vice President, Technology in July 2000. His title was changed to Chief Technology
Officer in April 2003. Mr. Cargnelli
earned both a Masters of Applied Science degree in Mechanical Engineering and a
Bachelor of Applied Science degree in Mechanical Engineering from the
University of Toronto. From April 1992
to April 1993, Mr. Cargnelli served as a Research Engineer with the
Laboratory of Advanced Concepts in Energy Conversion Inc., a laboratory engaged
in the research, development and demonstration of alkaline fuel cells and
hydrogen storage methods. Mr. Cargnelli
is a member of the Professional Engineers of Ontario. Mr. Cargnelli resides in Ontario, Canada.
Henry J.
Gnacke,
Director
. Mr. Gnacke joined our Board of
Directors in May 2008. Formerly, Mr. Gnacke was the Executive
Director, Global Purchasing Supply chain at General Motors Corporation. He was
responsible for fuel cell propulsion systems and General Motors Corporations
E-Flex programs. Mr. Gnacke has over 30 years of experience and has held
numerous positions at General Motors Corporation, including several
international assignments in the Middle East, Asia and Europe. Mr. Gnacke
is the nominee of General Motors in connection with our strategic alliance with
General Motors. Mr. Gnacke resides in Michigan, U.S.A.
Norman
M. Seagram,
Director
. Mr Seagram served as Chairman of our Board of Directors from July 2000 to December 2006,
as Lead Director from January 2007 to September of that year, and
subsequently as Chairman until May 2009. Mr. Seagram was
President of Sportsco International LP (SkyDome) from February 2001 to March 2003.
From September 1996 to May 1997, Mr. Seagram was President and
Chief Executive Officer of Molson Inc., a company he had previously served for
24 years in a variety of senior management positions. From October 1992
to August 1996, Mr. Seagram was Chairman and Chief Executive Officer
of Air Liquide Canada, Inc., a producer of industrial gases. Mr. Seagram
is a trustee of Trinity College School and the Toronto Symphony Foundation, and
he is a director of Harbourfront Foundation. He serves on the advisory
board of the Faculty of Applied Science and Engineering, University of Toronto,
and INSEAD, Fontainebleau, France. He is a former director of the Toronto
Economic Development Corporation (TEDCO). Mr. Seagram resides in
Toronto, Ontario, Canada.
Daryl
Wilson,
President and Chief Executive
Officer and Director
. Mr Wilson
was appointed
President and Chief Executive Officer in December 2006. Prior to joining
Hydrogenics, Mr. Wilson held senior leadership positions at Royal Group
Technologies Inc., ZENON Environmental Inc., Toyota and Dofasco Inc. In 1990 Mr. Wilson
earned an MBA from McMaster University in Operations Management/Management
Science. Mr. Wilson is a Professional engineer and holds a Bachelors
degree in Chemical Engineering from the
49
University of Toronto. Mr. Wilson is a Chartered Director (C.Dir),
having graduated in 2009 from Directors College. Mr. Wilson resides in
Ontario, Canada.
On November 30,
2009, V. James Sardo resigned from our Board of Directors due to limitations on
his availability because of other business activities and professional
commitments. Mr. Sardo had been a member of the Board of Directors since
May, 2003 and had been a member of the audit committee and human resources and
corporate governance committee of Hydrogenics. We have no immediate plans to
fill the vacancy in the board left by Mr. Sardos departure.
Executive
Officers
The following table sets
forth information with respect to our executive officers as of June 23,
2009:
Name and Province or State
and Country of Residence
|
|
Title
|
|
Director or
Executive Officer Since
|
Joseph Cargnelli
Ontario, Canada
|
|
Chief Technology Officer and Director
|
|
1996
|
|
|
|
|
|
Daryl Wilson
Ontario, Canada
|
|
President and Chief Executive Officer and Director
|
|
2006
|
|
|
|
|
|
Lawrence E. Davis
Ontario, Canada
|
|
Chief Financial Officer and Corporate Secretary
|
|
2005
|
|
|
|
|
|
Jennifer Barber
Ontario, Canada
|
|
Vice President, Finance and Corporate Controller
|
|
2005
|
|
|
|
|
|
Wido Westbroek
Geel, Belgium
|
|
Vice President and General Manager
|
|
2006
|
Lawrence
E. Davis,
Chief Financial Officer and
Corporate Secretary
. Mr. Davis has served as our Chief Financial
Officer since April 1, 2005. Mr. Davis has over 20 years of financial
and operational experience. He has been a Chartered Accountant since 1987. From
1999 to 2003, Mr. Davis was the Chief Financial Officer of GDI Global Data
Inc., a wireless data services company. Mr. Davis also acted as the
President of Saturn Capital Corporation, a merchant bank that advises, invests
in and assumes senior management positions for high growth businesses from 1997
until 1999. From 1987 to 1997, Mr. Davis served as a Vice President for
PricewaterhouseCoopers LLP and he previously worked for two years with Ernst &
Young.
Jennifer
Barber,
Vice President, Finance and
Corporate Controller
. Ms. Barber joined us through our acquisition of
Stuart Energy in January 2005 and was appointed to the position of Vice
President Finance and Corporate Controller in May 2005. Since taking on
this position, Ms. Barber has led the finance team through a full range of
financial consolidations arising from the acquisition, with the added
responsibility of integrating Sarbanes-Oxley requirements into all of our
financial processes and procedures. Hired by Stuart Energy in 2001, Ms. Barber
served as Director, Corporate Finance from 2003 onward, and prior to that as
Controller. She was employed from 1997 to 2001 by PricewaterhouseCoopers LLP. Ms. Barber
received Institute of Chartered Accountant accreditation in 2000.
Wido
Westbroek,
Vice President and General
Manager
.
Mr. Westbroek joined us in 2006 as Vice President, Operations of the
Belgium On-Site division. His former career, spanning 18 years, was with
Powerlasers, a developer and manufacturer of unique laser welding technology
and a maker of auto parts for major automotive OEMs based in Canada and the
U.S.. Mr. Westbroek received his Bachelor of Science in Physics at the
University of Waterloo in Ontario.
For information regarding
the backgrounds of Mr. Cargnelli and Mr. Wilson, see Directors
above.
COMPENSATION
As the Company reports
its financial results in U.S. dollars, the following discussion is prepared
showing U.S. dollars, except as otherwise noted, notwithstanding that the
currencies in which our President and Chief Executive Officer, our Chief
Financial Officer and our three most highly compensated executives, other than
the President and Chief Executive Officer and Chief Financial Officer
(collectively, the Named Executive Officers) are paid are in Canadian dollars
and euros. The average exchange rates for the year ended December 31,
2009, for the purposes of the following disclosure, are U.S.$1 = Cdn. $1.142,
and U.S.$1 = 0.719 euros.
50
The following
compensation discussion and analysis is intended to supplement the more
detailed information concerning compensation of executive officers and
directors that appears in the tables that follow. Our goal is to provide a
better understanding of our compensation
practices and decisions made concerning the compensation payable to our
executive officers and directors for 2009.
Elements
of Executive Compensation Program
Our executive
compensation program has three principal components:
·
base salary;
·
short-term incentive (paid in cash); and
·
long-term, equity-based incentives.
We believe that this
variable compensation encourages high performance, promotes accountability and
ensures that the interests of our executive officers are aligned with the
interests of shareholders by linking individual performance and increases in
shareholder value. Each of the components specified objectives are set forth
below.
The Company also offers
all employees, and the President and Chief Executive Officer, our Chief
Financial Officer and our three most highly compensated executives, other than
the President and Chief Executive Officer and Chief Financial Officer, certain
benefits, such as short-term disability income benefits, long-term disability
income benefits, healthcare, dental care, survivor benefits, dependent
coverage, employee life insurance, dependent life insurance, accidental death,
dismemberment and specific loss insurance, which form an integral part of the
total compensation offered by the Company.
Base Salary
The objectives of base
salary are to recognize market pay, acknowledge competencies and skills of
individuals and reward individual contribution.
The annual base salary for each of our Named Executive Officers was
initially determined at the time of hire based on a number of customary
factors, and is documented in an employment agreement provided to the executive
officer (see also Summary Compensation Table Employment Agreements).
Historically, we retain compensation consultants to assist in determining
appropriate levels of salary and bonus payable to our executive officers, based
on relevant market data concerning the market place and our peer group. This
data is then used as a basis for determining the executive officers initial
base salary.
Short-term Incentives
We provide a short-term
incentive plan in which the Named Executive Officers, as well as other managers
and employees participate. This incentive plan is intended to reward
achievement of short-term financial performance and milestones and focus on key
financial, strategic and other business objectives. Pursuant to the short-term incentive plan, we
have established layers of performance incentives up to certain percentages of
base salary based on market benchmarking. In landmark years, the committee may
elect to award a stretch maximum of 100% of base salary. The percentage that
an executive is awarded is based on the achievement of corporate objectives,
the achievement of business unit objectives and the achievement of individual
objectives. Certain Named Executive Officers have employment agreements with us
that modify our short-term incentive compensation (see Summary Compensation
Table Employment Agreements).
For 2009, the target
bonuses were equal to 40% of the base salary for the Vice President and General
Manager and Vice President, Finance and Corporate Controller, and 50% for each
of President and Chief Executive Officer, Chief Financial Officer and Corporate
Secretary and Chief Technology Officer.
Long-term Incentives
Long-term compensation is
designed to focus executives attention on the long-term interests of the
Company and its shareholders, and consists of two elements for our executive
officers:
·
Stock Option Plan pursuant to which we
grant options to certain employees and officers to purchase Shares at a fixed
price; and
·
RSU Plan pursuant to which we grant
certain executive officers RSUs, representing the cash equivalent of Shares,
subject to the vesting, forfeiture and other restrictions the Board of
Directors may determine.
Together, we believe
these stock options and RSUs link the executives long-term compensation
directly to the appreciation in the price of our Shares and align the interests
of executives with the interests of shareholders.
51
Stock Options
Our stock option plan
allows the Human Resources and Corporate Governance Committee to grant
directors, officers, eligible employees and consultants of the Company options
to acquire Shares. The purposes of the stock option plan are to attract, retain
and motivate key members of our team, to align incentives with the results
realized by shareholders, and to provide competitive compensation arrangements
that reward the creation of shareholder value over the long-term.
The stock option plan
provides that options will expire no later than 10 years from the grant date
or, if that date occurs during a blackout period or other period during which
an insider is prohibited from trading in our securities by our insider trading
policy, 10 business days after the period ends, subject to certain exceptions.
Options will have an exercise price per share of not less than the closing
price of the Shares on the TSX on the trading day before the option is granted.
Unless otherwise specified in a particular option agreement, options granted
under this plan will vest over three years with one third of the option grant
vesting each year.
Issuances of options
under the stock option plan are subject to the several restrictions. No more
than 10% of the Shares outstanding may be issued under the stock option plan
and all other security based compensation arrangements in any one year period.
In addition, the number of Shares reserved for issuance pursuant to options
granted to any one person under the stock option plan and all other security
based compensation arrangements cannot exceed 5% of the outstanding Shares.
The aggregate number of
Shares reserved for issuance pursuant to options granted to insiders under the
stock option plan cannot exceed 10% of the outstanding Shares. Further, within
any one year period, insiders may not, in the aggregate, be issued under the
stock option plan and all other security based compensation arrangements a
number of Shares which exceeds 10% of the outstanding issue and no individual
insider may be issued a number of Shares that exceeds 5% of the outstanding
issue.
Shareholder approval is
required for the following amendments to the stock option plan: (i) increasing
the number of Shares reserved for issuance under the stock option plan; (ii) reducing
the exercise price of an option except appropriate reductions in connection
with a subdivision or consolidation of Shares or payment of a stock dividend or
an amalgamation, combination or other reorganization involving the company; (iii) extending
the term of an option beyond the expiry date or beyond 10 years from its grant
date (except the automatic extension where the expiry date would have occurred
within a blackout period of the company); (iv) extending the participation
of non-employee directors and non-consultants in the stock option plan; (v) permitting
options to be transferred other than by testate or intestate succession; (vi) permitting
the addition or modification of a cashless exercise feature, payable in cash or
Shares, unless it provides for a full deduction of the number of underlying
Shares from the stock option plan reserve; (vii) permitting awards, other
than options, to be made under the stock option plan; or (viii) pursuant
to the companys bylaws or the rules or policies of any exchange, that
require shareholder approval.
Currently there are
348,466
Shares reserved for issuance under the
stock option plan representing approximately 8% of the total number of issued
and outstanding Shares.
As at December 31,
2009, the Company had 243,503 stock options outstanding. As of March 25,
2010, 109,304
stock options remain available
for grant, and a net total of 239,162 stock options have been granted to
participants in the stock option plan, with the underlying Shares representing
approximately 6% of the total number of issued and outstanding Shares, taking
into account options that have been forfeited or cancelled. Since the stock
option plan was adopted, options exercised resulted in the issuance of 131,534
Shares as of March 25, 2010.
If an option holders
employment or term as a director or consultant ceases as a result of the option
holders death, retirement or disability or because of the sale of the company
which employs the option holder, or to which the option holder is a director or
consultant, all options vest immediately and may be exercised for 180 days (or,
if earlier, to the end of the term). If an option holders employment or term
as a director or consultant is terminated without cause the option holders
options which are vested or which would otherwise have vested within the
reasonable or contractual notice period may be exercised for 90 days (or, if earlier,
to the end of the term). If an option holders employment or term as a director
or consultant is terminated by voluntary resignation, vested options may be
exercised for 90 days (or, if earlier, to the end of the term) and unvested
options are cancelled. If an option holders employment or term as a director
or consultant is terminated for cause, all options are immediately cancelled.
Notwithstanding the foregoing, but subject to applicable securities laws, the
Board of Directors may, in its discretion, permit the exercise of any or all
options held by an option holder in the manner and on the terms authorized by
the Board; provided that the Board may not authorize the exercise of an option
beyond 10 years from the date of grant, excluding any automatic extension for
an expiry date which falls in a blackout period.
Options are
non-transferable. The Board of Directors has the discretion to accelerate
vesting and expiration of options in connection with a change of control of the
company, a sale of all or substantially all of the assets of the company or a
dissolution or liquidation of the company. The Board of Directors may further
take such steps it deems equitable and appropriate to adjust the number of
Shares that may be acquired on the exercise of any options or the exercise
price in the event that the company effects a subdivision or consolidation of
the Shares, payment of a stock dividend (other than in lieu of a cash
dividend), or other change in capitalization of the company, or upon any
52
amalgamation,
continuation, reorganization involving the company, by exchange of Shares, by
sale or lease of assets or otherwise, to preserve the proportionality of the
rights and obligations of the option holders.
Restricted Share Units
The RSU Plan is designed
to retain certain employees of the Company and its affiliates and to allow them
to participate in the long-term success of the company. The RSU Plan
complements the stock option plan and allows the Company to offer, through
combinations of these equity-based incentive programs, optimal alignment of the
interests of management and certain employees of the Company and its affiliates
with that of its shareholders.
The RSU Plan provides for
grants of RSUs to certain employees (each a participant) of the Company and
its affiliates. In determining the number of RSUs to be granted, the Human
Resources and Corporate Governance Committee may take into account such
milestones and criteria it determines at the time of grant. An RSU is a right
to receive a cash payment based on the value of a Share, subject to the
vesting, forfeiture and other restrictions the Board of Directors may
determine. RSUs are credited to an account in the name of the participant. If a
dividend is paid on Shares, each participants RSU account is credited with
additional RSUs (a dividend RSU) equal to a fraction where the numerator is
the product of: (a) the number of RSUs credited to the participant on the
date the dividends are paid, and (b) the dividend paid per Share, and the
denominator is the closing price per Share on the TSX on the last trading day
on which the Shares were traded preceding the date on which dividends are paid.
Each RSU vests no later
than December 31 of the third calendar year following the calendar year in
respect of which the RSU is granted or such earlier date as is determined in
our Boards discretion. RSUs are redeemed within 30 days following the vesting
date (and no later than the December 31 date referenced above), by a cash
payment to the participant equal to the number of vested RSUs multiplied by the
closing price per Share on the TSX on the last trading day on which the Shares
were traded preceding the vesting date. A dividend RSU vests on the same day as
the RSU in respect of which it was granted and is redeemed by the Company on
the same date as the applicable RSU.
If a participant dies,
retires or his or her employment is terminated by the Company without cause, or
for disability or because of the sale of the Company which employs the
participant, or to which the participant is a director or consultant, then a
pro rata portion of unvested RSUs credited to the participant will vest and be
redeemed. If the employment of a participant is terminated by resignation of
the participant the participant forfeits all rights to unvested RSUs. If the
employment of a participant is terminated for cause, that participant forfeits
all rights to vested and unvested RSUs. The Board of Directors may accelerate
the vesting of RSUs in connection with a change of control.
RSUs are non-assignable.
The Board of Directors determines which employees will be granted RSUs; the
time or times when RSUs will be granted; the number of RSUs to be granted; and
the date or dates on which RSUs will vest. The Human Resources and Corporate
Governance Committee administers the RSU Plan.
The Board may from time
to time amend or suspend the RSU Plan in whole or in part and may at any time
terminate the RSU Plan without prior notice. However, except as expressly set
forth in the RSU Plan, no such amendment, suspension, or termination may
adversely affect the RSUs previously granted to a participant without the
consent of the affected participant.
Summary Compensation Table
The following table
provides a summary of compensation earned during the financial year ended December 31,
2009 by the Named Executive Officers.
53
Name and Principal
Position
|
|
Salary
($)
|
|
Share-
Based
Awards
($)
|
|
Option-
Based
Awards
($)
|
|
Non-Equity
Incentive Plan
Compensation
(1)
($)
|
|
All Other
Compensation
(2)
($)
|
|
Total
Compensation
($)
|
|
Daryl Wilson,
President & Chief Executive
Officer
|
|
345,159
|
|
34,668
|
|
241,930
|
|
Nil
|
|
Nil
|
|
621,757
|
|
Lawrence Davis,
Chief Financial Officer and Corporate
Secretary
|
|
219,298
|
|
57,934
|
|
51,821
|
|
Nil
|
|
Nil
|
|
329,05
3
|
|
Joseph Cargnelli,
Chief Technology Officer
|
|
179,133
|
|
47,508
|
|
42,459
|
|
Nil
|
|
Nil
|
|
269,100
|
|
Wido Westbroek,
Vice President and General Manager
|
|
175,694
|
|
16,892
|
|
15,121
|
|
Nil
|
|
Nil
|
|
207,707
|
|
Jennifer Barber,
Vice President, Finance and Corporate
Controlle
r
|
|
135,442
|
|
12,563
|
|
11,250
|
|
Nil
|
|
Nil
|
|
159,255
|
|
Notes
:
(1)
|
|
This represents the
Companys short-term incentive plan. The Company does not have any non-equity
long-term incentive plans.
|
|
|
|
(2)
|
|
Benefits did not exceed
the lesser of Cdn. $50,000 and 10% of the total annual salary and bonuses of
any of the Named Executive Officers.
|
Employment Agreements
Daryl Wilsons employment
agreement provides for a base salary of Cdn. $395,000, subject to annual
review, and a discretionary short-term incentive bonus of up to 50% of his base
salary.
Lawrence Davis
employment agreement provides for a base salary of Cdn. $250,000, subject to
annual review, and a discretionary short-term incentive bonus of up to 50% of
his base salary.
Joseph Cargnellis employment agreement provides for
a base salary of Cdn. $205,000, subject to annual review, and a discretionary
short-incentive bonus of up to 50% of his base salary.
Wido Westbroeks
employment agreement provides for a base salary 126,500 euros, and a
discretionary short-term incentive bonus of up to 40% of his base salary.
Jennifer Barbers
employment agreement provides for a base salary of Cdn. $155,000, subject to
annual review, and a discretionary short-term incentive bonus of up to 40% of
her base salary.
54
Incentive Plan Awards
Outstanding Share-Based
Awards and Option-Based Awards During the Year Ended December 31, 2009
|
|
Option-based Awards
|
|
Share-based Awards
|
|
Name
|
|
Number of
Securities
Underlying
Unexercised
Options
(#)
|
|
Option
Exercise
Price
(Cdn. $)
|
|
Option Expiration
Date
|
|
Value of
Unexercised
In-The-
Money
Options
|
|
Number of
Shares or
Units
of Shares
That Have
Not Vested
|
|
Market or Payout
Value of Share-
Based Awards
That
Have Not Vested
(Cdn. $)
|
|
Daryl Wilson
|
|
9,000
|
|
$
|
40.00
|
|
December 8,
2016
|
|
Nil
|
|
30,228
|
|
302,280
|
|
|
|
8,564
|
|
$
|
29.25
|
|
March 23,
2017
|
|
Nil
|
|
|
|
|
|
|
|
15,100
|
|
$
|
14.50
|
|
March 12,
2018
|
|
Nil
|
|
|
|
|
|
|
|
40,000
|
|
$
|
13.25
|
|
March 27,
2019
|
|
Nil
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lawrence Davis
|
|
4,000
|
|
$
|
127.50
|
|
February 8,
2015
|
|
Nil
|
|
26,948
|
|
269,480
|
|
|
|
2,600
|
|
$
|
112.75
|
|
May 16,
2015
|
|
Nil
|
|
|
|
|
|
|
|
4,214
|
|
$
|
84.25
|
|
May 23,
2016
|
|
Nil
|
|
|
|
|
|
|
|
11,116
|
|
$
|
29.25
|
|
March 23,
2017
|
|
Nil
|
|
|
|
|
|
|
|
9,556
8,568
|
|
$
$
|
14.50
13.25
|
|
March 12,
2018
March 27, 2019
|
|
Nil
Nil
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Joseph Cargnelli
|
|
6,268
7,020
|
|
$
$
|
14.50
13.25
|
|
March 12,
2018
March 27, 2019
|
|
Nil
Nil
|
|
19,740
|
|
197,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wido Westbroek
|
|
3,000
|
|
$
|
54.75
|
|
July 14,
2016
|
|
Nil
|
|
6,344
|
|
63,440
|
|
|
|
2,748
|
|
$
|
29.25
|
|
March 23,
2017
|
|
Nil
|
|
|
|
|
|
|
|
1,780
2,500
|
|
$
$
|
14.50
13.25
|
|
March 12,
2018
March 27, 2019
|
|
Nil
Nil
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jennifer Barber
|
|
222
|
|
$
|
192.50
|
|
October 1,
2011
|
|
Nil
|
|
5,060
|
|
50,600
|
|
|
|
1,000
|
|
$
|
112.75
|
|
May 16,
2015
|
|
Nil
|
|
|
|
|
|
|
|
1,016
|
|
$
|
84.25
|
|
May 23,
2016
|
|
Nil
|
|
|
|
|
|
|
|
2,580
|
|
$
|
29.25
|
|
March 23,
2017
|
|
Nil
|
|
|
|
|
|
|
|
1,552
1,860
|
|
$
$
|
14.50
13.25
|
|
March 12,
2018
March 27, 2019
|
|
Nil
Nil
|
|
|
|
|
|
Incentive Plan Awards -
Value Vested or Earned During the Year Ended December 31, 2009
Name
|
|
Option-Based Awards -
Value Vested During the
Year
($)
|
|
Share-Based Awards -
Value Vested During the
Year
($)
|
|
Non-Equity Incentive Plan
Compensation -
Value Earned During the
Year
($)
|
|
|
|
|
|
|
|
|
|
Daryl Wilson
|
|
Nil
|
|
Nil
|
|
Nil
|
|
Lawrence Davis
|
|
Nil
|
|
Nil
|
|
Nil
|
|
Joseph Cargnelli
|
|
Nil
|
|
Nil
|
|
Nil
|
|
Wido Westbroek
|
|
Nil
|
|
Nil
|
|
Nil
|
|
Jennifer Barber
|
|
Nil
|
|
Nil
|
|
Nil
|
|
55
Compensation
of Directors
Director Compensation Table
The following table
provides a summary of compensation earned during the financial year ended December 31,
2009 by our directors.
Name
|
|
Fees
Earned
($)
|
|
Share-Based
Awards
($)
|
|
Option-
based
awards
($)
|
|
Non-Equity
Incentive
Plan
Compensation
($)
|
|
All Other
Compensation
($)
|
|
Total
($)
|
|
Norman M. Seagram
|
|
Nil
|
|
82,000
|
|
n/a
|
|
n/a
|
|
Nil
|
|
82,000
|
|
Douglas S. Alexander
|
|
22,250
|
|
58,750
|
|
n/a
|
|
n/a
|
|
Nil
|
|
81,000
|
|
Michael Cardiff
|
|
34,000
|
|
27,000
|
|
n/a
|
|
n/a
|
|
Nil
|
|
61,000
|
|
Henry J. Gnacke
|
|
25,000
|
|
24,000
|
|
n/a
|
|
n/a
|
|
Nil
|
|
49,000
|
|
V. James Sardo (1)
|
|
35,062
|
|
25,500
|
|
n/a
|
|
n/a
|
|
Nil
|
|
60,562
|
|
Note
:
(1)
Mr. Sardo resigned from the Board of
Directors on November 30, 2009.
In 2009, each of our
directors who is considered independent was paid an annual fee of $12,000 for
his services as a director and an attendance fee of $1,000 for each Board or
committee meeting attended. Each
committee chair received an additional attendance fee of $500 for each
committee meeting attended. Our Chairman
of the Board was paid an annual fee of $25,000 for his services and an
attendance fee of $1,500 for each Board meeting attended. All directors were reimbursed for travel and
other reasonable expenses incurred in attending Board and committee meetings.
For compensation
information regarding Mr. Cargnelli and Mr. Wilson, please see Elements
of Executive Compensation Program above.
Deferred Share Units
Old Hydrogenics
established its deferred share unit plan and director ownership guidelines in
2004, in an effort to better align the interests of non-employee directors with
the interests of our shareholders by linking annual short-term incentive awards
to the future value of the Shares. On June 22,
2009, Old Hydrogenics Board of Directors approved certain administrative
amendments to its deferred share unit plan.
In October 2009, we adopted the DSU Plan, which is identical to Old
Hydrogenics deferred share unit plan.
Pursuant to the DSU Plan,
independent directors are entitled to elect to receive all or any portion of
their annual retainer and meeting fees in the form of deferred share units (DSUs)
instead of cash. A DSU is a right to receive a cash payment based on the value
of a common share, credited by means of a bookkeeping entry in the books of the
Company, to an account in the name of the independent director. At the end of
the directors tenure as a member of the Board, the director is paid, in cash,
the market value of the common shares represented by the DSUs. As a result of the implementation of the DSU
Plan, directors were not eligible to receive additional awards of stock
options. The Board of Directors has
approved the following annual DSU grants to independent directors: independent director $24,000 equivalent in
DSUs; Chair of the Human Resources and Corporate Governance Committee - $34,000
equivalent in DSUs; Chair of the Audit Committee - $34,000 equivalent in DSUs;
and Chairman of the Board of Directors - $39,000 equivalent in DSUs.
Contemporaneously with
the adoption of the DSU Plan, the Board also established ownership guidelines
for directors pursuant to which each non-employee director is required to hold
Shares and/or DSUs equal to five times the directors annual cash retainer
within three years of initial appointment.
56
Incentive Plan Awards
Outstanding Share-Based
Awards and Option-Based Awards During the Year Ended December 31, 2009
|
|
Option-based Awards
|
|
Share-based Awards
|
Name
|
|
Number of
securities
underlying
unexercised
options
(#)
|
|
Option
exercise
price
($)
|
|
Option
Expiration
Date
|
|
Value of
Unexercised
In-The-
Money
Options
|
|
Number of
Shares or
Units of
Shares That
Have Not
Vested
|
|
Market or Payout
Value of
Share-Based Awards
That
Have Not Vested
(Cdn. $)
|
Norman M. Seagram
|
|
n/a
|
|
n/a
|
|
n/a
|
|
n/a
|
|
n/a
|
|
n/a
|
Douglas S. Alexander
|
|
n/a
|
|
n/a
|
|
n/a
|
|
n/a
|
|
n/a
|
|
n/a
|
Michael Cardiff
|
|
n/a
|
|
n/a
|
|
n/a
|
|
n/a
|
|
n/a
|
|
n/a
|
Henry J. Gnacke
|
|
n/a
|
|
n/a
|
|
n/a
|
|
n/a
|
|
n/a
|
|
n/a
|
V. James Sardo
|
|
n/a
|
|
n/a
|
|
n/a
|
|
n/a
|
|
n/a
|
|
n/a
|
Incentive Plan Awards -
Value Vested or Earned During the Year Ended December 31, 2009
Name
|
|
Option-Based Awards -
Value Vested During
the
Year
($)
|
|
Share-Based Awards -
Value Vested During the
Year
($)
|
|
Non-Equity Incentive Plan Compensation -
Value Earned During the Year
($)
|
Norman M. Seagram
|
|
n/a
|
|
82,000
|
|
n/a
|
Douglas S. Alexander
|
|
n/a
|
|
58,750
|
|
n/a
|
Michael Cardiff
|
|
n/a
|
|
27,000
|
|
n/a
|
Henry J. Gnacke
|
|
n/a
|
|
24,000
|
|
n/a
|
V. James Sardo
|
|
n/a
|
|
25,000
|
|
n/a
|
BOARD
PRACTICES
For information regarding
the period during which the directors and executive officers have served in
office, see Item 6. Directors, Senior Management And Employees Directors and
Senior Management above. Each director
elected will hold office until the next annual meeting of shareholders or until
his successor is duly elected or appointed.
Termination
and Change of Control Benefits of Executive Directors
Mr. Wilsons
employment agreement provides that Mr. Wilson is entitled to 18 months
salary and bonus in lieu of notice if he is terminated without cause from his
position at any time, or if he is terminated upon a change of control of the
Company. This amount is equal to a maximum of approximately Cdn. $997,375 based
on Mr. Wilsons current compensation. The agreement also provides that all
outstanding stock options held by Mr. Wilson will immediately vest upon
termination without cause or termination resulting from a change of control of
the Company. Mr. Wilson has agreed to refrain from competing with and
interfering in the business of Hydrogenics for a period of one year subsequent
to his termination for any reason. Under the RSU Plan, if Mr. Wilsons
employment is terminated by the Company without cause, prior to the vesting
date of any awarded RSUs, then a pro rata portion of such RSUs will vest
immediately prior to the date of his termination of employment. The value of
such RSUs, as of December 31, 2009, is Cdn. $302,280.
57
Mr. Cargnellis
employment agreement provides that Mr. Cargnelli is entitled to 24 months
salary and one and a half times the average bonus paid in the two fiscal years
preceding termination in lieu of notice if Mr. Cargnelli is terminated
without cause from his position at any time, or if he is terminated upon a
change of control of the Company. This
amount is equal to a maximum of approximately Cdn. $717,500 based on Mr. Cargnellis
current compensation. Mr. Cargnelli has agreed to refrain from competing
with and interfering in the business of Hydrogenics for a period of three years
subsequent to his termination for any reason.
Under the RSU Plan, if Mr. Cargnellis employment is terminated by
the Company without cause, prior to the vesting date of any awarded RSUs, then
a pro rata portion of such RSUs will vest immediately prior to the date of his
termination of employment. The value of such RSUs, as of December 31,
2009, is Cdn. $197,400.
Human
Resources and Corporate Governance Committee
As of March 25,
2010, we have a Human Resources and Corporate Governance Committee.
Composition of Human Resources and Corporate
Governance Committee
The following individuals
served as the members of the Human Resources and Corporate Governance Committee
as at December 31, 2009 and March 25, 2010: Michael Cardiff (Chair),
Douglas S. Alexander and Norman M. Seagram.
Each member of the Human
Resources and Corporate Governance Committee is independent under tests
established by legal and stock exchange requirements to which the Company is
subject. None of the members of the
Human Resources and Corporate Governance Committee is an officer, employee or
former officer or employee of the Company or any of its affiliates.
Nomination of Directors and Compensation
Annually, the Human
Resources and Corporate Governance Committee assesses the size of the Board of
Directors, the competencies, skills and personal qualities required of the
Board of Directors in order to add value to the Company, and the competencies,
skills and personal qualities of existing directors. Based on this assessment, the Human Resources
and Corporate Governance Committee will consider whether to recommend any
changes to the composition of the Board of Directors, including proposing
nominations to the Board for approval. When required, the Human Resources and
Corporate Governance Committee will evaluate potential candidates for serving
as a director having regard to the background, employment and qualifications of
possible candidates and will consider whether the candidates competencies,
skills and personal qualities are aligned with the Companys needs.
In fulfilling its
charter, the committees role also includes reviewing and reporting to the
Board on: human resource planning, including the terms of the compensation packages
provided to our employees; succession planning and senior management
appointments; the levels and form of executive compensation in general; and the
specific compensation of senior executives, including the annual compensation
of the President and Chief Executive Officer. The committee also administers
the Companys stock option plan, the DSU Plan and the RSU Plan and reviews and
makes recommendations to the Board regarding the annual compensation of
non-employee directors.
Report of the Human Resources and Corporate Governance
Committee
The Human Resources and
Corporate Governance Committee ensures that the Company develops and implements
an effective and efficient approach to corporate governance and has a plan for
the continuity of its officers and an executive compensation plan that is
motivational and competitive, which will attract, retain and inspire executive
management and other key personnel.
The committee ensures
that the Companys business and affairs are carried out in a transparent manner
that will enhance shareholder value. The
committee assesses the effectiveness of the Companys corporate governance
processes and compensation policies and, where appropriate, makes
recommendations with respect to the implementation, development and modification
with respect to these processes and policies.
In 2009, the Human
Resources and Corporate Governance Committee, in fulfilling its
responsibilities, took the following measures:
·
monitored and reviewed emerging SOX,
Nasdaq, TSX and CSA corporate governance standards;
·
reviewed its own charter in the context
of emerging corporate governance best practices;
·
reviewed the size and composition of the
Board and committees to ensure that directors continue to have the appropriate
expertise and background to support corporate strategy and operations;
·
prepared nomination recommendations in
respect of the Board for approval by shareholders;
·
reviewed our approach to compensation for
our employees, officers and directors;
·
reviewed and approved incentive bonus
awards and the salary for each officer of the Company;
58
·
reviewed and recommended stock option
awards;
·
approved the short-term incentive awards
for our officers; and
·
engaged the services of an independent
external consultant to provide advice and expertise regarding director and
executive compensation.
The Human Resources and
Corporate Governance Committee met six times in 2009. The Human Resources and
Corporate Governance Committee is satisfied that it has fulfilled its charter
during the year ended December 31. 2009.
Other Committee Assessments
The Human Resources and
Corporate Governance Committee is responsible for supervising the assessment of
the effectiveness of the Board of Directors as a whole and each committee of
the Board of Directors, for evaluating the performance of the Chairman of the
Board, the Chair of each committee and the performance and contribution of
individual directors. The process
generally involves the Human Resources and Corporate Governance Committee
assigning the task of conducting a survey of directors (with respect to their
views on the effectiveness of the Board of Directors, Chairman of the Board,
each committee of the Board and its Chair and individual directors). The form of the survey is approved by the
Human Resources and Corporate Governance Committee. The results of the survey
are communicated in writing to the Chairman of the Board and the Chairman then
reports the overall results and the Chairmans recommendations to the
Board. The Chairman also meets in person
or by telephone with each Board member to confidentially discuss his peer
evaluation. The Chairman also meets with
the Chair of the Human Resources and Corporate Governance Committee to review
the results of the survey prior to the Human Resources and Corporate Governance
Committee meeting to finalize its recommendations for Board and committee
nominations. The Chair of the Human
Resources and Corporate Governance Committee meets with the Chairman of the
Board to discuss the Chairmans performance assessment.
The Human Resources and
Corporate Governance Committee administers the Companys executive compensation
program for executive officers, including with respect to the Named Executive
Officers.
The committee has primary
responsibility for determining executive remuneration and for the design and
review of the Companys compensation plans.
In fulfilling this role, the committee seeks to:
·
provide total compensation that is
closely linked to the Companys performance and to individual performance;
·
align the interests of the Companys
executive officers with those of its shareholders through potential stock ownership;
and
·
ensure that compensation and benefits are
at levels such that the Company is able to attract and retain the caliber of
executives and officers it needs to achieve its desired growth and performance
targets.
Audit
Committee
Our Board of Directors
has delegated to the Audit Committee responsibility for assisting the Board in
its oversight role with respect to the quality and integrity of financial
information and reporting disclosure, risk management, the performance,
qualifications and independence of the external auditors and legal and
regulatory compliance. The Audit
Committee regularly meets
in camera
to review managements financial stewardship.
The Audit Committee consists entirely of unrelated and independent and
financially literate directors.
During the past year, the
Audit Committee, in fulfilling its responsibilities, took the following
measures:
·
reviewed and discussed with management
and the auditors the audited annual consolidated financial statements and
managements discussion and analysis (MD&A);
·
discussed with the external auditors all
matters pertaining to professional auditing guidelines and standards in Canada
and the United States, including the external auditors independence; and
·
received written disclosure from the
external auditors as recommended by The Canadian Institute of Chartered
Accountants and the Independence Standards Board in the United States.
Based on this
information, the Audit Committee recommended to the Board that the consolidated
audited financial statements and MD&A be included in the annual report to
shareholders.
During the past year, the
Audit Committee also took the following measures:
·
reviewed the performance of the external
auditors and recommended reappointment of the external auditors for
shareholders approval;
59
·
reviewed the independence and
qualification of the external auditors based
on the external auditors disclosure of its relationships with the
Company;
·
approved the audit and non-audit fees
paid to the external auditors;
·
ensured that all services to be provided
by the auditors are approved in advance by the committee or are approved by the
Chair of the committee and subsequently reported to the committee as a whole in
the following meeting of the committee, all in accordance with the external
Auditors Pre-approval Policy;
·
reviewed with the external auditors and management
the overall scope and plans of the annual audit;
·
reviewed with management and the external
auditors the interim quarterly financial statements, including a discussion
with the external auditors of matters that are required to be disclosed under
generally accepted auditing standards;
·
reviewed with management and the auditors
all financial information and financial statements contained in this Form 20-F,
which is being filed in Canada as our annual information form, and our
management proxy circular, in each case prior to publication;
·
reviewed with management our investment
policy;
·
met with management and the external
auditors to discuss and review the Companys control environment and culture,
and the Companys program to maintain SOX Section 404 compliance;
·
reviewed our overall risk management
strategy;
·
reviewed our progress on the
implementation of International Financial Reporting Standards (IFRS);
·
reviewed and approved various aspects and
documents related to the APIF transaction;
·
met regularly
in camera
with the internal and external auditors; and
·
reviewed procedures for the receipt and
treatment of complaints regarding accounting, internal accounting controls or
auditing matters, and the confidential, anonymous submission by employees of
concerns regarding questionable accounting or auditing matters. These
procedures can be found on the Companys investor relations web page at
www.hydrogenics.com.
The Audit Committee met
six times in 2009. The Audit Committee is satisfied that it has fulfilled its
charter during the year ended December 31, 2009.
The Audit Committee of
our Board of Directors operates under a written charter that sets out its
responsibilities and composition requirements.
As at December 31, 2009 and March 25
,
2010, the members of the committee were: Norman M. Seagram (Chair), Douglas S.
Alexander and Michael Cardiff. The
following sets out the education and experience of each director relevant to
the performance of his duties as a member of the committee.
Norman M. Seagram is
Chair of our Audit Committee. Mr. Seagram was President of Sportsco
International LP (SkyDome) from February 2001 to March 2003.
From September 1996 to May 1997, Mr. Seagram was President and
Chief Executive Officer of Molson Inc., a company he had previously served for
24 years in a variety of senior management positions. From October 1992
to August 1996, Mr. Seagram was Chairman and Chief Executive Officer
of Air Liquide Canada, Inc., a producer of industrial gases. Mr. Seagram
is a trustee of Trinity College School and the Toronto Symphony Foundation, and
he is a director of Harbourfront Foundation. He serves on the advisory
board of the Faculty of Applied Science and Engineering, University of Toronto,
and INSEAD, Fontainebleau, France. He is a former director of the Toronto
Economic Development Corporation (TEDCO).Mr. Alexander is a Director and
member of the Audit Committee of Critical Outcome Technologies Inc., and has
served as the Chief Financial Officer of various Canadian public companies for
15 years. Mr. Alexander was formerly lead director and chair of the Audit
Committee of Saxon Financial Inc. Mr. Alexander served as a director of
Stuart Energy from 2003 to January 2005. From 1999 to 2004, Mr. Alexander
was Executive Vice President and Chief Financial Officer of Trojan Technologies
Inc., an international environmental high technology company. Mr. Alexander
is a Chartered Director, having graduated from the Directors College, a joint
venture between McMaster University and the Conference Board of Canada. Mr. Cardiff is the Chief Executive
Officer of Accelerents, a consulting firm focused on strategy development.
Prior to holding that position, Mr. Cardiff held numerous senior positions
in a number of technology companies including large multinationals such as EDS
and IBM as well as startup companies such as Fincentric, Convergent
Technologies, Tandem, and Stratus Computer. Mr. Cardiff is currently a
director of Descartes Systems Group and Burntsand Inc. Mr. Cardiff has
also served as a director of Husky Injection Molding Systems, Solcorp, Visible
Genetics, Spectra Security Software Visible Decisions and the Toronto Film
Festival, Roy Thomson Hall. Mr. Cardiff has received many awards including
A Canadian Export Life Time Achievement Award. In 1998, Mr. Cardiff was
named one of Canadas Top 40 Under 40, recognizing him as one of the nations
most successful young leaders. Mr. Cardiff is a member of, and holds the
ICD.d designation from, the Institute of Corporate Directors.
60
The Audit Committee
charter requires that each member of the Audit Committee be unrelated and
independent, and the composition of the Audit Committee satisfy the
independence, experience and financial expertise requirements of the Nasdaq,
the TSX and Section 10A of the Securities Exchange Act of 1934 (United
States), as amended by the Sarbanes-Oxley Act of 2002 (United States), and the rules promulgated
thereunder. Accordingly, all committee
members are required to be financially literate or be willing and able to
acquire the necessary knowledge quickly. Financial literacy means that the
person has the ability to read and understand financial statements that present
a breadth and level of complexity of accounting issues that are generally
comparable to the breadth and complexity of the issues that can reasonably be
expected to be raised by our financial statements. We believe all of the
current members of the Audit Committee are financially literate.
In addition, the Audit
Committee charter contains independence requirements that each committee member
must satisfy and each current member meets those requirements. Specifically,
the charter provides that no member of the committee may be an officer or
retired officer of Hydrogenics and each member must be independent of
Hydrogenics within the meaning of all applicable laws, rules and
regulations and any other relevant consideration, including laws, rules and
regulations particularly applicable to Audit Committee members.
The Audit Committee has a
policy restricting the provision of non-audit services by our auditors. Any
such services must be permitted engagements as provided by the Audit Committee
charter and must be pre-approved by the Audit Committee. The Audit Committee also pre-approves audit
services and the related fees.
EMPLOYEES
As at December 31,
2009, we employed approximately 130
full-time
staff. Our full-time staff is divided
between 61
full-time staff in our OnSite
Generation business, 65
full-time
staff in our Power Systems business, and four full-time staff in our corporate
services group.
As
of December 31, 2009, four
of our
employees were located in our
Mississauga, Ontario corporate headquarters, 67
employees were
located in our Mississauga, Ontario power systems group, 7 employees were located in our Mississauga,
Ontario OnSite generation group, nine
employees were
located in our Gladbeck, Germany power
generation group and 54 employees were located in our Oevel-Westerlo, Belgium
OnSite generation group. We also
employed 2 temporary and contract employees at our Mississauga, Ontario
facility and
11 subcontractors at our Oevel-Westerlo, Belgium facility.
As at December 31,
2008, we employed approximately 166 full-time staff. Our full-time staff is divided between 73
full-time staff in our OnSite Generation business, 81 full-time staff in our
Power Systems business, 5 full-time staff in our Test Systems business and 7
full-time staff in our corporate services group.
As
of December 31, 2008, seven of our employees were located in our
Mississauga, Ontario corporate
headquarters seventy-four employees were
located in our Mississauga, Ontario power systems group, 11 employees were located in our Mississauga,
Ontario OnSite generation group, eight employees were located in our Gladbeck, Germany power generation group and
62 employees were located in our Oevel-Westerlo, Belgium OnSite
generation group. We also employed 2
temporary and contract employees at our Mississauga, Ontario facility and eight
subcontractors at our Oevel-Westerlo,
Belgium facility.
As at December 31,
2007, we employed approximately 186 full-time staff. Our full-time staff is divided between 80
full-time staff in our OnSite Generation business, 84 full-time staff in our
Power Systems business, 13 full-time staff in our Test Systems business and 9
full-time staff in our corporate services group.
Our ability to attract,
motivate and retain qualified personnel is critical to our success. We attempt to align the interests of our
employees with those of shareholders through the use of incentive stock options
and a performance-based compensation structure.
A majority of employees own our common shares or options to purchase our
common shares. We have entered into
non-disclosure and confidentiality agreements with key management personnel and
with substantially all employees. None
of our employees are represented by a collective bargaining agreement and we
believe that our relations with our employees are good.
SHARE
OWNERSHIP
Below is a summary of the
securities ownership for each director and Named Executive Officer as of March 25,
2010.
61
|
|
Share-Based Awards
|
|
Option-Based Awards
|
|
|
|
|
|
% of
|
|
|
|
|
|
|
|
|
|
Number of
securities
|
|
Option
|
|
|
|
|
|
|
|
|
|
Common
|
|
|
|
% of
|
|
|
|
% of
|
|
underlying
|
|
exercise
|
|
Option
|
|
% of
|
|
|
|
Common
|
|
Shares
|
|
|
|
DSUs
|
|
|
|
RSUs
|
|
unexercised
|
|
price
|
|
Expiration
|
|
Options
|
|
Name
|
|
Shares
|
|
Outstanding
|
|
DSUs
|
|
Outstanding
|
|
RSUs
|
|
Outstanding
|
|
options
|
|
(Cdn. $)
|
|
Date
|
|
Outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Norman M. Seagram
|
|
1,428
|
|
Less than 1%
|
|
18,957
|
|
45%
|
|
Nil
|
|
Nil
|
|
196
|
|
$
|
125.00
|
|
June 30, 2010
|
|
1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
480
|
|
$
|
217.50
|
|
January 19, 2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
320
|
|
$
|
218.75
|
|
May 16, 2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
400
|
|
$
|
205.00
|
|
June 27, 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
480
|
|
$
|
147.75
|
|
March 30, 2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
600
|
|
$
|
164.50
|
|
April 27, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Douglas S. Alexander
|
|
999
|
|
Less than 1%
|
|
10,982
|
|
26%
|
|
Nil
|
|
Nil
|
|
Nil
|
|
N/A
|
|
N/A
|
|
Nil
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Michael Cardiff
|
|
Nil
|
|
Nil
|
|
4,170
|
|
10%
|
|
Nil
|
|
Nil
|
|
Nil
|
|
N/A
|
|
N/A
|
|
Nil
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Henry J. Gnacke
|
|
Nil
|
|
Nil
|
|
1,781
|
|
4%
|
|
Nil
|
|
Nil
|
|
Nil
|
|
N/A
|
|
N/A
|
|
Nil
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Joseph Cargnelli
|
|
158,660
|
|
4%
|
|
Nil
|
|
Nil
|
|
19,740
|
|
22%
|
|
6,268
|
|
$
|
14.50
|
|
March 12, 2018
|
|
5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,020
|
|
$
|
13.25
|
|
March 27,2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Daryl Wilson
|
|
4,000
|
|
Less than 1%
|
|
Nil
|
|
Nil
|
|
30,228
|
|
34%
|
|
9,000
|
|
$
|
40.00
|
|
December 8, 2016
|
|
30%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,564
|
|
$
|
29.25
|
|
March 23, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,100
|
|
$
|
14.50
|
|
March 12, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,000
|
|
$
|
13.25
|
|
March 27, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lawrence Davis
|
|
Less than 1%
|
|
Less than 1%
|
|
Nil
|
|
Nil
|
|
26,948
|
|
31%
|
|
4,000
|
|
$
|
127.50
|
|
February 8, 2015
|
|
16%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,600
|
|
$
|
112,75
|
|
May 16, 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,214
|
|
$
|
84.25
|
|
May 23, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,116
|
|
$
|
29.25
|
|
March 23, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,556
|
|
$
|
14.50
|
|
March 12, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,568
|
|
$
|
13.25
|
|
March 27, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wido Westbroek
|
|
Less than 1%
|
|
Less than 1%
|
|
Nil
|
|
Nil
|
|
6,344
|
|
7%
|
|
3,000
|
|
$
|
54.75
|
|
July 14, 2016
|
|
4%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,748
|
|
$
|
29.25
|
|
March 23, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,780
|
|
$
|
14.50
|
|
March 12, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,500
|
|
$
|
13.25
|
|
March 27, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jennifer Barber
|
|
Less than 1%
|
|
Less than 1%
|
|
Nil
|
|
Nil
|
|
5,060
|
|
6%
|
|
222
|
|
$
|
192.50
|
|
October 1, 2011
|
|
3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000
|
|
$
|
112.75
|
|
May 16, 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,016
|
|
$
|
84.25
|
|
May 23, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,580
|
|
$
|
29.25
|
|
March 23, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,552
|
|
$
|
14.50
|
|
March 12, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,860
|
|
$
|
13.25
|
|
March 27, 2019
|
|
|
|
For information regarding
arrangements for involving employees in the capital of our Company, see Item
6. Directors, Senior Management And Employees Compensation Elements of
Executive Compensation Program Long-term Incentives above.
62
ITEM
7. MAJOR SHAREHOLDERS AND RELATED PARTY
TRANSACTIONS
MAJOR
SHAREHOLDERS
To the knowledge of our
directors and officers, as of March 25, 2010, no person or company
beneficially owns, directly or indirectly, or exercises control or direction
over common shares carrying more than 5% of the voting rights attached to our
outstanding common shares other than the following:
·
General Motors Holdings LLC (General
Motors), which owns 454,560 common shares, representing 10.8% of our
outstanding common shares;
·
Alpha, which owns 250,000 common shares,
representing 5.9% of our outstanding common shares, 119,678 series A warrants
(representing the right to acquire the equivalent number of common shares) and
130,323 series B warrants of the Company (representing the right to acquire the
equivalent number of common shares); and
·
Iroquois Master Fund Ltd., which owns
250,000 common shares, representing 5.9% of our outstanding common shares,
119,678 series A warrants (representing the right to acquire the equivalent
number of common shares) and 130,323 series B warrants of the Company
(representing the right to acquire the equivalent number of common shares).
For information regarding
the pre-emptive right granted to General Motors, see Item 7. Major
Shareholders and Related Party Transactions Related Party Transactions
Transactions with General Motors below.
Our major shareholders do
not have voting rights different from those of our other shareholders.
As of
February 9,
2010
, approximately 15,916 U.S. shareholders held
approximately 2,523,689 common shares or approximately 68% of our outstanding
common shares.
RELATED
PARTY TRANSACTIONS
Transactions
with Viking Engineering & Tool Co.
In the normal course of
operations, we subcontract certain machining and sheet metal fabrication of
parts to Viking Engineering & Tool Co., a company owned by the father
and uncle of Joseph Cargnelli, a director and senior officer of the Company and
one of our principal shareholders. For the fiscal year ended December 31,
2009, billings by this related company totaled $0.1 million, a decrease of $0.1
million from the $0.2 million billed the previous year. For the year ended December 31,
2007, billings by this related company totaled $0.8 million, a decrease of $0.2
million from the $1.0 million billed in the previous year. At December 31,
2009, we had an accounts payable balance due to this related company of less
than ten thousand dollars. We believe that transactions with this company are
consistent with those we have with unrelated third parties. All related party
transactions have been recorded at the exchange amount, which is the
consideration paid or received as established and agreed by the related
parties.
Transactions
with General Motors
In October 2001, we
formed a strategic alliance with General Motors to accelerate the development
of fuel cell technology in global commercial markets. In connection with this strategic alliance,
we issued to General Motors approximately 11.4 million of our common shares, or
approximately 21% of our outstanding shares at October 2001, and warrants
to purchase approximately 2.5 million additional shares. We cancelled these warrants in a transaction
with General Motors in December 2005 for consideration of $750,000, which
we paid in the form of a credit against the amount due from General Motors in
respect of testing services. All testing
services have since been completed. We
have agreed that one director nominated by General Motors shall be included in
the slate of directors that is presented to shareholders for approval at our
general meeting.
In connection with this
strategic alliance, General Motors granted us a non-exclusive, royalty free
licence to use certain of General Motors proprietary fuel cell stack
intellectual property in certain applications and modules. The use or incorporation of General Motors
fuel stack intellectual property outside these defined areas requires the
consent of General Motors. We granted to
General Motors, its affiliates and any third parties with whom General Motors
has a technical or business relationship related to fuel cells a perpetual,
royalty-free, non-exclusive licence to use all of the intellectual property we
develop that (i) uses General Motors proprietary fuel cell stack
intellectual property, and/or (ii) is funded by General Motors. Intellectual property that is not funded by
General Motors but which uses General Motors fuel cell stack technology is
licensed to General Motors non-exclusively.
Intellectual property that has been developed through funding by General
Motors, whether owned solely by us or jointly by us and General Motors, is
licensed to General Motors on an exclusive basis for mobile applications and on
a non- exclusive basis for all other applications. In the event that we wish to liquidate or
discontinue activity in the fuel cell business, or
63
otherwise wish to
transfer any of the intellectual property associated with General Motors
proprietary fuel cell stack intellectual property developed using funds from
General Motors, we are required to offer it first to General Motors. We have also agreed to provide General Motors
with certain services, access to technology and testing resources in connection
with its fuel cell development program and we have agreed that all products,
material hardware and resources purchased from us by General Motors will be at
our most favourable commercial prices.
For so long as General Motors
holds at least 10% of our outstanding shares, in the event that any of our
founders, Pierre Rivard, Joseph Cargnelli or Boyd Taylor, wish to transfer (i) all
or substantially all of their shares to any person, or (ii) any of their
shares to a person actively competing with General Motors in the automotive or
fuel cell industry, he must first offer the shares to General Motors. In addition, in the event that we issue
additional equity securities or securities convertible into equity securities
for cash consideration, we have granted General Motors the right to participate
in such offering on a pro rata basis based on the fully diluted number of
common shares that it holds. General
Motors pre-emptive right is subject to certain limited exceptions, including
the issuance of shares in connection with acquisitions.
Indebtedness
of Directors and Executive Officers
From January 1, 2007
to March 25, 2010, none of our current directors or executive officers are
indebted to the Company.
Indebtedness of Directors and Executive Officers Under
(1) Securities Purchase and (2) Other Programs
Name and Principal
Position
|
|
Involvement
of
Company or
Subsidiary
|
|
Largest
Amount
Outstanding
During 2007
($)
|
|
Amount
Outstanding
as
at
March 25,
2
010
($)
|
|
Financially
Assisted
Securities
Purchases
During 200
7
|
|
Security
for
Indebtedness
(#
of shares)
|
|
Amount
Forgiven
During
2007 ($)
|
|
Securities
Purchase Program
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jon
Slangerup,(1)(2)(3) former President and Chief Executive Officer of
Stuart Energy
|
|
Provided loan by Stuart
Energy (now a subsidiary of the Company) to purchase common shares of
Stuart Energy(2)
|
|
957,887
|
|
Nil
|
|
Nil
|
|
150,775
|
|
957,887
|
|
Notes
:
(1) Jon
Slangerup was the President and Chief Executive Officer of Stuart Energy from July 2001
until January 2005, when he resigned in connection with our acquisition of
Stuart Energy.
(2) At the
time of hiring Mr. Slangerup in July 2001, Stuart Energys board of
directors determined that it was desirable and appropriate to align Mr. Slangerups
interests with those of the shareholders of Stuart Energy by encouraging Mr. Slangerup
to purchase up to 203,750 common shares of Stuart Energy. On September 28,
2001, as part of Mr. Slangerups inducement option which was approved by
the shareholders of Stuart Energy at the September 25, 2001 shareholders
meeting, Stuart Energy provided a loan to Mr. Slangerup in the principal
amount of approximately Cdn.$1,151,188 to facilitate the purchase by Mr. Slangerup
of 203,750 treasury common shares of Stuart Energy at Cdn.$5.65 per share. This
loan was secured by a demand promissory note and a pledge by Mr. Slangerup
of the purchased common shares. The loan was interest free, unless in default,
in which case the loan bears interest at 6% after default. In January 2005,
when we acquired Stuart Energy, our separation agreement with Mr. Slangerup
became effective. As part of that agreement, we agreed to extend until December 31,
2006 (the Extension Date) the term of this loan which would otherwise expire
upon the termination of Mr. Slangerups employment with Stuart Energy. The
203,750 common shares of Stuart Energy pledged by Mr. Slangerup as
security for the loan were exchanged for 150,775 Shares, which in turn have
been pledged in favour of the Company as security for the loan. Consistent with
the terms of Mr. Slangerups then employment arrangement, the separation
agreement provides that the outstanding loan may be forgiven by Hydrogenics at
any time. In addition, Mr. Slangerup and Hydrogenics had agreed that at
the end of the Extension Date (or any time prior to the Extension Date, at the
election of Hydrogenics), Hydrogenics shall purchase for cancellation the
pledged shares from Mr. Slangerup, subject to compliance with applicable
securities laws, and shall apply the proceeds from the sale to the loan
relating to such pledged shares. Should proceeds from the sale
64
of the pledged shares be
less than the amount of the loan, subject to applicable law, the balance of the
loan will be forgiven and Mr. Slangerup will be compensated for any
negative tax consequences resulting from forgiveness of the loan.
(3) On March 20,
2007 the Company purchased for cancellation the pledged shares and applied the
amount resulting therefrom to Mr. Slangerups loan. The balance of the
loan was forgiven and Mr. Slangerup will be compensated for any negative
tax consequences resulting from this forgiveness, in accordance with the
Companys contractual commitments to Mr. Slangerup.
INTERESTS
OF EXPERTS AND COUNSEL
None.
ITEM
8. FINANCIAL INFORMATION
CONSOLIDATED
STATEMENTS AND OTHER FINANCIAL INFORMATION
Financial
Statements
See Item 18.
Financial Statements. For accounting purposes, we are considered to be a
continuation of Old Hydrogenics and the financial statements of Old Hydrogenics
for the periods prior to October 27, 2009 are considered to be our
financial statements.
Legal
Proceedings
See Item 5. Operating and Financial Review and Prospects
Trend Information Delivery Outlook American Power Conversion Corporation
for information regarding the complaint we filed against APC in the U.S.
District Court for the District of Massachusetts on November 13, 2009, in
connection with a certain supply agreement with APC.
See Item 3. Key
Information Risk Factors
Risk Factors Related to Our Financial
Condition
We are
currently involved in litigation with Alpha Capital Anstalt, the outcome of
which could adversely affect our financial condition for information regarding
the suit filed by Alpha against Hydrogenics and two of our officers on February 23,
2010 in the Supreme Court of the State of New York (County of New York)
regarding our share consolidation, which was completed on March 12,
2010. We have also received
correspondence from the other institutional investor in the registered direct
offering completed on January 14, 2010 making allegations similar to those
made by Alpha.
We are not currently
party to any other material legal proceedings.
Dividends
Policy
We have never declared or
paid any cash dividends on our common shares.
We currently intend to retain any future earnings to fund the
development and growth of our business and we do not anticipate paying any cash
dividends in the foreseeable future.
SIGNIFICANT
CHANGES
For information regarding
significant changes since December 31, 2009, see Item 14. Material Modifications to the Rights of
Security Holders and Use of Proceeds Material Modifications to the Rights of
Security Holders, Item 4. Information
of the Company Business Overview Our Products and Services Recent
Developments, and note 21 to our consolidated financial statements on
beginning on page F-37.
65
ITEM
9. THE OFFER AND LISTING
LISTING
DETAILS
The following table sets
forth the reported trading prices in Canadian dollars and U.S. dollars for our
common shares on the TSX and Nasdaq, respectively. Trading prices prior to March 12, 2010
are on a pre-consolidation basis and trading prices for the period from March 12,
2010 to March 25, 2010 are on a post-consolidation basis.
66
|
|
TSX
|
|
Nasdaq
|
|
|
|
High
(Cdn$)
|
|
Low (Cdn$)
|
|
High ($)
|
|
Low ($)
|
|
Annual Market Prices
|
|
|
|
|
|
|
|
|
|
2005
|
|
6.45
|
|
2.93
|
|
5.38
|
|
2.50
|
|
2006
|
|
5.03
|
|
1.35
|
|
4.40
|
|
1.21
|
|
2007
|
|
1.73
|
|
0.90
|
|
1.65
|
|
0.84
|
|
2008
|
|
2.47
|
|
0.37
|
|
2.45
|
|
0.32
|
|
2009
|
|
0.80
|
|
0.38
|
|
0.75
|
|
0.29
|
|
Quarterly Market Prices
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
First
Quarter
|
|
1.05
|
|
0.51
|
|
1.07
|
|
0.49
|
|
Second
Quarter
|
|
1.99
|
|
0.50
|
|
1.95
|
|
0.50
|
|
Third
Quarter
|
|
2.47
|
|
0.60
|
|
2.45
|
|
0.55
|
|
Fourth
Quarter
|
|
0.98
|
|
0.37
|
|
0.92
|
|
0.32
|
|
2009
|
|
|
|
|
|
|
|
|
|
First
Quarter
|
|
0.73
|
|
0.38
|
|
0.63
|
|
0.29
|
|
Second
Quarter
|
|
0.80
|
|
0.56
|
|
0.55
|
|
0.51
|
|
Third Quarter
|
|
0.75
|
|
0.49
|
|
0.69
|
|
0.45
|
|
Fourth Quarter
|
|
0.70
|
|
0.38
|
|
0.69
|
|
0.36
|
|
2010
|
|
|
|
|
|
|
|
|
|
First Quarter (until March 11)
|
|
0.55
|
|
0.23
|
|
0.54
|
|
0.21
|
|
First Quarter (March 12 to March 25)
|
|
7.87
|
|
5.49
|
|
7.75
|
|
5.46
|
|
Monthly Market Prices
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
|
|
|
|
|
|
|
September
|
|
0.75
|
|
0.52
|
|
0.69
|
|
0.49
|
|
October
|
|
0.70
|
|
0.48
|
|
0.69
|
|
0.42
|
|
November
|
|
0.51
|
|
0.42
|
|
0.63
|
|
0.39
|
|
December
|
|
0.50
|
|
0.38
|
|
0.49
|
|
0.36
|
|
2010
|
|
|
|
|
|
|
|
|
|
January
|
|
0.55
|
|
0.38
|
|
0.54
|
|
0.36
|
|
February
|
|
0.40
|
|
0.23
|
|
0.37
|
|
0.21
|
|
March 1
to March
11
|
|
0.25
|
|
0.23
|
|
0.25
|
|
0.23
|
|
March 12
to March
25
|
|
7.87
|
|
5.49
|
|
7.75
|
|
5.46
|
|
Plan of
Distribution
Not
applicable.
MARKETS
Our common shares are
listed on the TSX under the symbol HYG. As a result of the share
consolidation implemented on March 12, 2010, our common shares are listed on
the Nasdaq under the symbol HYGSD until April 9, 2010, at which point they
will revert to trading under the symbol HYGS, which is the symbol they were
listed under prior to the share consolidation.
SELLING
SHAREHOLDERS
Not applicable.
DILUTION
Not applicable.
EXPENSES
OF THE ISSUE
Not applicable.
67
ITEM
10.
ADDITIONAL INFORMATION
SHARE
CAPITAL
Not applicable.
MEMORANDUM
AND ARTICLES OF ASSOCIATION
Company
Purpose
The Companys restated articles
of incorporation, together with any amendments thereto, which we refer to as
our articles of incorporation, are filed with Industry Canada, pursuant to the
Canada Business Corporations Act, which we refer to as the CBCA. Our articles
of incorporation do not have a stated purpose.
Directors
Pursuant to applicable
Canadian law, our directors, in exercising their powers and discharging their
duties must act honestly and in good faith with a view to the best interests of
the Company. They must also exercise the care, diligence and skill that a
reasonably prudent person would exercise in comparable circumstances.
Pursuant to the
provisions of the CBCA, a director who is party to a material contract or
transaction with the Company, is a director or an officer or an individual
acting in a similar capacity of a party to the contract or transaction, or who
has a material interest in a party to a material contract or transaction with
the Company must disclose to the Company the nature and extent of such interest
in writing or request to have such interest noted in the minutes of meetings of
the directors. Furthermore, a director who has a material interest in a matter
before the board must refrain from voting on the matter unless the contract: is
with one of our affiliates; relates to
the directors remuneration as a director or officer of the Company; or,
relates to our indemnity or insurance for our officers and directors.
Pursuant to the CBCA at
least 25% of our directors must be resident Canadians. The CBCA also requires
that we have not less than three directors, at least two of whom are not
officers, directors or employees of the Company. We currently have six
directors, five of whom are resident Canadians. Our articles of incorporation
provide that the minimum size of our Board of Directors be three and the
maximum size of our Board of Directors be twelve. Our directors may, from time
to time, determine the number of directors on the board by resolution, which is
currently six directors. Our articles of incorporation and our by-laws do not
impose any other director qualification requirements.
In February 2010,
the Board of Directors amended our by-laws to provide the Chairman of the Board
of Directors with a casting vote in the case of an equality of votes on a
question before the Board of Directors at a meeting of the Board of Directors.
Director Share Ownership Guidelines
We have established
director share ownership guidelines that require each of our directors to hold
Shares or DSUs equal to five times the directors annual cash retainer within
three years of his initial appointment. The General Motors nominee on the Board
is not required to comply with these guidelines.
Given the recent decline
in the price for our common shares, exacerbated by prevailing global economic
and credit market conditions, the Human Resources and Corporate Governance
Committee has amended the guidelines to permit the value to be measured at
either the year-end Share price, or a directors acquisition cost of Shares and
initial grant price of DSUs. The Board
has approved this amendment and all Directors are in compliance.
SHAREHOLDER
RIGHTS
Our authorized capital
consists of an unlimited number of common shares with no par value and an
unlimited number of preferred shares with no par value issuable in series, of
which 4,201,983
common shares and no preferred
shares were issued and outstanding as of
March 25, 2
010. As of
March 25, 2
010,
we also have 239,355 series A warrants and 260,644 series B warrants issued and
outstanding, whereby each warrant entitles the holder to purchase a common
share (see Item 14. Material
Modifications to the Rights of Security Holders and Use of Proceeds Material
Modifications to the Rights of Security Holders
Registered
Direct Offering of Common Shares and Warrants
for
information regarding the warrants.)
Our articles of
incorporation permit us to issue an unlimited number of common and preferred
shares. If we were to issue a
significant number of common shares, it would reduce the relative voting power
of previously outstanding shares.
68
Each common share carries
one vote on all matters to be voted on by our shareholders. Holders of
common shares are entitled to receive dividends if, as and when declared by our
Board of Directors and to share ratably in our remaining assets available for
distribution, after payment of liabilities, upon Hydrogenics liquidation,
dissolution or winding up. Common shares do not carry pre-emptive rights or
rights of conversion into any other securities. However, we have granted
General Motors a pre-emptive right. See Item 7 Major Shareholders and
Related Party Transactions Related Party Transactions Transactions with
General Motors. All outstanding common shares are fully paid and
non-assessable. There are no limitations on the rights of non-resident
owners of common shares to hold or vote their shares.
Our Board of Directors
has the authority, without further action by the shareholders, to issue an
unlimited number of preferred shares in one or more series and, in the event
that preferred shares are issued, the Board also has the authority to fix the
designations, powers, preferences, privileges and relative, participating,
optional or special rights of any preferred shares including any
qualifications, limitations or restrictions.
Special rights that may be granted to a series of preferred shares
include dividend rights, conversion rights, voting rights, redemption and
liquidation preferences, any or all of which may be superior to the rights of
the common shares. Preferred share
issuances could decrease the market price of common shares and may adversely
affect the voting and other rights of the holders of common shares. The issuance of preferred shares could also
have the effect of delaying or preventing a change in control of Hydrogenics.
We have never declared or
paid any cash dividends on our common shares.
We currently intend to retain any future earnings to fund the
development and growth of our business and we do not anticipate paying any cash
dividends in the foreseeable future.
CHANGES
TO SHAREHOLDER RIGHTS
Under the CBCA,
amendments to our articles of incorporation will generally require approval by
special resolution. A special resolution is a resolution passed by a majority
of not less than two-thirds of the votes cast by the shareholders who voted in
person or by proxy in respect of that resolution at the annual or special
meeting called for such purpose. If the amendment is of a nature affecting a
particular class or series of our shares in a manner requiring a separate class
or series vote, that class or series is entitled to vote on the amendment
whether or not it otherwise carries the right to vote. Under the CBCA, our directors
may make, amend or repeal any by-law that regulates our business or affairs.
Where our directors make, amend or repeal a by-law, they are required to submit
the by-law, amendment or repeal to the shareholders at the next meeting of
shareholders, and the shareholders may, by an ordinary resolution, which is a
resolution passed by a simple majority of the votes cast by shareholders who
voted in respect of the resolution, confirm, reject or amend the by-law,
amendment or repeal.
SHAREHOLDER
MEETINGS
Our board is required to
call an annual meeting of the shareholders no later than 15 months after the
holding of the last preceding annual meeting. Our board may also call a special
meeting of the shareholders at any time. The only persons entitled to attend a
meeting of our shareholders are our directors, our auditors and those persons
entitled to vote at such meeting and any other persons who, although not
entitled to vote at the meeting, are entitled to attend such meeting pursuant
the provisions of the CBCA. Under our by-laws, a quorum of shareholders shall
be two persons present in person or represented by proxy holding in the
aggregate not less than 25% of the outstanding shares of the Company.
LIMITATIONS
There are no limitations in our
articles of incorporation or by-laws or under Canadian federal or provincial
laws, on the right of non-residents of Canada or foreign owners to hold or vote
our common shares, except for transactions involving or being deemed to involve
an acquisition of control, which requires compliance with the Investment Canada
Act.
CHANGE
IN CONTROL
Our articles of
incorporation and by-laws do not contain any provisions that would have the
effect of delaying, deferring or preventing a change in control of the Company.
Under the CBCA, certain
extraordinary corporate actions, such as amalgamations, continuances, sales,
leases or exchanges of all or substantially all of the property of a
corporation other than in the ordinary course of business, and other
extraordinary corporate actions such as liquidations or dissolutions are also
required to be approved by special resolution. In certain cases, a special
resolution to approve an extraordinary corporate action is also required to be
approved separately by the holders of a class or series of shares.
69
DISCLOSURE
OF SHAREHOLDINGS
Our by-laws do not impose
an ownership threshold, above which shareholder ownership must be disclosed and
any obligation to make such disclosure would be the subject of applicable
securities laws.
MATERIAL
CONTRACTS
For the two years
immediately preceding the date of this Annual Report, no material contracts
have been terminated, entered into or assigned by us other than in the ordinary
course of business and other than the material contracts summarized below.
On July 22, 2009, we
announced that we formally notified American Power Conversion Corporation (APC)
of the termination of the manufacturing and supply agreement dated August 9,
2006 between Hydrogenics and APC. See Item
5. Operating and Financial Review and
Prospects Trend Information Delivery Outlook American Power Conversion
Corporation for information regarding the termination.
The following material
contracts were entered into in connection with the APIF Transaction described
under Item 4. Information of the Company History and Development of
Hydrogenics Corporation.
·
Support Agreement dated June 11,
2009, among the Trustees of Algonquin Power Income Fund (the Algonquin Board),
Hydrogenics and Old Hydrogenics. The
Support Agreement sets out the terms and conditions pursuant to which the
parties implemented the APIF Transaction, which involved (i) a plan of
arrangement among Hydrogenics, Old Hydrogenics and its wholly-owned
subsidiaries, Stuart Energy and Hydrogenics Test Systems Inc. (Test Systems),
and (ii) a take-over bid pursuant to which Old Hydrogenics will make
offers to acquire all of the issued and outstanding units and convertible
debentures of APIF.
·
Expense Reimbursement Agreement dated June 11,
2009, among Algonquin Power Management Inc. (APMI), Hydrogenics and Old
Hydrogenics. The Expense Reimbursement Agreement with APMI, the Manager
of APIF, provides for the payment by one party to the other of professional
advisory costs and expenses incurred in connection with the transactions
contemplated in the Support Agreement, to a maximum amount of Cdn. $1,000,000
if the transactions fail to be completed under certain conditions.
·
APMI Guarantee dated June 11, 2009,
among APMI, Hydrogenics and Old Hydrogenics. Pursuant to the APMI
Guarantee, APMI has agreed to unconditionally and irrevocably guarantee the
obligations of the Algonquin Board under the Support Agreement.
·
Algonquin Power Guarantee dated June 11,
2009, among APIF, APMI, Hydrogenics and Old Hydrogenics.
Pursuant to the Algonquin Power Guarantee,
APIF has agreed to unconditionally and irrevocably guarantee the obligations of
APMI under the Expense Reimbursement Agreement and the APMI Guarantee.
·
Indemnity Agreement dated October 27,
2009, between Hydrogenics and APUC. The
Indemnity Agreement is primarily designed to provide APUC with indemnification
from Hydrogenics, the resulting entity that is carrying on the business
previously carried on by APUC, for claims relating to Hydrogenics business
that are brought against APUC in the future.
·
Divestiture Agreement dated October 27,
2009, among Hydrogenics, Old Hydrogenics, Stuart Energy and Test Systems. Pursuant to the Divestiture Agreement, we
agreed to acquire from Old Hydrogenics, Stuart Energy and Test Systems all of
their assets (excluding their tax attributes) and to pay, assume, discharge,
perform and fulfill, as the case may be, all of their liabilities (excluding
certain liabilities specified in the agreement).
The following material
contracts were entered into in connection with the registered direct offering
described under Item 14. Material
Modifications to the Rights of Security Holders and Use of Proceeds Material
Modifications to the Rights of Security Holders Registered
Direct
Offering of Common Shares and Warrants
.
·
Securities Purchase Agreement dated January 11,
2010, among Hydrogenics and two investors.
Pursuant to such agreement, Hydrogenics agreed to sell common shares and
warrants in a registered direct offering to the two investors, resulting in
gross proceeds of $5 million before placement agents fees and other offering
expenses.
·
Warrant Agreement dated January 14,
2010 between Hydrogenics and Mellon Investor Services LLC. The Warrant Agreement appoints Mellon
Investor Services LLC as the warrant agent to act on behalf of Hydrogenics in
connection with the issuance, transfer, exchange and exercise of the warrants
issued in the registered direct offering and certain other related matters.
As described under Item
5. Operating and Financial Review and
Prospects Trend Information Delivery Outlook, on July 20, 2009, we
announced that we had terminated our manufacturing and supply agreement dated August 9,
2006 with American Power Conversion Corporation.
70
EXCHANGE CONTROLS
There is no law,
government decree or regulation in Canada restricting the export or import of
capital or affecting the remittance of dividends, interest or other payments to
a nonresident holder of common shares, other than withholding tax requirements.
TAXATION
Because Canadian and
United States tax consequences may differ from one holder to the next, the
discussion set out below does not purport to describe all of the tax
considerations that may be relevant to a shareholder and such shareholders
particular situation. Accordingly, a shareholder is advised to consult a tax
advisor as to the United States and Canadian federal, provincial, state and
other tax consequences of owning our common shares. The statements of United
States and Canadian tax law set out below are based upon the laws and
interpretations in force as of the date of this annual report, and are subject
to changes occurring after that date.
Canadian Federal Income
Tax Considerations
In this summary, a U.S.
holder means a person who, for the purposes of the Income Tax Act (Canada)
(the Income Tax Act) and the Canada-United States Income Tax Convention
(1980) (the Convention), is a resident of the United States and is not and
has not been a resident of Canada, does not have and has not had at any time, a
permanent establishment or fixed base in Canada and otherwise qualifies for the
full benefits of the Convention, and who, for the purposes of the Income Tax
Act:
·
deals at arms length and is not
affiliated with us;
·
holds our common shares as capital
property;
·
does not use or hold and is not deemed to
use or hold our common shares in the course of carrying on, or otherwise in
connection with, a business in Canada;
·
is not a registered non-resident insurer
or authorized foreign bank, each within the meaning of the Income Tax Act;
and
·
does not carry on an insurance business
in Canada and elsewhere.
Generally, our common
shares will be capital property to a U.S. holder unless they are held in the
course of carrying on a business of buying or selling securities or in an
adventure of concern in the nature of trade. This summary does not deal with
special situations, such as the particular circumstances of traders or dealers,
United States limited liability companies (which may not be considered to be a
resident of the Untied States for the purposes of the Convention), tax-exempt
entities, insurers or financial institutions.
Such holders and other holders who do not meet the criteria of a U.S.
holder described above should consult their own tax advisors. There are no Canadian federal estate taxes
applicable to the purchase or ownership of our common shares. Under the Income
Tax Act, on death, a U.S. holder would be deemed to dispose of all of his or
her assets, including our common shares.
This summary is based on
the current provisions of the Income Tax Act and the regulations in force under
the Income Tax Act on the date of this annual report, the Convention, current
published administrative and assessing practices of the Canada Revenue Agency, all specific proposals to
amend the Income Tax Act and the regulations publicly announced by the Minister
of Finance (Canada) prior to the date of this annual report and all judicial
decisions currently in effect.
This summary is not
exhaustive and, except for the proposed amendments to the Income Tax Act, does
not take into account or anticipate prospective or retrospective changes in the
law or the administrative or assessing practices of the Canada Revenue Agency,
whether these changes are effected by judicial, governmental or legislative
action or interpretation. This summary does not take into account tax
legislation or considerations of any province or territory of Canada. None of
the tax consequences described herein depend or rely upon any of the proposed
amendments to the Income Tax Act passing into law. Because Canadian tax
consequences may differ from one holder to the next, this summary does not
purport to describe all of the tax considerations that may be relevant to a
shareholder and his particular situation. The Canadian tax treatment to a U.S.
holder may differ from the treatment described herein. A shareholder is advised
to consult a tax advisor.
Dividends
Dividends paid, credited
or deemed to have been paid or credited on our common shares are subject to
non-refundable Canadian withholding tax under the Income Tax Act at the rate of
25%, although this rate may be reduced by the provisions of an applicable
income tax treaty. Subject to the exceptions noted immediately below, under the
Convention, U.S. holders who beneficially own the dividends will be subject to
a 15% withholding tax on the gross amount of such dividends. In the case of a U.S. holder that is a
corporation that beneficially owns at least 10% of our voting shares, the
applicable rate of withholding tax on dividends will be reduced to 5%. In the
case of dividends paid,
71
credited or deemed
to be credited to a U.S. holder that is a tax exempt organization as described
in Article XXI of the Convention, generally no withholding tax will be
payable.
Dispositions
A U.S. holder will
generally not be subject to tax under the Income Tax Act on any capital gain
realized on a disposition of our common shares, unless the common shares
constitute taxable Canadian property of the U.S. holder at the time of
disposition and the U.S. holder is not entitled to relief under the
Convention. Provided our common shares
are listed on a designated stock exchange (which includes the TSX and Nasdaq)
at the time of the disposition, our common shares generally will not constitute
taxable Canadian property of a U.S. holder unless, at any time during the 60-month
period immediately preceding the disposition, the U.S. holder, persons with
whom the U.S. holder does not deal at arms length, or the U.S. holder together
with such persons owned, 25% or more of the issued shares of any series or
class of our capital stock or unless our common shares are deemed under the
Income Tax Act to be taxable Canadian property to the U.S. holder. If our common shares constitute taxable
Canadian property to a particular U.S. holder, any capital gain arising on
their disposition may be exempt from Canadian tax under the Convention if, at
the time of disposition, our common shares do not derive their value
principally from real property situated in Canada.
On March 4, 2010,
the Department of Finance (Canada) announced in the 2010 Canadian Federal
Budget that it is proposing to amend the definition of taxable Canadian
property in the Tax Act to exclude shares (whether listed or not) of
corporations that do not derive, directly or indirectly, more than 50% of their
fair market value from one or any combination of (i) real or immovable
property situated in Canada, (ii) Canadian resource properties, (iii) timber
resource properties, and (iv) options in respect of or interests or civil
law rights in such property, at any time during the 60-month period immediately
preceding the disposition. If the
definition of taxable Canadian property is amended as proposed and our common
shares are not considered to have derived more than 50% of their fair market
value from one or any combination of properties described in (i) to (iv) at
any time during the 60-month period preceding the disposition, then our common
shares will not be taxable Canadian property at the time of the disposition
unless such shares are otherwise deemed to be taxable Canadian property to the
U.S. holder.
United States Federal
Income Taxation
The following discussion
summarizes the material United States federal income tax consequences to a U.S.
Holder (as defined below) of the acquisition, ownership and disposition of
our common shares. This summary assumes that you hold your common shares as
capital assets within the meaning of Section 1221 of the U.S. Internal
Revenue Code of 1986, as amended (the U.S. Tax Code). This summary does not
purport to be a complete analysis of all of the potential United States federal
income tax considerations that may be relevant to a particular holders
acquisition, ownership or disposition of our common shares in light of such
holders particular circumstances, nor does it address the United States
federal income tax consequences applicable to holders subject to special tax
rules, including without limitation banks, brokers, dealers in securities or
currencies, traders in securities that elect to use a mark-to-market method of
accounting for their securities holdings, tax-exempt entities, insurance
companies, persons liable for alternative minimum tax, persons that actually or
constructively own or have owned 5% or more of our common shares, persons that
hold common shares as part of a straddle or a hedge, constructive sale,
synthetic security, conversion or other integrated transaction, partnerships
and other pass-through entities, persons whose functional currency is not the
U.S. dollar, financial institutions, and expatriates of the United States. In
addition, this summary does not address the tax consequences arising under the
tax laws of any state, local or foreign jurisdiction.
If any entity that is
classified as a partnership for United States federal income tax purposes holds
common shares, the tax treatment of its partners will generally depend upon the
status of the partner and the activities of the partnership. Partnerships and
other entities that are classified as partnerships for United States federal
income tax purposes and persons holding common shares through a partnership or
other entity classified as a partnership for United States federal income tax
purposes are urged to consult their own tax advisors regarding the consequences
of the acquisition, ownership and disposition of our common shares.
This section is based on
the U.S. Tax Code, the Treasury regulations thereunder (the Treasury
Regulations), published United States Internal Revenue Service (IRS)
rulings, administrative interpretations and judicial decisions, all as
currently in effect. These authorities are subject to change, repeal or
revocation, possibly on a retroactive basis, which may result in United States
federal income tax consequences different from those discussed below.
For purposes of this discussion,
you are a U.S. Holder if you are a beneficial owner of common shares and
you are for United States federal income tax purposes (i) an individual
who is a citizen or resident of the United States, (ii) a corporation or
other entity taxable as a corporation created or organized under the laws of
the United States or any political subdivision thereof, (iii) an estate
whose income is subject to United States federal income tax regardless of its
source, or (iv) a trust (a) if a United States court can exercise
primary supervision over the trusts administration and one or more United
States persons are authorized to control all substantial decisions of the trust
or (b) that has a valid election in effect under applicable Treasury
Regulations to be treated as a United States person.
72
This summary does not
discuss the United States federal income tax consequences to any beneficial
owner of common shares that is not a U.S. Holder. Each U.S. Holder is urged to
consult with its own tax advisor regarding the tax consequences of the
acquisition, ownership and disposition of common shares, including the effects
of United States federal, state, local, non-United States and other tax laws.
Taxation of Distributions
on Common Shares
Subject to the PFIC rules discussed
below, the gross amount of any actual or deemed distribution by us (including
any Canadian taxes withheld therefrom) with respect to your common shares will
be included in your gross income as a dividend to the extent such distribution
is paid out of our current or accumulated earnings and profits, as determined
under United States federal income tax principles. A distribution in excess of
our current and accumulated earnings and profits will first be treated as a
tax-free return of capital to the extent of your adjusted tax basis in our
common shares and will be applied against and reduce such basis on a
dollar-for-dollar basis. Thereafter, to the extent that such distribution
exceeds your adjusted tax basis in our common shares, the distribution will be
treated as gain from the sale or exchange of such common shares. Dividends will
not be eligible for the dividends received deduction generally allowed to
United States corporations in respect of dividends received from other United
States corporations.
If you are a
non-corporate U.S. Holder, including an individual, dividends you receive in
taxable years beginning before January 1, 2011, may be subject to United
States federal income tax at the lower rates applicable to capital gains,
provided that (i) we are a qualified foreign corporation and (ii) certain
holding period and other requirements are satisfied. A qualified foreign
corporation includes a non-United States corporation that is eligible for the
benefits of a comprehensive income tax treaty with the United States that
includes an exchange of information program and that the United States Treasury
Department has determined to be satisfactory for purposes of the qualified
dividend provisions of the U.S. Tax Code. The United States Treasury Department
has determined that the Convention (as defined above) is satisfactory for
purposes of the qualified dividend provisions of the U.S. Tax Code. In
addition, a foreign corporation not otherwise treated as a qualified foreign
corporation shall be so treated with regard to any dividend paid by such
corporation if the stock with respect to which the dividend is paid is
regularly tradable on an established securities market in the United States. A
qualified foreign corporation does not include a non-United States corporation
that is a PFIC for the taxable year in which a dividend is paid or that was a
PFIC for the preceding taxable year. Accordingly, dividends on the common
shares will be eligible for these lower rates of taxation provided that (i) we
are not a PFIC for the taxable year the dividend is paid or for the preceding
taxable year, (ii) we are eligible for the benefits of the Convention or
our common shares are readily tradable on an established securities market in
the United States, and (iii) you satisfy certain holding period and other
requirements. You should consult your own tax advisors regarding the
application of these rules.
Any tax withheld under
Canadian law with respect to distributions on our common shares at a rate not
exceeding the rate provided in the Convention may, subject to a number of
complex limitations, be claimed as a foreign tax credit against your U.S.
federal income tax liability or may be claimed as a deduction for U.S. federal
income tax purposes. The limitation on foreign taxes eligible for credit is
calculated separately with respect to specific classes of income. For this
purpose, dividends distributed with respect to our common shares will be
foreign source income and generally will constitute passive category income
or, in the case of certain U.S. Holders, general category income. The rules relating
to United States foreign tax credits are complex and the availability of a
foreign tax credit depends on numerous factors. You should consult your own tax
advisors concerning the application of the United States foreign tax credit rules to
your particular situation.
The gross amount of
distributions paid in Canadian dollars will be included by each U.S. Holder in
gross income in a U.S. dollar amount calculated by reference to the exchange
rate in effect on the day the distributions are paid, regardless of whether the
payment is in fact converted into U.S. dollars on such date. If you convert
such Canadian dollars into U.S. dollars on the date of the payment, you should
not be required to recognize any foreign currency gain or loss with respect to
the receipt of the Canadian dollar distributions. If instead you convert such
Canadian dollars into U.S. dollars at a later date, any currency gain or loss
realized from the conversion of the Canadian dollars will be treated as U.S.
source ordinary income or loss.
Taxation of
Dispositions of Common Shares
Subject to the PFIC rules discussed
below, upon a sale or other taxable disposition of common shares, you generally
will recognize capital gain or loss for United States federal income tax
purposes equal to the difference, if any, between the amount that you realize
and your adjusted tax basis in your common shares. Your adjusted tax basis in
our common shares generally will be the cost to you of such shares, as
determined under United States federal income tax principles. For taxable years
beginning before January 1, 2011, capital gain of a non-corporate U.S.
Holder, including an individual, generally will be taxed at a maximum rate of
15% if the property has been held for more than one year. The deductibility of
capital losses is subject to limitations. The gain or loss generally will be
gain or loss from sources within the United States for United States foreign
tax credit limitation purposes.
If a U.S. Holder receives
any Canadian dollars on the sale or other taxable disposition of our common
shares, such U.S. Holder may recognize ordinary income or loss as a result of
currency fluctuations between the date of the sale or other taxable disposition
of our common shares and the date the sale proceeds are converted into U.S.
dollars.
73
Passive Foreign
Investment Company Considerations
Special, generally
adverse, United States federal income tax rules apply to United States
persons owning shares of a PFIC (as defined above). A non-United States
corporation will be classified as a PFIC for United States federal income tax
purposes in any taxable year in which, after applying relevant look-through rules with
respect to the income and assets of subsidiaries, either at least 75% of its
gross income is passive income, or on average at least 50% of the gross
value of its assets is attributable to assets that produce passive income or
are held for the production of passive income. For this purpose, passive income
generally includes, among other things, dividends, interest, certain rents and
royalties and gains from the disposition of property that produces such income.
If we are classified as a PFIC for any taxable year in which a U.S. Holder has
held our common shares, we may continue to be classified as a PFIC for any
subsequent taxable year in which the U.S. Holder continues to hold our common
shares, even if our income or assets would not cause us to be a PFIC in such
subsequent taxable year.
Based on the structure of
the Company, and the composition of our income and assets, the Company does not
believe that it was a PFIC for the taxable year ended December 31, 2009 or
its prior taxable year. However, there
can be no assurance that the IRS will not successfully challenge our position
or that we will not become a PFIC in a future taxable year, as PFIC status is
re-tested each year and depends on our assets and income in such year. If we
are classified as a PFIC at any time that you hold our common shares, you may
be subject to an increased United States federal income tax liability and a
special interest charge in respect of gain recognized on the sale or other
disposition of your common shares and upon the receipt of certain excess
distributions (as defined in the U.S. Tax Code).
To mitigate the adverse
consequences of this tax regime, you may be eligible to make:
·
a qualified electing fund election (a
QEF election), as defined in the U.S. Tax Code, to be taxed currently on your
pro rata portion of our ordinary earnings and net capital gain, whether or not
such earnings or gain is distributed in the form of dividends or otherwise, or
·
a mark-to-market election and thereby
agree for the year of the election and each subsequent tax year to recognize
ordinary gain or loss (but only to the extent of prior ordinary gain) based on
the increase or decrease in market value for such taxable year. Your tax basis
in our common shares would be adjusted to reflect any such income or loss.
In order for you to make
a QEF election, we would have to provide certain information regarding your pro
rata share of our ordinary earnings and net capital gain. We currently do not
intend to provide such information in the event we are classified as a PFIC. In
order for you to make a mark-to-market election, our common shares must be marketable. We believe that our common shares should
qualify as marketable stock (although there can be no assurance that this will
continue to be the case).
You should consult your
own tax advisors concerning the United States federal income tax consequences
of holding our common shares if we were a PFIC in any taxable year and its
potential application to your particular situation.
Information
Reporting and Backup Withholding
If you are a
non-corporate U.S. Holder, information reporting on IRS Form 1099 will
apply with respect to:
·
dividend payments or other taxable
distributions made to you within the United States, and
·
the payment of proceeds to you from the
sale of common shares effected at a United States office of a broker (and under
certain circumstances at a non-United States office of a broker),
unless you come within
certain categories of exempt recipients.
Additionally, backup
withholding may apply to such payments if you are a non-corporate U.S. Holder
that does not come within certain categories of exempt recipients and you:
·
fail to provide an accurate taxpayer
identification number,
·
are notified by the IRS that you have
failed to report all interest and dividends required to be shown on your United
States federal income tax returns, or
·
in certain circumstances, fail to comply
with other applicable requirements of the backup withholding rules.
A U.S. Holder who does
not provide a correct taxpayer identification number may be subject to
penalties imposed by the IRS. If backup withholding applies to you, under
current law 28% of the gross amount of any payments to you with respect to our
common shares will be withheld and paid over to the IRS.
Any amounts withheld from
payments to you under the backup withholding rules will be allowed as a
credit against your United States federal income tax liability and may entitle
you to a refund, provided the required information is timely furnished to the
IRS. You should
74
consult your own
tax advisor regarding the application of backup withholding in your particular
situation, the availability of an exemption from backup withholding, and the
procedure for obtaining such an exemption, if available.
DIVIDENDS AND PAYING AGENTS
Not applicable.
STATEMENT BY EXPERTS
Not applicable.
DOCUMENTS ON DISPLAY
Any statement in this Form 20-F
about any of our contracts or other documents is not necessarily complete. If
the contract or document is filed as an exhibit to the Form 20-F the
contract or document is deemed to modify the description contained in this Form 20-F.
You must review the exhibits themselves for a complete description of the
contract or document.
You may review a copy of
our filings with the SEC, including exhibits and schedules filed with it, at
the SECs Public Reference Room, 100 F Street, N.E., Washington,
D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information.
In addition, the SEC maintains an Internet site at http://www.sec.gov that
contains reports and other information regarding issues that file electronically
with the SEC. These SEC filings are also available to the public from
commercial document retrieval services.
We are required to file
reports and other information with the SEC under the Exchange Act and
regulations under that act. As a foreign private issuer, we are exempt from the
rules under the Exchange Act prescribing the form and content of proxy
statements and our officers, directors and principal shareholders are exempt
from the reporting and short swing profit recovery provisions contained in Section 16
of the Exchange Act.
In addition, we are
required to file documents required by Canadian securities laws electronically
with Canadian securities regulatory authorities and these filings are available
on our SEDAR profile at www.sedar.com.
Written requests for such documents should be directed to our Corporate
Secretary at 5985 McLaughlin Road, Mississauga, Ontario, Canada L5R 1B8.
SUBSIDIARY INFORMATION
Not applicable.
ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISK
For information regarding
quantitative and qualitative disclosures about market risk, please see Item 5.
Operating and Financial Review and Prospects Liquidity and Capital Resources.
ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN
EQUITY SECURITIES
Not applicable.
75
PART II
ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND
DELINQUENCIES
None.
ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF
SECURITY HOLDERS AND USE OF PROCEEDS
MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS
Share Consolidation
Shareholders approved a
special resolution at the annual and special meeting of shareholders on May 13,
2009 which gave authority to the Board of Directors to implement a
consolidation of our issued and outstanding common shares at any time prior to March 24,
2010. This special resolution gives our Board of Directors the authority,
in its sole discretion, to select the exact consolidation ratio, provided that (i) the
ratio may be no smaller than one post-consolidation common share for every 10
pre-consolidation common shares and no larger than one post-consolidation
common share for every 25 pre-consolidation common shares, and (ii) the
number of pre-consolidation common shares in the ratio must be a whole number
of common shares.
On February 8, 2010,
we announced that we will implement a share consolidation of our issued and
outstanding common shares in order to comply with the Minimum Bid Price
Rule. The consolidation was effective as
of March 12, 2010, and was implemented with a ratio of one
post-consolidation share for every 25 pre-consolidation shares (the Share
Consolidation). The consolidation
reduced the number of shares outstanding from approximately 105.0 million to
approximately
4.2
million.
Registered shareholders
of Hydrogenics received instructions by mail on how to obtain a new share
certificate representing their consolidated common shares. No fractional shares
were issued as a result of the consolidation. If the consolidation resulted in
a registered shareholder having a fractional interest of less than a whole
share, such fractional interest was rounded down to the nearest whole number.
Our common shares held through a broker, bank, trust company, nominee or other
financial intermediary were adjusted by that firm.
Principal Effects
of the Share Consolidation
The Share Consolidation
occurred simultaneously for all of the common shares and the consolidation
ratio was the same for all of such common shares. The consolidation affected all
shareholders uniformly. Except for any variances attributable to fractional
shares, the change in the number of issued and outstanding common shares that
resulted from the Share Consolidation caused no change in the capital
attributable to the common shares and did not materially affect any
shareholders percentage ownership in the Company, even though such ownership
will be represented by a smaller number of common shares.
In addition, the Share
Consolidation did not affect any shareholders proportionate voting rights.
Each common share outstanding after the Share Consolidation is entitled to one
vote and is fully paid and non-assessable.
The principal effects of
the consolidation include the following:
·
Reduction in number of common shares
outstanding the number of common shares issued and outstanding was reduced
from approximately 105,049,666 common shares pre-consolidation to 4,201,983
common shares immediately after consolidation; and
·
Reduction in number of common shares
reserved for issuance under the stock option plan the number of common shares
reserved for issuance under our stock option plan was reduced proportionately
based on the consolidation ratio selected by our Board of Directors.
Earnings per common share
has been proportionately affected as a result of the Share Consolidation.
Amendments to Share
Incentive Plans
On June 22, 2009,
Old Hydrogenics Board of Directors approved certain administrative amendments
to its stock option plan, RSU Plan and DSU Plan. Such amended plans are currently in force and
did not require approval of the shareholders of Old Hydrogenics because (i) in
the case of its RSU Plan and its DSU Plan, applicable securities laws do not
require shareholder approval as the plans do not provide for the issuance of
securities from treasury, and (ii) in the case of the stock option plan,
the amendments are of an administrative and technical nature and are permitted
to be made without shareholder approval under the express terms of the
plan. See Item 16. Directors, Senior
76
Management and
Employees Compensation for a description of these plans. In October 2009, we adopted Old
Hydrogenics stock option plan, RSU Plan and DSU Plan.
2008 Base Shelf
Prospectus
On June 30, 2009, we
withdrew our registration statement on Form F-10 filed with the U.S.
Securities and Exchange Commission as we no longer maintain the aggregate
market value of the public float of our outstanding Shares to utilize the
registration statement on Form F-10 in the U.S. On October 26, 2009, we also withdrew
our base shelf prospectus dated September 23, 2008 filed with certain
provincial securities authorities in Canada prior to completion of and as a
result of the APIF Transaction described under Item 4. Information on the Company History and
Development of Hydrogenics Coporation.
2009 Shelf Prospectus
On January 4, 2010, we announced that we have filed a
final short form base shelf prospectus with certain Canadian securities
regulatory authorities, and a corresponding registration statement on Form F-3
(File No. 333-162998)
has
been declared effective by the U.S. Securities and Exchange Commission on December 31,
2009. These filings were intended to
restore our flexibility to access the capital markets that was available to us
with our prior shelf prospectus and corresponding registration statement on Form F-10,
which were withdrawn in 2009.
Pursuant to the Form F-3,
we may offer up to $16 million of debt, equity or other securities over a
25-month period from December 31, 2009, provided that we cannot issue
securities with a value exceeding one-third of our public float (i.e., the
aggregate market value of our outstanding common shares held by non-affiliates)
in any 12-month period. As a result of
our registered direct offering in January 2010, which is described below
under
Registered
Direct Offering of Common Shares and Warrants
, we
may not issue any additional securities pursuant to the Form F-3 until January 14,
2011 based on our current public float unless there was a significant increase
in the market price of our common shares.
In addition, even if the market price of our common shares were to
increase significantly, we could not in any event issue more than $4.5 million
of additional securities pursuant to our existing shelf prospectus. See Item 3.
Key Information Risk Factors
Risk Factors Related
to Our Financial Condition
If we are unsuccessful in increasing our revenues and raising
additional funding, we may possibly cease to continue as we currently do.
Except as otherwise may be disclosed in a prospectus
supplement relating to a particular offering, Hydrogenics currently intends to
use the net proceeds received to fund current operations and potential future
growth opportunities. Should
Hydrogenics, offer any securities, it will make a prospectus supplement
available that will include the specific terms of the securities being offered.
Hydrogenics is not required to offer or sell all or any
portion of the securities in the future and will only do so if market
conditions warrant.
Registered Direct Offering of Common
Shares and Warrants
On January 11, 2010,
we announced that we will sell common shares and warrants in a registered
direct offering with two institutional investors, resulting in gross proceeds
of $5 million, before placement agents fees and other offering expenses. This offering closed on January 14,
2010.
Under the terms of the
transaction, Hydrogenics sold 12,500,000 units of the Company (units) at a price of $0.40 per unit,
before reflecting the share consolidation which took place on March 12,
2010. Each unit consists of (i) one common share in the capital of the
Company, (ii) 0.47871088 of one series A warrant expiring on the date
which is five years from the date of its issue (a series A warrant) and (iii) 0.52128912 of one series B
warrant expiring on the date which is five years from the initial exercise
date which is six months and one day from the date of its issue (a series B warrant and together with
the series A purchaser warrants, the warrants).
Each warrant entitles the holder to purchase one common share for $0.52
(subject to certain adjustments). The
series A warrants are immediately exercisable and the series B warrants are not
exercisable until six months and one day after issue. As of March 25, 2010, there are 239,355
series A warrants and 260,644 series B warrants issued and outstanding. Each of the warrants contains full-ratchet
anti-dilution protection as to the exercise price but not the number of shares
issuable thereunder.
The securities described
above were offered by us pursuant to the Companys shelf prospectus dated December 31,
2009, which is contained in the Companys Registration Statement on Form F-3
(described above under 2009 Shelf Prospectus), and the related prospectus
supplement no. 1 to the shelf prospectus, which was filed with U.S. Securities
and Exchange Commission on January 12, 2010.
We intend to use the net
proceeds from this offering for general working capital purposes.
As a result of this
offering, there are certain restrictions that may affect our ability to obtain
financing. The common shares and
warrants issued pursuant to this offering have a value of $11.5 million, which
is significantly greater than one-third of our current public float.
77
As described above
under
2009
Shelf Prospectus,
we may offer up to $16 million
of debt, equity or other securities over a 25-month period from December 31,
2009, provided that we cannot issue securities with a value exceeding one-third
of our public float (i.e., the aggregate market value of our outstanding common
shares held by non-affiliates) in any 12-month period. As a result, we may not issue any additional
securities pursuant to the Form F-3 until January 14, 2011 based on
our current public float unless there was a significant increase in the market
price of our common shares. In addition,
even if the market price of our common shares were to increase significantly,
we could not in any event issue more than $4.5 million of additional securities
pursuant to our existing shelf prospectus.
In addition, there are
other limits on our ability to issue securities to raise additional funding.
The Nasdaq generally requires an issuer to obtain shareholder approval prior to
the issuance of common shares or securities convertible into or exercisable for
common shares, other than in a public offering, equal to 20% or more of the
common shares outstanding prior to such issuance in one or an integrated series
of offerings if such securities are issued at a price below market value. In light of our registered direct offering in
January 2010, we may be required to obtain shareholder approval for
certain issuances of our securities.
Furthermore, the
securities purchase agreement that we entered into with the two institutional
investors in connection with the registered direct offering contains certain
restrictions that may affect our ability to obtain financing. The agreement requires us to seek shareholder
approval to (i) to allow an adjustment to the exercise price of the series
B warrants below the $12.00 floor price in certain circumstances and (ii) acknowledging
that, as a result of such resolutions, the aggregate number of our common
shares deemed to be have been issued in connection with the Offering exceeds a
certain shareholder approval threshold pursuant to the rules of the Nasdaq
Global Market. Until such shareholder
approval is obtained, the terms of the series B warrants dictate that no
adjustment to the exercise price of the series B warrants shall cause the
exercise price to be less than the Floor Price (as adjusted for any dividend,
share split, share combination, reclassification or similar transaction). If we do not obtain shareholder approval, the
securities purchase agreement requires us to hold an additional shareholder
meeting in each semi-annual period thereafter until shareholder approval is
obtained or until shareholder approval is no longer required under the rules and
regulations of the Nasdaq Global Market or is no longer required to eliminate
restrictions on adjustments to the exercise price below the $12.00 floor price
set forth in the series B warrants. In
addition, until shareholder approval is obtained, with certain exceptions, we
may not, directly or indirectly, issue or sell, or in accordance with the terms
of the warrants, be deemed to have issued or sold, any common shares for
consideration per common share less than the floor price at any time while any
of the warrants are outstanding without the prior written consent of each
investor, which consent may be granted or withheld in each investors sole
discretion. Until shareholder approval
is obtained, we are not able to issue, or be deemed to have issued, certain
other securities (including options or shares of common stock to directors,
officers or employees of Hydrogenics pursuant to an employee benefit plan,
certain convertible securities or unregistered common shares to a person who
enters into a strategic alliance with us) for less than the fair market value
of the common shares at the time such securities are issued or are deemed to be
issued. See the risk factor Item
3. Key Information Risk Factors
Risk
Factors Related to Our Financial Condition
We require shareholder approval to allow an
adjustment to the exercise price of our series B warrants, the failure of which
could materially adversely affect our flexibility in obtaining necessary
financing and our financial condition for additional information regarding
such restrictions.
In addition, under the
securities purchase agreement, we agreed that until April 15, 2010,
neither the Company nor any of its subsidiaries shall directly or indirectly
issue, offer, sell, grant any option to purchase, or otherwise dispose of (or
announce any such action with respect to) any of their respective equity or
equity equivalent securities, including, without limitation, any debt,
preferred stock, rights, options, warrants or other instrument that is
convertible into or exchangeable for capital stock and other securities of the
Company. See Item 3. Key Information Risk Factors
Risk
Factors Related to Our Financial Condition
If we are unsuccessful in increasing our revenues
and raising additional funding, we may possibly cease to continue as we
currently do for additional information regarding restrictions on our ability
raise additional funding.
We are currently involved
in litigation with one of the institutional investors. See Item 3. Key Information Risk
Factors
Risk Factors Related to Our Financial Condition
We are currently involved in litigation
with Alpha Capital Anstalt, the outcome of which could adversely affect our
financial condition.
USE OF PROCEEDS
Not applicable.
ITEM 15. CONTROLS AND PROCEDURES
EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES
As of the end of the
period covered by this Annual Report on Form 20-F, an evaluation was carried
out by our management, under the supervision, and with the participation, of
our Chief Executive Officer (the CEO) and Chief Financial Officer (the CFO),
of the
78
effectiveness of
our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)). Based on that evaluation, the CEO and CFO concluded that such
disclosure controls and procedures were effective and designed to ensure that
material information relating to us and our consolidated subsidiaries would be
made known to them by others within those entities.
EVALUATION OF INTERNAL CONTROLS
Our management is
responsible for establishing and maintaining adequate internal control over
financial reporting. Internal control over financial reporting is a process
designed by, or under the supervision of, the President and CEO and the CFO and
effected by the Board of Directors, management and other personnel to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
generally accepted accounting principles.
Due to its inherent
limitations, internal control over financial reporting may not prevent or
detect misstatements. Also, projections of any evaluation of the effectiveness
of internal control over financial reporting to future periods are subject to
the risk that the controls may become inadequate because of changes in
conditions, or that the degree of compliance with the policies or procedures
may deteriorate.
Management assessed the
effectiveness of the Companys internal control over financial reporting as at December 31,
2009, based on the criteria set forth in Internal Control Integrated
Framework issued by the Committee of Sponsoring Organizations of the Treadway
Commission. Based on this assessment,
management believes that, as at December 31, 2008, the Companys internal
control over financial reporting is effective. Also, management determined that
there were no material weaknesses in the Companys internal control over
financial reporting as at December 31, 2009.
LIMITATIONS OF CONTROLS AND PROCEDURES
Our management, including
our CEO and CFO, believe that any disclosure controls and procedures or internal
controls over financial reporting, no matter how well conceived and operated,
can provide only reasonable, not absolute, assurance that the objectives of the
control system are met. Further, the design of a control system must reflect
the fact that there are resource constraints, and the benefits of controls must
be considered relative to their costs. Because of the inherent limitations in
all control systems, they cannot provide absolute assurance that all control
issues and instances of fraud, if any, within us have been prevented or
detected. These inherent limitations include the realities that judgments in
decision-making can be faulty, and that breakdowns can occur because of a
simple error or mistake. Additionally, controls can be circumvented by the
individual acts of some persons, by collusion of two or more people, or by
unauthorized override of the control. The design of any systems of controls also
is based in part upon certain assumptions about the likelihood of future
events, and there can be no assurance that any design will succeed in achieving
its stated goals under all potential future conditions. Accordingly, because of
the inherent limitations in a cost effective control system, misstatements due
to error or fraud may occur and not be detected.
REPORTS ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Our managements Report
on Internal Control Over Financial Reporting can be found on page F-3 in
this form. Our independent auditors,
PricewaterhouseCoopers LLP, a registered public accounting firm has audited the
accompanying annual consolidated financial statements for the year ended December 31,
2009 and our internal control over financial reporting as at December 31,
2009. Their attestation report can be
found beginning on page F-4 of our consolidated financial statements.
CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING
During the year ended December 31,
2009, there were no changes in our internal control over financial reporting
that have materially affected, or are reasonably likely to materially affect,
our internal control over financial reporting.
ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT
IDENTIFICATION OF THE AUDIT COMMITTEE
We have a
separately-designated audit committee established in accordance with section
3(a)(58)(A) of the Securities Exchange Act of 1934. Our audit committee is comprised of
independent members: Norman M. Seagram (Chair), Douglas S. Alexander and
Michael Cardiff.
79
AUDIT COMMITTEE FINANCIAL EXPERT
Our Board of Directors
has determined that it has at least one audit committee financial expert
serving on its audit committee. Douglas Alexander has been determined to be an
audit committee financial expert and is independent, as that term is defined by
Nasdaqs listing standards. The U.S.
Securities and Exchange Commission has indicated that the designation of this
individual as an audit committee financial expert does not make him an expert
for any purpose, or impose any duties, obligations or liabilities that are
greater than those imposed on members of the audit committee and board of
directors who do not carry this designation or affect the duties, obligations
or liabilities of any other member of the audit committee or board of
directors.
ITEM 16B. CODE OF ETHICS
CODE OF ETHICS
We have adopted a written
Code of Business Conduct and Ethics (the Code) which governs the behavior of
our directors, officers, and employees. The Code also includes provisions
required by the
Sarbanes-Oxley Act of 2002
that are applicable to our CEO, CFO and other senior financial officers. The
Board of Directors, through the Human Resources and Corporate Governance
Committee, oversees compliance with the Code. Any amendments to, or waivers
from, any provisions of the Code will be publicly disclosed. The Code is also accessible on our investor
relations web page at www.hydrogenics.com.
ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES
PRINCIPAL ACCOUNTANTS FEES AND SERVICES
The following
table sets forth the total remuneration that was paid by us and our
subsidiaries to our independent accountants, PricewaterhouseCoopers LLP (PwC),
in each of the year ended December 31, 2009 and 2008:
|
|
2009
|
|
2008
|
|
|
|
Cdn. $ (unaudited)
|
|
Audit
fees
|
|
519,940
|
|
724,548
|
|
Audit-related fees
|
|
4,725
|
|
8,904
|
|
Tax fees
|
|
42,821
|
|
90,535
|
|
All other fees
|
|
282,626
|
|
64,425
|
|
Total
|
|
850,112
|
|
888,412
|
|
Audit Fees
In 2009 and 2008, PwC
charged us audit fees totaling, Cdn. $519,940 and Cdn. $724,548, respectively.
In 2009 and 2008, these fees included professional services rendered for the
review of interim financial statements, statutory audits of annual financial
statements, consultations about financial and reporting standards and other
regulatory audits and filings, including Sarbanes-Oxley compliance.
Audit-Related Fees
In 2009 and 2008, PwC
charged us audit-related fees of Cdn. $4,725 and Cdn. $8,904,
respectively. In 2009 and 2008, these
fees included professional services that reasonably relate to the above
services and Canadian Public Accounting Board Fees.
Tax Fees
In 2009 and 2008, PwC
charged us tax fees of Cdn. $42,821 and Cdn. $90,535 respectively. In 2009 and 2008, these fees included
professional services for tax compliance, tax advice, tax planning and advisory
services relating to the preparation of corporate tax returns.
All Other Fees
In 2009 and 2008, PwC
charged us other fees of Cdn. $282,626 and Cdn. $64,425, respectively. In 2009,
these fees related to advisory services related to assistance with the
transaction with Algonquin Power Income Fund, the implementation of IFRS,
assistance with the
80
preparation of our base
shelf prospectus filed in January, 2010 and other regulatory matters. In 2008,
these fees related to assistance with the preparation of our base shelf
prospectus filed in September, 2008 as well advisory services related to the
implementation of IFRS and other regulatory matters.
PRE-APPROVAL POLICIES
Our audit committee
approved all audit and non-audit services provided to us and to our
subsidiaries during the periods listed above.
Our audit committee has adopted pre-approval policies and procedures to
ensure that all services provided by the auditor are approved in advance by the
audit committee or are approved by the chair of the audit committee and
subsequently reported to the committee as a whole at the following meeting of
the committee, all in accordance with the external auditors pre-approval
policy.
ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR
AUDIT COMMITTEES
Not applicable.
ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE
ISSUER AND AFFILIATED PURCHASERS
None.
ITEM 16F. CHANGE IN REGISTRANTS CERTIFYING
ACCOUNTANT
None.
ITEM 16G. CORPORATE GOVERNANCE
We are a foreign private
issuer and our common shares are listed on the Nasdaq. Nasdaq Rule 5615(a)(3) permits a
foreign private issuer to follow its home country practice in lieu of the
requirements of the Rule 5600 Series, provided, however, that such an
issuer shall: comply with Rules 5625 (regarding notification of material
noncompliance), 5640 (regarding voting rights), have an audit committee that
satisfies Rule 5605(c)(3), and ensure that such audit committees members
meet the independence requirements in Rule 5605(c)(2)(A)(ii). We are
intending not to follow Rule 5620(c) (shareholder quorum) and Rule 5605(b) (majority
independent director requirement) but instead to follow the practice described
below.
Shareholder
Meeting Quorum Requirements
. The Nasdaq minimum quorum requirement under Rule 5620(c) for
a shareholder meeting is 33-1/3% of the outstanding shares of common stock. In
addition, a company listed on Nasdaq is required to state its quorum
requirement in its By-Laws. On March 7, 2008, our Board of Directors
approved an amendment to our By-Laws to provide that the quorum requirement for
a meeting of our shareholders is two persons present in person or represented
by proxy holding in the aggregate not less than 25% of the outstanding common
shares entitled to vote at the meeting.
This amendment was approved by our shareholders at an annual and special
meeting of shareholders on May 6, 2008. We believe the foregoing is
consistent with Canadian public companies and consistent with corporate
governance best practices in Canada.
Independent
Director Requirements
.
Nasdaq Rule 5605(b) requires a majority of independent
directors on the board of directors and that the independent directors convene
regularly scheduled meetings at least twice a year at which only independent
directors are present. The CBCA requires
a distributing corporation to have at least 2 directors who are not officers
and employees of the corporation or its affiliates. As a result of the resignation of V. James
Sardo on November 30, 2009, there are now six members of our Board rather
than seven members. Half of the Companys
directors are independent. The Boards
determination as to each directors independence is made with reference to
definitions under applicable securities laws and stock exchange
regulations. In order to facilitate open
and candid discussions among independent directors, independent directors may
meet at the end of each regularly scheduled Board meeting, in an
in camera
session without the non-independent members. From time to time, the independent directors
will have a special meeting with only independent directors. In addition, we believe the fact that our
Audit Committee and Human Resources and Corporate Governance Committee are both
composed entirely of independent directors facilitates the Boards exercise of
independent judgment. As described under
Item 6. Directors, Senior Management
and Employees Board Practices Human Resources and Corporate Governance
Committee Nomination of Directors and Compensation, the Human Resources and
Corporate Governance Committee has oversight over executive compensation and
director nominations.
81
PART III
ITEM 17. FINANCIAL STATEMENTS
We have responded to
Item 18 in lieu of responding to this item.
ITEM 18. FINANCIAL STATEMENTS
The following financial
statements are filed as part of this annual report on Form 20-F.
|
|
Page
|
|
|
|
Index
to consolidated financial statements
|
|
F-1
|
|
|
|
Managements Responsibility for Financial Reporting
|
|
F-2
|
|
|
|
Managements Report on Internal Control Over Financial
Reporting
|
|
F-3
|
|
|
|
Independent
Auditors Report
|
|
F-4
|
|
|
|
Comments
by Independent Auditors on Canada US Reporting Difference
|
|
F-6
|
|
|
|
Consolidated
Balance Sheets
|
|
F-7
|
|
|
|
Consolidated
Statements of Operations
|
|
F-8
|
|
|
|
Consolidated
Statements of Cash Flows
|
|
F-9
|
|
|
|
Consolidated
Statements of Shareholders Equity
|
|
F-10
|
|
|
|
Notes
to Consolidated Financial Statements
|
|
F-11
|
82
HYDROGENICS
CORPORATION
INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS
|
Page
|
|
|
Index
to consolidated financial statements
|
F-1
|
|
|
Managements
Responsibility for Financial Reporting
|
F-2
|
|
|
Managements
Report on Internal Control Over Financial Reporting
|
F-3
|
|
|
Independent
Auditors Report
|
F-4
|
|
|
Comments
by Independent Auditors on Canada US Reporting Difference
|
F-6
|
|
|
Consolidated
Balance Sheets
|
F-7
|
|
|
Consolidated
Statements of Operations
|
F-8
|
|
|
Consolidated
Statements of Cash Flows
|
F-9
|
|
|
Consolidated
Statements of Shareholders Equity
|
F-10
|
|
|
Notes
to Consolidated Financial Statements
|
F-11
|
F-1
Managements Responsibility for Financial Reporting
Managements Discussion and Analysis of Financial Condition and Results
of Operations and the Consolidated Financial Statements have been prepared by
management and approved by the Board of Directors of the Company. The
Consolidated Financial Statements were prepared in accordance with Canadian
generally accepted accounting principles and, where appropriate, reflect
managements best estimates and judgments. Where alternative accounting methods
exist, management has chosen those methods considered most appropriate in the
circumstances. Management is responsible
for the accuracy, integrity and objectivity of the Consolidated Financial
Statements within reasonable limits of materiality, and for maintaining a
system of internal controls over financial reporting as described in Managements
Report on Internal Control Over Financial Reporting. Management is also
responsible for the preparation and presentation of other financial information
included in the Annual Report and its consistency with the Consolidated
Financial Statements.
The Audit Committee, which is appointed annually by the Board of
Directors and comprised exclusively of independent directors, meets with
management as well as with the independent auditors to satisfy itself that
management is properly discharging its financial reporting responsibilities and
to review the Consolidated Financial Statements and the independent auditors
report.
The Audit Committee reports its findings to the Board of Directors for
consideration in approving the Consolidated Financial Statements for
presentation to the shareholders.
The Audit Committee considers, for review by the Board of Directors and
approval by the shareholders, the engagement or reappointment of the
independent auditors.
The Consolidated Financial Statements have been independently audited by
PricewaterhouseCoopers LLP, Chartered Accountants, on behalf of the
shareholders, in accordance with Canadian generally accepted auditing standards
and, with respect to the Consolidated Financial Statements for the years ended December 31,
2009, December 31, 2008 and December 31, 2007 in accordance with the
standards of the Public Company Accounting Oversight Board (United States).
Their report outlines the nature of their audit and expresses their opinion on
the Consolidated Financial Statements of the Company. In addition, our auditors
have issued an attestation report on managements assessment of the Companys
internal controls over financial reporting as of December 31, 2009. PricewaterhouseCoopers LLP has direct access
to the Audit Committee of the Board of Directors.
|
|
|
Daryl Wilson
|
|
Lawrence Davis
|
President
and Chief Executive Officer
|
|
Chief
Financial Officer
|
|
|
|
|
|
|
March 25,
2010
|
|
|
Mississauga, Ontario
|
|
|
2009 Consolidated Financial
Statements
F-2
Managements Report on Internal Control Over Financial
Reporting
Management of Hydrogenics Corporation (the Corporation) is
responsible for establishing and maintaining adequate internal control over
financial reporting. Internal control
over financial reporting is a process designed by, or under the supervision of,
the President and Chief Executive Officer and the Chief Financial Officer and
is effected by the Board of Directors, management and other personnel to
provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance
with Canadian generally accepted accounting principles. It includes those policies and procedures
that:
·
provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use or disposition
of the Corporations assets that could have a material effect on the
Corporations financial statements.
·
pertain to the maintenance of records that
accurately and fairly reflect, in reasonable detail, the transactions related
to and dispositions of the Corporations assets;
·
provide reasonable assurance that
transactions are recorded as necessary to permit preparation of consolidated
financial statements in accordance with Canadian generally accepted accounting
principles, and that the Corporations receipts and expenditures are made only
in accordance with authorizations of management and the Corporations
directors; and, due to its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements. Also, projections
of any evaluation of the effectiveness of internal control over financial
reporting to future periods are subject to the risk that the controls may
become inadequate because of changes in conditions, or that the degree of
compliance with the policies or procedures may deteriorate.
Management assessed the effectiveness of the Corporations internal
control over financial reporting as at December 31, 2009, based on the
criteria set forth in Internal Control Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway Commission (COSO).
Based on this assessment, management concluded that, as at December 31,
2009, the Corporations internal control over financial reporting was
effective.
Hydrogenics internal control over financial reporting as at December 31,
2009, has been audited by PricewaterhouseCoopers LLP, independent auditors, who
also audited the Corporations consolidated financial statements for the year
ended December 31, 2009. As stated
in the Independent Auditors Report to the Shareholders of the Corporation,
PricewaterhouseCoopers LLP, express an unqualified opinion on the effectiveness
of the Corporations internal control over financial reporting.
|
|
|
Daryl Wilson
|
|
Lawrence Davis
|
President
and Chief Executive Officer
|
|
Chief
Financial Officer
|
|
|
|
|
|
|
March 25,
2010
|
|
|
Mississauga,
Ontario
|
|
|
F-3
Independent Auditors Report
To
the Shareholders of Hydrogenics Corporation
We
have completed integrated audits of Hydrogenics Corporations 2009, 2008 and
2007 consolidated financial statements and of its internal control over
financial reporting as at December 31, 2009. Our opinions, based on our audits, are
presented below.
Consolidated financial statements
We
have audited the accompanying consolidated balance sheets of Hydrogenics
Corporation as at December 31, 2009 and December 31, 2008,
consolidated statements of operations, shareholders equity and cash flows for
each of the years in the three year period ended December 31, 2009. These financial statements are the
responsibility of the Companys management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We
conducted our audits of the Companys financial statements as at December 31,
2009 and for each of the years in the three year period then ended in
accordance with Canadian generally accepted auditing standards and the
standards of the Public Company Accounting Oversight Board (United States).
Those standards require that we plan and perform an audit to obtain reasonable
assurance about whether the financial statements are free of material
misstatement. An audit of financial
statements includes examining, on a test basis, evidence supporting the amounts
and disclosures in the financial statements.
A financial statement audit also includes assessing the accounting
principles used and significant estimates made by management, and evaluating
the overall financial statement presentation. We believe that our audits
provide a reasonable basis for our opinion.
In
our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the financial position of the Company as at December 31,
2009 and December 31, 2008 and the results of its operations and its cash
flows for each of the years in the three year period ended December 31,
2009 in accordance with Canadian generally accepted accounting principles.
Internal control over financial reporting
We
have also audited Hydrogenics Corporations internal control over financial
reporting as at December 31, 2009, based on criteria established in
Internal Control - Integrated Framework
issued by the Committee of Sponsoring Organizations of the Treadway Commission
(COSO). The Companys management is
responsible for maintaining effective internal control over financial reporting
and for its assessment of the effectiveness of internal control over financial
reporting, included in the accompanying report entitled Managements
Responsibility for Financial Reporting.
Our responsibility is to express an opinion on the Companys internal
control over financial reporting based on our audit.
We conducted our audit of internal control over financial reporting in
accordance with the standards of the Public Company Accounting Oversight Board
(United States). Those standards require
that we plan and perform the audit to obtain reasonable assurance about whether
effective internal control over financial reporting was maintained in all
material respects. An audit of internal
control over financial reporting includes obtaining an understanding of
internal control over financial reporting, assessing the risk that a material
weakness exists, testing and evaluating the design and operating effectiveness
of internal
F-4
control based on the assessed risk, and performing such other
procedures as we consider necessary in the circumstances. We believe that our audit provides a
reasonable basis for our opinion.
A
companys internal control over financial reporting is a process designed to
provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles.
A companys internal control over financial reporting includes those
policies and procedures that (i) pertain to the maintenance of records
that, in reasonable detail, accurately and fairly reflect the transactions and
dispositions of the assets of the company; (ii) provide reasonable
assurance that transactions are recorded as necessary to permit preparation of
financial statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company are being made
only in accordance with authorizations of management and directors of the
company; and (iii) provide reasonable assurance regarding prevention or
timely detection of unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the financial statements.
Because
of its inherent limitations, internal control over financial reporting may not
prevent or detect misstatements. Also,
projections of any evaluation of effectiveness to future periods are subject to
the risk that controls may become inadequate because of changes in conditions,
or that the degree of compliance with the policies or procedures may
deteriorate.
In
our opinion, the Company maintained, in all material respects, effective
internal control over financial reporting as at December 31, 2009 based on
criteria established in Internal Control Integrated Framework issued by the
COSO.
Chartered
Accountants, Licensed Public Accountants
Toronto,
Ontario
March 25,
2010
F-5
Comments by Independent Auditors on Canada US Reporting
Difference
In
the United States, reporting standards for auditors require the addition of an
explanatory paragraph (following the opinion paragraph) when the financial
statements are affected by conditions and events that cast substantial doubt on
the companys ability to continue as a going concern, such as those described
in Note 1 to the 2009 consolidated financial statements of Hydrogenics
Corporation. Our report to the shareholders on the consolidated financial
statements dated March 25, 2010 is expressed in accordance with Canadian
reporting standards which do not permit a reference to such events and
conditions in the auditors report when these are adequately disclosed in the
financial statements.
Chartered
Accountants, Licensed Public Accountants
Toronto,
Ontario
March 25,
2010
F-6
Hydrogenics
Corporation
Consolidated
Balance Sheets
(in
thousands of US dollars)
|
|
December 31
2009
|
|
December 31
2008
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
9,159
|
|
$
|
21,601
|
|
Restricted cash
|
|
1,603
|
|
1,130
|
|
Accounts receivable (note 6)
|
|
3,685
|
|
3,974
|
|
Grants receivable
|
|
490
|
|
505
|
|
Inventories (note 7)
|
|
11,746
|
|
10,101
|
|
Prepaid expenses
|
|
1,270
|
|
1,161
|
|
|
|
27,953
|
|
38,472
|
|
|
|
|
|
|
|
Restricted cash
|
|
240
|
|
|
|
Property, plant and equipment (note 8)
|
|
3,169
|
|
4,082
|
|
Goodwill
|
|
5,446
|
|
5,025
|
|
|
|
$
|
36,808
|
|
$
|
47,579
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
Accounts payable and accrued liabilities (note 9)
|
|
$
|
14,782
|
|
$
|
17,298
|
|
Unearned revenue
|
|
4,546
|
|
4,785
|
|
|
|
19,328
|
|
22,083
|
|
|
|
|
|
|
|
Deferred research and development
grants
|
|
|
|
13
|
|
|
|
19,328
|
|
22,096
|
|
|
|
|
|
|
|
Shareholders Equity
|
|
|
|
|
|
Common shares (nominal par value)
|
|
307,038
|
|
307,000
|
|
Contributed surplus
|
|
16,713
|
|
16,300
|
|
Deficit
|
|
(300,795
|
)
|
(291,420
|
)
|
Accumulated other comprehensive loss
|
|
(5,476
|
)
|
(6,397
|
)
|
Total deficit and accumulated other comprehensive
loss
|
|
(306,271
|
)
|
(297,817
|
)
|
|
|
17,480
|
|
25,483
|
|
|
|
$
|
36,808
|
|
$
|
47,579
|
|
Going concern (note 1)
Contingencies, guarantees and commitments (notes 12 and 13)
|
|
|
Douglas Alexander
|
|
Norman Seagram
|
Chairman
|
|
Director
|
The
accompanying notes form an integral part of these Consolidated Financial
Statements.
F-7
Hydrogenics
Corporation
Consolidated
Statements of Operations
(in
thousands of US dollars, except for share and per share amounts)
|
|
2009
|
|
2008
|
|
2007
|
|
Revenues
|
|
$
|
18,841
|
|
$
|
39,340
|
|
$
|
37,990
|
|
|
|
|
|
|
|
|
|
Cost of revenues
|
|
15,113
|
|
31,446
|
|
33,601
|
|
|
|
3,728
|
|
7,894
|
|
4,389
|
|
Operating expenses
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
16,995
|
|
15,022
|
|
24,006
|
|
Research and product development (note 11)
|
|
5,219
|
|
7,296
|
|
9,690
|
|
Windup of test equipment business (note 5)
|
|
|
|
|
|
2,016
|
|
Impairment
of property, plant and equipment (note 8)
|
|
317
|
|
|
|
|
|
Amortization of property, plant and equipment
|
|
984
|
|
855
|
|
903
|
|
Amortization of intangible assets
|
|
|
|
249
|
|
251
|
|
|
|
23,515
|
|
23,422
|
|
36,866
|
|
Loss from operations
|
|
(19,787
|
)
|
(15,528
|
)
|
(32,477
|
)
|
|
|
|
|
|
|
|
|
Other income (expenses)
|
|
|
|
|
|
|
|
Sale
of assets
|
|
|
|
44
|
|
|
|
Loss on disposal of property, plant and equipment
|
|
(14
|
)
|
|
|
(308
|
)
|
Provincial capital tax
|
|
(154
|
)
|
170
|
|
(127
|
)
|
Interest
|
|
169
|
|
923
|
|
2,249
|
|
Foreign currency gains
|
|
40
|
|
188
|
|
2,617
|
|
|
|
41
|
|
1,325
|
|
4,431
|
|
|
|
|
|
|
|
|
|
Loss before income taxes
|
|
(19,746
|
)
|
(14,203
|
)
|
(28,046
|
)
|
Provision for (recovery of) income
taxes (notes 2 and 16)
|
|
(10,371
|
)
|
116
|
|
22
|
|
Net loss for the year
|
|
$
|
(9,375
|
)
|
$
|
(14,319
|
)
|
$
|
(28,068
|
)
|
|
|
|
|
|
|
|
|
Net loss per share
|
|
|
|
|
|
|
|
Basic and diluted
(note
17)
|
|
$
|
(2.54
|
)
|
$
|
(3.89
|
)
|
$
|
(7.64
|
)
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding
(note 17)
|
|
3,697,740
|
|
3,683,226
|
|
3,671,916
|
|
The
accompanying notes form an integral part of these Consolidated Financial
Statements.
F-8
Hydrogenics
Corporation
Consolidated
Statements of Cash Flows
(in
thousands of US dollars)
|
|
2009
|
|
2008
|
|
2007
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents provided
by (used in)
|
|
|
|
|
|
|
|
Operating activities
|
|
|
|
|
|
|
|
Net loss for the year
|
|
$
|
(9,375
|
)
|
$
|
(14,319
|
)
|
$
|
(28,068
|
)
|
Items not affecting cash
|
|
|
|
|
|
|
|
Amortization of property, plant and equipment
|
|
1,326
|
|
1,106
|
|
1,611
|
|
Amortization of intangible assets
|
|
|
|
249
|
|
251
|
|
Impairment of property, plant and equipment
|
|
317
|
|
|
|
|
|
Unrealized foreign exchange losses (gains)
|
|
(148
|
)
|
695
|
|
29
|
|
Stock-based compensation expense
|
|
413
|
|
694
|
|
1,553
|
|
Loss on disposal of property, plant and equipment
|
|
14
|
|
|
|
308
|
|
Net change in non-cash working capital (note 18)
|
|
(3,632
|
)
|
4,817
|
|
(4,100
|
)
|
|
|
(11,085
|
)
|
(6,758
|
)
|
(28,416
|
)
|
Investing activities
|
|
|
|
|
|
|
|
Decrease in short-term investments
|
|
|
|
15,032
|
|
39,318
|
|
Increase in restricted cash
|
|
(713
|
)
|
(1,130
|
)
|
|
|
Purchase of property, plant and equipment
|
|
(752
|
)
|
(929
|
)
|
(1,331
|
)
|
Proceeds from sale of asset
|
|
|
|
44
|
|
|
|
|
|
(1,465
|
)
|
13,017
|
|
37,987
|
|
|
|
|
|
|
|
|
|
Financing activities
|
|
|
|
|
|
|
|
Repayment of long-term debt
|
|
|
|
(11
|
)
|
(83
|
)
|
Deferred research and development grants
|
|
70
|
|
(235
|
)
|
204
|
|
Common shares issued (purchased and cancelled), net
of issuance costs
|
|
38
|
|
128
|
|
(169
|
)
|
|
|
108
|
|
(118
|
)
|
(48
|
)
|
Increase (decrease) in cash and
cash equivalents during the year
|
|
(12,442
|
)
|
6,141
|
|
9,523
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
Beginning of year
|
|
21,601
|
|
15,460
|
|
5,937
|
|
Cash and cash equivalents
End of year
|
|
$
|
9,159
|
|
$
|
21,601
|
|
$
|
15,460
|
|
|
|
|
|
|
|
|
|
Supplemental disclosure
|
|
|
|
|
|
|
|
Interest paid
|
|
$
|
11
|
|
$
|
17
|
|
$
|
52
|
|
Income taxes paid
|
|
87
|
|
118
|
|
63
|
|
The
accompanying notes form an integral part of these Consolidated Financial
Statements.
F-9
Hydrogenics
Corporation
Consolidated
Statements of Shareholders Equity
(in
thousands of US dollars, except for share and per share amounts)
|
|
Common shares
|
|
Contributed
|
|
|
|
Accumulated
other
comprehensive
|
|
Total
shareholders
|
|
|
|
Number
|
|
Amount
|
|
surplus
|
|
Deficit
|
|
income
(loss)
|
|
equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at Dec. 31, 2006
|
|
3,676,659
|
|
$
|
307,376
|
|
$
|
13,718
|
|
$
|
(249,033
|
)
|
$
|
(5,304
|
)
|
$
|
66,757
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss for the year
|
|
|
|
|
|
|
|
(28,068
|
)
|
|
|
(28,068
|
)
|
Foreign
currency translation adjustments
|
|
|
|
|
|
|
|
|
|
311
|
|
311
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
(27,757
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
issued:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
returned to treasury
|
|
(6,031
|
)
|
(504
|
)
|
335
|
|
|
|
|
|
(169
|
)
|
Stock-based
compensation expense
|
|
|
|
|
|
1,553
|
|
|
|
|
|
1,553
|
|
Balance at Dec. 31, 2007
|
|
3,670,628
|
|
306,872
|
|
15,606
|
|
(277,101
|
)
|
(4,993
|
)
|
40,384
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss for the year
|
|
|
|
|
|
|
|
(14,319
|
)
|
|
|
(14,319
|
)
|
Foreign
currency translation adjustments
|
|
|
|
|
|
|
|
|
|
(1,404
|
)
|
(1,404
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
(15,723
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
issued:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common shares on exercise of stock options
|
|
25,599
|
|
128
|
|
|
|
|
|
|
|
128
|
|
Stock-based
compensation expense
|
|
|
|
|
|
694
|
|
|
|
|
|
694
|
|
Balance at Dec. 31, 2008
|
|
3,696,227
|
|
$
|
307,000
|
|
$
|
16,300
|
|
$
|
(291,420
|
)
|
$
|
(6,397
|
)
|
$
|
25,483
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss for the year
|
|
|
|
|
|
|
|
(9,375
|
)
|
|
|
(9,375
|
)
|
Foreign
currency translation adjustments
|
|
|
|
|
|
|
|
|
|
921
|
|
921
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
(8,454
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
issued:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common shares on exercise of stock options
|
|
5,760
|
|
38
|
|
|
|
|
|
|
|
38
|
|
Stock-based
compensation expense
|
|
|
|
|
|
413
|
|
|
|
|
|
413
|
|
Balance at Dec. 31, 2009
|
|
3,701,987
|
|
$
|
307,038
|
|
$
|
16,713
|
|
$
|
(300,795
|
)
|
$
|
(5,476
|
)
|
$
|
17,480
|
|
The
authorized capital stock of the Corporation consists of an unlimited number of
common shares and an unlimited number of preferred shares issuable in series.
The accompanying notes form an integral part of these
Consolidated Financial Statements.
F-10
Hydrogenics
Corporation
Notes
to Consolidated Financial Statements
(in
thousands of US dollars, except share and per share amounts)
Note 1.
Description of Business and Going Concern
Hydrogenics Corporation (Hydrogenics
or the Corporation), as reorganized (note 2), together with its subsidiaries,
designs, develops and manufactures hydrogen generation products based on water
electrolysis technology and fuel cell products based on proton exchange
membrane, or PEM, technology.
While the accompanying
consolidated financial statements have been prepared on a going concern basis,
which contemplates the realization of assets and discharge of liabilities
during the normal course of operations and the continuation of operations for
the foreseeable future, there are material uncertainties related to certain
conditions and events that cast significant doubt upon the Corporations
ability to continue as a going concern. These events and
conditions that cast significant doubt include the Corporations recurring
operating losses and negative cash flows from operations. The Corporation
expects these conditions to continue in the near term.
The Corporation needs to
increase its revenue to generate profits and related operating cash flows.
During 2009, the Corporation experienced a decline in revenue due to variations
in the timing of delivery combined with lower order intake due to the
prevailing conditions in the Corporations markets and the current global
economy. There are various uncertainties affecting our revenues related
to the current market environment including the level of sales orders, the
length of sales cycles, the continuing development of products by the
Corporation, the adoption of new technologies by customers, price competition,
and continuation of government incentives for the Corporations customers and
the ability of customers to finance purchases.
The Corporation also
requires additional funding in the form of debt or equity in addition to the
funding obtained during the year and subsequent to year-end. During the
year, the Corporation generated cash proceeds of $10,464 from the transaction
with the trustees of Algonquin Power Income Fund (see note 2 for further
discussion). Subsequent to December 31, 2009, the Corporation
completed an offering of common shares and warrants for gross cash proceeds of
$5,000 before placement agents fees and other offering expenses. While
the Corporation is pursuing various sources of financing, there are no
definitive plans at this stage and there is no assurance these initiatives will
be successful or provide additional funds sufficient to continue operations.
The material
uncertainties referred to above relate to the Corporations ability to increase
revenue and to raise additional funding to support operations.
Additionally, a continuation of the broad economic recession or slow
recovery could continue to have a negative impact on the Corporations
business, results of operations and consolidated financial condition, or
Hydrogenics ability to forecast results and cash flows, and it may cause a
number of the risks the Corporation currently faces (such as the ability to
increase revenue and to raise capital) to increase in likelihood, magnitude and
duration. Macro-level changes in the global economy began to affect the
Corporations business in the fourth quarter of 2008 and have continued
throughout 2009.
The Corporations ability
to continue as a going concern and manage the material uncertainties is
dependent on the successful execution of its business plan, which involves: (i) securing
additional financing to fund its operations, (ii) continued investment in
research and development through advancing product designs for efficiency,
durability, cost reduction and entry into complementary markets to improve
overall gross margins; (iii) increasing market penetration and sales to
improve operating cash flow; and (iv) actively managing its working capital to
preserve cash resources. At present, the success of these initiatives
cannot be assured due to the material uncertainties described above.
F-11
Hydrogenics
Corporation
Notes
to Consolidated Financial Statements
(in
thousands of US dollars, except share and per share amounts)
These consolidated financial
statements do not include any adjustments or disclosures that may result from
the Corporations inability to continue as a going concern. If the going
concern assumption were not appropriate for these consolidated financial
statements, adjustments may be necessary in the carrying values of assets and
liabilities and the reported expenses and balance sheet classifications; such
adjustments could be material.
Note 2. Basis of Preparation
The accompanying consolidated financial statements of Hydrogenics and
its subsidiaries have been prepared in accordance with Canadian generally
accepted accounting principles (Canadian GAAP) which, in the case of the
Corporation, conform in all material respects with accounting principles
generally accepted in the United States (US GAAP), except as outlined in note
20.
Continuity
of Interest Accounting
On June 11, 2009,
the Corporation, the Corporations original predecessor (Old Hydrogenics),
the board of trustees of Algonquin Power Income Fund (APIF) and APIFs
manager, Algonquin Power Management Inc., agreed on the terms of a series of
transactions (collectively, the APIF Transaction) and agreements, pursuant to
which Old Hydrogenics agreed to transfer its entire business and operations to
the Corporation, including all assets, liabilities, directors, management and
employees, but excluding its tax attributes.. Under the APIF Transaction, the
Corporations shareholders had their
common shares in the capital of Old Hydrogenics redeemed for common shares of
the Corporation on a one-for-one basis. At the same time APIF unitholders exchanged their units for Algonquin Power &
Utilities Corp (APUC) common shares.
As a result of completion
of the APIF Transaction on October 27, 2009, unitholders of APIF did not
retain any interest in the business of the Corporation nor did the Corporations
shareholders retain any interest in the business of APIF. The Corporation
continued to carry on the hydrogen generation and fuel cell business as a
public entity with all of the assets (including the intellectual property, but
excluding tax attributes) of its predecessor prior to the APIF Transaction.
Pursuant to continuity of
interest accounting, the assets transferred including intellectual property
(exclusive of tax attributes) and liabilities assumed were recorded at their carrying values as
reported by the Corporation immediately prior to the completion of the APIF
Transaction. As a result, the cash proceeds were recorded as a recovery of
income taxes reflecting the disposal of the tax attributes. The Corporation recorded a benefit of $10,464
in the consolidated financial statements. Of the benefit, $9,994 was received
in cash during the year and the remaining $470 was included in Accounts
receivable. The amount included in
Accounts receivable was collected subsequent to December 31, 2009. The Corporation incurred transaction costs of
$3,300 relating to the APIF transaction and these costs were included within
selling, general and administrative expenses for 2009. In addition, as the future income tax benefits
of Old Hydrogenics Canadian non-capital losses, capital losses, scientific
research and development expenditures and investment tax credits generated
prior to the date of the completion of the transaction are not available to the
Corporation after the completion of the transaction, the gross future income
tax assets related to these Canadian tax pools was reduced to $nil (note 16).
Principles
of Consolidation
The consolidated
financial statements include the accounts of the Corporation and its
subsidiaries, which are wholly owned.
All intercompany transactions and balances have been eliminated on
consolidation.
Use of
Estimates
The preparation of consolidated financial statements in accordance with
Canadian GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and the disclosure of contingent
assets and liabilities at the date of the consolidated financial statements
F-12
Hydrogenics
Corporation
Notes
to Consolidated Financial Statements
(in
thousands of US dollars, except share and per share amounts)
and the reported amounts of revenues and expenses during the year.
Actual results could differ from those estimates.
Significant estimates made by the Corporation include allowances for
the fair value of goodwill, warranty provisions, stock-based compensation,
potentially uncollectible accounts receivable, provisions for inventory, which
is carried in excess of net realizable value, and provisions for costs to
complete contracts in progress and valuation allowances for future income tax
assets.
Cash and
Cash Equivalents
Cash and cash equivalents consist of cash on deposit and highly liquid
short-term interest bearing securities with maturities at the date of purchase
of less than 90 days. Cash and cash equivalents are designated as
held-for-trading and carried at fair value.
Changes in fair value are recorded in earnings.
Restricted
Cash
Restricted cash consists of cash on deposit and highly liquid
short-term interest bearing securities with maturities at the date of purchase
of less than 90 days. These instruments are held as full or partial security
for standby letters of credit and letters of guarantee (The Letters). The Corporation cannot utilize this
restricted cash until the Letters have expired.
Where these Letters have maturities of greater than one year, the
associated security is classified as a non-current asset. Restricted cash is
designated as held-for-trading and carried at fair value based on Level 1
inputs such as quoted prices in active markets.
Changes in fair value are recorded in earnings.
Inventories
Raw materials, work-in-progress and finished goods are valued at the lower
of cost, determined on a first-in, first-out basis, and net realizable
value. Inventory costs include the cost
of material, labour, variable overhead and an allocation of fixed manufacturing
overhead including amortization based on normal production volumes.
Property,
Plant and Equipment
Property, plant and equipment are recorded at cost less accumulated
amortization. Property, plant and equipment are amortized from the date of
acquisition or, in respect of internally constructed assets, from the time an
asset is substantially completed and ready for use. The cost of internally
constructed assets includes materials, labour and directly attributable
overhead costs.
Amortization is computed using the declining balance method as follows:
Test equipment
|
|
30% per annum
|
Computer
hardware and software
|
|
30% per annum
|
Furniture and
equipment
|
|
20% per annum
|
Automobiles
|
|
30% per annum
|
Leasehold improvements are amortized on a straight-line basis over the
term of the lease.
Long-lived assets are tested for impairment whenever circumstances
indicate the carrying value may not be recoverable. When events or
circumstances indicate the carrying amount of long-lived assets are not
recoverable, the long-lived assets are tested for impairment by comparing the estimate
of future expected cash flows to the carrying amount of the assets or groups of
assets. If the carrying value is not recoverable from future expected cash
flows, any loss is measured as the amount by which the assets carrying value
exceeds fair value and amounts recorded in the period. Recoverability is
assessed relative to undiscounted cash flows from the direct use and
disposition of the asset or group of assets.
The Corporation reviews the recoverability of the carrying amount of
property, plant and equipment when events or circumstances indicate that the
carrying amounts may not be recoverable. This evaluation is based on
projections of future undiscounted net cash flows. The total of these projected
net cash flows is referred to as the net recoverable amount. If the net
recoverable amount is less than the carrying value, the asset is written down
to fair value.
F-13
Hydrogenics
Corporation
Notes
to Consolidated Financial Statements
(in
thousands of US dollars, except share and per share amounts)
Goodwill
Goodwill represents the excess of purchase price over the fair value of
identifiable assets acquired in a business combination accounted for using the
purchase method of accounting. Goodwill
is not amortized but is subject to fair value impairment tests on at least an
annual basis and, additionally, whenever events and changes in circumstances
indicate that the carrying value might not be recoverable. Impairment of
goodwill is tested at the reporting unit level by comparing the reporting units
carrying amount, including goodwill, to the fair value of the reporting unit.
The fair values of the reporting units are estimated using a combination of the
income or discounted cash flows approach and the market approach, which
utilizes comparable companies data. If the carrying amount of the reporting
unit exceeds its fair value, then a second step is performed to determine the
amount of impairment loss, measured as the amount by which the carrying value
of the reporting units goodwill exceeds its fair value, if any. Any impairment
loss would be expensed in the consolidated statements of operations.
Revenue
Recognition
Revenues from the sale of equipment are recognized when there is
persuasive evidence of an arrangement, goods have been delivered, the amount is
fixed or determinable, and collection is reasonably assured. When customer
acceptance clauses are considered to be substantive, recognition of revenue is
deferred until customer acceptance is received.
If delivery has not occurred, the Corporation will recognize revenue
provided all other criteria are met and the risks of ownership have passed to
the customer, the customer has a fixed commitment to purchase the goods, the
customer requests that the delivery not occur until a later date, there is a
fixed schedule for delivery of the goods, the Corporation has not retained any
specific performance obligations such that the earnings process is not
complete, the ordered goods have been segregated from the Corporations
inventory and is not subject to being used to fill other orders and the product
is complete and ready for shipment.
Revenues from long-term contracts are determined under the
percentage-of-completion method whereby revenues are recognized on a pro rata
basis in relation to contract costs incurred. Costs and estimated profit on
contracts-in-progress in excess of amounts billed are reflected as unbilled
revenues. Losses, if any, are recognized immediately.
Revenues relating to engineering and testing services are recognized as
services are rendered. Cash received in advance of revenue being recognized on
contracts is classified as unearned revenue.
The Corporation also
enters into transactions that represent multiple element arrangements, which
may include any combination of equipment and service. These multiple element
arrangements are assessed to determine whether they can be separated into more
than one unit of accounting or element for the purpose of revenue recognition.
When the appropriate criteria for separating revenue into more than one unit of
accounting is met and there is objective evidence of the fair value for all
units of accounting or elements in an arrangement, the arrangement
consideration is allocated to the separate units of accounting or elements
based on each units relative value. This objective evidence of fair value is
established through prices charged for each revenue element when that element
is sold separately. The allocation based on each units relative value is the
same as using the relative fair value. For the periods presented, the
Corporation has had fair value for each of the elements in its revenue
arrangements. The revenue recognition policies described above are then applied
to each unit of accounting.
Product
Warranties
The Corporation typically provides a warranty for parts and/or labour
for up to one year or based on certain operating specifications such as hours
of operation. Warranty cost provisions are based on managements best estimates
of such costs, taking into account the specific arrangements of the transaction
and past history.
Research
and Product Development Costs
Research costs are expensed as incurred. Product development costs
(which typically include applying for patents and licenses) are expensed as
incurred until the Corporation can demonstrate each of the following criteria: (i) the
technical feasibility of completing the intangible asset so that it will be
available for use or sale, (ii) its intention to complete the intangible asset
and use or sell it, (iii) its ability to use or sell
F-14
Hydrogenics
Corporation
Notes
to Consolidated Financial Statements
(in
thousands of US dollars, except share and per share amounts)
the intangible asset, (iv) how the intangible asset will generate
probable future economic benefits, (v) the availability of adequate
technical, financial and other resources to complete the development and to use
or sell the intangible asset and (vi) its ability to measure reliably the
expenditure attributable to the intangible asset during its development. To
date, no product development costs have been capitalized.
Funding for
research
and
product
development
includes government and non-government research and product development
support. Research and
product
development support is recognized as the applicable costs are incurred unless
it is for reimbursement of an asset, in which case it is accounted for as a
reduction in the cost of the applicable asset.
Stock-based
Compensation
The Corporation has stock-based compensation plans, which are described
in note 10. The Corporation estimates
the fair value of stock-based compensation to employees and directors and
expenses the fair value over the estimated vesting period of the stock options
with the off-set being recorded in contributed surplus. Any consideration paid
by employees or directors on the exercise of stock options or purchase of stock
is credited to share capital together along with any previously recognized
compensation expense. If shares or stock options are repurchased from employees
or directors, the excess of the consideration paid over the carrying amount of
the shares or vested stock options cancelled is charged to deficit, unless a
portion of the consideration represents payments over the fair value of the
share or stock option, in which case that portion is recognized in compensation
expense. Forfeitures of stock-based
compensation awards are accounted for in the period in which the forfeiture occurs.
Deferred
Share Units
The intrinsic value of the Corporations deferred share units is
charged to selling, general and administrative expenses using the graded
vesting method. Since the deferred share units will be settled in cash, the
intrinsic value of the vested share units is revalued each quarter until the
settlement date. The Corporation has set up a liability in the consolidated
balance sheets, included within accounts payable and accrued liabilities, for
the total intrinsic value of the vested deferred share units. Forfeitures of deferred share units are
accounted for in the period in which the forfeiture occurs.
Restricted
Share Units
The intrinsic value of the Corporations restricted share units is
charged to selling, general and administrative expenses using the graded
vesting method. Since the restricted share units will be settled in cash, the
intrinsic value of the vested share units is revalued each quarter until the
settlement date. The Corporation has set up a liability in the consolidated
balance sheets, included within accounts payable and accrued liabilities, for
the total intrinsic value of the vested restricted share units. Forfeitures of restricted share units are
accounted for in the period in which the forfeiture occurs.
Income
Taxes
Income taxes are recorded using the liability method. Future income tax amounts arise due to
temporary differences between the accounting and income tax basis of the
Corporations assets and liabilities and the unused tax losses of the Corporation.
Future income tax assets and liabilities are measured using substantively
enacted income tax rates in effect for the year in which those temporary
differences are expected to be recovered or settled. The effect on future
income tax assets and liabilities of a change in income tax rates and laws is
recognized in the period that includes the date of substantive enactment. Future income tax assets are recognized to
the extent that realization of such benefits is considered to be more likely
than not.
Foreign
Currency Translation
Monetary assets and liabilities denominated in currencies other than
the functional currency are translated at the rate of exchange in effect at the
end of the period. Non-monetary assets and liabilities are translated at historical
rates of exchange. Revenue and expense items denominated in currencies other
than the functional currency are translated into the functional currency at the
average rate of exchange for the period, except for amortization, which is
translated at historical rates. Resultant gains and losses are included in the
results of operations.
F-15
Hydrogenics
Corporation
Notes
to Consolidated Financial Statements
(in
thousands of US dollars, except share and per share amounts)
Assets and liabilities of the Corporations Belgian subsidiary are
considered to be self-sustaining and are translated into US dollars at the
period-end exchange rates, and the results of its operations are translated at
the average rate of exchange for the period. The resulting translation
adjustments are accumulated in a separate component of shareholders equity.
The operations of the Corporations other subsidiaries are considered
integrated with those of the Corporation and, accordingly, their accounts are
translated into US dollars using the temporal method. Under this method,
monetary assets and liabilities are translated using the period-end exchange
rate, and non-monetary items are translated using historical rates of exchange.
Revenues and expenses of these subsidiaries are translated at the average
exchange rate for the period, except for amortization, which is translated at
historical rates of exchange. Resultant gains and losses are included in the
results of operations.
Net Loss
Per Share
Basic net loss per share is calculated based on the weighted average
number of common shares outstanding for the year. Diluted net loss per share is
calculated using the daily weighted average number of common shares that would
have been outstanding during the year had all potential common shares been
issued at the beginning of the year or when the underlying options or warrants
were granted, if later unless they were anti-dilutive. The treasury stock method is used to
determine the incremental number of shares that would have been outstanding had
the Corporation used proceeds from the exercise of options and warrants to
acquire common shares.
Financial Instruments
All financial instruments are measured at fair value on initial
recognition. After initial recognition, financial instruments are measured at
their fair values, except for loans and receivables and other financial
liabilities, which are measured at amortized cost. The Corporation has
designated cash and cash equivalents and restricted cash as held-for-trading.
Accounts receivable are classified as loans and receivables, and approximate
fair value. Financial liabilities included within accounts payable and accrued
liabilities are classified as other financial liabilities and approximate fair
value.
Restructuring Costs
Costs associated with exit or disposal activities, including lease
termination costs and employee severance costs associated with restructuring,
plant closing or other activity, are recognized when specified criteria are
met. With respect to lease termination
costs, we recognize these costs at the cease-use date and record these amounts
at the present value of the estimated lease payments, net of estimated sublease
income. Severance and termination
benefits result from a specific event and therefore are considered to be
contractual termination benefits. The costs related to contractual termination
benefits are recognized as a liability and expensed when it is probable that
the employees will be entitled to benefits and the amount can be reasonably
determined. The benefits provided were either specified in an employment
agreement or were based on existing legislative formula or were consistent with
the Corporations past practice. The amounts were accrued when management
approved the plan and committed the entity to the restructuring event that
obligated the Corporation to the employees, management had identified all
significant actions to take to cause the obligating event to occur and actions
required by managements plan were to commence shortly thereafter and be
completed within an appropriate time such that there would not be significant
changes to managements plan.
F-16
Hydrogenics
Corporation
Notes
to Consolidated Financial Statements
(in
thousands of US dollars, except share and per share amounts)
Note 3. New Accounting
Standards
The Corporation has adopted the following changes to its accounting
policies:
(i)
Canadian standards
In February 2008,
The Canadian Institute of Chartered Accountants (CICA) issued Handbook Section 3064
Goodwill and Intangible Assets, which replaced existing Handbook Sections
3062 Goodwill and Other Intangible Assets and 3450 Research and Development
Costs. The new standards introduced changes to the recognition, measurement
and disclosure of goodwill and intangible assets. The new standard also
provides guidance for the recognition of internally developed intangible
assets, including assets developed from research and development activities,
ensuring consistent treatment of all intangible assets, whether separately
acquired or internally developed. Handbook Section 3064 applies to interim
and annual financial statements relating to fiscal years beginning on or after October 1,
2008, with earlier adoption encouraged. The Corporation adopted this standard
effective January 1, 2009. The
adoption of this standard did not have a material impact on the Corporations
consolidated financial position, results of operations or cash flows.
(ii)
US standards
The following changes
only apply to note 20 of the consolidated financial statements.
Effective July 1,
2009, the Corporation adopted the Financial Accounting Standards Board (FASB)
Accounting Standards Codification (Codification). The Codification is the source of
authoritative accounting principles recognized by FASB to be applied by
nongovernmental entities in the preparation of financial statements in
conformity with US GAAP. Rules and interpretive releases of the Securities
and Exchange Commission (SEC) under authority of federal securities laws are
also sources of authoritative US GAAP for SEC registrants. All guidance
contained in the Codification carries an equal level of authority. The
Codification superseded all existing non-SEC accounting and reporting
standards. References made to FASB guidance throughout this document have been
updated for the Codification. The
adoption of the Codification did not have a material impact on the Corporations
consolidated results of operations and consolidated financial position.
In December 2007, the FASB issued FASB ASC Topic 805 Business
Combinations (ASC 805). The standard retains the purchase method of
accounting for acquisitions, but requires a number of changes, including changes
in the way assets and liabilities are recognized in purchase accounting. It
also changes the recognition of assets acquired and liabilities assumed arising
from contingencies, requires the capitalization of in-process research and
development at fair value, and requires the expensing of acquisition related
costs as incurred. The Corporation adopted ASC 805 on January 1, 2009 and
it is applied prospectively to business combinations (and related
non-controlling interest, if any) completed on or after this date.
In September 2006,
the FASB issued FASB ASC 820, Fair Value Measurements and Disclosures (ASC 820).
ASC 820 establishes a framework for measuring the fair value of assets and
liabilities. This framework is intended to provide increased consistency in how
fair value determinations are made under various existing accounting standards
that permit, or in some cases require, estimates of fair market value. ASC 820 also expands financial statement
disclosure requirements about a corporations use of fair value measurements,
including the effect of such measures on earnings. This standard is effective
for fiscal years beginning after November 15, 2007. The Corporation adopted
this new guidance effective January 1, 2008. This standard did not change
the Corporations consolidated financial position, results of operations or
cash flows. For non-financial assets and non-financial liabilities, the
standard is effective for financial statements issued for fiscal years
beginning after November 15, 2008. The Corporation adopted this guidance
effective January 1, 2009. The
adoption of this guidance did not have a material impact on the Corporations
results of operations and consolidated financial position.
F-17
Hydrogenics
Corporation
Notes
to Consolidated Financial Statements
(in
thousands of US dollars, except share and per share amounts)
In April 2009, the
FASB issued amendments to ASC 820 Fair Value Measurements and Disclosures (ASU
2009-05). ASU 2009-05 requires disclosures, in interim reporting periods and
in financial statements for annual reporting periods, regarding the fair value
of all financial instruments for which it is practicable to estimate that
value, whether recognized or not on the Corporations balance sheet. ASU
2009-05 is effective for interim reporting periods ending after June 15,
2009. The Corporation adopted the
disclosures required under this standard effectively for the year ended December 31,
2009. While the adoption of ASU 2009-05 impacts the Corporations disclosures,
it did not have an impact on the Corporations results of operations or
consolidated financial condition.
In May 2009, the
FASB issued ASC 855, Subsequent Events (ASC 855), which was effective for the
Corporation during 2009. ASC 855 sets
forth the circumstances and the period after the balance sheet date for which
an entity should evaluate events for recognition or disclosure in its financial
statements. In addition, ASC 855 identifies the disclosures that an entity
should make about such events. The Corporation adopted ASC 855 in 2009
and has evaluated subsequent events from December 31, 2009, through to the
date of issuance of the consolidated financial statements in accordance with
the statement. Adoption of ASC 855 did not have an effect on the
Corporations results of operations and consolidated financial position.
The Corporation will be
adopting the following changes to its accounting policies in the future.
(i)
Canadian standards
In January 2009, the
CICA issued Handbook Sections 1582 Business Combinations, 1601 Consolidated
Financial Statements, and 1602 Non-controlling Interests. These sections replace the former Handbook Section 1581,
Business Combinations and Handbook Section 1600, Consolidated Financial
Statements, and establish a new section for accounting for a non-controlling
interest in a subsidiary. Handbook Section 1582
is effective for business combinations for which the acquisition date is on or
after the beginning of the first annual reporting period beginning on or after January 1,
2011. Handbook Sections 1601 and 1602
apply to interim and annual consolidated financial statements relating to years
beginning on or after January 1, 2011.
The Corporation is currently assessing the effect these standards may
have on the Corporations results of operations and consolidated financial
position.
The CICA has announced
that Canadian GAAP for publicly accountable enterprises will be replaced with
IFRS over a transition period expected to end in 2011. The Corporation will
begin reporting its financial statements in accordance with IFRS on January 1,
2011.
In December 2009,
the CICA issued EIC 175, Multiple Deliverable Revenue Arrangements, replacing
EIC 142, Revenue Arrangements with Multiple Deliverables. This abstract was
amended to: (1) provide updated guidance on whether multiple deliverables
exist, how the deliverables in an arrangement should be separated, and the
consideration allocated; (2) require, in situations where a vendor does
not have vendor-specific objective evidence (VSOE) or third party evidence of
selling price, that the entity allocate revenue in an arrangement using
estimated selling prices of deliverables; (3) eliminate the use of the
residual method and require an entity to allocate revenue using the relative
selling price method; and (4) require expanded qualitative and
quantitative disclosures regarding significant judgments made in applying this
guidance. The accounting changes summarized in EIC 175 are effective for fiscal
years beginning on or after January 1, 2011, with early adoption
permitted. Adoption may either be on a prospective basis or by retrospective
application. If the Abstract is adopted early, in a reporting period that is
not the first reporting period in the entitys fiscal year, it must be applied
retroactively from the beginning of the Corporations period of adoption. The
Corporation is currently assessing the future impact of these amendments on its
consolidated financial statements and has not yet determined the timing and
method of its adoption.
F-18
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
(ii)
US standards
In October 2009, the
FASB issued amendments to ASC 605, Revenue Recognition (ASU 2009-13) and
amendments to ASC 985, Software (ASU 2009-14). ASU 2009-13 requires entities
to allocate revenue in an arrangement using estimated selling prices of the
delivered goods and services based on a selling price hierarchy. The amendments
eliminate the residual method of revenue allocation and require revenue to be
allocated using the relative selling price method. ASU 2009-14 removes tangible
products from the scope of software revenue guidance and provides guidance on
determining whether software deliverables in an arrangement that includes a
tangible product are covered by the scope of the software revenue guidance. ASU
2009-13 and ASU 2009-14 should be applied on a prospective basis for revenue
arrangements entered into or materially modified in fiscal years beginning on
or after June 15, 2010, with early adoption permitted. The Corporation
does not expect adoption of ASU 2009-13 or ASU 2009-14 to have a material
impact on the Corporations consolidated results of operations or consolidated
financial condition.
Note 4.
Risk Management Arising From Financial Instruments
Under Canadian GAAP,
financial instruments are classified into one of the following categories: held-for-trading, held-to-maturity,
available-for-sale, loans and receivables, and other financial liabilities. The following table summarizes information
regarding the carrying value of the Corporations financial instruments:
|
|
2009
|
|
2008
|
|
Held-for-trading
(i)
|
|
$
|
11,002
|
|
$
|
22,731
|
|
Loans
and receivables (ii)
|
|
4,175
|
|
4,479
|
|
Other
financial liabilities (iii)
|
|
10,414
|
|
13,063
|
|
|
|
|
|
|
|
|
|
(i)
Includes cash and cash equivalents and
restricted cash
(ii)
Includes accounts receivable
(iii)
Includes financial liabilities included
within accounts payable and accrued liabilities
Liquidity
The Corporation has
sustained losses and negative cash flows from operations since its
inception. At December 31, 2009,
the Corporation had approximately $9,159 (December 13, 2008 - $21,601) of
cash and cash equivalents. Liquidity
risk is the risk that the Corporation will encounter difficulty in meeting its
financial obligations associated with financial liabilities that are settled by
delivering cash or another financial asset.
The Corporation is exposed to significant liquidity risk as it continues
to have net cash outflows to support its operations. The Corporations approach to managing
liquidity risk is to ensure it will have sufficient liquidity to meet
liabilities when due. The Corporation
achieves this by maintaining sufficient cash and cash equivalents and
short-term investments. The Corporation
monitors its financial position on a monthly basis and updates its expected use
of cash resources based on the latest available data. Substantially all of the Corporations
financial liabilities will mature within one year. There are uncertainties related to the timing
and use of the Corporations cash resources.
Note 1, Description of Business and Going Concern, discloses the risks
surrounding the timing and the use of the Corporations cash resources.
The Corporation continued
to use cash in its operating activities of $11,085 and investing activities of
$1,465 for the year ended December 31, 2009 (2008 used cash in
operations of $6,758 and received from investing activities of $13,017
respectively).
F-19
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
The table below
summarizes the Corporations financial and accrued liabilities into relevant
maturity groups based on the remaining period at the balance sheet date to the
contractual maturity date. The amounts disclosed in the table are the
contractual undiscounted cash flows:
|
|
Anticipated settlement
within six months from
December 31, 2009
|
|
Anticipated settlement between
six and twleve months from
December 31, 2009
|
|
Total
|
|
Financial
liabilities included within Accounts payable and accrued liabilities
|
|
$
|
9,297
|
|
$
|
1,117
|
|
$
|
10,414
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit
risk
Credit risk arises from
the potential that a counterparty will fail to perform its obligations. The Corporation is exposed to credit risk
from customers. At December 31, 2009, the Corporations two largest
customers accounted for 9% (18% at December 31, 2008) and 7% (7% at December 31,
2008) of revenues, respectively. In
order to minimize the risk of loss for trade receivables, the Corporations
extension of credit to customers involves a review and approval by senior
management as well as progress payments as contracts are executed and in some
cases irrevocable letters of credit. The
majority of the Corporations sales are invoiced with payment terms between 30
and 60 days. The Corporations objective
is to minimize its exposure to credit risk from customers in order to prevent
losses on financial assets by performing regular monitoring of overdue balances
and to provide allowance for potentially uncollectible accounts receivable.
The Corporation reviews
its trade receivable accounts regularly and writes down their carrying values
to their expected realizable values, by making an allowance for doubtful
receivables, as soon as the account is determined not to be fully collectible,
which is done based on managements evaluation of the situation on a customer
by customer basis. The Corporations assessment
of outstanding receivables from customers is primarily based on the Corporations
assessment of the creditworthiness of the customer. The allowance is charged against earnings.
Shortfalls in collections are applied against this provision. Estimates for the
allowance for doubtful receivables are determined on a customer-by-customer
evaluation of collectibility at each balance sheet reporting date, taking into
account the amounts that are past due and any available relevant information of
the customers liquidity and going concern problems.
The Corporations trade
receivables have a carrying value of $2,919 as at December 31, 2009
($3,661 as at December 31, 2008), representing the maximum exposure to
credit risk of those financial assets, exclusive of the allowance for doubtful
accounts. Normal credit terms for
amounts due from customers call for payment within 30 to 60 days. An insignificant amount of these receivables
were past due as at December 31, 2009. The Corporations exposure to
credit risk for trade receivables by geographic area as at December 31 was
as follows:
|
|
2009
|
|
2008
|
|
Europe
|
|
51
|
%
|
46
|
%
|
United
States
|
|
13
|
|
13
|
|
Asia
|
|
8
|
|
32
|
|
Rest
of world
|
|
28
|
|
9
|
|
|
|
100
|
%
|
100
|
%
|
F-20
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
The activity of the
allowance for doubtful accounts for the period is as follows:
|
|
2009
|
|
2008
|
|
Allowance
for doubtful accounts beginning of year
|
|
$
|
228
|
|
$
|
351
|
|
Bad
debt expense
|
|
283
|
|
126
|
|
Write-off
of bad debts
|
|
(223
|
)
|
(249
|
)
|
Allowance
for doubtful accounts end of year
|
|
$
|
288
|
|
$
|
228
|
|
The Corporation believes
that the credit quality is high for the neither past due nor impaired accounts
receivable based on prior experience of collections of accounts within 0-30
days of billing.
The Corporation may also
have credit risk relating to cash and cash equivalents and restricted cash,
which it manages by dealing with large chartered Belgian, Canadian and German
banks. The Corporations objective is to
minimize its exposure to credit risk in order to prevent losses on financial
assets by placing its investments in lower risk bank acceptances of these
chartered banks. The Corporations cash and cash equivalents and restricted
cash carrying value is $11,002 ($22,731 at December 31, 2008),
representing the maximum exposure to credit risk of these financial
assets. Approximately 52% (82% - December 31,
2008) of the Corporations cash and restricted cash at December 31, 2009
was held by four financial institutions. The Corporations exposure to credit
risk relating to cash and cash equivalents and short-term investments,
segmented by geographic area as at December 31, was as follows:
|
|
2009
|
|
2008
|
|
Canada
|
|
71
|
%
|
37
|
%
|
Belgium
|
|
20
|
|
54
|
|
Germany
|
|
9
|
|
9
|
|
|
|
100
|
%
|
100
|
%
|
Foreign
currency risk
Foreign currency risk
arises because of fluctuations in exchange rates. The Corporation conducts a
significant portion of its business activities in currencies other than the
functional currency of the parent company (US$) and the functional currency of
our self-sustaining subsidiary (euros).
This primarily includes Canadian dollar transactions at the parent
company and US$ transactions at our self-sustaining subsidiary. The Corporations
objective in managing its foreign currency risk is to minimize its net exposure
to foreign currency cash flows by converting foreign denominated financial
assets into the applicable functional currency of the subsidiary to the extent
practical to match the obligations of its financial liabilities. Financial assets and financial liabilities
denominated in foreign currencies will be affected by changes in the exchange
rate between the functional currency and these foreign currencies. This primarily includes cash and cash
equivalents, accounts receivable and accounts payable and accrued liabilities,
which are denominated in foreign currencies.
The Corporation recognized foreign exchange gains in the year ended December 31,
2009 of $40 compared to $188 in the year ended December 31, 2008.
If a shift in the
Canadian dollar relative to the US$ of 10% were to occur, the exchange gain or
loss on the net financial assets could be plus or minus $601 (December 31,
2008 - $335) due to exchange rate fluctuations and this amount would be
recorded in the consolidated statements of operations.
The Corporation conducts
a significant portion of its business activities in foreign currencies. It
therefore seeks to manage its foreign currency risk and to minimize its net
exposures to foreign currency cash flows by converting cash balances into
foreign currencies to the extent practical to match other foreign currency
obligations.
F-21
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
Interest
rate risk
Interest rate risk arises
because of the fluctuation in market interest rates. The Corporations objective in managing
interest rate risk is to maximize the return on its cash and cash equivalents
and restricted cash. The Corporation is subject to interest rate risk on its
cash and cash equivalents; however, the Corporation does not have any long-term
debt and hence is not subject to interest rate risk from borrowings. If a shift in interest rates of 10% were to
occur, the impact on cash and cash equivalents and restricted cash and the
related net loss for the period could be plus or minus $100.
Fair
value
The carrying value of
cash and cash equivalents, restricted cash, accounts receivable, and accounts
payable and accrued liabilities approximate their fair value given their
short-term nature. The fair value of
cash and cash equivalents and restricted cash was determined based on quoted
prices in active markets for identical assets.
Management
of capital
The Corporations
objective in managing capital is to ensure sufficient liquidity to pursue its
growth strategy, fund research and product development, undertake selective
acquisitions, while at the same time taking a conservative approach toward
financial leverage and management of financial risk.
The Corporations capital
is composed of share capital, contributed surplus, accumulated deficit and
foreign currency translation adjustments included within accumulated other
comprehensive income (loss). The total capital as at December 31, 2009 is
$17,059 (December 31, 2008 -
$25,483). The Corporations primary uses of capital are to finance
operations, increases in non-cash working capital and capital
expenditures. The Corporation currently
funds these requirements from existing cash resources and cash raised through share
issuances and the APIF transaction (note 2).
The Corporations objectives when managing capital are to ensure the
Corporation will continue to have enough liquidity so it can provide its
products and services to its customers and returns to its shareholders.
The Corporation monitors
its capital on the basis of the adequacy of its cash resources to fund its
business plan. In order to maximize the
capacity to finance the Corporations ongoing growth, the Corporation does not
currently pay a dividend to holders of its common shares.
Note 5. Business Streamlining Initiatives and Windup of Test
Equipment Business
Business
Streamlining Initiatives
In March and November 2007,
the Corporation recorded charges for severance and related expenses for
business streamlining initiatives, aimed at reducing expenses to improve future
cash flows by reducing the Corporations headcount. These charges were included
in selling, general and administrative expenses as at December 31,
2007. The business streamlining
activities relating to the March 2007 and November 2007 annoucements
were complete as at December 31, 2008. The expenses resulting from the March 2007
announcement were exclusively charged to the Power Systems business unit. The
expenses related to the November 2007 announcement were charged to the
business units as follows: $846 for Power Systems; $142 for OnSite Generation;
and $1,002 for Corporate and Other. For both the March 2007 and November 2007
announcements, the amount expensed for the twelve months ended December 31,
2007 (which is identical to the expected cumulative charge) was $2,100 and $1,990,
respectively.
F-22
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
A summary of the
movements in the liability are as follows;
|
|
March 2007
|
|
November 2007
|
|
Total
|
|
December 31,
2006
|
|
|
|
|
|
|
|
Expense
for the period
|
|
$
|
2,100
|
|
$
|
1,990
|
|
$
|
4,090
|
|
Cash
payments
|
|
(2,100
|
)
|
|
|
(2,100
|
)
|
December 31,
2007
|
|
|
|
1,990
|
|
1,990
|
|
Cash
payments
|
|
|
|
(1,981
|
)
|
(1,981
|
)
|
December 31,
2008
|
|
|
|
9
|
|
9
|
|
Cash
payments
|
|
|
|
(9
|
)
|
(9
|
)
|
December 31,
2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On January 5, 2009 and December 10, 2009, in order to further
streamline operations, the Corporation reduced its headcount and implemented
additional cost saving measures in order to maximize the Corporations cash
resources. The Corporation recorded
charges of $582 and $409 respectively for severance and related expenses, which
are included in selling, general and administrative expenses. These amounts
were charged to the Corporations business segments as follows: Corporate -
$146; OnSite Generation - $99; and Power Systems - $746.
A summary of the
movements in the liability are as follows;
|
|
January 2009
|
|
December 2009
|
|
Total
|
|
December 31,
2008
|
|
|
|
|
|
|
|
Expense
for the period
|
|
$
|
582
|
|
$
|
409
|
|
$
|
991
|
|
Cash
payments
|
|
(582
|
)
|
(33
|
)
|
(615
|
)
|
December 31,
2009
|
|
|
|
376
|
|
376
|
|
|
|
|
|
|
|
|
|
|
|
|
Windup
of Test Equipment Business
On November 7, 2007,
the Corporation announced plans to wind up its fuel cell test products design,
development and manufacturing business, due to lower than planned gross margin
and growth prospects and not achieving certain operating targets. During the
year ended December 31, 2007, the Corporation incurred $2,016 in respect
of severance and related expenses, and the writeoff of inventory. The windup of the Test Equipment business is
expected to be completed in 2010. The expenses relating to the windup of the
Test Equipment business all relate to the Test segment. The Corporation expects
to incur a cumulative charge of approximately $3,500 relating to the windup of
the Test Equipment business, of which $2,016 was incurred in 2007. $853 was
incurred in 2008 and $619 was incurred in 2009, representing a total of $3,488
incurred to date. The remainder will be
charged to expenses in 2010.
The majority of the costs
associated with the windup of the Test Equipment business are expensed as
incurred. However, a reconciliation of the beginning and ending liability
balances for severance and other termination benefits is as follows:
|
|
Windup of Test Equipment
Business
|
|
December 31,
2006
|
|
|
|
Accrual
for contract termination costs
|
|
$
|
1,598
|
|
Cash
payments
|
|
(648
|
)
|
December 31,
2007
|
|
950
|
|
Cash
payments
|
|
(950
|
)
|
December 31,
2008
|
|
|
|
|
|
|
|
|
F-23
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
Note 6. Accounts
Receivable
|
|
2009
|
|
2008
|
|
|
|
|
|
|
|
Trade accounts
receivable
|
|
$
|
2,919
|
|
$
|
3,661
|
|
Less: Allowance for
doubtful accounts
|
|
(288
|
)
|
(228
|
)
|
Goods and services tax
and other receivables
|
|
1,054
|
|
541
|
|
|
|
$
|
3,685
|
|
$
|
3,974
|
|
Note 7. Inventories
|
|
2009
|
|
2008
|
|
Raw
materials
|
|
$
|
3,239
|
|
$
|
4,938
|
|
Work-in-progress
|
|
5,336
|
|
5,004
|
|
Finished
goods
|
|
3,171
|
|
159
|
|
|
|
$
|
11,746
|
|
$
|
10,101
|
|
During the year ended December 31,
2009, the Corporation recorded provisions of $349 (December 31, 2008 -
$1,298). During the year, approximately $13,630 of inventory was expensed in
cost of revenues (December 31, 2008 and December 31, 2007 - $29,851
and $29,725 respectively).
Note 8. Property, Plant and Equipment
As at December 31, 2009, the net book value of property, plant and
equipment is as follows:
|
|
Cost
|
|
Accumulated
amortization
|
|
Net book
value
|
|
|
|
|
|
|
|
|
|
Test equipment
|
|
$
|
5,179
|
|
$
|
4,724
|
|
$
|
455
|
|
Furniture and equipment
|
|
4,482
|
|
2,897
|
|
1,585
|
|
Computer hardware and
software
|
|
2,642
|
|
2,129
|
|
513
|
|
Leasehold improvements
|
|
1,097
|
|
906
|
|
191
|
|
Automobiles
|
|
564
|
|
554
|
|
10
|
|
Assets held-for-sale
|
|
855
|
|
495
|
|
360
|
|
|
|
$
|
14,819
|
|
$
|
11,705
|
|
$
|
3,169
|
|
As at December 31, 2008, the net book value of property, plant and
equipment is as follows:
|
|
Cost
|
|
Accumulated
amortization
|
|
Net book
value
|
|
|
|
|
|
|
|
|
|
Test equipment
|
|
$
|
6,250
|
|
$
|
5,336
|
|
$
|
914
|
|
Furniture and equipment
|
|
4,040
|
|
2,471
|
|
1,569
|
|
Computer hardware and
software
|
|
2,619
|
|
1,874
|
|
745
|
|
Leasehold improvements
|
|
1,000
|
|
799
|
|
201
|
|
Automobiles
|
|
43
|
|
29
|
|
14
|
|
Assets held- for-sale
|
|
639
|
|
|
|
639
|
|
|
|
$
|
14,591
|
|
$
|
10,509
|
|
$
|
4,082
|
|
F-24
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
Test equipment and Furniture and equipment under construction, as at December 31,
2009, not yet subject to amortization, amounted to $55 (2008 - $28).
The net book value of equipment under capital lease as at December 31,
2009 was $nil (2008 - $33).
During 2009, the Corporation recorded a write-down of certain property,
plant and equipment which has been classified as held-for-sale. These held-for-sale assets have been recorded
at fair value, less estimated costs to sell.
Note 9. Accounts
Payable and Accrued Liabilities
|
|
2009
|
|
2008
|
|
Trade accounts payable
|
|
$
|
3,296
|
|
$
|
4,506
|
|
Warranty
liability accruals
|
|
3,185
|
|
3,717
|
|
Severance and related
compensation payments
|
|
2,298
|
|
1,693
|
|
Accrued
payroll costs
|
|
1,694
|
|
2,067
|
|
Facility
accruals
|
|
1,560
|
|
1,400
|
|
Supplier
accruals
|
|
1,503
|
|
3,165
|
|
Accrued
professional fees
|
|
590
|
|
433
|
|
Excise
tax payable
|
|
384
|
|
|
|
Provincial
capital tax payable
|
|
|
|
25
|
|
Current
portion of long-term debt
|
|
|
|
10
|
|
Other
|
|
272
|
|
282
|
|
|
|
$
|
14,782
|
|
$
|
17,298
|
|
Included within severance and related compensation payments is a
post-retirement benefit obligation of $1,184 (December 31, 2008 -
$1,050). The liability, which is
unfunded and payable in Canadian dollars, is a defined benefit plan to be paid
to a beneficiary. The key assumptions
used in this valuation are annual payments ($100), the expected life of the
beneficiaries (approximately 11.5 years) and the discount rate (4%). The amount expensed in 2009 is $134 (2008 -
$340). Actuarial gains and losses as a
result of changes in these assumptions are recognized into income in the period
of the change. During 2009, the
post-retirement benefit obligation was reduced by the amount of annual cash
payments ($100) and was increased by annual interest accretion ($34) and
foreign exchange movements during the year ($200).
Information regarding the changes in the Corporations aggregate
product warranty liabilities is as follows for the years ended December 31,
2009 and December 31, 2008:
|
|
2009
|
|
2008
|
|
Balance,
December 31, 2008 and 2007
|
|
$
|
3,717
|
|
$
|
3,592
|
|
Accruals for warranties
during the year
|
|
1,585
|
|
2,332
|
|
Settlements made during
the year
|
|
(1,146
|
)
|
(1,499
|
)
|
Reversal of warranty
accruals during the year
|
|
(971
|
)
|
(708
|
)
|
Balance,
December 31, 2009 and 2008
|
|
$
|
3,185
|
|
$
|
3,717
|
|
Note 10. Employee stock-based compensation
On February 8, 2010
the Corporation announced that it would implement a share consolidation of its
issued and outstanding common shares in order to comply with the Minimum Bid
Price Rule of the Nasdaq Global Market (NASDAQ). The consolidation was
effective as of March 12, 2010 and was implemented with a ratio of one
post-consolidation share for every 25 pre-consolidation shares. The Corporation
has amended the disclosures in the consolidated financial statements to reflect
the share consolidation as if it had occurred on December 31, 2006.
F-25
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
Stock
Option Plan
During 2000, the Corporation adopted an employee stock option plan. As
at December 31, 2009, the number of common shares that may be issued under
the stock option plan was 348,466. As at December 31, 2009, 131,534 common
shares had been issued through the exercise of stock options under this plan.
Up to 348,466 additional common shares are available to be issued in connection
with the exercise of stock options. Of the 348,466 available common shares,
243,503 have been granted as stock options that were outstanding at December 31,
2009. All options are for a term of ten
years from the date of grant and vest over four years unless otherwise
determined by the Board of Directors.
A summary of the Corporations employee stock option plan activity is
as follows:
|
|
2009
|
|
2008
|
|
2007
|
|
|
|
Number of
shares
|
|
Weighted
average
exercise
price
(CA$)
|
|
Number of
shares
|
|
Weighted
average
exercise
price
(CA$)
|
|
Number of
shares
|
|
Weighted
average
exercise
price
(CA$)
|
|
Outstanding, beginning
of year
|
|
245,191
|
|
91.00
|
|
277,292
|
|
101.25
|
|
275,734
|
|
121.25
|
|
Granted
|
|
77,144
|
|
13.25
|
|
52,000
|
|
14.50
|
|
65,798
|
|
29.25
|
|
Exercised
|
|
(5,760
|
)
|
7.25
|
|
(25,599
|
)
|
5.00
|
|
|
|
|
|
Forfeited
|
|
(71,148
|
)
|
97.75
|
|
(54,994
|
)
|
104.25
|
|
(50,032
|
)
|
118.00
|
|
Expired
|
|
(1,924
|
)
|
268.50
|
|
(3,508
|
)
|
184.00
|
|
(14,208
|
)
|
141.25
|
|
Outstanding, end of
year
|
|
243,503
|
|
65.00
|
|
245,191
|
|
91.00
|
|
277,292
|
|
101.25
|
|
Options exercisable,
end of year
|
|
131,824
|
|
106.50
|
|
173,350
|
|
124.00
|
|
161,753
|
|
111.75
|
|
The following table summarizes information about the Corporations
share options outstanding as at December 31, 2009:
Exercise price
CAN$
|
|
Number
outstanding at
December 31
2009
|
|
Weighted
average
remaining
contractual life
|
|
Weighted
average
exercise
price CAN$
|
|
Number
exercisable at
December 31
2009
|
|
Weighted
average
exercise
price
CAN$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.25
13.25
|
|
74,340
|
|
9.23
|
|
13.25
|
|
|
|
|
|
13.26
- 25.00
|
|
46,525
|
|
8.19
|
|
14.50
|
|
20,830
|
|
14.50
|
|
25.01
- 100.00
|
|
60,751
|
|
6.34
|
|
42.50
|
|
49,105
|
|
43.75
|
|
100.01
- 200.00
|
|
28,656
|
|
3.51
|
|
136.75
|
|
28,656
|
|
136.75
|
|
200.01
- 303.50
|
|
33,231
|
|
1.67
|
|
231.00
|
|
33,231
|
|
231.05
|
|
|
|
243,503
|
|
6.61
|
|
65.00
|
|
131,824
|
|
106.50
|
|
Stock options granted to employees during 2009 and 2008 are valued
using the Black-Scholes option pricing model with the following assumptions:
risk-free interest rate 2.93% (2008 - 3.46%), average expected life of four
years, expected volatility 66% (2008 - 64%) and no dividends. The fair value of
the stock options granted during 2009 was $424 (2008 - $387) (weighted average
$5.50 per share) (2008 - $7.50) per share and the related expense recognized in
the consolidated statement of operations for the year ended December 31,
2009 was $413 ($0.11 per share on a basic and diluted basis) (2008 - $694, 2007
- $1,553).
F-26
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in
thousands of US dollars, except share and per share amounts)
Deferred
Share Unit Plan
The Corporation has a deferred share unit plan (DSU Plan) for
directors. Pursuant to the DSU Plan, non-employee directors are entitled to
receive all or any portion of their annual cash retainer and meeting fees in
the form of deferred share units (DSUs) instead of cash. In addition, the
Board of Directors may, at its discretion, make annual awards to non-employees
of DSUs as or in lieu of non-cash compensation. As a result of the
implementation of the DSU Plan, directors are not eligible to receive
additional awards of stock options. A DSU is a unit, equivalent in value to a
common share of the Corporation, credited by means of a bookkeeping entry in
the books of the Corporation, to an account in the name of the non-employee
director. Each DSU entitles the participant to receive a cash payment or common
shares, at the option of the Corporation, upon termination of directorship in
an amount calculated with reference to the trading price of a Hydrogenics
common share on the Toronto Stock Exchange on the date of termination. Compensation cost for DSUs granted under the
DSU Plan is recorded as an expense with a corresponding increase in accrued
liabilities and is measured at intrinsic value.
Changes in intrinsic value between the grant date and the measurement
date result in a change in the measure of compensation cost.
During the year ended December 31, 2009, 17,883 (2008 13,470)
DSUs were issued with immediate vesting on the date of issuance. As at December 31,
2009, 42,371 (2008 30,004) DSUs were outstanding under the DSU Plan.
The Corporation recognized a compensation expense of $216 for the year
ended December 31, 2009 (2008 - ($170); 2007 - $281) related to the DSUs.
Restricted
Share Unit Plan
In 2008, the Board of
Directors authorized a restricted share unit (RSU Plan) for senior
executives. Pursuant to the RSU Plan, senior executives may be granted a
portion of their long term incentive plan in the form of restricted share units
(RSUs) instead of stock options. A RSU is a unit, equivalent in value to a
common share of the Corporation, credited by means of a bookkeeping entry in
the books of the Corporation, to an account in the name of the senior
executive. Each RSU entitles the participant to receive a cash payment no later
than December 31 of the third calendar year following the year in respect
of which the RSUs were granted.
Compensation cost for RSUs granted under the RSU Plan is recorded as an
expense with a corresponding increase in accrued liabilities and is measured at
intrinsic value. Changes in intrinsic
value between the grant date and the measurement date result in a change in the
measure of compensation cost.
During the year ended December 31, 2009, 36,820 (2008 51,500)
RSUs were awarded with vesting over a three-year period. As at December 31, 2009, 88,320 (2008 -
51,500) RSUs were outstanding under the RSU Plan. As a result, the
Corporation recognized a compensation expense of $190 for the year ended December 31,
2009 (2008 - $113, 2007 - $nil).
Note 11. Research and Product Development
Research and product development expenses are recorded net of third
party program funding received or receivable. For 2009, 2008 and 2007, research
and product development expenses and program funding, which have been received
or are receivable, are as follows:
|
|
2009
|
|
2008
|
|
2007
|
|
Research and product
development expenses
|
|
$
|
6,625
|
|
$
|
8,716
|
|
$
|
10,346
|
|
Research and product
development funding
|
|
(1,406
|
)
|
(1,420
|
)
|
(656
|
)
|
Total research and
product development expenses
|
|
$
|
5,219
|
|
$
|
7,296
|
|
$
|
9,690
|
|
F-27
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
Note 12. Commitments
The Corporation incurred rental expenses of $1,755 under operating
leases in 2009 (2008 - $1,856; 2007 - $1,823). The Corporation has future
minimum lease payments under operating leases relating to premises and office
equipment as follows:
2010
|
|
$
|
1,039
|
|
2011
|
|
587
|
|
2012
|
|
589
|
|
2013
|
|
501
|
|
2014
|
|
290
|
|
Thereafter
|
|
125
|
|
|
|
$
|
3,131
|
|
The Corporation has entered into repayable contribution and other
research and development arrangements with various Canadian governmental
ministries and public sector enterprises.
Under these arrangements, the Corporation is eligible to receive up to
$12,664 (2008 - $10,927; 2007 - $13,430) toward agreed upon research and
development project costs. The amount received or receivable as at December 31,
2009 was $12,664 (2008 - $10,927; 2007 - $13,430). The amounts are repayable based on the future
revenue of the Corporation. These
arrangements will expire in stages ending on March 31, 2016 or when total
amounts repaid reach the utilized amount of the advance, depending on the terms
of the individual contracts.
Note 13. Contingencies
As at December 31, 2009, the Corporation has outstanding standby
letters of credit and letters of guarantee issued by several financial
institutions, which total $3,173 (December 31, 2008 - $2,306) with expiry
dates extending to October 2011. The Corporation has restricted cash
totalling $1,843 as partial security for these standby letters of credit and
letters of guarantee. These instruments
relate primarily to obligations in connection with the terms and conditions of
the Corporations sales contracts. The standby letters of credit and letters of
guarantee may be drawn upon by the customer if the Corporation fails to perform
its obligations under the sales contracts and the Corporation would be liable
to the financial institution for the amount of the standby letter of credit or
letter of guarantee in the event the instruments are drawn on.
In 1998, Stuart Energy, a
wholly owned subsidiary of the Corporation until October 27, 2009, entered
into an agreement with Technologies Partnerships Canada (TPC), a program of
the Ministry of Industry of the Canadian government to develop and demonstrate
Hydrogen Fleet Fuel Appliances. This agreement was amended in 2003 to expand
the scope of work and resulted in Stuart Energy receiving a total of $5,557 of
funding from TPC. Pursuant to an
ammendment to the TPC agreement, Stuart Energy received an additional $1,335 of
funding. Stuart Energy undertook to
repay $16,466 (the Repayable Loan Amount). The amended agreement requires
Stuart Energy to commence making royalty payments against the Repayable Loan
Amount on the earlier of revenues of Stuart Energy reaching a minimum of CA
$90,000 or April 1, 2007. In accordance with the terms of the agreement,
Stuart Energy is required to commence payments to TPC at 0.53% of its annual
gross business revenues for a period of 12 years or until the Repayable Loan
Amount is fully repaid. To date, the Corporation has recognized $51,325 (2008 -
$42,800) in revenues and recorded a repayable amount of $272 (December 31,
2008 - $227).
The Corporation has entered into indemnification agreements with its
current and former directors and officers to indemnify them, to the extent
permitted by law, against any and all charges, costs, expenses, amounts paid in
settlement and damages incurred by the directors and officers as a result of
any lawsuit or any other judicial, administrative or investigative proceeding
in which the directors and officers are sued as a result of their service.
These indemnification claims will be subject to any statutory or other legal
F-28
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
limitation period. The nature of the indemnification agreements
prevents the Corporation from making a reasonable estimate of the maximum
potential amount it could be required to pay to counterparties. The Corporation
has purchased directors and officers liability insurance. No amount has been
recorded in the consolidated financial statements with respect to these
indemnification agreements.
In the normal course of operations, the Corporation may provide
indemnification agreements, other than those noted above, to counterparties
that would require the Corporation to compensate them for costs incurred as a
result of changes in laws and regulations or as a result of litigation claims
or statutory sanctions that may be suffered by the counterparty as a consequence
of the transaction. The terms of these indemnification agreements will vary
based on the contract. The nature of the indemnification agreements prevents
the Corporation from making a reasonable estimate of the maximum potential
amount it could be required to pay to counterparties. No amount has been
recorded in the consolidated financial statements with respect to these
indemnification agreements.
Note 14. Lines of Credit
As at December 31, 2009, the
Corporation had operating lines of credit available up to 3,500 euros, or US
equivalent $5,005 (December 31, 2008 $11,535.
Pursuant to the terms of a new credit facility, Hydrogenics Europe NV (the
Borrower), a wholly owned Belgian-based subsidiary, may borrow a maximum of
75% of the value of awarded sales contracts, approved by the Belgian financial
institution, to a maximum of 2,000 euros, along with a maximum of 1,500 euros
for general business purposes. The
credit facility bears interest at a rate of EURIBOR plus 1.45% per annum and is
secured by a 1,000 euro first secured charge covering all assets of the
Borrower. The credit facility may be increased to 1,500 euros in certain
circumstances, and contains a negative pledge precluding the Borrower from
providing security over its assets. Additionally, the Borrower is required to
maintain a solvency covenant, defined as equity plus current account divided by
total liabilities, of not less than 25% and ensure that its intercompany
account with the Corporation does not fall below a certain level. As at December 31,
2009, the Corporation was in compliance with these covenants.
The amount of the available line of credit is reduced by $2,061, the
amount of the outstanding standby letters of credit and letters of guarantee,
if any, issued from time to time by the Belgian financial institution. As at December 31,
2009, the Corporation did not have any availability under this line of credit
as the Corporation did not submit any sales contracts for approval.
As at December 31, 2009 and 2008, the Corporation had no
indebtedness on these lines of credit.
Note 15. Related Party Transactions
In the normal course of operations, the Corporation subcontracts
certain manufacturing functions to a corporation owned by a relative of one of
the principal shareholders of the Corporation. Billings by this related
corporation for material totalled $92 in 2009 (2008 - $220; 2007 - $823). At December 31, 2009, the Corporation
has an accounts payable balance due to this related party of $6 (2008 - $34;
2007 - $58). All related party transactions have been recorded at the exchange
amount, which is the consideration paid or received as established and agreed
to by the related parties.
F-29
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
Note 16. Income Taxes
As outlined in Note 2, the Company received proceeds of $10,464 from
APIF in exchange for the benefit of certain tax attributes retained by APIF. APIF retained the benefit to non-capital
losses, scientific research and experimental development expenses, property,
plant and equipment and intellectual property and investment tax credits with a
carrying value of approximately $177,000 at October 27, 2009.
The break-down of income tax expense for each of the years is as
follows:
|
|
2009
|
|
2008
|
|
2007
|
|
Current income taxes
|
|
93
|
|
116
|
|
22
|
|
Proceeds received from
APIF transaction
|
|
(10,464
|
)
|
|
|
|
|
Income
tax (recovery) expense
|
|
(10,371
|
)
|
116
|
|
22
|
|
The Corporations computation of income tax expense is as follows:
|
|
2009
|
|
2008
|
|
2007
|
|
|
|
|
|
|
|
|
|
Loss before income
taxes
|
|
$
|
(19,746
|
)
|
$
|
(14,203
|
)
|
$
|
(28,046
|
)
|
Statutory income tax
rate
|
|
33.00
|
%
|
33.50
|
%
|
36.12
|
%
|
Income tax recovery at
statutory rate
|
|
(6,516
|
)
|
(4,758
|
)
|
(10,130
|
)
|
Non-deductible
expenses
|
|
143
|
|
185
|
|
433
|
|
Other
permanent differences
|
|
|
|
1,018
|
|
24
|
|
Expiry of non-capital
losses
|
|
2,019
|
|
7,438
|
|
|
|
Effect
of income tax and rate changes on future income taxes
|
|
|
|
(1,111
|
)
|
10,651
|
|
Effect of foreign currency
rate changes on future income taxes
|
|
(13,116
|
)
|
21,119
|
|
(15,528
|
)
|
Currency effect of
difference in US dollar financial reporting compared with CA dollar income
tax reporting
|
|
(600
|
)
|
1,340
|
|
(1,390
|
)
|
Change
in valuation allowance related to the current year
|
|
18,163
|
|
(25,231
|
)
|
15,940
|
|
Other
|
|
|
|
116
|
|
22
|
|
Proceeds
received from the APIF transaction
|
|
(10,464
|
)
|
|
|
|
|
Income
tax expense
|
|
$
|
(10,371
|
)
|
$
|
116
|
|
$
|
22
|
|
F-30
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
As at December 31, 2009, the Corporation has available income tax
loss carryforwards of $44,125 that may be used to reduce taxable income in
future years, in certain jurisdictions, expiring as follows:
2029
|
|
$
|
138
|
|
No
expiry
|
|
43,987
|
|
|
|
$
|
44,125
|
|
As at December 31, 2009, the Corporation has no unclaimed
scientific research and experimental development expenditures (2008 - $27,355)
that can be used to offset future income over an indefinite period. The
Corporation also has no non-refundable investment tax credits (2008 - $6,775)
that can be used to reduce future federal income taxes payable.
Components of the Corporations net future income tax asset are:
|
|
2009
|
|
2008
|
|
Assets
|
|
|
|
|
|
Non-capital losses
|
|
$
|
15,453
|
|
$
|
66,844
|
|
Scientific research and
experimental development expenses
|
|
|
|
7,835
|
|
Property, plant and
equipment and intellectual property
|
|
123
|
|
12,321
|
|
Investment tax credits
|
|
|
|
5,759
|
|
Warranty and other
provisions
|
|
545
|
|
533
|
|
Share issue costs
|
|
1
|
|
(201
|
)
|
Valuation allowance
|
|
(16,122
|
)
|
(93,091
|
)
|
Net
future income tax asset
|
|
$
|
|
|
$
|
|
|
The Corporation has recorded a valuation allowance to reflect
uncertainties associated with the realization of all future income tax
assets. The movement in the valuation
allowance during 2009 consists of an increase as a result of current year
results of $18,163 and a reduction in the valuation allowance as a result of
the APIF transaction (note 2) of $95,132 reflecting the disposal of tax
attributes.
Note 17. Net Loss Per Share
On February 8, 2010
the Corporation announced it would implement a share consolidation of its
issued and outstanding common shares in order to comply with the Minimum Bid
Price Rule of the NASDAQ. The consolidation was effective as of March 12,
2010 and was implemented with a ratio of one post-consolidation share for every
25 pre-consolidation shares. The consolidation reduced the number of shares
outstanding from approximately 105,049,666 to approximately 4,201,987. The Corporation has amended the disclosures
in the consolidated financial statements to reflect the share consolidation as
if it had occurred on December 31, 2006.
Net loss per share is calculated using the weighted average number of
common shares outstanding for the year of 3,697,740 shares in 2009 (2008
3,683,226; 2007 3,671,916). No effect
has been given to the potential exercise of stock options and warrants in the
calculation of diluted net loss per share as the effect would be anti-dilutive.
F-31
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
Note 18. Consolidated Statements of Cash Flows
Components of the net change in non-cash working capital are as
follows:
|
|
2009
|
|
2008
|
|
2007
|
|
Decrease (increase) in
current assets
|
|
|
|
|
|
|
|
Accounts receivable
|
|
$
|
754
|
|
$
|
7,335
|
|
$
|
(2,687
|
)
|
Grants receivable
|
|
(69
|
)
|
320
|
|
1,290
|
|
Inventories
|
|
(1,645
|
)
|
2,558
|
|
59
|
|
Prepaid expenses and
other current assets
|
|
(174
|
)
|
(89
|
)
|
507
|
|
Increase (decrease) in
current liabilities
|
|
|
|
|
|
|
|
Accounts payable and
accrued liabilities
|
|
(2,259
|
)
|
(1,050
|
)
|
(3,486
|
)
|
Unearned revenue
|
|
(239
|
)
|
(4,257
|
)
|
217
|
|
|
|
$
|
(3,632
|
)
|
$
|
4,817
|
|
$
|
(4,100
|
)
|
Note 19. Segmented Financial Information
The Corporations reportable segments include: (i) OnSite
Generation; (ii) Power Systems; and (iii) Test Systems. Where
applicable, corporate and other activities are reported separately as Corporate
and Other. Accordingly, operating segments have changed from prior years and
all years have been restated to reflect the new organization.
OnSite Generation includes the design, development, manufacture, and
sale of hydrogen generation products. Power Systems includes the design,
development, manufacture, and sale of fuel cell products. Test Systems, which
is in the process of being wound up, included the manufacturing and sale of
fuel cell test products and diagnostic testing services.
Financial information by reportable segment for the years ended December 31,
2009, 2008 and 2007 is as follows:
|
|
Year ended
December 31, 2009
|
|
|
|
OnSite
Generation
|
|
Power
Systems
|
|
Test
Systems
|
|
Corporate
and Other
|
|
Total
|
|
Revenue from external
customers
|
|
$
|
12,303
|
|
$
|
6,538
|
|
$
|
|
|
$
|
|
|
$
|
18,841
|
|
Amortization of
intangible assets
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of
property, plant and equipment
|
|
|
|
|
|
|
|
984
|
|
984
|
|
Interest income
|
|
|
|
|
|
|
|
180
|
|
180
|
|
Interest expense
|
|
|
|
|
|
|
|
(11
|
)
|
(11
|
)
|
Income tax recovery
|
|
|
|
|
|
|
|
(10,371
|
)
|
(10,371
|
)
|
Segment loss (i)
|
|
(1,758
|
)
|
(6,972
|
)
|
(307
|
)
|
(338
|
)
|
(9,375
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31,
2008
|
|
|
|
OnSite
Generation
|
|
Power
Systems
|
|
Test
Systems
|
|
Corporate
and Other
|
|
Total
|
|
Revenue from external
customers
|
|
$
|
31,207
|
|
$
|
5,643
|
|
$
|
2,490
|
|
$
|
|
|
$
|
39,340
|
|
Amortization of
intangible assets
|
|
|
|
|
|
|
|
249
|
|
249
|
|
Amortization of property,
plant and equipment
|
|
|
|
|
|
|
|
855
|
|
855
|
|
Interest income
|
|
|
|
|
|
|
|
940
|
|
940
|
|
Interest expense
|
|
|
|
|
|
|
|
(17
|
)
|
(17
|
)
|
Income tax expense
recovery
|
|
|
|
|
|
|
|
116
|
|
116
|
|
Segment income (loss)
(i)
|
|
2,106
|
|
(9,757
|
)
|
(469
|
)
|
(6,199
|
)
|
(14,319
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-32
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
|
|
Year ended December 31,
2007
|
|
|
|
OnSite
Generation
|
|
Power
Systems
|
|
Test
Systems
|
|
Corporate
and Other
|
|
Total
|
|
Revenue from external
customers
|
|
$
|
19,608
|
|
$
|
6,103
|
|
$
|
12,279
|
|
$
|
|
|
$
|
37,990
|
|
Amortization of
intangible assets
|
|
|
|
|
|
|
|
251
|
|
251
|
|
Amortization of
property, plant and equipment
|
|
|
|
|
|
|
|
903
|
|
903
|
|
Interest income
|
|
|
|
|
|
|
|
2,301
|
|
2,301
|
|
Interest expense
|
|
|
|
|
|
|
|
(52
|
)
|
(52
|
)
|
Income tax expense
|
|
|
|
|
|
|
|
22
|
|
22
|
|
Segment loss (i)
|
|
(5,436
|
)
|
(14,283
|
)
|
(1,465
|
)
|
(6,884
|
)
|
(28,068
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
Segment income (loss) includes revenues
less cost of revenues, directly attributable selling, general and
administrative costs, research and product development costs net of associated
grants, amortization of property, plant and equipment and intangible assets,
other expenses (or income) and income taxes. Amortization of property, plant
and equipment is not allocated to the
segments as a significant portion of the Corporations assets are common across
the segments.
The accounting policies for inter-segment transactions are the same as
those described in Note 2.
Goodwill relating to the Corporations OnSite Generation segment as at December 31,
2009 was $5,446 (2008 - $5,025), respectively. OnSite Generation primarily
consists of the Corporations self-sustaining subsidiary located in Belgium
with a functional currency of the Euro.
The goodwill balance increased in 2009 as a result of currency
fluctuations between the US$ and Euro.
There is no goodwill relating to Power Systems or Test Systems. The
Corporation currently does not allocate its remaining assets among reportable
segments.
A significant portion of the Corporations goodwill is common across
the locations. Therefore, management does not classify goodwill on a location
basis.
Revenues and cost of revenues derived from products and services are as
follows:
|
|
2009
|
|
2008
|
|
2007
|
|
Revenues
|
|
|
|
|
|
|
|
Products
|
|
$
|
14,736
|
|
$
|
38,693
|
|
$
|
34,486
|
|
Services
|
|
4,105
|
|
647
|
|
3,504
|
|
|
|
$
|
18,841
|
|
$
|
39,340
|
|
$
|
37,990
|
|
|
|
2009
|
|
2008
|
|
2007
|
|
Cost of revenues
|
|
|
|
|
|
|
|
Products
|
|
$
|
13,219
|
|
$
|
31,090
|
|
$
|
32,402
|
|
Services
|
|
1,894
|
|
356
|
|
1,199
|
|
|
|
$
|
15,113
|
|
$
|
31,446
|
|
$
|
33,601
|
|
F-33
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
Revenues are segmented by geographic location, as follows:
|
|
2009
|
|
2008
|
|
2007
|
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
2,561
|
|
$
|
8,428
|
|
$
|
5,609
|
|
Canada
|
|
2,320
|
|
534
|
|
4,378
|
|
Germany
|
|
2,227
|
|
655
|
|
1,395
|
|
Turkey
|
|
1,857
|
|
77
|
|
|
|
France
|
|
1,678
|
|
1,144
|
|
2,633
|
|
India
|
|
1,361
|
|
85
|
|
774
|
|
Austria
|
|
1,147
|
|
|
|
3
|
|
Russia
|
|
793
|
|
12,927
|
|
5,629
|
|
Spain
|
|
791
|
|
1,815
|
|
138
|
|
Sweden
|
|
210
|
|
1,600
|
|
119
|
|
United Arab Emirates
|
|
187
|
|
20
|
|
1,255
|
|
United Kingdom
|
|
178
|
|
1,076
|
|
552
|
|
China
|
|
127
|
|
1,351
|
|
1,435
|
|
Romania
|
|
74
|
|
83
|
|
277
|
|
Belgium
|
|
43
|
|
2,020
|
|
|
|
Poland
|
|
34
|
|
639
|
|
|
|
Japan
|
|
24
|
|
492
|
|
2,256
|
|
Saudi Arabia
|
|
11
|
|
1,790
|
|
|
|
Brazil
|
|
1
|
|
712
|
|
2,017
|
|
Korea
|
|
|
|
1,271
|
|
1,070
|
|
Argentina
|
|
|
|
8
|
|
2,010
|
|
Slovenia
|
|
|
|
3
|
|
1,275
|
|
Rest of world
|
|
3,217
|
|
2,610
|
|
5,165
|
|
|
|
$
|
18,841
|
|
$
|
39,340
|
|
$
|
37,990
|
|
The Corporations largest customers comprise the following percentages
of revenues:
|
|
2009
|
|
2008
|
|
2007
|
|
|
|
%
|
|
%
|
|
%
|
|
|
|
|
|
|
|
|
|
First
|
|
9
|
|
18
|
|
12
|
|
Second
|
|
7
|
|
7
|
|
5
|
|
Third
|
|
6
|
|
5
|
|
5
|
|
Fourth
|
|
5
|
|
5
|
|
4
|
|
Others
|
|
73
|
|
65
|
|
74
|
|
|
|
100
|
|
100
|
|
100
|
|
Property, plant and equipment are located in the following countries:
|
|
2009
|
|
2008
|
|
Canada
|
|
$
|
1,356
|
|
$
|
2,100
|
|
Belgium
|
|
1,813
|
|
1,982
|
|
|
|
$
|
3,169
|
|
$
|
4,082
|
|
A significant portion of the Corporations production, testing,
equipment, and facilities are common across the segments. Therefore, management
does not classify asset information on a segmented basis.
F-34
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
Note 20. Differences Between Canadian and United States
Accounting Principles
The Corporations consolidated financial statements have been prepared
in accordance with Canadian GAAP, which differs in certain respects from those
principles that the Corporation would have followed had its consolidated
financial statements been prepared in accordance with US GAAP.
A reconciliation of net loss for the year from Canadian GAAP to conform
with US GAAP is as follows:
|
|
2009
|
|
2008
|
|
2007
|
|
Net loss for the year
based on Canadian GAAP
|
|
$
|
(9,375
|
)
|
$
|
(14,319
|
)
|
$
|
(28,068
|
)
|
Stock-based
compensation (i)
|
|
151
|
|
88
|
|
|
|
Net loss for the year
based on US GAAP
|
|
$
|
(9,224
|
)
|
$
|
(14,231
|
)
|
$
|
(28,068
|
)
|
|
|
|
|
|
|
|
|
Basic and fully diluted
comprehensive net loss per share based on US GAAP
|
|
$
|
(2.49
|
)
|
$
|
(3.86
|
)
|
$
|
(7.64
|
)
|
Weighted average number
of shares used in calculating comprehensive net loss per share
|
|
3,697,740
|
|
3,683,226
|
|
3,671,916
|
|
|
|
2009
|
|
2008
|
|
2007
|
|
Shareholders equity
based on Canadian GAAP
|
|
$
|
17,480
|
|
$
|
25,483
|
|
$
|
40,384
|
|
Stock-based
compensation (i)
|
|
239
|
|
88
|
|
|
|
Shareholders equity
based on US GAAP
|
|
$
|
17,719
|
|
$
|
25,571
|
|
$
|
40,384
|
|
The condensed statements of operations and cash flows for the years
ended December 31, under US GAAP, are as follows:
|
|
2009
|
|
2008
|
|
2007
|
|
Revenues
|
|
$
|
18,841
|
|
$
|
39,340
|
|
$
|
37,990
|
|
Cost of revenues
|
|
15,113
|
|
31,446
|
|
33,601
|
|
Operating expenses
|
|
23,364
|
|
23,334
|
|
36,866
|
|
Loss
from operations
|
|
(19,636
|
)
|
(15,440
|
)
|
(32,477
|
)
|
Net loss for the year
|
|
(9,224
|
)
|
(14,231
|
)
|
(28,068
|
)
|
|
|
|
|
|
|
|
|
Cash
used in operating activities
|
|
(11,085
|
)
|
(6,758
|
)
|
(28,416
|
)
|
Cash provided by (used
in) investing activities
|
|
(1,465
|
)
|
13,017
|
|
37,987
|
|
Cash
provided by (used in) financing activities
|
|
108
|
|
(118
|
)
|
(48
|
)
|
|
|
|
|
|
|
|
|
|
|
|
(i)
Under US GAAP, stock-based compensation
cost is based on the estimated number of instruments expected to vest, which
are then re-estimated at reporting dates to the extent that subsequent
information indicates the actual number of instruments expected to vest is
likely to differ from previous estimates. Under Canadian GAAP, forfeitures of
stock-based compensation awards, DSUs and RSUs can be accounted for in the
period in which the forfeiture occurs.
F-35
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
A reconciliation of additional disclosures to conform with US GAAP is
as follows:
Consolidated
statements of cash flows
The consolidated
statements of cash flows have been prepared in accordance with International Accounting
Standard 7, Cash flow statements. As a
result, a reconciliation to US GAAP is not required.
Revenue
Sales taxes collected are
excluded from revenue.
Stock-based
compensation
The Corporation adopted
the provisions of ASC 718 Compensation - Stock Compensation for US GAAP
effective January 1, 2006. No
income tax benefit is recorded in the consolidated statements of operations for
these costs.
The total intrinsic value
of options exercised during the year ended December 31, 2009, 2008 and 2007
was approximately $27, $5, and $nil, respectively. As of December 31, 2009, there was
approximately $323 (December 31, 2008 - $325) of unrecognized compensation
cost related to stock option awards that is expected to be recognized as
expense over a weighted average period of 2.8 years (2008 - 2.6 years). The total fair value of stock options that
vested during the years ended December 31, 2009, 2008 and 2007, was
approximately $495, $1,329, and $1,502, respectively.
The total intrinsic value
of options outstanding as at December 31, 2009 was $nil (December 31,
2008 - $25). The total intrinsic value
of options exercisable as at December 31, 2009 was $nil (December 31,
2008 - $25). The total number of options
fully vested as at December 31, 2009 and expected to vest beyond December 31,
2009 was 238,287 (December 31, 2008 220,672). The total intrinsic value of these options
was $nil at December 31, 2009 ($25 - December 31, 2008) with a
weighted average contractual term of 6.5 years (2008 - 6.2 years) and a
weighted average exercise price of $66.07 (2008 - $91.00). The weighted average contractual term of the
options exercisable is 4.8 years (2008 - 5.0 years).
The Corporations
estimate of an expected option term is based on the exercise behaviour of its
employees. The estimated stock price
volatility was derived based on the Corporations actual historical stock
prices over the past four years, which represents the Corporations best
estimate of expected volatility. The
risk free interest rate for periods within the contractual life of the award is
based on the interest rates of government bonds with similar contractual lives.
DSUs granted to
non-employee directors during 2009, 2008, and 2007 are valued using the
Black-Scholes option pricing model with assumptions materially consistent with
those used to value stock options. In
2009, 2008 and 2007, 17,883, 13,470, and 13,417, DSUs were granted. In 2009, 5,517 DSUs were exercised (2008 -
738).
Income
taxes
The components of loss
before income taxes for the years ended December 31, 2009, 2008 and 2007
are as follows:
Loss before income taxes:
|
|
2009
|
|
2008
|
|
2007
|
|
Canada
|
|
$
|
(15,231
|
)
|
$
|
(14,471
|
)
|
$
|
(24,834
|
)
|
Foreign
|
|
(4,364
|
)
|
268
|
|
(3,212
|
)
|
Total
|
|
$
|
(19,595
|
)
|
$
|
(14,203
|
)
|
$
|
(28,046
|
)
|
F-36
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
The significant
components of the income tax benefit for the years ended December 31,
2009, 2008 and 2007 are as follows:
|
|
2009
|
|
2008
|
|
2007
|
|
Current taxes:
|
|
|
|
|
|
|
|
Canadian
|
|
$
|
17
|
|
$
|
|
|
$
|
|
|
Proceeds from APIF
transaction (note 2)
|
|
(10,464
|
)
|
|
|
|
|
Foreign
|
|
76
|
|
116
|
|
22
|
|
|
|
$
|
(10,371
|
)
|
$
|
116
|
|
$
|
22
|
|
|
|
2009
|
|
2007
|
|
2006
|
|
Future income taxes:
|
|
|
|
|
|
|
|
Canadian
|
|
$
|
|
|
$
|
|
|
$
|
|
|
Foreign
|
|
|
|
|
|
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
At December 31,
2009, the Corporation adopted the provisions of ASC 740 - Income Taxes, on January 1,
2007. The Corporation does not have any uncertain tax filing positions.
As a result, the Corporation has included all of its tax benefits in its
disclosure of future income tax assets. There are no significant changes
to this assessment of uncertain tax filing positions anticipated within the
next 12 months.
The Corporation
recognizes accrued interest and penalties related to unrecognized tax benefits
as a component of income tax expense.
This accounting policy did not change as a result of the adoption of FIN
48. During the year ended December 31,
2009, the Corporation recognized $nil in interest and penalties (2008 - $nil,
2007 - $nil). The Corporation had $nil
of interest and penalties accrued at December 31, 2009 (December 31,
2008 - $nil, December 31, 2007 - $nil).
The Corporation files
income tax returns in the Canadian federal jurisdiction and various provincial
and foreign jurisdictions. In the normal course of business, the Corporation is
subject to examination by taxing authorities. Open tax years in Canada range
from 2004 to 2009. Open tax years in
foreign jurisdictions range from
2005 to 2009. However, upon examination in subsequent
years, if net operating loss carry forwards and tax credit carry forwards are
utilized, the Canadian and foreign jurisdictions can reduce net operating loss
carry forwards and tax credit carry forwards utilized in the year being
examined if they do not agree with the carry forward amount. As of December 31, 2009, the Corporation
was not under audit in Canada or non-Canadian taxing jurisdiction.
Note 21. Subsequent events
On January 14, 2010
the Corporation issued units in a registered direct offering with two
institutional investors, resulting in gross proceeds of $5,000 before placement
agents fees and other offering expenses. Under the terms of the transaction,
Hydrogenics sold 12,500,000 units for $0.40 per unit (500,000 and $10.00
respectively on a post consolidated basis). The units consisted of 12,500,000
shares (500,000 on a post consolidated basis) of the Corporation and warrants for the purchase of one common share
for each common share purchased; 5,983,886 (239,356 on a post consolidated
basis) of these warrants are exercisable at any time until January 14,
2015, at an exercise price of $0.52 per common share ($13.00 on a post
consolidated basis). The remaining 6,516,114 warrants (260,646 on a post
consolidated basis) are exercisable for a period of five years beginning July 12,
2010, at an exercise price of $0.52 per common share. Each of the warrants
contains protection as to the exercise price but not the number of shares
issuable thereunder and conditions subject to Shareholder approval.
F-37
Hydrogenics Corporation
Notes to Consolidated Financial Statements
(in thousands of US dollars, except share and
per share amounts)
Subsequent to year end,
the Corporation completed the second tranche of the transaction (the Transaction)
with Algonquin Power Income Fund (note 2).
An additional $0.4 million was received by the Corporation on February 23,
2010.
On February 25,
2010, Alpha Capital Anstalt (Alpha) filed suit against the Corporation and
two of its Officers in the Supreme Court of the State of New York (County of
New York) regarding the Companys proposed share consolidation, which was
announced on February 8, 2010. The Corporation issued common shares and
warrants to Alpha and another institutional investor in a registered direct
offering (the Offering) completed on January 14, 2010. The terms of the
Offering were set out in a securities purchase agreement (the Purchase
Agreement) dated as of January 11, 2010 between the Corporation, Alpha
and the other institutional investor. Under the terms of the Offering, Alpha
and the other institutional investor each paid $2,500 for 6,250,000 common
shares (250,000 on a post-consolidated basis), 2,991,943 series A warrants
(119,678 on a post-consolidated basis) and 3,258,057 series B warrants (130,323
on a post consolidated basis) of the Company. In its complaint, Alpha alleges
that the Corporations proposed share consolidation triggers a put right
pursuant to the terms of the warrants and gives rise to breach of contract,
negligent misrepresentation and fraud claims. Alpha is seeking damages of at
least $2,000 plus interest, costs and fees with respect to the alleged put
right and damages of at least $1,375 plus interest, costs and fees with respect
to the alleged breach of contract, negligent misrepresentation and fraud
claims. The Corporation believes that the claims are without merit and the
Corporation will take such action as is advised to protect the Corporations
interests. The Corporation has also received a letter from the other
institutional investor making similar allegations but no suit has been filed.
On February 8, 2010
the Corporation announced it would implement a share consolidation of its
issued and outstanding common shares in order to comply with the Minimum Bid
Price Rule of the NASDAQ. The consolidation was effective as of March 12,
2010 and was implemented with a ratio of one post-consolidation share for every
25 pre-consolidation shares. The consolidation reduced the number of shares
outstanding from approximately 105,049,666 to approximately 4,201,987. The Corporation has amended the disclosures
in the consolidated financial statements to reflect the share consolidation as
if it had occurred on December 31, 2006.
F-38
ITEM 19. EXHIBITS
Number
|
|
Description
|
|
|
|
1.1*
|
|
Articles of
Incorporation (incorporated by reference from Exhibit 99.2 to Companys
Report of Foreign Private Issuer on Form 6-K, File No. 000-31815,
filed with the Securities and Exchange Commission on October 27, 2009)
|
|
|
|
1.2
*
|
|
Articles of Arrangement
(incorporated by reference from Exhibit 99.4 to the Companys Report of
Foreign Private Issuer on Form 6-K, File No. 000-31815, filed with
the Securities and Exchange C
ommission on
October 27, 2009)
|
|
|
|
1.3
*
|
|
Certificate of
Arrangement (incorporated by reference from Exhibit 99.5 to the
Companys Report of Foreign Private Issuer on Form 6-K, File
No. 000-31815, filed with the Securities and Exchange Commission on
October 27, 2009)
|
|
|
|
1.4
*
|
|
Articles of Amendment
to the Companys Articles of Incorporation (incorporated by reference from
Exhibit 99.3 to the Companys Report of Foreign Private Issuer on
Form 6-K, File No. 000-31815, filed with the Securities and
Exchange Commission on March 9, 2010)
|
|
|
|
1.5
*
|
|
By-law No. 1
(incorporated by reference from Exhibit 99.3 to Companys Report of
Foreign Private Issuer on Form 6-K, File No. 000-31815, filed with
the Securities and Exchange Commission on October 27, 2009)
|
|
|
|
1.6
|
|
Amendment to By-law
No. 1
|
|
|
|
2.1
|
|
Form of share
certificate
|
|
|
|
2.2
*
|
|
Warrant agreement dated
as of January 14, 2010 between the Company and Mellon Investor Services
LLC (including form of warrants) (incorporated by reference from
Exhibit 99.1 to the Companys Report of Foreign Private Issuer on
Form 6-K, File No. 000-31815, filed with the Securities and
Exchange Commission on January 14, 2010)
|
|
|
|
4.1*
|
|
Stock Option Plan dated
June 22, 2009
(incorporated by reference from Exhibit 4.1 to Old
Hydrogenics Annual Report on Form 20-F, File No. 000-31815, filed
with the Securities and Exchange Commission on June 30, 2009)
|
|
|
|
4.2*
|
|
Restricted Share Unit
Plan dated
June 22, 2009
(incorporated by reference from Exhibit 4.2 to Old
Hydrogenics Annual Report on Form 20-F, File No. 000-31815, filed
with the Securities and Exchange Commission on June 30, 2009
)
|
|
|
|
4.3*
|
|
Deferred Share Unit
Plan dated
June 22, 2009
(incorporated by reference from Exhibit 4.3 to Old
Hydrogenics Annual Report on Form 20-F, File No. 000-31815, filed
with the Securities and Exchange Commission on June 30, 2009
)
|
|
|
|
4.4*
|
|
Lease, dated
June 23, 2000 (as amended by a Lease Extension Agreement dated
February 10, 2005), by and between Orlando Corporation and Hydrogenics
(incorporated by reference from Exhibit 4.4 to Old Hydrogenics Annual
Report on Form 20-F, File No. 000-31815, filed with the Securities
and Exchange Commission on June 30, 2009)
|
83
4.5
*
|
|
Support Agreement dated
June 11, 2009, among the Company, Old Hydrogenics, and the Trustees of
Algonquin Power Income Fund (incorporated by reference from Exhibit 99.2
to Amendment No. 1 to Old Hydrogenics Report of Foreign Private Issuer
on Form 6-K, File No. 000-31815, filed with the Securities and
Exchange Commission on August 17, 2009)**
|
|
|
|
4.6
*
|
|
Expense Reimbursement
Agreement dated June 11, 2009, among Algonquin Power Management Inc.,
the Company and Old Hydrogenics (incorporated by reference from
Exhibit 99.3 to Old Hydrogenics Report of Foreign Private Issuer on
Form 6-K, File No. 000-31815, filed with the Securities and
Exchange Commission on June 16, 2009)
|
|
|
|
4.7
*
|
|
APMI Guarantee dated
June 11, 2009, among Algonquin Power Management Inc., the Company and
Old Hydrogenics (incorporated by reference from Exhibit 99.4 to Old
Hydrogenics Report of Foreign Private Issuer on Form 6-K, File
No. 000-31815, filed with the Securities and Exchange Commission on
June 16, 2009)
|
|
|
|
4.8
*
|
|
Algonquin Power
Guarantee dated June 11, 2009, among Algonquin Power Income Fund, Algonquin
Power Management Inc., the Company and Old Hydrogenics (incorporated by
reference from Exhibit 99.5 to Old Hydrogenics Report of Foreign
Private Issuer on Form 6-K, File No. 000-31815, filed with the
Securities and Exchange Commission on June 16, 2009)
|
|
|
|
4.9
*
|
|
Divestiture Agreement
dated October 27, 2009, among the Company, Old Hydrogenics, Stuart
Energy Systems Corporation and Hydrogenics Test Systems Inc. (incorporated by
reference from Exhibit 99.8 to the Companys Report of Foreign Private Issuer
on Form 6-K, File No. 000-31815, filed with the Securities and
Exchange Commission on October 27, 2009)
|
|
|
|
4.10
*
|
|
Indemnity Agreement
dated October 27, 2009, between the Company and Algonquin
Power & Utilities Corp. (incorporated by reference from
Exhibit 99.7 to the Companys Report of Foreign Private Issuer on
Form 6-K, File No. 000-31815, filed with the Securities and
Exchange Commission on October 27, 2009)
|
|
|
|
4.12
*
|
|
Securities Purchase
Agreement dated January 11, 2010, among the Company, Iroquois Master
Fund Ltd. and Alpha Capital Anstalt (incorporated by reference from
Exhibit 99.1 to the Companys Report of Foreign Private Issuer on
Form 6-K, File No. 000-31815, filed with the Securities and
Exchange Commission on January 12, 2010)
|
|
|
|
8.1
|
|
List of Significant
Subsidiaries
|
|
|
|
12.1
|
|
Certification of the
Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002
|
|
|
|
12.2
|
|
Certification of the
Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002
|
|
|
|
13.1
|
|
Certification of the
Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
13.2
|
|
Certification of the
Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
15.1
|
|
Consent of
PricewaterhouseCoopers LLP
|
84
* Previously
filed.
** Portions of
this exhibit have been omitted pursuant to a request for confidential
treatment.
85
SIGNATURE
The registrant hereby
certifies that it meets all of the requirements for filing on Form 20-F
and that it has duly caused and authorized the undersigned to sign this annual
report on its behalf.
|
HYDROGENICS CORPORATION
|
|
|
|
|
|
|
Dated: March 26, 2010
|
By:
|
/s/ Lawrence Davis
|
|
|
Name:
|
Lawrence Davis
|
|
|
Title:
|
Chief Financial Officer
|
|
|
|
|
|
86
HYDROGENICS
CORPORATION
INDEX
TO EXHIBITS
Number
|
|
Description
|
1.1*
|
|
Articles of
Incorporation (incorporated by reference from Exhibit 99.2 to Companys
Report of Foreign Private Issuer on Form 6-K, File No. 000-31815,
filed with the Securities and Exchange Commission on October 27, 2009)
|
|
|
|
1.2
*
|
|
Articles of Arrangement
(incorporated by reference from Exhibit 99.4 to the Companys Report of
Foreign Private Issuer on Form 6-K, File No. 000-31815, filed with
the Securities and Exchange C
ommission on October 27,
2009)
|
|
|
|
1.3
*
|
|
Certificate of
Arrangement (incorporated by reference from Exhibit 99.5 to the
Companys Report of Foreign Private Issuer on Form 6-K, File
No. 000-31815, filed with the Securities and Exchange Commission on
October 27, 2009)
|
|
|
|
1.4
*
|
|
Articles of Amendment
to the Companys Articles of Incorporation (incorporated by reference from
Exhibit 99.3 to the Companys Report of Foreign Private Issuer on
Form 6-K, File No. 000-31815, filed with the Securities and
Exchange Commission on March 9, 2010)
|
|
|
|
1.5
*
|
|
By-law No. 1
(incorporated by reference from Exhibit 99.3 to Companys Report of
Foreign Private Issuer on Form 6-K, File No. 000-31815, filed with
the Securities and Exchange Commission on October 27, 2009)
|
|
|
|
1.6
|
|
Amendment to By-law
No. 1
|
|
|
|
2.1
|
|
Form of share
certificate
|
|
|
|
2.2
*
|
|
Warrant agreement dated
as of January 14, 2010 between the Company and Mellon Investor Services
LLC (including form of warrants) (incorporated by reference from
Exhibit 99.1 to the Companys Report of Foreign Private Issuer on
Form 6-K, File No. 000-31815, filed with the Securities and
Exchange Commission on January 14, 2010)
|
|
|
|
4.1*
|
|
Stock Option Plan dated
June 22, 2009
(incorporated by reference from Exhibit 4.1 to Old
Hydrogenics Annual Report on Form 20-F, File No. 000-31815, filed
with the Securities and Exchange Commission on June 30, 2009)
|
|
|
|
4.2*
|
|
Restricted Share Unit
Plan dated
June 22, 2009
(incorporated by reference from Exhibit 4.2 to Old
Hydrogenics Annual Report on Form 20-F, File No. 000-31815, filed
with the Securities and Exchange Commission on June 30, 2009
)
|
|
|
|
4.3*
|
|
Deferred Share Unit
Plan dated
June 22, 2009
(incorporated by reference from Exhibit 4.3 to Old
Hydrogenics Annual Report on Form 20-F, File No. 000-31815, filed
with the Securities and Exchange Commission on June 30, 2009
)
|
|
|
|
4.4*
|
|
Lease, dated
June 23, 2000 (as amended by a Lease Extension Agreement dated
February 10, 2005), by and between Orlando Corporation and Hydrogenics
(incorporated by reference from Exhibit 4.4 to Old Hydrogenics Annual
Report on Form 20-F, File No. 000-31815, filed with the Securities
and Exchange Commission on June 30, 2009)
|
4.5
*
|
|
Support Agreement dated
June 11, 2009, among the Company, Old Hydrogenics, and the Trustees of
Algonquin Power Income Fund (incorporated by reference from Exhibit 99.2
to Amendment No. 1 to Old Hydrogenics Report of Foreign Private Issuer
on Form 6-K, File No. 000-31815, filed with the Securities and
Exchange Commission on August 17, 2009)**
|
|
|
|
4.6
*
|
|
Expense Reimbursement
Agreement dated June 11, 2009, among Algonquin Power Management Inc.,
the Company and Old Hydrogenics (incorporated by reference from
Exhibit 99.3 to Old Hydrogenics Report of Foreign Private Issuer on
Form 6-K, File No. 000-31815, filed with the Securities and
Exchange Commission on June 16, 2009)
|
|
|
|
4.7
*
|
|
APMI Guarantee dated
June 11, 2009, among Algonquin Power Management Inc., the Company and
Old Hydrogenics (incorporated by reference from Exhibit 99.4 to Old
Hydrogenics Report of Foreign Private Issuer on Form 6-K, File
No. 000-31815, filed with the Securities and Exchange Commission on
June 16, 2009)
|
|
|
|
4.8
*
|
|
Algonquin Power
Guarantee dated June 11, 2009, among Algonquin Power Income Fund,
Algonquin Power Management Inc., the Company and Old Hydrogenics
(incorporated by reference from Exhibit 99.5 to Old Hydrogenics Report
of Foreign Private Issuer on Form 6-K, File No. 000-31815, filed
with the Securities and Exchange Commission on June 16, 2009)
|
|
|
|
4.9
*
|
|
Divestiture Agreement
dated October 27, 2009, among the Company, Old Hydrogenics, Stuart
Energy Systems Corporation and Hydrogenics Test Systems Inc. (incorporated by
reference from Exhibit 99.8 to the Companys Report of Foreign Private
Issuer on Form 6-K, File No. 000-31815, filed with the Securities
and Exchange Commission on October 27, 2009)
|
|
|
|
4.10
*
|
|
Indemnity Agreement
dated October 27, 2009, between the Company and Algonquin
Power & Utilities Corp. (incorporated by reference from
Exhibit 99.7 to the Companys Report of Foreign Private Issuer on
Form 6-K, File No. 000-31815, filed with the Securities and
Exchange Commission on October 27, 2009)
|
|
|
|
4.12
*
|
|
Securities Purchase
Agreement dated January 11, 2010, among the Company, Iroquois Master
Fund Ltd. and Alpha Capital Anstalt (incorporated by reference from
Exhibit 99.1 to the Companys Report of Foreign Private Issuer on
Form 6-K, File No. 000-31815, filed with the Securities and
Exchange Commission on January 12, 2010)
|
|
|
|
8.1
|
|
List of Significant
Subsidiaries
|
|
|
|
12.1
|
|
Certification of the
Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002
|
|
|
|
12.2
|
|
Certification of the
Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002
|
|
|
|
13.1
|
|
Certification of the
Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
13.2
|
|
Certification of the
Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
15.1
|
|
Consent of
PricewaterhouseCoopers LLP
|
* Previously filed.
** Portions of
this exhibit have been omitted pursuant to a request for confidential
treatment.
Hydrogenics - Common Shares (MM) (NASDAQ:HYGSD)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Hydrogenics - Common Shares (MM) (NASDAQ:HYGSD)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024